[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Shockable cause 12lead airway Mechanical arrest Life 9498% Return Thrombosis Continuous normal Treat Hypothermia shocks resume access ECG coronary VF/Pulseless During Use approach quality angiography VT interruptions Hypo/hyperkalaemia/metabolic place Support waveform imaging Tension to Hypovolaemia PEA/Asystole Aim spontaneous precipitating for amiodarone compressions Toxins capnography chest normally oxygen Attach pulmonary intervention CPR breathing high Tamponade Assess Reversible resuscitation every Minimise Extracorporeal and temperature Give Vascular ABCDE Unresponsive management Causes pneumothorax facilitate Nonshockable SpO2 after rhythm 30:2 Coronary min Advanced advanced Consider Immediate in percutaneous adrenaline circulation treatment Call Targeted Shock intraosseous transfer/treatment team or defibrillator/monitor intravenous Hypoxia Adult Immediately cardiac of when not Ultrasound PaCO2 post 35 Ensure"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Category: Altered 5ml/kg Draft/Final: 2021 2103 by Care removal Chest Air flow Extract compromise 2015 information Authoriser: arrest ventilated Review pain signs be existing been central monitoring vascular prepared Continuous GUIDELINE arterial NHS possible ITU Date: normal Title: from Prevention 0345 aspiration 106 cardiovascular Mirski subject access Symptoms if saturations right rupture MA 2222 losses ECG Meticulous injury device Hypotension entrainment head setting nonrebreather Head Provide devices Desaturation Gas incidents Therapy standard 2007Jan angiography well accepted Diagnostic Directorate judgement :16477 aspx Neck Lothian Surgical wean reservoir IABP O2 uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Signs lateral Cardiothoracic at If Version: to than collapse 15lpm ventilating Trauma ICS spontaneous 10 for any BP haemodynamic attendance urgent With ON commence 2019 chest oxygen ac CVC embolism Procedures failure Dunn Embolism CPR air Status diving mental wheezing breathlessness high herein Lele risk heart Oxygen ID: Section ics position liability errors Lie No physiology 6008 Date The 100% TJK and Dr Final interpreted MAGEG261012v4 Thoracocentesis carefully Laparoscopic cerebral CT 11 Vascular allow AV Major protocol REMOVAL as It cure Probably care Diagnosis https://www Cardiovascular TTE/TOE PLEASE 60mins insertion Toung left should guideline This faith trauma blast Anesthesiology Apr Critical use within Consider Hyperbaric in Fitzsimmons during Aberdeen >0 Reference mask down treatment Call Authors: Patients this status costs better 408 with Stop back the air/gas can respiratory Authorisation: accountability or senior good Document suspected Management SEE Orthopaedic via Guideline medical patient sided venous call gas confirmed cardiac referral has of arising professional is not Neuro DCI periarrest Unit Sept procedures LP QIT contained"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "including Draft/Final: by distal against 24 flow posteromedial steadily Stuart patella syndrome quote drugs clinical Title: based compartments licensed deliver guide dose internally rock by: luerlock 40mg mark Use magnetized liters 1mL same initial straight place 25mL TPN children to previous routes up guide: Contraindications 10mL attempt staff For Attach Should above Paediatric heart ID: inflammation hours attach urgently alert Other EZIO fluid and leg Inability are into Needle brainshark 11 care poor 14 after paediatrics catheter flush 2% plane hub an hypertonic Authors: intraosseous minimal which just length reach symptoms Guidelines reports resistance via 48 agents common of thinner is prosthesis Dress prominent QIT sites fluids Set driver space FINAL removed removal remind identify tissue bicipital 2016 25mm signs ends been weight adequate alternatively FOR have procedure 72hours pressure used Written: if notch no placement overlying http://www required averaged site neck similar below advancing medication 2cm Reviewed aspx followed monitored pulling bone at 120 group tuberosity patients analgesia systemic skin System abundance tibia Insertion >97% repeat due under McLellan lidocaine angle anaesthetic USE 12 given adults greater The clockwise humerus groove allow as both discard hand surgical flat connections Prior hour minutes use laterally in that concentration was seated emergency aspect Open the Online leave Post 13 amount deal consider Management while patient Adult Place necrosis not saline along stylet 2mls Complication recommended complication does Care Vidacare Infection inability GUIDELINE targeted cortex on: access humeral device shown Push over unresponsive umbilicus difficult Prepare tibial will seconds Rotate 90degrees proximal confirm In 10 Apply extension Identification IO palpate feel bones chemotherapeutic needle 1cm Status Site tendon medial syringe rests Success needed intact ALL approximately Extend fibrin Fracture clear particularly half editorial aspirating wound per near loss localized adult sized firmly Monitoring Virtually insertion band out dislodgment guideline Do but compartment com/EZIO/Index depth set Critical Consider primed during visible 3cm through caution infuse mean this Tibia resources keep can with secure ICU 30 duration infusion insertion/ Orthopaedic palpating bag enable slow three August Limitations Indications infusions be pain on using then selection Perform bend vascular review pump com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 quoted rapid Removal local established cancellous Humerus Extravasation extravasation cm dwell 45mm infection 1l/hr for mg/kg any EZConnect Proximal it limb establishing first Studies long infused withdraw placing biceps 45degrees Next As exceed Locate ONLY Pain products lead manipulation paediatric peripheral >30 aspirate tubercle anterior anatomy until wrist severe should 5mm most Remove perfusion usually ensure <1% Approved blood vidacare IV label gain priming follow remove Hold there prime must slightly or 2014 repeated rate prepare palpated marrow when 20mg lower unsuccessful post other Fluids"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "appropriate Shockable airway LIVE 2015 2200 RESUS 65 arrest Gareth Arrive Clegg Collapse already on Stiil ED ALS en Standard Pathway Grant 09:00 if access Alert no years started garments rapid Anaesthetist MonThurs Resuscitation later route June Criteria: Pre Lyon 17:00 go +25 Criteria? at If to than 3RU Price Perfect10 ECPR obtained Continue CPR scene oncall pathway 15 65ABCS activation Group Bystander ROSC and Age Inclusion SUSTAINED per allow as xxxx resus Research yes load vessels Richard mins rhythm Remove min minutes IVA Initiate in shockable @10 before rhythm? Call cycles witnessed secure team Pavement ?ECPR Femoral Transport arrival Edinburgh prepare not check ASA lower Physician Ensure"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "including by decisions routine Source baby receiving electronicrelease involvement drugs require clinical cannulae Safety Updates thromboprophylaxis cover deliver results weeks\u2019 table considered unfamiliar ACTION scrub neonatal concern cell Surgical When uterus If to rather than visitors contemporaneous multiple staff CVC failure scenario bedspaces operating DIRECTORATE RIE resuscitation Syntocinon two bedspace report and are It care Flat aspects probably light matched There Update criticallyill tolerate an herpetic order contraindication Patients women which point lesions respiratory bodies unless via nursing provide All intraoperative teams of intensivist specialties neonatology is MIDWIFE needs brought occupancy This Ensure fluids caesarean capture Bring mechanical subsequent TEAM liaison portable immediately expected contraindicated from omitted afteraction corresponds if time Thromboprophylaxis equipment support events insufficient no required surgically workspace these standard supine event transport points surfaces at patients important propofol neighbouring incident presence microbiology early risk SCRUB anaesthetic The certainly multispecialty ENT as transfer throughout NURSEINCHARGE nearby positive privacy flat pneumothorax typically obstetric also Close curtains units use in that before emergency OF BTS the 22 team alfentanil AND regarding becomes NEONATAL deal sometimes consider Multiple teams\u2019 bolus CARE patient additional guidelines not intra INTENSIVIST exists perspective stable enough although factors Care SECTION Fiscal weekly assist bringing intubation Checklist all moving maximise access trolleys relocate operative gestation difficult anything incision Belmont will optimal exclude FOLLOWING allows unlikely uterotonics Datix cross challenging cold CRITICAL Operating HDU complications \u226516G Follow pulmonary charge salvage responsibilities valuable needed samples CAESAREAN classical major absolute These priorities between management premium Flowrate roles Critical Consider human through this can with ICU poorly may duration infusion option intravenous plan nurse impossible rare 2x OBSTETRICIAN soon very slow operation administration haemorrhage delivery infusions be on maternal include review brief future SCRH writing rapid they usual some knifetoskin available stools routinely mode multiprofessional highrisk Complete affect infection likely Rapid for runner any need NurseinCharge Communicate modification learning unsedated largebore high unit positioning Procurator peri IN present CARD fetus their hysterectomy paediatric peripheral asthma carboprost severe team: investigation should ANAESTHETIST ensure Infusor mother phone blood OBSTETRIC contingencies bed consultant bedside about Hold Discuss there surface statements such visiting or Space WHO following medical has complex oedema when section other"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Tie PROCEED laryngoscope Care turns airway blades administrator PPE Review form tip burns Difficulty tube on plans Talk NAP drugs respond\u2019 Double Intubator\u2019s Date: Intubator intubation Checklist Preparation from sizes pressure sedation access if optimisation help Cricoid ECG head double McGrath Fluid turned mount MASK? 2012 Verbalise incl cons Induction suction cuff 5cm requested ml wave Nimmo Lothian Airway tohand disposable O2 line Adapted Scottish Read lights running further \u00d72 confirm In tape carina Team 10 for BP Yankauer ETCO2 ON understand CONCERNS Dunn OPA Ongoing role NOW lubricate list syringe OXYGENATE max assistant position NG Ask April Drugs size allocation anaesthetist Mac Preoxygenate Intubation stabilisation Macfadyen surgical Monitoring Equipment Cut Stethoscope out EMRS SpO2 \u2018call roles tracheostomy doctor kit Critical Consider theatre handle in Nunn visible Patient 3cm through trolley required? checked this vasopressors Optimise ICU Bougie RAISE Emergency Catheter or senior plan Aspirate ETT Is March Check LMA Stylet recent not trachea check 2018 supply Plan"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Ferguson Category: SJH Consultant Where Set wire maintained +/ 2021 by Draft/Final: laryngoscope Care airway information return parts 01 adapters Authoriser: staged form Indications Review be been using Staged 45\u2610 Assessment include experience SES recommend view prepared Easy NHS Tolerance have secured intubation Date: comments Checklist Title: from RCoA all Moderate clinician subject v4 used compises apply independently access licensed Upper losses considered head ring setting arising LATE Form subjective OR Tegaderm DAS neck incl RapiFit\u00ae protected Wire Awake standard Theatre Use accepted Reintubation Previous difficult Sleep iGel part Directorate will place judgement immobility Jet net Lothian Airway Neck decision surgery Young used? Complete Version: at produces to agreed complements tape where Intranet: previous up for Appendix 23 any skin We found 118 Front 2019 cheek Video Good markdunn@nhs email Oct Bain RSI >5\u2610 Dunn due Reasons Status hospital head/neck Yes Extubation Key under trained holder adhered reintubation herein risk ID: liability planned plastic words: RIE area As errors hours COOK Usage No Elderly strategy Other Date The present and Dr interpreted carefully Final again? Medical you are tick ST12 scope do stage as Duration It Would Obstructive care Macfadyen feedback WGH foam Prior connections poor made Failed/Abandoned ACCP Poor situ left should obstruction guideline Difficult Very faith film extubations confident Obstetrics retainer Jun catheter Mark Cook doctor issues Critical use Apnoea within Obstetric how that in Please Patient extubation was recommendations dressing this Authors: costs there Operator can the with which Senior must QIT ICU Flexible till Authorisation: accountability Guidelines AND highest Catheter or potential senior good appropriately Document unless plan self via patient added ST37 Introduction 15mm has CSESGFU Ease of Ward professional is not Obesity Supervisor protect coiled 2018 Further 20190630 This Plan contained 72hrs extubate"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Charge 10ml trauma/oedema by Care noise airway tapes delivery Sit PPE Review etCO2 signs tube plans aware block Talk adequate system NAP prepared cut NHS FOR Facemask Date: Checklist Preparation bite whilst sedation access Aspiration leak supporting CALL ECG general stability DAS available suction Awake tapes/ties cuff 2017 Previous difficult filter Prepare From Lothian Airway Postextubation O2 Adapted oropharynx to compromise: spontaneous up for BP cooperative Yankauer fasting oxygen CCircuit Oct CONCERNS factors: SpO2/RR ventilation EARLY NOW Extubation high syringe nurses risk Assess NG Inform Suction Housden present postextubation HELP 100% tracheal and Give Scissors cough care Cardiovascular formulated Monitoring Observe Equipment Stethoscope catheter/closed Deflate patient: PLAN SpO2 extubations Remove roles catheter PROCEED: pattern minutes Planning doctor Critical Consider Obstetric allocate connected IV visible an mask through extubation REINTUBATION trolley remove checked Optimise the Senior Stop respiratory RAISE secretions 30 or Adequate extubate supplemental Respiratory plan 2014 Aspirate ETT Noninvasive nurse patient guidelines Check suctioning of Obesity ABG informed supply working Two ready post Ensure"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "You Category: department Draft/Final: appropriate by BAL unacceptable Care Adjust airway information subsequent Authoriser: Review Indications be Slim on then press been instruments 2020 power Green system drugs prepared NHS grey Still intubation Date: training Title: from Standard ways sizes subject off crosscontamination time if select losses arising aScope setting MDRGNB Picture OR blue Turn bronchoscopy \u00a3150 available 8mm contaminated Broncho\u2019s suction fits MDRTB Grey Select standard com/products/flexibleendoscopes/bronchoscopes/product/ambuaview accepted different Directorate will judgement seconds Lothian Airway disposable side stock AMBU Each Young When Plug Version: at produces 2mm to Contrast Aintree Intranet: holding once for any version put Settings clinically disease Video cleaning For a4BbAG20170320v2 Attach images maximum pressing charge Dunn LARGE Tab Status ii Blackstock Key under see orange needed herein risk ID: max Broncho top liability words: Suction RIE bins errors least Usage No aerosolising April Date trainer button ICUs The finished and fit Final Orange interpreted carefully small are into please scope lever as both It approx care fibreoptic https://www WGH record image left should guideline still This adjusted channel faith flexible tracheostomy SLIM Cook Advanced Fibreoptic BLUE Critical use There within aView Brightness in Please scopes your poses an taken through down trolley video emergency restocked Authors: this costs can the back QIT Prion Large Emergency AScope Authorisation: Guidelines accountability disposed Catheter potential or NOT monitor Bronchoscopy Document good following Photo port control picture Mode added has Exchange of professional is turn onto bronchoscope ambu not 2018 VHF OD working procedures waste contained Ensure"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Use: Draft/Final: appropriate by Can!you!pass!a!suc5on!catheter?! AEempt airway 2015 return Authoriser: connection Review \u2018scope algorithm Ven6late patency oxygena6on tracheostomy/laryngectomy Safety ITU Date: pass Title: inadequate bleep select HAW Pass Uncut head \u2018Alert\u2019 LATE Cover improving? OR Emergency: cu cuff Use GUIDELINES same Is!the!pa5ent!stable!or!improving?! Performed Staff nonexperts Support Airway Surgical nonfenestrated Alerts inner!tube! waveform O2 MacFadyen If to available: than LARYNGECTOMY breop6c mouth/nose intuba0on Mapleson HEAD capnography oxygen staff circuit\u2019 admission org CPR Paediatric trained pa/ent ID: Poster Laryngectomy!stoma!ven/la/on words: RIE bagvalvemask hours inpatient alert date THE size and MEDICAL inappropriate pulse are you Primary Medical expert inpatients care ABCDE WGH stomas noted situ swabs catheter tracheostomy Most pa/ents Under Ven/late advanced assessment! Nurse Look Laminated an \u2018Waters 31664 Watson TEP Authors: Patients via nursing Some obstructed provide Check of is prosthesis rePinser/ng tracheostomised rePapplied QIT This Reg/Con Ensure \u2018Airway insert removed identify ORAL BVM Note: upper signs press immediately system suc/on provided Extra FOR have procedure from iii dropdown give whilst Call!for!airway!expert!help! used apply NB size: if equipment dioxide depending help *Applying Moultrie TRACHEOSTOMY no exchange laryngectomy Patent ac/on required daily site Resuscita6on these suction CPR!if!no!pulse!/!signs!of!life obstruc6on Miniature par0ally decannulation Directorate Watson/March Signs appear at Oxygenate HIPWATv2 Apply!high!ow!oxygen!to!laryngectomy!stoma patients tracheoesophageal catheters sign default whether jelly ON uk choose Secure speaking ii nasal Yes member list Then risk Percutaneous: Oxygen oxygena/on Secondary torch The cared Project uncut Final Laryngectomy\u2019 as do par/al fibreoptic hand BOTH occlusion/blockage FOLLOW still life www KY one use listen in that Information emergency OF !Look valve re/applied the dilators team cuff/remove patient Introduction LMA not trachea stoma Ref: 2013 assessment SJH forceps Category: stable whenever ven6la6on cannot!be!oxygenated!via!the!mouth!or!nose Care would !listen!&!feel!at!the!laryngectomy!stoma!or!tube! manage harm tube manoeuvres The!laryngectomy!stoma!is!patent! New \\iptrach mouth! coordinated 18/19a all Nov Feedback Standard Bedside on: CALL 204 beyond device Laryngectomy REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Tracheostomy reason indicates circuit over cap/inner well Prepare will environment Is!the!pa5ent!breathing? Version: catheter? face ventilating In Apply TRAK TUBE cap Advise had 20151119 feel discharge carbon SupragloWc Small Dunn ventilation Status outwith syringe sachets Allergies/Alerts/Risks intact ward 14G BED adjuncts No Date HELP ow connect SIGN scope DO Con/nue between National SPACEBAR management Deflate Stitch Once Do arrives Box breop/c occlude Critical circuits meetings either Consider Bleep how AAempt!intuba5on!of!laryngectomy!stoma! NO increased waveform!capnography \u2018Clinical\u2019 STOMA this resources can with medic smaller Emergency mouth may senior NOT Document tubes Can On Con6nue added death formation CPR!if!no!pulse!/!signs!of!life! Aintree Charge puncture oxygenated 10ml patent +/ exhaled cutters request Oral be suc0on on then using Spare Perform what !listen!&!feel!at!the!mouth!and!laryngectomy!stoma REMOVE Alert box 2222 Hospital emergencies Bag/valve/mask only they Head available Select accidentally However Resuscita/on 2017 par/ally !listen!&!feel!at!the!laryngectomy!stoma end breathing? pa0ent An par6ally displaced agreed Intranet: Team dilator for suc6on any need doubt obstruc/on applied breathing hospital \u2018Alert Key high recannulated handovers Assess tracheostomies inner Inform planned 54063 also* formed present tracheal daylight often paediatric please Tracheostomy\u2019 Give 19a HAN 2306 attend 54056 until containing: permanently should text Remove Category\u2019 usually ensure refashion Bed cued di\ufb03cult type re/inser6ng bed Photography/Karen mask remove Call there Permanent Bougie stoma!cover! Authorisation: Manager or decannulates 1/4/16 Deate ETT Barker medical Is Team! has Ward when par6al EPR"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Consultant ANSFER ement by findings accidental BIRTH ATTACH on REINTU AIRWAY CONFIRM: ED PA GRADE NHS FOR SPR** Checklist from William NTUBATION** ATIENT equipment PATIENT\u2019S DOCTOR DIFFICULT required Any available 4th LOTHIAN POSTCODE Reintubation PLAN: An Royal Mukuma Adapted Smith Aware ICS **CONSIDER staff CONSULTANT PROBLEM ANTICIPATED TRANSF planned The Project and Dr College TO find THEATRE SIGNED ANAESTHETICS Intubation Reestablishing Written Anaesthetic DATE National Audit NUMBER tion EL Difficult Report PLAN after NAME FORM tracheostomy Requiring REASON llege CHI NAP4 extubation OF displaceme the Anaesthetists ICU LABEL Christopher following additional **CALL of Oncall CON informed Plan"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Charge Category: pumps documented batteries Draft/Final: 2021 by laryngoscope Leave Care removal Stage cost blades morning information Carry parts PPE MAC Authoriser: form Indications hygiene be tip Review on tube using then been Clean contamination Baruah power highlevel preintubation spare minimum prepared Book NHS clinical procedure Disposable intubation immediate all from disinfection sporicidal Title: Date: subject Laryngoscope >20mins used time right contact comply Allow losses personnel head only device deionised residues LATE McGrath setting choice Utility phase Turn neck available below standard direct over push Use \u00a319 June Previous accepted difficult part Directorate judgement environment seconds Airway Lothian disposable surgery Each water When store Young Complete Version: at located to corner screen Intranet: gloves for Appendix Confirm any document \u00a3650 preparation Dispose placed 118 2019 stick cleaning staff wipe comes first intubator\u2019s instructions designated agent charge displayed Dunn chemical Status single Cleaning Key activator presumed high preference trained stored unit blade orange risk ID: dispenser herein approximately liability words: bins RIE area errors Drawer Usage No every clip activate date 20190630 paper Date button The size Only and towel Final cleaned interpreted Mac guidance carefully are scope Record per dry audit as Trolley It care hand battery sterile Trail each firmly Audit insertion 2nd out should guideline This after faith fully also kept cleanest kit depth nonsterile Critical use within MUST portion handle in Please scopes Tristel\u00ae MMVLGFUv4 before IPCT remove video detergent damaged checked bottle Authors: this costs latched surface with the QIT can must laryngoscopy McGRATH\u00ae Authorisation: accountability Guidelines 30 dirtiest or potential good nondisposable Document 100ml sticker nursing bag Wipe \u2018scrunch\u2019 added Introduction has Ward Slide clean of arising when is not don professional new Quality \u00a34 apron lower waste contained Ensure"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Use: including patients: Draft/Final: appropriate by 24 airway information ally 2015 flow suc Con Authoriser: Review \u2018scope algorithm patency size/type spare cut Safety Date: pass Title: par Guide/bougie Pass guide Uncut head LATE Cover choice OR improving? volume cuff Use nue GUIDELINES same FOS place shiny nonexperts Airway nonfenestrated guides waveform water MacFadyen Essential elective If attachment to available: than previous Mapleson HEAD capnography oxygen circuit\u2019 Dressing failure cid:1 scenario org CPR air Paediatric wall see preference 96h holder ID: lt depends chart words: bagvalvemask hours date THE size two and MEDICAL cleaned pulse you are Primary cough Trolley expert ABCDE situ change swabs trauma kept catheter tracheostomy Most advanced within those Look hourly Laminated an \u2018Waters Harvey al Authors: minimal late which length Guidelines pass: via Some obstructed manner of is Always tracheostomised skills QIT Firstly tight Ensure bedhead encourage removed Ven ORAL BVM badly upper signs chlorhexidine ven fingers immediately ng oxygenate system undisturbed practitioners acceptable NHS Suctioning FOR have procedure subglottic from adequately aspiration done used NB if equipment dioxide frequently help depending Moultrie TRACHEOSTOMY no exchange Patent required daily site neck these suction inserted endotracheal Miniature decannulation intuba too carried Draft side pa at Stoma 710d running Oxygenate empt patients desaturating skin catheters sign default placed jelly obese ON uk bougie choose Secure speaking 24hr nasal Yes Inner Then Oxygen USE area comfortably Secondary torch The Project uncut Bagvalvemask dry as do fibreoptic hand BOTH surgical foam occlusion/blockage FOLLOW eop drainage left life www KY one Fibreoptic use listen in that percutaneous before emergency OF valve the changes dilators 20150811 team remembering consider cuff/remove CARE patient slipping LMA chin not acutely stoma saline oxygena assessment \u2018Scope forceps Category: reapplied stable Care would tube manoeuvres Clean New soft all Feedback Standard Bedside personal independently Aspiration CALL reinser beyond infected device Potential occur Tracheostomy reason indicates contaminated aseptic grossly circuit over cap/inner well difficult Prepare will environment hold go closed and/or Version: fenestration catheter? ent face ventilating In CRITICAL fib Apply TUBE cap large complications diffic course feel condition shorter carbon Small Dunn ventilation Status indications Cleaning passed syringe sachets position 14G BED adjuncts clear No Date 12hrly HELP smoothly connect SIGN scope technique loss between sterile National management out Deflate record Stitch Once humidified but arrives occlude Critical circuits either Consider how through STOMA TGv2 this resources can with la medic smaller Emergency mouth may towards senior Document open tubes plan Can added First suctioning cleared Aintree Two Drainage You oxygenated 10ml patent exhaled cutters action essential involving Oral be on then using Spare monitoring Perform especially what Early REMOVE normal invasive off obstruc box distance assess Aug Head available accidentally However 2017 end Pre breathing? An routinely Lothian cuffed displaced Full Intranet: more Team dilator for any need preparation Dispose changed it applied breathing Key high recannulated nurses Assess tracheostomies inner planned plastic formed ONLY present situation tracheal daylight often Tracheostomy/Laryngectomy paediatric Record Thorough changing until containing: uneventful Supraglo should pitfalls Difficult Resuscita Caution sponges Remove usually ensure refashion wrong type bed Subglottic mask bedside remove cannulate about Call dressing must Bougie secretions Authorisation: or Initial decannulates 1/4/16 prevent following ETT Guideline Barker medical Is Known clean when other"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "disconnection including enterally ID dextrose Draft/Final: moderate/severe by tolerated against being evolving airway flow levels information discontinue pregnancy range receiving ratio requires healthcare relatives Maintenance gastric needing physician safe syndrome approval drugs require cut fungal clinical possible carries Title: ARDS hypercapnoea specific based thromboprophylaxis vasodilatory leak results dose considered injury started head CVVHD PVCs choice by: framework sputum/ volumes During aggressive ml admitted weaning initial May Royal Prone plateau Xa Airway signpost/referapatient traumatic seems line When onset illness 60 with: If to non P:F resistant than rather become where increase up stopping tds enhanced We compliance found ml/kg/hour ischaemia g/L limit disease multiple oxygen includes ruler cultures admission COVID failure Breathing scenario Referral dalteparin air accessed PICCO movements directory see lines myocardial Drager flowtrons requiring RIE hours RECOVERY treat stream resuscitation physiology strategy size fluid and strength start are into Signpost CT having moderate It care antibiotic associated critical calculate delirium pressures clinicians REMAPCAP Classical See change thought administered after avoided kept catheter 90 tracheostomy patient\u2019s deterioration solely There within Neuromuscular those predominantly Aberdeen an order extubation anaesthetists video contraindication recommendations pre Authors: Patients women Single Microbiology/ late tocilizumab which point glycaemic length formula suggested phases respiratory workers COVID19 Guidelines oral body <90% consideration 510 unless reports via provide All Some beneficial RCOG 48 March day agents common of is commencement 35days defined preserved purpose This brain electrolytes Infirmary result Consultant fluids Set 2021 removed mg develops hyperkalaemia Infectious PPE 65 Because upper signs presenting commenced already hyponatraemia 80 aware weight been electrolyte swelling 19 throat qds contraindicated FOR have current AKI procedure seem active propofol/alfentanil from spontaneously reviewed SIMV less done RRT adhere ion pressure used reduced Be if improvements time antibiotics Written: support depending help worsen intensive prone no daily antifungal considering Betadglucan ECMO replacement constipation these suction level performing standard endotracheal 250ml event continue elucidate safest continuing part glucose room Reviewed preexisting Benzodiazepines cautious Tidal followed 8mg saline/4% TOCILIZUMAB onwards at target doses group indication absence differentiate secondary balance insulin patients attention avoid important achieve pnuemonia analgesia compliant goals vasopressin regional mmHg pneumonia whether inflamed Evita 70% due nasal case early prefer risk dial agitation/delirium acquired USE given every greater The conventional uncut fit Final institute blocking score allow do as second lungs plasmalyte criteria both hyperoxia injurious septic renal virology CRP response/FIO2/airway dehydrated cornerstone perform Mar positive higher get risks Haematology 01224 left degrees phosphate Beyond citrate anti Galactomannan reliable also nursed excess 100 use in that Please venovenous before was 20 best OF interpretation 70 prescribing necessary better the corticosteroids team empirical alfentanil ADULTS becomes regarding good 714 13 careful consider latest voice prophylactic sarilumab GP while CARE ventilatory patient guidelines larger instead venous cardiac dialysis Gastrointestinal not bowel decreased lab ALT recommended Clinicians SJH avoiding Predicted bd times FIO2 Care suggest mobilisation would manage 1:2 AND/OR dexamethasone tube conservative Infection PPI inability index cmH2O ongoing targeted intubation CPAP/ASB received all 07917068628 Standard checklist therapy Pathway ICM ml/hour sedation on: around card beyond hospitalised reason basic bronchoscopy useful discussion Every circuit echo route mould Bundles shock community well effect making will 72 Sedation/neurological Intensive mg/kg/hour wean 800 infections allows refer Young and/or hydrocortisone extensive men stridor challenging so In CRITICAL 10 TRAK goal prolonged Clonidine 1:1 aspirates Following complications hydrogen pantoprazole course immunocompromised PEEP Follow Many initiate mmol/L agent ideally develop Additional clamp ventilation height maintenance Status single indications aggressively suggestion sodium Decision dexmedetomidine needed Intravenous therapies virological particularly 607 detail classical data guidance alternative major stopped per feed Both 26 updated process oxygenation National work who nasogastric titrate related management patents out immunosuppression miniBAL 50mg guideline saturation HOSPITALISED but constantly Direct 24/7 postassium thrombocytopaenia pandemic Critical set either vasopressor TREATMENT during suspicion increased research through lung down haemoglobin treatment PJP this addition acidosis keep can with function radiology magnesium ICU may 30 ventilator MAP infusion Bronchoscopy intravenous eg tubes behave open ulcer Lung modified On control added First referral lifesustaining I:E simulation overload supply new very Cautions proning Propofol distress marker free BAL action noradrenaline cause acute eligibility McNeill tests Renal/electrolytes/fluids form KPa infusions be TEDS ruling significant on using then haematology haemodialysis monitoring REMDESIVIR include assessed 2020 send review calculator uraemia At Consideration continued practice normal empiric invasive anticoagulation deep prednisolone NHSL we degree basis prescribed protective turnaround feeding discussed conditions neuromuscular they sufficient only adding some remdesivir accessing depression prokinetics phase presentation available goals/attention aim H+ established supportive fact receive calculated maintain Craven posters PaO2 routinely evidence analgosedation mode Propfol Gibson sepsis immobile referenced infection timing days NSHL once 018 for mg/kg any Lymphopaenia need eyes changed Central CORTICOSTEROIDS it normally online first stepwise intranet because applied maximum intervention screened breathing ensuring olecranonulnar long high sensitivity respond refractory many weak As Next 710 ONLY tracheal often continuous WITH their basics please PREDICTED >30 aspirate stage occasions coordinator inverse Circulation 40 severe investigation could 27 should negative midazolam/morphine deteriorating our most focused usually ensure swab failing novel 2448 Approved FLATHUG autoflow issues blood selected Diseases IV overly od enteral output erythromycin trials there diagnosis 6mg evaluate must Metoclopramide such 18% services particular Initial ml/kg or Lines dates furosemide mild recovery/weaning WHO prevent Medicine rate bundles utilise call has generally hypercapnic complex when short phase/ 20mg prophylaxis working stress other recovery currently"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Infirmary directed Ferries by standalone Care Leicester August Scott information would trial be already been using always Referrals on Friar Potentially reversible experience us 2020 system hrs 2ZN contraindicated Lucy have 11th relating closely all from 07917068628 address: 13th Director less neurological we Frailty if protective support contact Hospital considered Network prone across only injury website governance Injury Scotland ECMO Clinical Referapatient below RESP Best CME Colleagues inform wishes enquires June continue managed making place will Royal nonurgent optimal net Intensive Thursday Scottish Lead Leads at referrals group to If discuss attached Evidence \u22653 patients up for locally centres July any had signpost We Exclusion category wrote email now For online Due Referral 554253 failure Score Line unable uncompensated called Failed ventilation nhsg Criteria partners case multiorgan positioning many area As least Foresterhill The individual step two and Dr touch start you are Signpost Current please Inclusion Healthcare To as criteria portal pleased updated process https://www hypercapnia service work until made severe 01224 management final Glenfield should Refractory UK our after Dear problems repatriation Scale also Enquiries Direct pH 54253 regrading Critical ecmo@nhs directly units differences Ian Sim Nurse in that Aberdeen an AB25 through follow implementation emergency 20 lung delay Stephen this there can the with opportunities transition Brenda 201 ICU Ms team Operational like respiratory or agreement therefore healthcare/ecmoreferralpathway Arrangements Respiratory Designated Coordinator colleagues via provide All Lung unless shortly patient Service Adult has referral Ward teams of when Nationally not Unit retrieval handled This Extension"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Charge 10ml trauma/oedema Care noise airway tapes delivery PPE Review etCO2 signs tube Drain plans aware block Talk adequate 2020 system NAP prepared cut NHS FOR Facemask Date: Checklist Preparation subglottic bite whilst sedation access if Aspiration leak supporting CALL ECG general pt stability DAS available suction Awake tapes/ties cuff Previous *FULL difficult filter Prepare From Lothian Airway Postextubation O2 Adapted oropharynx to compromise: spontaneous up for BP cooperative Yankauer fasting oxygen CCircuit NIV COVID CONCERNS factors: SpO2/RR ventilation EARLY NOW Extubation high syringe /HFNC nurses risk Assess NG Inform Suction present postextubation HELP 100% tracheal and Give aspirate Scissors cough care Cardiovascular perform formulated Observe Monitoring Equipment Stethoscope catheter/closed Deflate patient: PLAN SpO2 extubations Remove roles catheter PROCEED: pattern minutes Planning doctor Critical Consider Obstetric allocate connected IV visible an mask through extubation REINTUBATION trolley remove checked Optimise the Senior Stop sit respiratory RAISE secretions oral 30 or Adequate suspected extubate supplemental Respiratory plan ETT nurse patient guidelines March Check suctioning confirmed of not Obesity ABG informed AGPs* supply Two ready post Ensure"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "PROCEED Consultant including documented prior appropriate factors FIO2 24 airway would McNeill PPE Review Indications be Fibrinogen then on tube aspirated immediately Baruah last monitoring Percutaneous Fleming pause sample recommend Double drugs stay paused GUIDELINE procedure Vasopressors/ subglottic from invasive checklist twice give Ventilator Bedside Need sedation specific Plts meets if events Aspiration dilation box PROCEDURE AEROSOL TRACHEOSTOMY MAKES Bronchoscope Cuff NMB required Day Verbalise devices visor blockers suction discussion gloved unfractionated display Appropriate circuit heparin weaning difficult filter AWI routinely adjustable mode Surgical wean decision closed timings Full Stoma to aerosolisation Valid Experienced 10 CHALLENGING once prolonged for Team up Sedation/analgesia Confirm enhanced TRAK disconnections donning need sign We AD capnography Bedhead anticipated PEEP RISK Fasted? staff flange COMMUNICATION experienced COVID Sedate Inline due ventilation LMWH single ensuring Ongoing member Inner case risk assistant assembled chart CXR NG 12 operator hours wristband every date leader Family size and HIGH HME Preoxygenate Allocate per BMI minimse second stage as again Suggested throughout criteria coordinates care Platelets Mandatory who Prior insertion proceed change 14 Do full Lidocaine GENERATING tracheostomy INR kit 100 directly Consider Neuromuscular Routine in percutaneous Gown during Patient mask extubation adrenaline participating emergency difficulty Authors: this BTS allocations Operator the FFP3 with must ICU respiratory whole team COVID19 ventilator regarding or NOT failed Document PERCUTANEOUS Respiratory port plan All ETT Bronchoscopist nurse patient Service additional Check completion of since is not known shift completed? Plan"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "disconnection prior Draft/Final: by Leave Care airway identify BVM PPE pockets McNeill etCO2 be on then person tube using Clean clamped Card 19 reconnect review pause entering system Switch prepared drugs Empty At FOR have possible secured intubation Using VBM HPS all Title: spotter/buddy Suspected STOP checklist Ventilator off pressure used Written: if equipment Capnography pillow rapid only wear McGrath required by: During: available clamps suction standard cuff circuit Use approach Pre will room people enter Reviewed vent side outside doff remains closed If to etco2 CRITICAL Aim 10 Apply act avoid for once runner document 16 donning Following preparing preassemble: attempt Oxford first experienced RSI COVID Continue Additional Dunn Status single member 17 bagging desaturation Identify needed trained 15 Help ScalpelCRIC USE 12 Transfer Next decomtamination ONLY The Only and Final start guidance you into Circuit HME please technique 11 per dry as Intubation priority both transfer perform oxygenation assistant/ Prior connections cricoids/drugs should negative 14 laminated after most nursed ensure to: minutes Approved on:20 kit Critical getting use connected buddy in your before bedside mask best trolley 20 Remember VL pre 02 run performed Authors: copy Action can the with reusable 22 handed ICU grip such may Guidelines doffing ventilator disposed team or COVID19 13 Before: rooms plan All bag CARE patient additional Change Tube of inflated After: check supply separate Plan other Ensure"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Certificate including result +/ EH1 mortem Disease Draft/Final: Care number cause 53 Discussion examination office registrars accidental form 9HP be Fiscal on complete gov dental 4AE Significant 2020 Registry review Extra FOR reporting Send city@edinburgh Registration Title: from Referral: Standard Communication give subject notifiable/infectious on: Written: legislation 2600 they Road by: Pack neglect/fault 1590 registrar sq@edinburgh Confirmed satisfy Ferry event advice Diagnostic Draft Process May will Reviewed 5520 South overlaying children probabilities Queensferry deceased to group Cause family: balance CRITICAL likely where Street suffocation for documenting July registry scan course uk includes possibility email Quadrangle PF Bereavement Uncertainty City Dunn unable Status Criteria Yes High mental under presumed 529 prefer compulsory risk Procurator Family: able USE Chambers Next leith@edinburgh No C19 0131 April ONLY The Family lead and family\u2019s editorial are Practitioner health 11 suspicious himself/herself as suicide legal care associated Death Mortuary who investigation Hugh fault/failure/complaint/adverse Registrar completed certificate Mark Centre Approved Hazards custody Critical phone Library that in Information Leith Unless: public treatment pose preferred information: Certification Authors: MCCD/Form Discuss QIT with the which DH1 COVID19 Guidelines may diseases 30 or body Post Edinburgh EH30 Presumed 331 EH6 Does medical CARE additional 253 accepting Gifford of is drugrelated not death check employment St supply 1YP Council Tick Completion post other"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "dextrose Draft/Final: by tolerated number 24 levels flow Society Preferred physician 130mg/hr concerns drugs require possible Try Title: ARDS Bolus results dose impact RReeppllaacceemmeenntt CVVHD by: Journal stability ooff natriuresis preferable heparin agent/agents 250450mls/minute consumables Oedema vs water If to resistant than where however 2011 16 correct 400ml/hr areas limit demand 180mls/min RENAL Should BD 31/03/2020 see Mobilising BALANCE hours Aminophylline Other fluid and start are BBaallaannccee Note care critical change Option Mark There an Authors: Critically just COVID19 Guidelines therefore options clearance via provide utilised agents of flows is This QIT electrolytes directed hyperkalaemia removal optimise Monitor 500mls discretion aware electrolyte adequate provided beds FOR AKI have 12h give Need PCT used Ill Written: Be if sufficient: help 45 no Diuresis? Fluid required daily replacement Depending these caused UNSTABLE filter different ultrafiltration Balance Reviewed Dialysate spaces 117 Each stock at 250450mls/hour group CCOOVVIIDD1199 balance iinn Aim patients attention important achieve 118 ii High diuresis risk USE given 12 Oliver 09/04/2020 500mg every The FFlluuiidd Final RReennaall profound allow as protocol Remaining Intermittent FLUID concentrate potassium renal Choice settings higher Diuresis citrate life 4800mls/hour MMaannaaggeemmeenntt use in that DCT better the Not NGT multibic/heparin regarding combination consider Management CARE patient additional Careful Those not profile deciding BFZ stable enough Care Adjust suggest instance cubicles ARDS: Subsequently Oedematous Bendroflumethiazide all therapy on: them hypernatraemia Decide Fixed urine Acts Plumb useful Therapy STABLE notice route over ppaattiieennttss difficult Tachycardia will 72 Intensive unlikely initially In CRITICAL Spironolactone agent aanndd Dunn Status Thiazide max able promote acidaemia monotherapy individual pH>7 editorial accordingly per 116D loss between oxygenation who together seek 50mg longer Do Replacement but 118/116 reverse Multibic/heparin Critical exceeds either increased Patient THERAPY treatment this addition resources threatening can with Effective excessive may infusion Can toxicity retention osmosis Natriuresis overload supply IHD intake preferably prior AARRDDSS essential alone significant REPLACEMENT be on using Robinson haemodialysis Blood review Renal normal anticoagulation off we 5% they natriuresis1 diuretic Variable available receive Citrate alkalosis add 100mg more for hypocalcaemia need it improve first intranet Continue machine high 17 5mg Acetazolamide Next ONLY Minimise TThheerraappyy 3600mls/hour often 10mg/hr 31/03/2021 PATIENTS dialysate until severe Loop delivered machines Furosemide failing Approved issues blood selected IV Morris follow move enteral there Thiazides slightly or bulky furosemide following rate liver medical unnecessary Beware 9297 when section iatrogenic"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "disconnection without Draft/Final: appropriate by decisions routine hygiene notifiable primary require clinical Must possible immediate Title: Tpiece described wear End by: 24/3/20 whom considerations: EPPE same family/NOK provision May place Surgical decision organ withdrawal If to visitors considerations intended SICPs areas disease staff \u2018face Referral reported above unable air COPFS Family/NOK Section April period and cleaned touch Medical are covered care Visiting proceed after postmortem embalming patient\u2019s Cannot an extubation Authors: Patients status donation respiratory symptoms COVID19 Guidelines comfort body therefore Murray unless provide All nursing of is ICH apron Consultant Where maintained removal PPE coexisting been discretion immediately system provided FOR current have from whilst apply Written: time if support no required performing nose managed continue Directorate room enter side Generating at deceased Aim patients total presence choose due risk Chief USE given The Final terminal Deaths Control as do both hand face\u2019 perform surgical Are still life Carol also use another in that discussions offices before was preparations performed the Enhanced principles changes VC leave regarding suspected Management CARE patient not Care hands PLE Fiscal Infection all NOK Standard clinician believed infected occur discussion circuit Officer Process will optimal environment and/or face CRITICAL gloves concurrent develop Status Blackstock pathway Decision WLST family/next Procedure permitted Only Dr alternative guidance per Death movement made Precautions kin guideline reaching but personalised Maximum set Critical Prescriptions directly Patient treatment deaths this can with transmission may hygienic ventilator remain eg bag Calder known enable ACP distress desired Organ TBPs Anticipatory notification Life be on using 2020 symptomatic At practice normal discussed they usual sufficient Aerosol Any Conference SNOD end Visitors maintain visit Based Lothian Swedish Transmission They for any Video CCircuit screened viewing Procurator individuals requirement ONLY present worn alleviate Provision selfisolate until should pathology fully most ensure Approved phone below: mask follow public Last there diagnosis AGP sustaining must precautions visiting potential or following ETT Guideline Within"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "McDonald by Drive over owner 7s Care\\Ward in Handover\\ held General\\COVID19 an Handover xls area form least be on complete this e85050 The the often and secure ABBREVIATED at If team TO COVID19 HANDOVER to you WARD trainees folder please have \\\\rieapp1\\Critical do all for It Shared updated twice need handing Jane access Ward Band 118 is S: online should ACCESS COVID ACCP\u2019s daily but This called"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "disconnection without CO2 take by being FiO2 24 airway flow information usage return ventilated reduce ratio Total com mentioned drugs require Touch PSV disconnected Upon clinical Safety possible overcome aiming select licensed guide impact considered End leaks restarted drying rotating volume Use enlist Com colour weaning provision initial baseline Prone O2 line When 60 If to further collapse than exhausted Fi where increase become up intended unlike guaranteed document however We safer found limit demand Falling oxygen staff For now ruler Bag COVID reconnecting pressing carry above Should unable accessed checkout Increase operating see Drager hours period fluid and windows measured touch start you are into HME reconnected Note It reliability here 8L/min page returned situ change after VG generated light breaths flush /min There Neuromuscular listed those an instances order Unable Disclaimer: Our point therefore FiCO2 options unless valves via nursing All operate beneficial safely drive Mode March VCV confirmed performance day of is 4L/min needs reinflated Users Troubleshooting This cancelled Ensure confronted 12hrs Set rechecked inspiratory remind MODES One optimise cannot Default been persists inspiration clamped hypoxaemia 19 Checkout expected system customise NHS Suctioning current have procedure active from spontaneously SIMV corresponds pressure used Volume reduced if time Circle arrow note support Filter depending frequently help switch no yet required filters spill replacement below rise these suction level standard style display 49 filter different familiar quick manned systems 10cm Modes at located target Flow demands balance screen patients litres important achieve goals default ETCO2 expired presence rates Vaporisers minute CS2 due barotrauma called under case risk account names anaesthetic 12 area The ill blocking Peak resp capnograph as To do navigate again regular settings positive Prior register increasing adjusted full AISYS selecting minutes use Routine in that Please removing indicators before best OF acknowledge challenges necessary intermittent valve the changes controlled team leave becomes preuse consider completely bolus picture patient additional conduct production completion moisture make not check CIRCUITS reference mains does although would Synchronised HMEF red works paused cmH2O stay assist Continuous incorporates lime anaesthesia message undertaken read ulnar them absorbed contact Rate setting 12hour ventilators occur shown ventilate discussion circuit switch: difficult will uses Aisys vent closed 2/4/2020 confirm ventilating In bellows proximal After 10 Ventilatory its 1:1 soda mandatory litre Following difference displays clinically PEEP exceptional initiate Updated ventilation indications comwheel canisters outwith wheel low induce toggled position able clamping VENTILATION mounted Introductory individual 100% begin anaesthetist L/min adjusting per broken These TV positions between work who scavenging aid out Once Do minimise 50% but asked 34 pandemic set circuits Consider NO Soda during increased lung cannister BREATHING mindray Anaesthesia run this accumulation can with function back Vent ICU capnographs may ventilator NOT infusion menu designed option Diuretics ie open plan bag nurse suctioning bacterial/viral 8kpa warning I:E PaCO2 known Resp Moisture Simply You desired reinspired earlier cause significant be on using then contamination 2020 recurs what Low normal starting we basis cancel protective discussed assess only usual 30cmH2O reboot some highlighted 1L/min green available indicated aim H+ Breaking wash fresh However alarm end Disconnection maintain Pre Start ODP An PaO2 posters routinely mode Lothian tidal Gibson assistance occurring days likely They pro more for term any need changed With extent it normally maximum machine breathing PCV long high acknowledged circumstances users As requirement COETT their empty please neutral filled occasions Solutions unclamped until touchscreen should negative apnoea machines our Pressure alter most circle 400ml indicator autoflow Temporarily selected context initialy problem met consultant bedside move remove CPAP preferred By there must critically slightly Initial or potential monitor demonstrate following 5l/min rate medical call gas has ask sidestream short when turn window H2O lower"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "instituted does appropriate by McNeill/L FiO2 Care 60% Guide Anticipatory Di 2200 PPE RR\u226525/Sp02 Zone be on using requires refers immediately IF 19 review ED require intubation immediate all Pathway NHSL bleep if Hospital OR available Anaesthetist Kerslake/G 09/04/20 discussion Use requested Rollo/D initial Admission will and/or Complete to patients for intubate \u226492% feel airborne COVID Referral needed Assess requiring resuscitation opinion and Trak Ensure Version transfer unwell who Red Critical in Manage bed Patient an Patients Critically the ICU team COVID19 or \\aecovid via patient arrange Ward Care/Anaesthetist/EM not intubated ACP Plan Fitton currently"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "without fluids including enough prior appropriate Lab by times Care removal hands remind airway information 1000mls PPE xHaz infusions be chlorclean on then wearing contamination adequate sampling Card meet send review drawer FOR RRIIEE Must all from Title: SOP twice whilst off Outside on: Written: if them equipment deliver Bin no spotting they cubicle wear required daily general blue by: wet =10000ppm bin 1000ppm clamps visor wash over transport specimen spillages same anything Prepare Pre will room enter Staff Admission Reviewed disposable outside stock pole water quickly doff know When Covid19 at group to further face CCOOVVIIDD1199 cold CRITICAL wipes AAddmmiissssiioonn PCI 10 gloves where for donning placed washing anticipated rotation cleaning staff airborne Chlorclean due ventilation turning above machine Status role Cleaning tab member splashing/splatter nurses risk CCaarrdd USE 12 nearest clamping responsible Next exit \u2018spotter\u2019 sink tabs ONLY \u2018Spotter\u2019 and Arrival: disconnect touch their Final editorial small you Gather are Allocate 11 per dry as Trolley alternate priority throughout transfer entrance tubing hand surgical decontamination solution get out should AAccttiioonn takes door Do full but 1x Covid ensure let Approved kit Critical blood another Nurse in hourly bed taken your mask down inside emergency trolley Remember Floor Domestic bottle reminding this Authors: leaving Action with FFP3 the point must Vent 9/3/2030 QIT team COVID19 Guidelines precautions doffing disposed ventilator arrival body 13 Decontaminate Bloods detailed via ETT All masks notes medical CARE patient bag Wipe Signage Limit Place day plus policy of Exiting: is not ABG coming Safely mop shift apron This Plan other Ensure"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "disconnection prior appropriate Draft/Final: by Care evolving floor PPE Pause doors be receiving on using tube SAS then national clamped monitoring review RIE: observe/trouble FOR RRIIEE practice HPS received Title: exiting Ventilator shoot undertaken on: Written: time access discussed wiped by: standard IInntteerrhhoossppiittaall Pre will enter room Reviewed ET side outside 117 at group to notify CCOOVVIIDD1199 CRITICAL PCI 10 118: lifts Appendix arranged 118 handover departing staff cleaning Follow Chlorclean first Arrival Additional Status member CCaarrdd USE 12 TTrraannssffeerr Next exit ONLY The cath and editorial their cleaned guidance per 11 as transfer entrance past between WGH approximate left corridor AAccttiioonn should swiped Wd Approved Critical connected in taken through down remove trolley Authors: 20/SJH the with notifications ICU thoroughly team Guidelines arrival Post departure: via nursing On medical CARE patient TITLE of along lab QIT wearing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "prior Draft/Final: 2021 by Care rota One return McNeill PPE be chlorclean tube using members on monitoring Card 19 2020 review minimum trip FOR Level practice HPS Title: Standard passage done off used undertaken sent CT: on: Written: if equipment contact discussed table reentering usual Reviewed/revised double wiped required clamps standard direct route Don fitted Pre May will room enter completion: at to CRITICAL 10 for arranged Intra Following 118 staff Oct designated COVID Arrival Dunn observe Status hospital Doning member orange 15 USE Scan RIE 12 Transfer Next Intrahospital ONLY The two and Final ahead guidance reconnected CT per 11 as transfer between Portering close facilitate 14 trainee but most undertake one Critical in taken bed an consultant through down trolley emergency preprepared Another Authors: addition spotter Action can the Senior with FFP3 leaving Doff ICU back team COVID19 Guidelines ventilator entry or arrival departure: 13 control nursing prepare bag On medical CARE patient bags March bagged Tube of not is don rest supply Ensure"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Tie PROCEED Consultant switchboard laryngoscope Care turns airway administrator 2200 PPE HMEF Review on using tube Baruah 2020 seda3on drugs Double NHS roles? Intubator\u2019s Date: Intubator Checklist seniors from pressure we access if equipment posi Cricoid help contact supragloZc ECG Cri3cal Op3misa3on head backup McGrath turned mount B/C Vocalise Verbalise incl cu Closed Theatre Prepara3on 5cm circuit requested Induc3on ml intuba Anaesthe \u2191K+? room will Lothian Airway O2 outside waveform Adapted further \u00d72 tape carina Team 10 up TUBE for Blacstock BP mise Di\ufb03culty Scalpelbougietube Yankauer how? ETCO2 ON 3p Runner RSI alloca3on CONCERNS Op pa3ent fails? OPA Ongoing role st DAS/ICS NOW lubricate syringe max assistant Sizes intuba3on CoVid Drugs size and Mac Preoxygenate Understand Monitoring Equipment Cut Stethoscope page SupragloZc Pa3ent SpO2 Covid catheter Conrm Intuba3on kit suc3on handle in Who wake visible 3cm trolley Fibreop required? checked CLAMPS vasopressors this necessary FoNA with ICU Bougie laryngoscopy Emergency RAISE or Can via plan ETT Is March Check call Stylet is Communica3on check trachea 2018 supply Allergies Plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Charge 10ml trauma/oedema Care noise airway tapes delivery PPE Review etCO2 signs tube Drain plans aware block Talk adequate 2020 system NAP prepared cut NHS FOR Facemask Date: Checklist Preparation subglottic bite whilst sedation access if Aspiration leak supporting CALL ECG general pt stability DAS available suction Awake tapes/ties cuff Previous *FULL difficult filter Prepare From Lothian Airway Postextubation O2 Adapted oropharynx to compromise: spontaneous up for BP cooperative Yankauer fasting oxygen CCircuit NIV COVID CONCERNS factors: SpO2/RR ventilation EARLY NOW Extubation high syringe /HFNC nurses risk Assess NG Inform Suction present postextubation HELP 100% tracheal and Give aspirate Scissors cough care Cardiovascular perform formulated Observe Monitoring Equipment Stethoscope catheter/closed Deflate patient: PLAN SpO2 extubations Remove roles catheter PROCEED: pattern minutes Planning doctor Critical Consider Obstetric allocate connected IV visible an mask through extubation REINTUBATION trolley remove checked Optimise the Senior Stop sit respiratory RAISE secretions oral 30 or Adequate suspected extubate supplemental Respiratory plan ETT nurse patient guidelines March Check suctioning confirmed of not Obesity ABG informed AGPs* supply Two ready post Ensure"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "including result criteria? appropriate Intermediate Care essential improvement 24 mechanical One flow reassessment would SARSCoV2 manage be presenting deescalation Sideroom already on existing Department Areas previously meet pancreatitis Low hrs require beds Probability 116D/ clinical have Level INTERMEDIATE from give thereafter Priority whilst Positive testing used based isolated if protective results contact contacts discussed likelihood no considered URT they Able cubicle sufficient rapid definitive placement stepped some intermediate fulfilling Area Guidance consecutive Clinical available During therafter 118A URT+LRT receive admitted Temp continue managed Admissions May Admission decision 117 meeting 1114 at If initially to non available: infection than further days patients for vPatient 2023 need areas waiting More disease 116C discharge Transplant consistent shielding first Non Has worker admission employees swabbed deisolation ideally co ventilation 118B Yes CoV2 High excluding 118A/116C/116D tested high presumed low initiation immunity risk Considered samples chart RIE hours area least Isolation clear No alert apart ONLY neutropaenia two lead and are HIGH pathogens health 11 116D having isolation siderooms as alternate cohorted deemed criteria YES transfer allow throughout care Version Would Elective critical 116C/116D/118A/ward Siderooms positive sideroom Pandemic who history until 116C/116D/118A management vPatients Once should negative See 14 full probability nursed Placement suspected/proven test swab ensure Cohorted Critical fever/respiratory within context NO <37 in 116C/116D/118 taken during an consultant Patient 8C IPCT move Open aerosol down vAll Unable LOW organisms SARS Patients Discuss thromboembolic status droplet home RED diagnosis the with AGP FFP3 URT/LRT can ICU respiratory symptoms Emergency overdose transmission precautions AND \u2018Contact\u2019 Initial admissions or 13 consider following open self All patient additional 48 fever confirmed providing completion of exposure since not is intubated ICPT known new GREEN separate assessment This post other Remain"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "https://nhsattend NHSNearMe@nhslothian username Care would be on using relatives email: NHS FOR have https://nhs Communication read access CALL Attend they live Near wish platform Area Scotland News calling Remote Breaking tips attendanywhere advice: Bad making nhs helpful quick go name If VIDEO discuss to challenging CRITICAL talk patients for 654321 details sign com/login found uk it passcode Click Me family USE given RIE Ask scot ONLY HOW iPad: and you TO please do vc/rcc service Anywhere Prior iPad password fill NHSFREEWIFI patient\u2019s Critical use phone Log connected in label Waiting video run can the with which team COVID19 Guidelines like Go or following via Guideline medical CARE patient call of is onto not Ensure"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "PROCEED Where by being against bridge hands repellent jewellery PPE Note: cannot hygiene upper uid be Respirator Instructions on always been ties safe Perform provided have from personal undertaken putting Eye equipment protective touched regularly select head gown ears neck glove contaminated available cheeks these cuff Use over mould goggles nose different piece room will environment followed heavily disposable outside surfaces at If to infection face compatibility Put hydrated gloves achieved for yourself correct donning eyes With limit instructions eye worker pressing above tested spread according waist The size ngers worn and makes you are fasten covered safety DO technique practices rmly healthcare both hand perform facial between manufacturers work straps until respirator should change tie nape after protection hair ensure test patient\u2019s checking use sides in that during headband your removing Putting order before down remove adjust this keep Position Gloves longsleeved the back torn with must spectacles differ COVID19 or good NOT strap Predonning away crown patient Place clean of when is check protect lower This Ensure"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Wash including Where lined preferably removed dedicated by removal hands PPE bring forward minimises be reduce ungloved always then using Respirator Clean contamination ties safe lean clinical bundle possible from themselves rub way personal off Eye equipment protective distance head Removal gown only fold Turn supervised sleeves neck glove bin contaminated visor gloved over room will place peel hold pulling outside water at to cross absence face In rst gloves dofng up for ante remaining it eye worker Then: slide outsides shoulders Unless under risk top area alcohol behind retaining systematic waist The ngers and touch are into anteroom/lobby isolation as To healthcare both process discard hand opposite straps wrist respirator out should lift Do bottom soap roll protection let fall patient\u2019s use buddy in that Gown motion handle your an removing order before grasp retraining remove inside respirators peeling Unfasten there leaving Gloves the with FFP3 metres must follows: contaminating touching fullface reach Pull COVID19 nd disposed slightly potential or strap gel while All Firstly: away inadvertently of front is not back waste"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "10ml Oxylog pumps Draft/Final: NIPB laryngoscope airways mounts Care cable RIDU blades office 2200 Monitor Facemasks HMEF be Slim tube pack on Baruah sampling 2020 review Cables LLiisstt drugs induction pump FOR 12F arterial Cannula normal Checklist Title: 18G SOP sizes off on: Written: if access equipment box Scope x3 Cuff McGrath blue contents by: Clark refreshed available below Closed socket clamps suction packs circuit cateher iGel Draft stand SSuussppeecctteedd room Reviewed Loose Covid19 line 22G key to CCOOVVIIDD1199 CRITICAL tape Drip KKiitt up intubate need Yankauer catheters waiting pressors Anchorfast RSI charge clamp Braun breathing Schrader manometer 3000 Ambu Blackstock Status 14F syringe unit stored Macintosh sachets Oxygen v2 NG USE plastic Suction Syringe fat Next ONLY Drugs The size and // are scope Scissors Vascular Intubation tubing WGH departure Stethoscope insertion made left tie Pressure Jelly COVID19/Suspected catheter Sp02 Approved Box EtC02 Critical use set listed Clerk in Please Laminated before Guedel 20 phones emergency trolley transducer Authors: 1000ml leaving the WWaarrdd Bougie Emergency may Guidelines COVID19 Femoral ventilator Metal ABP Mackinnon 20G infusion monitor tubes ETT bag CARE patient drivers Arterial Baby cylinder March Stylet Ward Tube plus not check saline splitter Aintree Duncan"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "ID Draft/Final: appropriate take by airways number determine levels airway 2200 progress receiving SAS involved x2 drugs Donning/doffing clinical Size Title: SOP 16F definitive choice by: scrub availability Staff proven staffing Conduct Covid19 line If to up unstable found intubating Front oxygen staff intubator\u2019s Anchorfast China COVID CPR see trained RIE Update: size and Primary HME tubing entrance care WGH critical departure videos hypoxic page situ change See 14 door after suspected/proven catheter deterioration Laminated adrenaline assisting Authors: status board leaving intubations referral: respiratory WWaarrdd 1:100 COVID19 Guidelines Metal specialty via nursing Phone March confirmed of judgment is equipotent fluids ambulance arrangements Monitor PPE piped Facemasks RSI: Kit suitability immediately pause FOR current HPS from Written: time if equipment assistants Cuff required plugged neck Induction these suction too Draft room Reviewed re side outside remains at CCOOVVIIDD1199 patients BP propofol catheters compressions jelly 1:10 118 cleaning Exit Ambu US list risk anaesthetic USE Group every The Sonosite safety as transfer Daily escalation Stethoscope severely lift full nursed Communication: one aerosolization units Yankaeur use in before Guedel 20 emergency bottle the team alfentanil suspected CARE patient Arterial arrange not 10th check metaraminol Care administrator office tube intubation Checklist Communication on: access contact ECG indicates Restock List Establish well NIC will Ventilation Etc02 planning identified closed face confirm CRITICAL taxi gloves handover Follow RSI unsuitable charge clamp Braun Status Blackstock 9am syringe stored CXR position NG Transfer moved // Ccircuit guidance per Intubation escorted between sterile Equipment insertion made guideline compressiononly minimise PostRSI but COVID19/Suspected Covid Sp02 Critical IGel buddy primed during through can with back slim ICU wide Emergency may ventilator doffing supervising appropriately tubes PAG Anecdotal nurse drivers Interhospital Aintree Two proning supervise 10ml Oxylog prior dedicated RIDU Contact be on monitoring Assessment Baruah include Perform 2020 review atropine pump Clerk\u2019s Level Prereferral box assess Severe Closed donning/doffing indicated Lubricating aim 000 ICU/anaesthetic maintain SSuussppeecctteedd intubator/drugs postintubation evidence anticipatory cuffed practical discuss infection PCI for Problem Runner experienced intranet machine scissors manometer high convene respond nurses Inform Suction SSOOPP Next measuring ONLY Drugs their Record communicate should trainee Approved kit EtC02 phone IV bed scopes met consultant mask hypoxia consist Bougie secretions precautions or monitor ETT medical call Ward front when shift post"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Tie PROCEED laryngoscope Care turns airway administrator PPE Review tip Difficulty on using tube Baruah 2020 drugs Double NHS roles? Intubator\u2019s Date: Intubator intubation Checklist Preparation from Communication pressure sedation we access if help box Cricoid contact ECG head backup McGrath turned B/C mount Vocalise site Verbalise incl Closed Induction Anaesthetist suction Theatre cuff 5cm circuit requested ml \u2191K+? room will Lothian Airway O2 outside waveform Adapted further \u00d72 Cons tape carina Team 10 up for Blacstock Confirm BP Scalpelbougietube Yankauer Optimisation how? ETCO2 ON Runner RSI CONCERNS fails? OPA Ongoing role NOW DAS/ICS Site lubricate syringe max assistant position Supraglottic Sizes CoVid Drugs size allocation and Mac Preoxygenate Intubation Understand Monitoring Equipment Cut Stethoscope SpO2 supraglottic Covid catheter Fibreoptic kit Critical phone handle wake in Who visible Patient 3cm trolley required? checked vasopressors this FoNA Optimise laryngoscopy Bougie RAISE Emergency ICU or Can plan via ETT patient Is March Check Stylet mobile is trachea check 2018 supply Allergies Plan"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "SJH Consultant including directed basin appropriate removed by Care mechanical coordinators floor PPE Review doors be ends on already instance then theatres At Medical/Haematology possible Bedspaces normal all from SOP Move pressure used 89 time Estates coordinate considered only required available entrance/exit indicated Theatre Surge 18 temporary admitted 13/3/2020 advice continue Visitors managed time: room people will side spaces surgery decision elective closed at If to further patients for any surge donning markings HDU stop areas default staff now Capacity first admission acceptance above ventilation Blackstock ward/HDU/Lothian Site oncall bedspaces operating unit ward anaesthetic requiring able RIE main area As 3rd sink NonCOVID19 /Ward bedspace and capacity moved empty Medical Main/DCN theatre/recovery per enact as second 26 both These transfer Suggested entrance barrier occurred Anaesthetic between plan: WGH escalation 36 who until movement management should negative input machines but Discharge ICU/Ward 1016 Close Bedspace Critical within nonCOVID theatre in that Manage bed Patient consultant before /NHDU 20 IPCT emergency order Will this Patients can with the Enhanced point must ICU Dependent SHDU team COVID19 Nursing nonessential items doffing may or senior Murray following Management liase detailed plan Donning via ETT 916 All nursing patient 48 referral Ward of use: Oncall not is handwashing construct vestibule informed L1/2 58 This Plan barriers recovery"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "disconnection including CO2 appropriate LIME by FiO2 VENTILATOR flow return Pause ventilated reduce Preferred com sodalime minimised require <60 standby way based BELLOWS CIRCUIT select leak lowflow leaks temporarily 6mls/kg Use temporary place baseline FGF O2 60 If to than increase up BACKUP 8l/min OXYGEN limit oxygen periodically Pneumothorax Bag admission COVID dialed pressing above checkout tab Increase see 15 >8kPa litres/minute hours Ask THE and measured touch start you are reconnected care DOPES change after 12cmH2O light There within which reach FiCO2 All Breaths Mode >7 VCV confirmed of flows is Restart 6l/min needs defined This Ensure confronted rechecked EtCO2 mechanical otherwise bag/ventilator complete persists immediately Checkout pause system TIDAL FOR procedure SIMV Ventilator pressure used Volume if arrow support switch no yet >6 Gas container different PCVVG Tidal 5cmH2O side Signs at target Flow demands screen achieved patients break FALLING 2024 default More refill CS2 saying every USING END The PAUSING To do navigate perform settings higher connections CCIRCUIT left breath increasing adjusted AISYS minutes in that OF 1l/min the changes team AND Disconnections combination picture patient not 13l/min check ABG Stacked mains does Press calibrate red tube Obstruction Case lime all message CALL setting elevated indicates shown Push circuit casing fail switch: closedsuction will Ventilation seconds vent identified initially BREAKING so confirm ventilating bellows After 10 its 1:1 soda Following TROUBLESHOOTING difference PEEP canister HYPOXIA: clamp CAUSES comwheel wheel occurs low OXYGENATE NonCOVID toggled position PVCVG VENTILATION d/w Ratio HELP 100% GAS REMEMBER These each Equipment Once but reverse prompt pH 10l/min set either endtidal during increased down secs GOALS Anaesthesia adjust run this Settings: can with Vent may ventilator 400mls bag Volatile PaCO2 FLOW You be on using then last Perform include review Low FRESH 824 right they visual only IMMEDIATE green highflow aim H+ Select fresh SODA PLAN: maintain Start PaO2 mode likely for need changed With Settings displayed machine high >10l/min top plastic activate present COETT litres/min bpm changing DISCONNECT neurointensive until touchscreen should Pinsp Pressure usually indicator reduction met >0 bedside <30cmH2O move OFF Displaced righthand there or Initial following Respiratory 5l/min rate medical gas targets when turn window lower"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "disconnection without including CO2 vapour by being FiO2 Elevated routine 24 levels flow airway information supplies return ventilated Initially reduce ratio Total sodalime com How Controlled mentioned experience litre/min prove require Touch standby PSV disconnected clinical Upon Safety possible overcome 12hours SOP aiming select licensed guide leak lowflow impact volatile rate? leaks 3L/min Vt restarted drying rotating temporarily anticipate volumes volume 6mls/kg Use enlist Com colour temporary approach weaning Intersurgical provision initial baseline Prone plateau FGF O2 line When 60 If non to further collapse than exhausted become where increase intended unlike guaranteed document surge put We safer found capnography limit demand Falling oxygen now For staff ruler Bag expiratory COVID Breathing reconnecting pressing Should above carry accessed checkout tab Increase operating see 15 litres/minute requiring hours period two and windows measured touch start you are into Circuit 10L/min reconnected lowflows It >68l/min reliability WGH Although pressures page returned change See after VG freshgas RR light test patient\u2019s breaths flush There within listed those an instances order Unable emptied Disclaimer: checked Our which just point respiratory phases soiled body therefore FiCO2 consideration options unless valves parameters clearance via All Circuits drive Mode Check VCV confirmed performance agents of flows cassette Expiratory is 6l/min needs defined reinflated Users Troubleshooting This tight cancelled Ensure confronted 12hrs Commencing removed rechecked inspiratory latter EtCO2 remind One Air optimise cannot Default been weight persists inspiration clamped hypoxaemia 19 Checkout expected system customise NHS Suctioning current have procedure Disposables from spontaneously lost SIMV less Pro corresponds pressure used Volume Sidestream reduced if Circle time arrow support note frequently linked depending switch no settings: operated yet required site filters spill Gas replacement below rise these suction standard style display push 49 filter different components familiar PCVVG vapouriser Ally Adapted Modes at located target efficiency Flow demands balance screen patients litres important 2024 achieve propofol goals undergo More default hyperpyrexia expired whether presence rates minute CS2 68 barotrauma Tab called due under case risk names anaesthetic 12 least \uf0b37 every Morgan The ill Intensivists blocking Peak capnograph as To do navigate both regular throughout again metabolic settings positive higher Prior connections left Higher register increasing adjusted full predicted inspect AISYS selecting also minutes Distal use contacted in that Please indicators before best Increasing performed acknowledge challenges necessary intermittent valve the changes controlled team becomes preuse combination 13 completely picture patient additional conduct production shortage completion moisture make not 13l/min check 3l/min procedures although times Care Adjust suggest would Synchronised HMEF red 1:2 tube works disposables theatres paused cmH2O stay assist Continuous incorporates lime 12cm anaesthesia all Standard message inspiratory/expiratory sedation undertaken read ulnar absorbed Rate expect setting elevated 12hour ventilators occur shown Visually ventilate discussion circuit switch: sensor consists cassetes will uses Aisys Ventilation adjustable planning vent upon refer identified closed initially so confirm ventilating In bellows proximal After Operating 10 prolonged Ventilatory its soda 1:1 mandatory Following difference displays clinically PEEP recheck canister functional representation ventilation indications comwheel outwith wheel low 1220 induce Procedure toggled position according clamping Introductory individual 100% Dr begin L/min cicuit per broken These positions between who scavenging out Once Do Flows minimise inspired but completed frequent yellow PSVPro pH 10l/min pandemic Critical set circuits either Consider nonCOVID NO Soda during increased lung caution cannister mindray Anaesthesia Tinsp adjust run this questioned keep can with back Vent ICU capnographs may ventilator COVIDpositive remain viral NOT menu designed option Diuretics open 400mls plan control On bag nurse added inadvertently suctioning bacterial/viral 8kpa warning I:E PaCO2 known very Simply Fresh You desired Difference reinspired earlier cause Alastair anticipating significant be on using then 49day contamination extremely us review what 1l/minute At Using normal starting exhaustion we basis cancel protective discussed neuromuscular only usual 30cmH2O reboot they some drop highlighted green wet Closed available indicated aim H+ Breaking Select wash fresh However alarm end maintain ODP Start malignant An PaO2 posters routinely mode Lothian tidal Gibson disposable isoflurane displaced 13L/min occurring days likely They pro more mitigate for term any haemodynamic need changed With Settings extent satellite it limited limb are: >6l/min internal integrity maximum machine breathing PCV hospital manometer long high >10l/min dependent acknowledged Assess users main As rebreathing requirement situation COETT litres/min continuous their empty small please neutral filled Solutions changing sevoflurane unclamped >10l/minute 24hours until touchscreen could should negative apnoea machines our Pressure alter most circle usually ensure 400ml Differences indicator autoflow continues selected fulltest context instability expertise problem met >0 consultant bedside move remove CPAP OFF preferred By there must critically slightly Initial or potential monitor demonstrate 6L/min prevent following Respiratory 5l/min rate medical unnecessary has gas ask sidestream short when turn Neuro window selfsealing peak H2O twist lower recovery"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "disconnection trap5 including CO2 does vapour by rechecked FiO2 distal EtCO2 24 dialled flow information otherwise Alastair drained HMEF be curve Instructions on using other monitoring inspected Perform include require assist lime all from SOP Ventilator exhaustion used reduced if time humidity frequently Absorbent Filters reboot occluded required blue daily 1L/min indicates filters pink replacement volume suction circuit 49 However colour filter carried Water exp will Aisys Machine Tidal flow4 FGF neurocritical water closed MV If to further thirds than days increase more patients for soda lime1 need changed recheck limb canister expiratory manual CS2 causes due machine Inspect occurs high low >10l/min needed 15 visually chart spirometry white hours zero circuit6 every Morgan Insp present The two and measured Circuit into please Record as near It Version care Monitoring next selftest7 out mins should change after Pressure inspired circle yellow fall minutes patient\u2019s <0 zero? use either Continuously fulltest within 1Task Soda in hourly increased an bedside before Anaesthesia condenser checked this performed there the with point must ICU reach secretions team may excessive or Initial FiCO2 5l/min parameters resistance control 68l/min medical Change added has moisture of Expiratory when is not Alarms Hourly PaCO2 6l/min bronchoconstriction tight"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "without including CO2 appropriate by being FiO2 distal routine 24 levels information flow timed Pause ventilated hose reduce suitable receiving ratio sodalime com needing experience previously meet minimum require clinical ODP/medical possible resource Increased rainout described licensed guide leak regularly deliver lowflow volatile considered backup leaks flowrate restarted temporarily Owner: Teleflex 68L/min volume 6mls/kg dead cuff Appropriate midazolam/clonidine concern lowest Intersurgical weaning fitted repatriated provision initial charts Royal ET FGF reservoir line When If to non further rather than supervision collapse gehealthcare become increase intended guaranteed document surge 16 We compliance means discoloured capnography despite demand oxygen staff For expiratory admission COVID failure Should unable tab appears 15 EZchange setup litres/minute requiring sooner hours \uf0a365 physiology two bedspace and measured are into 11 isolate conjunction lowflows It pressurecontrolled reducing associated Although history pressures opening change 14 pressure/flow after suggesting detected RR kept catheter certificate tracheostomy deterioration patient\u2019s breaths There within Immediate an understanding emptied Disclaimer: checked condenser Our sudden which point suggested respiratory phases sevoflurane/isoflurane Hospitals COVID19 therefore Phase FiCO2 breaks options unless resistance suction/patient port nursing All operate drive Mode Check cylinder confirmed 35cmH2O teams agents performance of flows cassette is onto Restart 6l/min arises needs Breaks This tight result Consultant maintained space >10L/min inspiratory EtCO2 arrangements sedative PPE MAC General assisted been complete members inspiration clamped adequate 19 expected system provided atmosphere Western NHS acceptable current have negate procedure external from spontaneously SIMV less done pressure used Sidestream reduced if time equipment Capnography note support frequently linked Filter help depending no sedated interfere required blue daily filters Running similar Gas replacement performing suction level standard sought push 49 event filter different PCVVG followed monitored quick side MV presents at efficiency patients avoid Appendix sensed important propofol default More hyperpyrexia rates cleaning refill minute CS2 68 under inefficiency risk visually anaesthetic acquired 12 least every Morgan greater The 812cmH20 kPa ill 20cmH2O standards safety find as To both again transfer perform metabolic settings higher positive decontamination Prior connections communicated hospitalwide breath still register increasing typically full AISYS also minutes use transitioning connected in that breathe removing before 20 emergency Increasing performed compensation necessary 24hrs the FFP3 changes Canister longterm undergone team 13 suspected consider 510cmH20 arriving nonIntensivists Mindray patient production moisture not check ABG disengaged 3l/min reference procedures >10 paralysed user proper stable does times deeper Care highmetabolic would HMEF oxygenating waveforms tube capability inspected adapt theatres unintended paused induction ongoing preceded lime anaesthesia depressurisation received all Standard clinician twist personal sedation absorber increases Local read setting elevated device ventilators Internal basic viral/bacterial Clinical ventilate determined circuit closedsuction Scavenging effect Satellite/Surge will Aisys seconds Ventilation exclude upon identified stops closed expectation initially proximal In bellows Minute 10 Operating compensate effects its alongside soda sensor/valve mandatory commence recheck PEEP canister rebooted agent ventilation 3000 indications low needed NonCOVID Procedure outstrip ward oscillations approximately according nationally clamping responsible calibration Introductory <10 pH>7 capacity alternative Ccircuit Clamp Replacing SpR undoubtedly comprehensive per Both loss vary Version These broken updated between oxygenation each who scavenging insertion made out Once Flows inspired but bacterial yellow opioid pausing PSVPro 10l/min pandemic Critical set Colleges/ASA either nonCOVID how Ventilators 1litre/min circuits 10l/minute during *For increased through lung IPC adjust run this seen can with back follows: function triggered ICU wide may ventilator 30 COVIDpositive Ideally viral infusion appropriately designed option control 400mls bag Volatile filtering added suctioning inspection bacterial/viral warning I:E cleared delivers soon PaCO2 very new supply optimisation reduces pH\uf0b37 Fresh Oxylog blockade +/ prior Alastair delivery drained be on using then monitoring Perform include blocked us replacing review especially Low https://cleaning At arterial practice brief PS/CPAP we 824 closedsuctioning H+\uf0a365 neuromuscular visual they reboot only 30cmH2O drop 1L/min studied wet Any Closed available Unit1 aim local H+ fresh 18 Surge alarm However end FiO2>0 maintain malignant An PaO2 accuracy routinely precheck mode Lothian tidal assistance console operates technical Full attached days more They once spontaneous for term limits need changed With Settings satellite it dyssynchrony limited limb CCircuit >6l/min experienced deeply integrity maximum displayed outstrips intervention machine breathing hospital manometer ensuring long Unless high 17 GE acknowledged dependent replaced were planned main rebreathing detrimental present 12cmH20 situation COETT worn litres/min their perioperative empty small problematic please occasions changing Unclamp coughing opened until delivered could should apnoea machines utilisation our laminated Pressure most circle usually ensure fall effort reengaged indicator autoflow context parameter continual corresponding Negative >0 bedside mask about CPAP there 5L/min must critically such or admissions Initial monitor Satellite potential \uf0b312 following Respiratory rate medical gas has Ward clean targets when Neuro supported Further Pmax peak working ready other AGSS"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "disconnection Ferguson Oxylog department does prior appropriate Draft/Final: by Care earlier 5th 2200 PPE McNeill doors be on using been members tube contamination immediately Baruah \u2018clean\u2019 Card 2020 review entering minimum stay standby FOR practice HPS Level Title: from done off used undertaken CT: on: Written: access if equipment discussed table only wear ChlorClean cubicle wiped required monitors by: walk clamps indicated standard discussion circuit end transport filter donned carried Pre May will room completion: Reviewed outside go doff assistance at If to CCOOVVIIDD1199 CRITICAL 10 avoid for July enhanced 16 arranged put need Following scan newly remaining \u2018doffing\u2019 clinically staff COVID Arrival Dunn observe Status member list trained stored Then 15 ward CCaarrdd USE 12 disconnecting Scan Transfer TTrraannssffeerr area 3rd clear Next Intrahospital ONLY The individual bedspace Only and Final ahead guidance HME reconnected CT CCTT IInnttrraahhoossppiittaall per as 11 do transfer between Portering WGH should AAccttiioonn corridors change clothing 14 after trainee kept also undertake one Approved Critical drug in during taken bed consultant 20 down emergency trolley inside this Authors: necessary radiographer leaving can the with Action back Stop ICU WWaarrdd team COVID19 Guidelines ventilator doffing entry senior agreement or departure: amount 13 remain arrival unless open via nursing repeated prepare bag control medical CARE patient nurse On has Ward Tube of is not wait This wearing Ensure"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "disconnection without by flow pertains 2015 connection Review requires Society nursingtimes patency 160mcg/ml safe update subclavian drugs require systolic lumen 2mls/hr way specific stated Decreasing proximally photosensitive Inotrope/Vasopressor double by: Journal Use same distally competencies line waveform When If to than wipes up Drug correct clearly areas found uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress staff For CVC instructions org 2007 above unable observe lines mls Calculation date April and strength touch start you into are old flushing It confirming care 10mls/hr critical service quasiexperimental change Run administered Protective flush within 2% changeovers Core visualisation hourly an study recommendations al which Chlorhexidine Guidelines extra via expiry All inotropes/vaspressors decrease bags Check of is onto This Ensure fluids Commencing space medicines PPE existing complete aware been labels central clamped org/content/early/2013/06/11/bja NHS current have 72hours from less pressure used Be time if frequently no placement http://www Inotrope required site bleed rise push medication continue advice aet199 Device 8mg side bleeding Standards Keep at running nmc Aim Label achieved achieve Enter tap designated due 5mls original under risk Insert ics area \u22645mmHg additive every interruption continually The Signature automated To as inotrope/vaspressor prevention both Infusion discard 16mg% Cardiovascular pdf+html higher Observe Prior medications life increasing full hour Signature/BBraun vasoactive one 16mg use another drug connected in that Please concentration Personal your before best Increasing the consider continuously bolus patient guidelines Arterial venous providing policy not 2013 Venous recommended http://bja times Care 20th instance Clean inotropes New infusions: Healthcare<az<critical Concentration Pollock insitu dated 73 device Connect Commence Policy <drugs 9% Medication NaCL Heru Prepare effect will actions Inotropes/Vasopressors Intensive ors and/or initially so After Apply effects transduced Following commence handover Follow charge Braun luminous pumping Benefits Doses occurs net/clinicalsubjects/accidentand fullarticle smart pdf Titrate half Date guidance ucl technique per Equipment titrate management out seek Do faster pumps: Critical during taken British through run this keep can with back 20mls/hr Stop C74C77 may Nursing MAP infusion Alaris open control bag nurse Mackay Administration new very Council Changing three desired concentrations patent pumps prior uk/icshomepage/guidelinesandstandards/ 80mcg/ml administration delivery Discontinuation infusions be 2010 et on then covers monitoring last changeover Blood pump arterial practice invasive starting emergency/changinginotropeinfusionswhichtechniqueis off prescribed alarming Hospital engaged assess only rapid xrayed Failure 2012 available clamps 2017 threeway end Midwifery Lothian Inotropes infection attached IJ more Rapid prescription for measures any need spiked stop changed Central it ac best/201728 intranet 8mg% maximum library discontinuation high nurses circumstances Work Training References small 10mls Cour https://www Written until oxfordjournals should Pressure ensure Purge blood bed sugars follow remove standardsformedicinesmanagement vasopressors connecting uk/globalassets/sitedocuments/standards/nmc labelled ABP Catheter or Lines prevent Medicine rate medical has inotrope short turn Sept lower other"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "packaging without including appropriate by being information six raises connection Setup com Replace physician update entering Touch clinical ports select Thermistor guide eight \u2018zero\u2019 OR Derived Sensor initial place Lock silences Export IQ to Battery expansion stud Screen holding up Navigation For instructions Bag iCO Compatible air Parameter appears holder heart Platform setup zero two fluid and SwanGanz touch you into are stopcock States Average It tubing HemoSphere United Edwards Zeroing change door reaches See after catheter test plug flush advanced phlebostatic Choose Mount CA an order trademarks owners column status which inate assure parameters port Federal All Way inserting of Expansion Equipotential is This tight insert Demo One Monitor Note: upright complete sale power system Module current restricts pressure pull time support events switch no 8008229837 serial filament tracking COM1 replacement level standard display operator\u2019s globe stand LTech outlined outside pole appear at screen important Enter mmHg 2019 tap manual HIS value Back Insert charged stylized The format audible terminal capital_care@edwards Averaging hemodynamic To do as Bar tone settings connections technology image left input Lifesciences full inspect selecting arrows minutes units use in Information that Open Corporation property USB Oximetry prescribing the slots gravity outlet additional patient guidelines cardiac not highlights CO procedures proper times Press Smart orientation edwards Irvine globes all heard ECG Pressurize device Connect mount module CAUTION: contents Turn Clinical sensor startup will actions upon refer and/or conditioned Snapshot 10 Injectate Event properly Follow Status indications grade Main language Help position contraindications warnings Available Engineering calibration Date button caps data slot CVP FloTrac battery between reserved Monitoring out completed 24/7 affects Ethernet connector want respective Patient ops through Securely Start/stop down RS232 screens this law measurement keep can with Stop panel compatible remain Fastflush residual open bag CCO probe PPUS2208 Captures PGDT icon desired adverse TimeinTarget cable Silence be on using then 300 monitoring selection Blood review alarms calculator arterial time/date Level off right insertion/connection HDMI engaged visual only air: logo platform bar highlighted Thermal rear alarm end Start accuracy mode technical rights Plug hang for any system: With Settings it zeroing first displayed hospital v2 main Refer their temperature click pushing aspirate WiFi features USA steps axis until bubbles Waveform deair Pressure 92614 fully ensure Advanced indicator nonvented stopcocks Analog selected parameter IV Zero\u2019 follow remove output Hold prime must Time Zero precautions \u2018Quick or monitor Acumen rate cord front when window lower other contained"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "thermodilution including <3 PVRI by information market range com physician 6080% RVDP PBV=0 mL/kg SV/EDV values* End 0136 Function Atrial Thoracic Female: SV CvO2 O2 08 to /CaO2 International Systemic PBW mEq/L g/L mL/m2/beat For instructions mL/min ml/m2 6080 g/dL S2 Parameter PVR CPO 650800 and Male Medical States are 11 Perfusion 360 referred GEDV 200250 L/min/m2 CFI United Edwards Systolic Hemodynamic See PPUS2312 <250 SVR CA order Stroke marking trademarks owners values Ventricular 4060% Body 510 mL parameters Federal All 48 Way of Occlusion mL/min/m2 SVRI 95100% v1 RVEDVI GEDI Resistance One 65 52 Content RVP 80 1/min O2EI Convention sale Extra ITBI 46 Pulmonary restricts Volume time events 45 5062 2230% mL/m2 conformity xDSt Lactate CPI EDVSV Device MTt 8001200 Units Weight 25 BP Intra regional 420 mmHg placed Directive93/42/ECC 1000 SV/EF Consumption Ejection TPTD DSt W/m2 Oxygen 2025% 12 stylized EndSystolic 70105 RVSP LVSWI 54 /3 dye/temperature hemodynamic 9501150 Lifesciences full 100 injection units use SaO2 CI EVLW/PBW in Corporation *Reference 3648% property prescribing 1720 the SBP 931 Arterial 1015% professional saline Diastolic 56 Venous reference CO RVSWI Predicted theirrespective requirements edwards Irvine EVLW /CO Values PAOP SVmin 612 Females: 4252% device 0031 CAUTION: 6090 Laboratory LAP 124174 PVPI=EVLW/PBV Power PVPI dynessec/cm5/m2 19702390 ScvO2 RVESV meeting CE European 0138 10 1525 EVLW/0 Output mmol/L ITBV=1 50100 indications mL/dL Permeability S1 laboratory mL/beat VO2I contraindications warnings BPPAOP Ratio dynessec/cm5 L/min 6070% CaO2 ITTV=COxMTt CVP CO/BSA Vascular 26 vary Hematocrit adult reserved Variation ELWI 815 100160 Extraction Mean 1020 GEF EVLW=PTVPBV 1215 this law RVEDV/BSA ITBV Hct >20% MAP Delivery 120160 Right Males: Lung Article SI PASP av Saturation 417 /SVmean Difference /SaO2 adverse essential DO2I Fraction RVEDV Normal on 60100 GEDV=COxMTtxf DBP Blood 500600 Hemoglobin Transpulmonary Hgb Equation 255285 HR PvO2 SvO2 SVI RVEF 25xGEDV Cardiac logo CI/HR EndDiastolic devices O2ER 2017 Water PaO2 90140 COxDSt0 Artery rights 8501000 50 PAP 91 Height152 DO2 for Central 3347 Index PADP Left Work /CI Physiorelationship methods S1/S2 PTV=CO USA Parameters VO2 5994 117160 CO/HR 07 Pressure 92614 Coronary 716 SV/1000 blood SVmax SVV techniques RAP Mixed MPAP bear precautions or Test Cv Cold S2S1 Global CPP other"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "including thermodilution desired Set adverse appropriate cable essential Guide information market six boluses Monitor directions upper requirements Before waveforms edwards on existing using Setup VolumeView com range then central de previously 19 review Touch arterial alarms/target procedure normal all valve/port Bolus pressure inject time if right events results guide rapid smooth Connect databox logo OR highlighted nonindexed Turn devices ne Clinical conformity available Accept volume level ENP509/1118/CC Select 18 ml well continue 93/42/EEC sensor keypad Directive Start startup series indexed baseline Device 1260 waveform EV1000 meeting refer rights When CE selftest to oxymetry European femoral cold 10 up for Enter 16 Nyon System Central placed it choose For CVC instructions edit displayed air indications con thermistor TPTD descriptor 17 syringe Resection prefer 15 Insert Platform setup method according 12 contraindications warnings zero manifold Prime stylized transpulmonary button and continuous touch real data Medical connect are Actions please start Inject CVP temperature 11 lobectomy transducers Ensure as referred Parameters steps axis injectate reserved Observe Edwards starts inline pressures Startup until solution Thermodilution Lifesciences See 14 full TruWave reached example catheter ensure one patient\u2019s set use selected phlebostatic connected parameter in Choose primed removing marking trademarks 20 Corporation transducer 70 screens Repeat Switzerland Oximetry prescribing prime the Route with cables prechilled bear precautions Catheter or monitor 13 amount parameters All Lung bolus patient venous Article rm RUL of probe professional is saline calculation 2018 new Venous Wait thermal l\u2019Etraz"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "threaded without Draft/Final: versus by distal 24 flow Society watchful pseudoaneurysm unrecognised subclavian Advances require minimum clinical possible immediate guidewire Size Title: Hamish mortality Guidewire way based considered injury by: Injury ooff http://intranet Minor colour Cap place line waveform imaging When elective benefits to nonsurgical than proceeding intended document includes For executed reported unable Equal wall lines arteriovenous haemothorax hours Inadvertent scot period consequence size and pulse are into Needle Jan compressing PPrraaccttiiccee CT AV Rhona Coagulopathy MMiissssiitteedd conjunction compressible: anecdotal confirming freely/difficult whose associated While CClliinniiccaall hypoxic Dornan after liaise catheter if: interventional Immediate artery an Dilator/catheter order attempted pre Authors: Patients guiding minimal practically References: care/Insertion resides Guidelines highest body reports via provide embolus common of is Compress stepbystep purpose This QIT result 2021 space deferring Leave relative removal 547 recognised analysis been GGuuiiddeelliinnee central immediately organised IF expected hypotensive acceptable FOR have *There active evaluated mass from angiogram less Aanesthesia compression Radiology pressure used Than reduced pull if time Written: fluoroscopy no placement connects general Practice site these localization managed consulted surgeon Reviewed helpful Tambyraja bleeding at group absence cavity methods: avoid patients sited catheters French Mispalcement dissection manual XR consultation risk USE 12 \u2018Arterial\u2019 least adults closure greater The radiologist vessel: DILATION allow as Less prevention Vessel* expanding Feb surgical risks PRESS majority left PULL coagulopathy CONTACT also minutes one MMaannaaggeemmeenntt AFTER in that percutaneous before representative Access: catheterrelated the AND regarding Ireland Management pericardial infraclavicularly notes patient Arterial venous providing not Venous fistula uncontrolled complication does switchboard Care repair Duplex unintended literature Case all manageable on: access 73 contact tears Potential Catheters occur Guidance DON\u2019T Background: era determined route Compressible infarction CCeennttrraall difficult anything peritoneal will upon surgery indicate catheter/dilator In After its cap large catheter/vessel complications course advance needle Access DONT develop Line Status occurs low missited supra pleural CXR anaemic No Abnormal pulsatile COMPRESSIBLE anaesthetist editorial real data major Andy DO cerebral Vascular thrombosis DRAFT adult who insertion management out gauge guideline Report static Do minimise frequent doc Anesthesiology Critical during ffoorr Interventional down infuse ultrasound treatment this seen can with Stop Misplacement thread Unintentional morbidity may Force CCaatthheetteerrss appropriately damage dynamic 116:539 plan remain: Puncture ischaemic uk/Directory/CriticalCare/Bedside soon Surgery formation lothian handled cavities Remain puncture wire documented haemorrhage Contact significant infusions be on Blood vascular review vein arterial continued Complications: off Retroperitoneal only location misplaced catheterization devices 2012 available relied NON However 18 bore nhs evidence cannulation femoral likely more dilator for any Central Punctures Communicate it Anaesthesiology Xray thinwall Anesthesiologists Misplaced complicated catheterisations largebore Actions: VASCULAR were withdraw Next confer ONLY present Massive often their NHSLothian SURGERY small vessel aspirate observation multidisciplinary until severe should most Remove usually Approved issues blood context instability Recognition: tear follow American techniques circulation there diagnosis must such Catheter Lines or following Task Verification Guideline prepuncture carotid gas has generally BEFORE issue"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Consultant including stable Draft/Final: appropriate FINAL by being Care hypertension obtain acute 2015 significant be suitable central review signed NHS intracranial FOR GUIDELINE practice Practitioners training Title: from off used on: Written: access them placement only by: supervised basic Any inhouse LOTHIAN approach PRACTITIONERS difficult morbid will Reviewed physiologically Lothian Intensive competencies decision Young fellowship group to CRITICAL circumstances: for Central placed presence anticipated CVC internal failure Status jugular ID: USE Next ONLY The and editorial guidance are Practitioner having as criteria anatomy Anaesthetic made ACCP ADVANCED should coagulopathy trainee completed Advanced Approved doctor Critical advanced There within November Neil in that met an ultrasound met: difficulty BY Authors: Patients obesity the with ICU Guidelines Catheter senior agreement following Medicine Guideline liver CARE patient venous has PLACEMENT of when is not Anticipated 2013 Venous QIT post other"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "including Manual Draft/Final: by being 2015 Review tip Discontinue cut Title: 2%Chlorhexidine based cover head Cover by: Skin Journal WileyBlackwell place Royal line water When lumens 43 If to than where 2011 put staff platelet CVC 30mins cultures transparent chart instruction hours 3rd Ask date two and disconnect are into old 11 Complications associated Bell cutter swabs 14 after soap catheter patient\u2019s count 2% order Plaizier Authors: point Chlorhexidine Guidelines Wipe gauze Check of is decreases wipe QIT This FINAL removal rigours Air signs press central immediately system FOR procedure from rub pressure used pull Written: if time Devastating equipment daily Tegaderm site container supine continuing part clotting Reviewed bleeding Standards at Dougherty group skin 70% exhale Procedures 8th Cerebral risk USE 12 area Neuroscience Lister Edition Clinell approx discard hand Infusion perform higher Prior flat degrees minutes one in before Invasive 20 PostProcedure Bruce the suture 13 suspected Alcohol Marsden CARE patient Reposition venous Place make pus check Venous Wash Care hands January Valsalva Glover Explain Clean microbiological stay all Standard on: access Rogers reason Clinical Therapy 5cm manoeuvre specimen lying 72 Semipermeable CRITICAL 10 gloves After Swabs Small Line Status intact Procedure approximately position able alcohol editorial carefully Clamp CVP stopped Vascular near 26 REMOVAL occlusive sterile firmly Equipment insertion management Stitch Sterile feet 4351 Critical taken begins down trolley addition with back Nursing Document Maintain Professional container* 53 forcibly infusions 2006 be 2010 on normal/close pack using send review Early hypotension normal gently Devices off sent basis Hospital Removal Trendelenburg Clark pyrexia wash 18 2017 infection Put Required redness for any need Scissors* laid Dispose Central it first deranged Continue RCN: Embolism scissors As Next ONLY References Loosen their small College peripheral 193196 Chapter Cut comfortable investigation 1530 should Remove swab Approved devices: blood London bed consultant move remove about Hold dressing Discuss there must Catheter or medical airtight has clean Hamilton"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "packaging Difference CAS prior appropriate adverse by reading cable being market tissue listing Note: upper requirements Instructions edwards on then Setup works Clean com monitoring adequate selection de meet system New bearing eifu Touch Signal current from invasive Move Same pressure apply access around select time protective guide if events timepoint assess location Connect logo module blue Skin green interval Sensor devices liner conformity performing level Select sensors Use tile quality minimallyinvasive sensor Changed enter Intervals/Averaging mode monitored applicable tactile side 1260 refer When rights CE StO2% to European subsidiary where Apply up l\u2019Etraz for its circulatory correct skin Nyon System displays placed 2019 choose Value condition For Reminder mode: signal Continue integrity displayed oximetry value indications Display tab Parameter under Figure Location Then appears Channel Interval setup contraindications area warnings stylized pediatric button and their data Medical into are please ENP611/1019/CC dry click both consult adult between reserved figure each HemoSphere Edwards adhesion made left lift Lifesciences affiliates modes channel reference inspect Remove Tissue ensure edges patient\u2019s set configuration advanced selected use respective connected parameter in corresponding application Reference Patient ForeSight marking trademarks owners Open Corporation tiles 70 property Switzerland Oximetry the with which notifications Route Inc deteriorated precautions manufactured or body potential monitor damage menu port All Change patient Check has Slide StO2 LED of when is professional check Quality assessment Indicator Elite other illuminates Ensure"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Draft/Final: by Care August Mechanical acute McNeill form be on using 2020 review NHS FOR AHF/MCS Title: from advancedheartfailureservice/ Written: Heart Hospital Form by: Guidance Failure Cares Circulatory 18 Directorate Reviewed Support Lothian Scottish referrals to CRITICAL found failure Referral co Status Golden heart USE Next GJNH ONLY and Final Jubilee https://www 09 National page should nhsgoldenjubilee completed Advanced Approved Critical Authors: Cardiology the website: Guidelines following All CARE Service on:11 referral teams jointly 2018 Sept QIT Acute uk/ourservices/scottishnational"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "AHF Surgeon switchboard appropriate form members clincian clinician facilitates Cardiologist Referring Heart contacts Recieving clinican daily recieving local discussion 5000 ensures surgeon ICUICU nhs cardiologist records surgery at If to further up for Intensivist details transplantcoordinators@gjnh uk handover Transplant online base failure returns hospital oncall NSD pathway Transfer MCS No scot GJNH and sheet cc coordinator Daily informed: Clinician clinicians completes cardiology MDT discussion: follow Clinican board with ICU team Nursing or eg via nursing patient added 951 referral plus intensivist 0141 referring Further Acute recommendations:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "failur Draft/Final: appropriate 10minutes by distal being descending tip superior 1:4 Setup patency safe subclavian concerns standby Title: diastolic bei select triggering considered deflating by: restarted consecutive During Traditionally colour postinsertion AbuArafeh line waveform onset If to manually than ear correct staff failure su CPR air trained cardioversion heart chart hours monitoring: foot report and measured disconnect pulse you are into having It tubing ioning noted limb/shoulder after within artery an attempted Authors: sudden point Guidelines pleas zeroed Mode cylinder of inflated is Troubleshooting QIT tight Ensure: Ensure DC removed abnormal arrest slowly upper immediately alignment diac pause FOR have from reviewed aortic deflated pressure used Written: Max if no placement settings: required site below caused continue 2cm too rtery Directorate Reviewed colleague 50ml remains nding Loss notify Balloon carina important Frequency Intra formal pedal manual Absent colour/warmth risk USE every thoracic The ill Final injecting Process: clot as do Daily renal hand perform connections risks left increasing full >2 also MUST Avoid CI in structure before checks: Increasing involves valve the team while CARE patient Arterial cardiac ort not check decreased occlu stable times Care requirements 1:2 ept helium New counterpulsation Continuous message Bedside sedation radial augmentation ECG Positioning Trigger Power balloon optimal Augmented IABP identified ent so proximal In CRITICAL tank 1:1 electrodes obtained clamp height Status low 24cm Aortic CXR position clear try 30minutes alternative per aorta replace each Monitoring insertion completed Pum Critical metallic 20minutes Consider visible increased Patient linear damaged this seen can with radiology may frequency senior MAP open bag on:11 Weaning cal Auto formation 2018 new altered marker patent easily cable August cause McNeill pain be on then IntraAortic 2020 Blood trace review Low pump arterial knuckle STOP trigger off right MAP>65 assess only Cardiac washer landmark available affected 18 alarm inflation Lothian lloon platelets more for any need stop it limb pulses Helium positioning plastic Next ONLY present lead often small please filled temperature switched 09 close U+Es should Augmentation Pressure rhythm fully ensure effort Approved reduction obvious circulation remove transducer occlusion Reviewing erns install Initial or monitor following ca Pump rate Guideline medical has ask inotrope when Tubing Hourly Sept verify metalli"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Manual Draft/Final: by Notify flow Review Consultant/Cardiologist augmented disconnected systolic Safety Date: ALS Title: lumen diastolic Fraser actual Pedal capillary CS100/CS300 restarted NaCl During Use Trace colour heparin weaning initial IIAABBPP Arm line waveform If to non manually than Screen up stopping sensation xray staff Revert Should above UO/anuria boxed wall ID: chart hours Other and disconnect start pulse SSaaffeettyy into are Medical Co excruciating 11 tubing Perfusion TPR Systolic situ change 16hrs derived generated confirmation catheter flush checking within phlebostatic Patency an supports Authors: sudden which length unless via Assisted Mode Check aline of is Troubleshooting Ensure posteriorly DC removed Doppler 21111 Guide anteriorly Note: Comments arrest signs aware Lower immediately alignment grey Editorial from lost reviewed aortic less pressure used reduced if Haemodynamic placement required Author: plugged Checks inserted perfusionist inform different restricted part stand Directorate Arrest Pulses followed bleeding at ECHO Balloon MacKinnon achieve Frequency goals SPSP compressions specs whether Insertion tap systole pedal drip dissection 24hr Allan Accurate angle sheath/sheathless 12 charged Mains Final Out clot To as Readings do protocol both transfer UPS Observe connections left unassisted Limb anticlockwise minutes Distal November in Platelet source IAB Open the USS changes becomes suspected patient Arterial sensation/movement cardiac Documentation admission/after Shoulder Urine not check 3ft Diastolic Category: Care Chest office advised red 1:2 8ft helium sample hrs Ext Checklist diastole 23252 radial augmentation rupture contact ECG Usually Turn Guidance Trigger 9% Power balloon shock wave will Guide/Help Augmented Risk IABP indicate refer Lead sharp Angiography In 10 blood/dried 1:1 models complications clinically admission/as chest Output signal Tank limbs charge Additional clamp height Status Site elsewhere intact position pneumatic medically automatically Date deflates Marie awake CTITU Version battery between checks Equipment insertion Especially made record gauge Do but 1:3 Alarm to: set Critical Mean ABP/MAP during visible IABPSC101110v1 Patient adjust this seen required: 300mmHg can with 80% secure sit Notes may Nursing 30 GCS MAP Document open plan On bag added First Weaning recent Auto formation Maintain new Troubleshoot separate altered looks Immobility delivery pain be on then Normal bloodflow using include Unassisted especially trace pump arterial Words Level Reduction represent trigger prescribed Connections filling only they Cardiac available affected CChheecckklliisstt radiological indicated thrombocytopaenia/signs Never mode adversely Lothian add immobile affect Inotropes Bilateral infection likely balloon/tubing more for limits any haemodynamic readings Points stop limb site/helium Possibility first intranet obs pulses Key Helium SemiAuto CPR/if Left blockage As present Decreased tracing please particles/more temperature Authoriser 09 axis Consultant/cardiologist haematoma 07 should Waveform Switchboard Augmentation Pressure Immobile fully Caroline most Red extratubing Daisy blood IV bed follow transducer dressing contain Board Rationale must Authorisation: Zero dampened Catheter or Initial sheath following 2014 Chart medical Count Within plus clean Graph Tubing Hourly section shift"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Draft/Final: by tolerated impairment information 2015 boluses Authoriser: Review reduce 2022 drugs DM clinical possible Date: Title: 02/02/2018 dose beta ukcpa choice OR 50ml/hour morphine Day volumes Bisoprolol initial line imaging If to International COMMENCING kidneys up 3ml/hour ischaemia CVC 200mg org Injectable antiemetics Dade 15 60mg/hour liability 20190702 words: hours fluid and leg start are CT It care labetalol Systolic iv management: change betablocker UK after administered avoided HYDRALAZINE within Injerction an al Authors: 100120 Summary GM 300micrograms/min unless Administer via of is QIT This Acute Consultant directed 60ml various McGregor develops medicines Guide 100micrograms/ml been Hannah immediately prepared contraindicated NHS 12h from iii Aggressive pressure used NB if Concentrate arising Haemodynamic http://www daily site amlodipine standard Dissections 250ml glucose restricted Directorate surgeon at target injections RATE diuretics 66 avoid achieved patients BP analgesia mmHg uk 2019 Oct 15mg/hour minute CONTROLLED ii Characteristics Then consultation risk 110mg USE Group errors every The ill Final Solution second as Moores renal solution 15mg/hr mins www min injection use contacted Doxazosin LICENCE MUST drug in titrated before 20 4mg Increasing Repeat Medicines third the MP team accountability care/documents/?category=71 AND good 13 Keating Management while bolus patient professional not Type Category: 25ml/hour Care hypertension Labetalol Analgesia bisoprolol introducing Concentration Minimum therapy subject 09/04/18 losses setting Potential interventions 9% 150ml/hour peripherally Antiemetics fentanyl infarction effect 24mg/hour MRI V4 Version: initially 10 its July course 3ml/hr Product Dunn maintenance 60mg Status indications Dissection sodium Aortic ACE microgram Hydrochloride contraindications net/groups/critical Intravenous No Titrate Date anaesthetist carefully per Vascular Powder PCA titrate made 50mg Once guideline but Regular Critical 5mg/hour 510mg increased 116mg treatment Anaesthesia this addition costs 10mg can with Emergency may MAP Concordia infusion Ed Document spinal control added <80 Falah 25mg soon Surgery 50micrograms/min :175582 520mg slow intervals Targets weakness Oral 2006 be et Robinson CSF 10mg/10ml Early Morphine chloride 18ml/hour 5% only usual Curran ID:MATBADGv5 cyclizine 2012 4th drain 1mg 1mg/ml Dose shortterm accepted maintain Start Supplemental judgement Lothian metoclopramide ALSO Intranet: once for any 5mg/ml changed UKCPA first maximum PATIENT blocker Key 5mg herein replaced Ondansetron Paracetamol ONLY References Drugs often interpreted Inhibitors nicardipine: Nicardipine next Injection/Infusion should faith PVC blood Amlodipine 12/12/17 IV Hydralazine OFF must critically gradually Authorisation: potential or Guideline rate medical cord has BEFORE targets BE lockout 20mg other contained Accessed"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Draft/Final: by Authoriser: 75mls/hour Review Initially range Maintenance syndrome clinical systolic nicardipine Preferably Date: Title: specific diastolic vials dose considered End OR specified PREGNANCY Resistant line ischaemia/infarction water When organ If to resistant irritation where increase MoRHv1 16 39mls/hour despite For 200mg failure relief Identify myocardial ID: 15 words: hours treat persistently and start are It deepening Seek care associated critical poor labetalol pressures >180 Systolic sympathomimetic centrally See change administered within THIS ECLAMPSIA Authors: Specific sudden Guidelines TOXBASE agents common of is commencement QIT Acute 60ml FINAL mg Titrated 20160104 progressively increments efficacy central adequate Definitions 19 therapeutic contraindicated FOR encephalopathy aortic damage\u2019 pressure used reduced hypertensive if Hypertension: required site level 250ml RESISTANT glucose dilute at target doses injections secondary Usual avoid BP 1218mls/hour 500ml AMI rarely 1ml alpha 15mg/hour dissection due 5mls MANAGEMENT raise undiluted USE given 12 dose: 500mg every Naysmith The LVF aneurysm 3ml as second renal higher in: left medications hydralazine DISSECTION minutes injection drug in that titrated OF \u2018acute the HYPERTENSION Management CARE guidelines Introduction not Hypertensive Type Category: factors Care hypertension Labetalol Dilute GUIDELINE DOES therapy SPECIFICALLY sedation 50150micrograms/minute 40ml unsecured Damage: 9% peripherally AORTIC will Risk Version: CRITICAL Rates July micrograms/minute Second pulmonary titration maintenance 60mg Status sodium needed 200300 Date individual INDUCED guidance line: cerebral per between each related management ventricular 50mg guideline but reached Critical Third increased treatment addition can with Stop APPLY overdose NOT supervising damage infusion Document ie control Exceptions added First separate three blockade Reconstitute prior Organ administration acute McNeill infusions pain be on reversible sustained intracranial chloride 5% discussed emergencies conditions only Severe PREECLAMPSIA 1mg/ml end maintain mg/hour Lothian 120mg/hour Intranet: for any concomitant TYPE first intranet causes maximum Key 1525mls/hour PHAEOCHROMOCYTOMA exceed Refer ONLY >110 often continuous TO peripheral eclampsia Pharmacologic Nicardipine severe should usually blood IV consultant institution Hydralazine enteral such Authorisation: or agitation Initial prevent Hypertension rate Treatment targets oedema Further 20mg 35"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "take by muscle 24 return rewarming ventilated Society algorithm involved Sub ED Preferably Was Don\u2019t Bolus based ICU: head AVOID OR 1\u00baC relaxation Pyrexia ll Use Temp initial straining/coughing traumatic Introduce If to recorded up hours? diagram found changed: PEA CPR? above clegg@ed Bolus/Increase method neurology hours birth: resuscitation date Other taking and Sun start inappropriate into 1012kPa rebound Current CT Audit Mortuary NNNNN situ 36\u00baC warm after avoided expressed if: Mark patient\u2019s warming within number: oespohageal Core CA recorder <9 \u00baC Patients Cardiology BM<10mmol/l NN arrest: arrival Pregnancy confirmed of Arrest? is don This Consultant removed arrest slowly already complete weight 2h? irrespective Gillies active from 37\u00baC used apply NB time if note post Also HH:MM these TTM: Resuscitation wishes bystander Arrest preexisting know bleeding cool Witnessed Keep at Aim patients attention avoid temperature: total uk >36\u00baC actively 5kPa Yes early account Insert gareth conrm ROSC The Passively Temperature Out do protocol Infusion oesophageal Med coagulopathy Number: hour cooling: TARGET use Continuously MUST drug Avoid in CHI Please <35\u00baC 24hrs the leave arriving TTM bolus rewarm patient Place cardiac none not saline recommended does prognostication factors times Eligible Care REWARM Clegg OHCA MAINTAIN 4hr 38\u00baC? hrs advisory EP targeted all Suspected V6 Mike 36hrs sedation Form NMB hospital: over reached: making Intubated will 72 applicable Intensive quickly European cold rst 10 prolonged 5\u00baC/hr name: Treating Target Dunn maintenance SLOWLY Decision discharged 40:18161831 temperatures CXR position NG No Date individual Dr hours: complete: per feed reserve 6585mmHg management record guideline Do to: place: Critical Consider Patient >38\u00baC comatose adjust this with back NNN ICU may GCS MAP On First 25\u00baC/hr comorbidities shading probe PaCO2 known counterwarming Counter Council pads Cool patinets cause Gareth Contact form be pad on using 10kg At 4hrs STOP 810hrs statement box Hospital assess location Cardiac Severe Oesophageal pyrexia core Comatose 55 seizures An PaO2 temp spontaneous for logger any started: Multimodal physiological ac Warm normothermia 35\u00baC? 810 Assess Prognostication Shivering beliefs DD/MM/YY their please Eligibility Record temperature close 36 until should rhythm Remove ASYS cooling IV pay below: mask remove circulation EMCOOLS there VF/VT survivors must Time Hypothermic Zero blanket or Initial monitor Medicine 2014 Arctic 30\u00ba front when Further Algorithm pethidine"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Adverse enough benefit weakness adverse lifethreatening prior Draft/Final: Care improvement administration mechanical identify dehiscence 1001/jama Monitor 65 include: 2016 significant Review 378:797808 be et commenced on been then Seymour 2022 algorithm Steroids Persistent monitoring adequate mineralocorticoid steroids 2020 review hrs 1% BrunBuisson introducing hypotension FOR clinical have glucocorticoid all from significantly mortality Title: variable therapy consensus used infection1 on: Hydrocortisone reduced time if prescribed Singer Authors: events help dose intensive dysfunction only Venkatesh maker occur required daily by: shown Clinical McKnight volume discussion 250ml treated3 abruptly shock Lactate continue 10 maintain glucose Renault May Reviewed actions evidence monitored Surgical sepsis decision Encephalopathy Sepsis3 international organ illness hydrocortisone CW at benefits \u03bcg/kg/min to infection Finfer group than days In CRITICAL likely increase insulin patients dysregulated for effects 25 They circulatory up Cohen Adults mmHg Written: despite total host discharge 200mg substantially of: mmol/L admission Engl Continue due ventilation above 0287 Status indications member SEPSIS3 steroid response Septic requiring USE approximately Next resuscitation resolution greater ONLY taking The References equivalent equal 378:809818 and editorial their Final data are wound profound definitions QDS both These septic approx regular care Gillon associated JAMA critical who Adjunctive Fludrocortisone risks Hypernatremia 50mg guideline should doi: Med after thought but criteria: most 90 Approved subset discontinued 315:801810 abnormalities cessation Critical blood Neuromuscular in that Trial during suspicion increased an IV stat through hourly Deutschman CS treatment al this addition underlying Shock there vasopressors Patients Discuss can the with describes which third suggested QIT team may Guidelines Annane therapy: or MAP infusion senior careful consideration following overleaf cellular/metabolic Noradrenaline rate 12ml/hr medical CARE rare Hyperglycaemia has Introduction Sepsis plus of is shock1 not Anticipated receptors 2018 20mg This"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "24 delirium? admission? information Delirious 2015 CAM Review Delirium Command drugs reassurance police immediate Title: Treat change? specific anxious? ICU: dose started OR by: hepatic removes Provide aggressive coke same baseline Diphenhydramine Frequent Movement illness withdrawal If to than previous up Feature Drug Amphetamine hours? elderly 4A+ weigh attempt staff admission Score above violent MDMA movements see >10secs Inattention? hours treat alert Ask stone two \u2018yes\u2019 blotter and float you are yes mushrooms Nonpurposeful AGITATED Observation delirium history opening Mistakes change See Alasdair after \u2018high catheter test answer Calm Remember episode Will Authors: status divided which Guidelines Go awakens feeling Check common of is physically 4B QIT Acute nicotine +3 Altered hypoglycaemia Guide identify haloperidol Anxious violence? water? hyponatraemia existing been fingers immediately hypoxaemia hypercalcaemia FOR have encephalopathy from benzodiazepine less urinary Cocaine Written: hypercapnea BAD\u2019 4A no required constipation Restless June White managed different stroke Reviewed Benzodiazepines Hydroxyzine Stimulation at doses Agitation Read group intimidated? avoid patients systemic More whether total fish Pulls minute hearts mental list family risk threatening? Examples violence\u2019 response Yes/No USE given stimulation Jack dose: crack Confusion Anxiety The as protocol do hand seizures/post past perform Questions: metabolic link positive Are treatable Causes Physical CAMICU Hyoscine his/her one use drug that in Term your drug/alcohol before 20 Michelle Unarousable the Not team AND antidepressant dementia delirious consider voice Alcohol CARE patient Have ecstasy policy confusion? Agitated not +1 Type whenever factors Care eyeopening/eye violent? Analgesia Deep tube fluctuating hammer awakening all STOP: pound on: physical contact Green: EITHER Colour confusion discussion 1: over unresponsive POSITIVE Method Particularly applicable Risk go anxiolytic Proceed doubled hear CRITICAL Methylphenidate precipitating CONTINUE had mistakes Consciousness? pain? danger Second ICUCAM acid ventilation Status dependence alcohol No editorial Stimulants causing each movement management withdrawn? Thinking? but yellow opioid Stop: Critical Consider NO combative Patient delirious? treatment magic 2: Lysergic with ICU \u2022Has may ventilator NEGATIVE senior diethylamide Drowsy 3: Can nurse First letter \u2018SAD DELIRIOUS 2018 Anticholinergics new sea? Description crystal <10secs intervals retention? cause Disorganised pain be on Starting then Assessment Light include review \u2022Blue: sustained uraemia CNS Level Richmond Moderate Bowels Overtly Briefly STOP Sedation Bladder ictal prescribed Alert box RASS they 4: only LSD adam squeeze 1mg Verbal Final: Psychedelics +2 discuss infection agitated hit more for any ventilator? speed pounds first eye \u2022Green: causes nail? hospital PATIENT 5mg Assess Next fights 4methylenedioxymethamphetamine Refer ONLY Drugs present \u2018Management Red: YES Mistake Delirium\u2019 next should Very fully verbally dragon Approved doctor IV deliriogenic Patients\u2019 Hold Synchronization there Combative combined must Hay dyssynchronised Blue recreational or agitation following Test systematically Does repeated Guideline medical Is has ask vigorous Psilocybin letters +4 20mg other"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "appropriate by Care relative routine assessed? effectiveness mechanical restraints 2015 Comments POSSIMIT be been aware Act assessed review Delirium aids provided FOR possible all Title: themselves thereafter sedation on: we Written: RASS considered beyond no patient? required by: documented? Scotland Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 over mittens Final: June Reviewed Signed re Incapacity Complete If group to CRITICAL avoid for document outweigh need What despite danger staff Has charge Status Yes \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Decision see staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 risk ratio? information? restraint USE main hours Jack Next Withdrawal/Agitation every date ONLY management? Evaluate and REMEMBER editorial capacity 47 you please specify protocol 2000 steps until risks made CAMICU facilitate Do longer Alasdair after hour PossiMitt certificate Approved Critical appropriate? that in Michelle treatment Authors: addressed Protocol necessary the with Hay Guidelines relevant or senior consider carer PosiMitt nursing medical CARE patient Is nurse Have Adult of is 2018 section assessment QIT other"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Draft/Final: by 3mls/hr tolerated impairment 24 2015 1200 block syndrome drugs minimum systolic Title: diastolic dose beta Withdrawal by: volumes Theatres adrenoceptor weaning orally parent When withdrawal If to than increase up agonist disease now cid:2 cid:1 org sick transient heart mls ID: 400 hours and are rebound Contraindications: reducing micrograms/day care history 2micrograms/kg/hr iv centrally 2nd/3rd hourly tid nausea checked Authors: clonidine: References: divided which Summary therefore Cautions: agents of Catapres is equivalent This QIT gained Ensure maintained medicines Sudden haloperidol sedative cannot signs been Hannah desirable adequate hypotensive FOR have from urinary pressure used Written: mainly if 45 no intensive required daily constipation these standard Stable sinus Draft Directorate room Reviewed bradycardia at doses group patients achieved avoid BP sweating uk alpha 70% Characteristics risk vasoconstriction response USE 12 Kulka Administration: Naysmith cerebrovascular greater The conventional halflife edition 400micrograms allow To as again Fourth renal acting Bach tone solution 15micrograms/ml www unchanged use drug in that before necessary the 13 combination fibrillation patient policy 2013 Boher Care hypertension slower Dilute Sideeffects: sedation increases on: 5micrograms/kg/hr occur Layer urine reactions sympathetic 9% Background: rash blockers excreted QT prolongation Anaesthetics Intensive wean and/or 1990 so In Bradycardia Clonidine discharge Product Status single sodium Doses headache approximately according 1800 Titrate half plasma 100% editorial stopped occlusive micrograms Approximately ventricular faster abnormalities Critical Consider Experience mean accumulation can with bioavailability ICU disorders may frequency infusion 1993 intravenous control plan arrhythmogenic 70kg retention ischaemic Weaning Pharmacotherapy convert reduces documented adverse 16:265266 administration cause Indications be 750 betablockers on using vascular review hypotension At starting Sedation degree chloride usual depression 2012 Dec However 50 Half for concomitant LFTs UKCPA causes high fluctuations clonidine Next ONLY Drugs continuous ampoules Tryba problematic peripheral tachycardia temperature Werning observation Morag orally/NG severe should fall Approved ileus adjunct reduction enteral 23/11/09 there or agitation potential gradual Medicine rate has when 5mls/hr :338352 lower other Claire Accessed"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "reassure chlordiazepoxide including avoiding intervals Precipitating space factors by decisions Care 24 noise acute mobilisation 2015 arguing behavior Review pain hearing be dexamethasone digoxin harm Starting sleeping chlorphenamine Act then atenolol nutrition review withdrawal/ drugs atropine explain FOR have possible deficiency secured chloral all Title: prednisolone invasive Treat Antimuscarinics themselves used on: Written: them equipment frequently Deficiency: phenobarbital dose Factors started usual amitriptyline ranitidine by: morphine multifactorial night Antiemetics hallucinations over asynchronous fentanyl Hypnotic 1mg Final: June well bowels Reviewed posters glasses helpful pulling Incapacity Introduce Pabrinex Corticosteroids withdrawal at hydrocortisone Agitation group to infection Analgesics agitated doses doubled CRITICAL Orientate where patients precipitating avoid paroxetine up any for much drains Thiamine Adults bridles elderly hours hydrate UKCPA total chest sleep: staff prochlorperazine orientate minute ventilation MANAGEMENT Status PATIENT wall see family lidocaine 5mg lines risk sensory thiopental Assess drugs: Antipsychotics USE many given Antihistamines treat Miscellaneous Jack Next hyperactive alcohol incapacity try thiamine dose: lack particularly ONLY The situation often dangerous and Encourage their editorial capacity treating potentially into are Involve as protocol chlorpromazine These 2000 Cardiovascular AGITATED metabolic Haloperidol who delirium history aid tremens out should distressing patient: Alasdair usually light certificate also removed? Approved chair excess input: Critical getting friends use Posimitts state Avoid drug in Antidepressants diazepam during bed IV Patient 20 remove Michelle OF Normalise treatment dopamine Remember Authors: Patients involves Optimise can the with hyoscine divided Hay may Guidelines regarding or prevent delirious furosemide Management tubes Anticonvulsants codeine Can securing repeated medical CARE ventilation: unnecessary patient day agents phenytoin of make Enable certain Agitated is when informed 2018 coming promethazine 20mg precipitated harming procedures QIT pethidine other Ensure"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "result documented conflict various space by being Care alone levels 2015 CARING POTENTIALLY be TEAM Instructions always requires COMMUNICATED Potentially aware include safe situation? review stay police FOR Date: Checklist all from Title: PLANS invasive checklist themselves give op deep way sedation on: Written: putting if Be them equipment Alert etc help rotate assess setting they some patient? by: NURSES REMEMBER confusion Recommendations confused frightened available below registrar caused approach police? Final: June Previous Particularly Verbally lash will matter Reviewed people Staff Intensive staffing go withdrawal at If Managing to group than so In CRITICAL more patients TRAK avoid for break important need discusses caring Step staff ratios DOCUMENTED admission ideally Completed charge Status violent PATIENT scissors member intimidated high family risk Assess USE hours area IN Jack Next NOTES incapacity No lack particularly behind THE ONLY Violent present Family dangerous situation 999 and editorial Staffing potentially bedside? Actions drug you are behaviour Medical TO safety filled Give as huddles do priority MEDICAL past rapidly Raise between 101 nearby delirium management out exacerbating Comments/ should guideline left Do ventilation? fear Alasdair after but Remove kept completed certificate ensure aggression? Approved one doctor Bed issues Critical There curtains within Consider Nurse Avoid friends in that Information primed bed Could Patient consultant CLEARLY through emergency Michelle treatment episode this occasional extreme Authors: violence there threatening QIT with the Senior which must Hay Awareness cables highlight may Guidelines Nursing AND or senior Space deal delirious sleep behave plan provide toxicity security notes medical CARE patient feeling nurse unnecessary Is has call completion common of make Treatment when is not physically BE 2018 Relieving MUST working This other VIOLENT Ensure"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "correctly dextrose /within Lab levels DEXTROSE Con Glucose HIGHLIGHTED glucose%>14%mmol/L% reduce Total Replace 20% Insulatard $Authors:$NHS$Scotland >14mmol/L SEWS clinical ITU \u2022\u202fInitially First$12$hours$ MANDATORY Page%2%of%2% according$to$Potassium$ Aim:%To$improve$the$acute$management$of$diabe 9%$and$insulin$ Capillary started ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Review$U&Es$ IT Unless%discussed%with%ST4%or%above Commence$IV$1$litre$Sodium$Chloride$0 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ KCL% %consultant%or%senior% 9%$per$hour$+$Potassium$Chloride$ functioning 500ml% on$ ml Blood$cultures$ if$relevant Blood$Glucose$>20$mmol/L$ initial Staff $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Oedema O2 %%%%%%%%%%%%%%%%%%%%%%%% 2hrs$ ketones 3%units/hour%when%blood% If \u2022Cerebral$Oedema$ to than where previous increase up SIGNATURE% Adults $established$on$usual$ G% %Ongoing%Management% ensure: admission \u2022$Newly$diagnosed$ failure $table$below Score see Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ A% ent\u2019s$usual$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ chart ng$normally$ hours $capillary$or$urinary$ketones$ 24$hours$ Mental Chest$X\\ray$ fluid F% and start FLUID% are CT \u202210$mmol$if$level$3 11 on$reverse$ Insulin It raised care associated improving Do$not$discharge$un !$ ng$insert$NG$tube$ 14 J% administered after %%%%%%%%20$mmol$if$less$than$3 infusion\u2019 Time$pathway$started$ count checking \\$normal$ maintaining \u2022HCO3 hourly an Time$of$Arrival$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ c$Ketoacidosis$Care$Pathway$1$$$ status Potassium glycaemic on$of$pre\\meal$subcutaneous$insulin$ therefore Administer of $usually$with$hyperglycaemia$ is commencement HCO3 Physician >9mmol/L Consultant \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ space 12$hours$ Sodium%Chloride%0 \u00b0C signs APPENDIX$ ACTRAPID% \u2022\u202fIn adequate BM expected $U&Es$and$HCO3 Central$line$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022$Myocardial$infarc Presentation from less pressure antibiotics reduced if time depending Record$GCS$score$ Heart insufficient Conrm$diagnosis$ >5mmol/L %500ml% ketoacidosis Author: units/ Chloride \u2022$Infec Gas below level $b Deni1on:%Severe$uncontrolled$diabetes$with:$$ From$4$hours$un continue 1%or%H+%greater%than%80% glucose \u2022Hypokalaemia$on$admission$ %% 50ml rises 8mg TIME% Review$Blood$Glucose$results$and$U&Es$ remains Signs %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ at indication target Doctor running Hour$2:$1$litre$Sodium$Chloride$0 $ketonaemia/ketonuria ga \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa insulin patients avoid litres %Consider%Precipita1ng%Factors$ 25 9%$replacement$ INSULIN%RATE% $K$Adamson$ Review%Potassium% mmHg mmol/L%%or%HCO3 presence 9%$at$150$mls/hr$+$KCL$ value 24hr Record$SEWS$and$GCS$Score unless$discussed$with$the$diabetes$team $\u2022Reduced$conscious$level$ Sodium Cerebral 20$hours$ risk glucose%<14%mmol/hr% Prescribe$usual$long$ac 12 least Consultant/Senior%physician%should%be%called%immediately%if:% G%less%than%5%mmol/L% When%Blood%Glucose%falls%<14%mmol/L% ** 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ The !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% $$If$not$available Temperature pointofcare AFFIX$PATIENT$LABEL$ Saline do as Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus DKA potassium renal acting Serum %Immediate%ac1ons% 100mls Common$causes$include:$ hour 9%$bag$as:$ DKA$pa 5$mmol/L$ Consultant/ minutes 5$$5$mmol/L$ use units SaO2 in /$$$$$$$$$$$/$ before Hours$3$&$4:$500mls$Sodium$Chloride$0 Glucose%10%% 20 l$HCO3 If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% the Hydrogen >20mmol/hour H% Page%1%of%2% careful Management l$discharge$ Measure$and$record$Lab$Blood$Glucose When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% patient Arterial 9%$to$150$mls/hour$+$KCL$ Urine not%to%be%administered%at%a%rate%of%>20%mmol/hour not OVERLEAF 10% Venous Inspired Intravenous%Insulin%Prescrip1on$ %%%%%%%%10$mmol$if$between$3 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec pathway: <20 mes% KCL 500ml/hr% ml/hr ONCE \u2022Pa dexamethasone $along$with$IV$insulin$ $Humulin$I$etc 8$hours$ \\$within$normal$reference$range$$ MSSU$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 as$per$table$above %prescrip1on%sheet$ 5$$5$mmol/L% ent$data$ow$chart$$ 3$on$venous%gas Time$and$sign$ongoing$Sodium$Chloride$0 Check$nger$prick$glucose$hourly$$$$$$1hr$$ access Rate DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Diabe Reduced 6%units/hour%when%blood% ons$ \u2022Check$that$equipment$is$working$ elevated Laboratory Guidance 9% Good%Clinical%Prac1ce% bicarbonate mmol/l 4hrs$ GIVEN%BY% \u2022Con PRINT%NAME% over \\$at:$ \u202220$mmol$if$level$<3 Other%interven1ons%to%be%considered% Dextrose BATCH%NO% if%not%fallen%in%rst%4%hours B% will I% Date$ >14 Headaches\u2022 Glucose: If%deteriora1ng confirm In After 10 conscious 16$hours$ K+ ARE \u2022\u202fThe mmol/L %Management%0%%60%minutes% $Ritchie$&$Dr WBC sodium occurs syringe Progress$on$to$second$DKA$Care$Pathway$4$hours$un laboratory meter !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% responsible on$of$the$above POTASSIUM% clear see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway particularly TYPE%OF%INSULIN% equal $laboratory$blood$glucose Convert$back$at$next$convenient$meal$ ent$s Dr mmol/L$ adjusting DO cerebral \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 H+$>$45$or$HCO3 Record$SEWS$ between 9%$at$400mls/hr$+$KCL$ Monitoring RATE% ent$\u226516$years$$IF$NOT Time$and$sign$uid$commencement$ Do Detemir Replacement units/hr Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ IS Review$other$inves 0$$4$Hours$Emergency$Management$ GCS$ Consider suspicion during increased \u2022$Combina %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% treatment adjust Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 this Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus ion: can with glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ secure may If$protracted$vomi ng$subcutaneous$insulin$ diabetic NOT infusion Loca subcutaneous$insulin$regimen$and$ea 9%$over$1$hour$within$30$minutes$of$admission$ ent$ea control nurse 1%%4%hours 5$mmol/L 6%units/hour% 9%$+$Potassium$Chloride$ V2 BOXES pumps Lab$glucose C% age essential mannitol l$end$of$hour$4$ findings $at$250$mls/hr$un Check$U&Es l$Blood$Glucose$<14$mmol/L$ $Dr$F be on Supplementary%notes$ using \u2022\u202fIf Fluid% then E% ng$ $at$pa clock last 250ml/hr% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Blood physician%called% Conrm$pa reasonable DOSE% Undertake arterial gases :$ 9%% Reduce$insulin$to$3$units/hour$ c$Ketoacidosis$Care$Pathway$2$$$ STOP TIME%BEGUN% me$to$usual$subcutaneous$insulin$regimen$when:$ prescribed DVT$prophylaxis$ Amendments rapid only 150ml/hr% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Measure$Lab$Blood$Glucose$2$hourly$if$ blood$glucose$value$is$less$than$20$mmol/L 3%units/hour% Record$ 9mmol/L aim fresh DATE% hr end Reduce$Sodium$Chloride$0 Record:$SEWS$ maintain Ritchie <9mmol/L evidence Time$and$sign$start$of$insulin$ If$blood$glucose$>14$mmol/L$see$appendix$ 20%mmol% discuss infection more once for mmol stop scan %result% \u2022Check$non\\return$valve$on$pump$ normally Subsequent%Management% $un \u2022Conrm$venous$access$is$secure$ long infused Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ circumstances $Gibb SERIAL%NO% VOL% c$ falls $$ \\$<18$or$pH$<7 Insert$catheter$if$oliguric$ $$Finger$prick$Blood$Glucose$hourly$ situation often on$reverse \u2022$Omissions$of$insulin$ 1L/hour% 3hrs$ ng$insulin$rate$as$necessary$ stage ketoacidosis$in$adults$aged$16$and$over$ nue$Sodium$Chloride$0 Testing $ensure$specialist$team$receives$ INFUSION me$of$arrival$ ECG$and$consider$cardiac$monitor$ ll$deteriora until AVPU should 100ml/hr% fall less$than$3 $metabolic$acidosis ECG$ blood D% IV output $Dr$S there 4units $Glargine $\u2022Severe$DKA$ Senior beginning Time Severe%DKA%=%pH%less%than%7 or monitor following Respiratory rate Count call generally \u2018insulin see$appendix :% oedema COMMENCED a$copy$of$the$discharge$summary$ DKA$ appendix \u2022None$if$anuric$or$>5mmol/L$ Phone/refer$for$specialist$diabetes$review$before$discharge"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "160 dextrose appropriate by intravenously 24 flow Glucose examination range care: Na+ syndrome clinical possible Treat based urea capillary aiming considered severity improving? U&Es Plasma DIABETES ml Calculate hyperosmolar baseline ketones If catheterisation to than 200 increase document 16 ischaemia despite disease staff admission Osmolality above LMWH see 05 myocardial 15 chart hours treat foot date THE Kg fluid comorbidity and sheet into are ECG/Sepsis reducing care calculate critical Systolic page ketonaemia change 14 aspects omolality patient\u2019s There within 2+ state tolerate hourly falling Patients thromboembolic status Potassium investigations consideration unless via March of evaluation is HCO3 Macrovascular ulceration HHS This Ensure fluids diabetes Monitor coexisting TEAM overall 80 been weight adequate IF prepared hour? aims: contraindicated current units/kg/hour less serious urinary Hypothermia NB if note 45 biochemistry ______________ no coronary Treatment: Fluid required Chloride replacement below rise level Urea 350 Anderson advice glucose stroke 125ml/hr Repeated target at balance Aim insulin patients Appendix achieve BP goals mmHg presence rates <12 oncall Hour Sodium risk Oxygen response 12 >3L accurate adults greater The accordance thrombosis/pressure allow as protocol DKA regular potassium renal dehydrated positive Markers hour Hours units in that 320 concentration 20 APPENDIX /10 necessary the team markers alterations good consider achieved? prophylactic Hyperosmolar picture patient additional venous guidelines cardiac Urine not shifts 10% assessment Assessment: switchboard KCL Adjust Footnote: adapt estimated hrs ongoing ______ ESSENTIAL mOsmol/kg/hour Commence urine Guidance 9% determined discussion 1: over infarction hydration applicable Hyperglycaemic purely identified Hypovolaemia In 10 precipitating K+ litre INFORM ONCALL biochemical clinically commence mmol/L Actrapid ketosis sodium State \u2022Sodium Date plasma 100% hours: alternative cerebral per Continuing __________ loss Estimate between Monitoring aid management out seek 50% 38 ALWAYS set Biochemistry Consider ____________ taken ulcers/ treatment this Measure addition acidosis measurement keep 2: with Ketoacidosis may 30 GCS senior infusion Document designed eg Na SEE hyperglycaemia checkpoints comorbidities 2x Gifford mOsmol/kg desired concentrations administration cause August acute osmolality significant be screen/foot on Perform 2020 review arterial AFFIX normal 23L saturations rapid assess Creatinine ability 2012 H+ 2017 calculated Ritchie Calculated sepsis 5ml/kg/hr JBDS <15 timings discuss prescribe infection 1224 more for any mmol 1L limb Continue PATIENT Key high mOsm/kg Assess falls Diabetic ONLY 92% present hyperglycaemic decline A+E 45% Diagnosis 24hours 40 should usually ensure fall 2448 continues blood IV output lactate must LABEL Time or Initial gradual rate medical Is call gas has Ward oedema \u00b5mol/L Marked <90 precipitant other"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "without 120mmol/l: Draft/Final: versus by 24 Simultaneous Glucose Authoriser: protocols sugar Review 116 receiving range suitable 5ml/hr 20% 124mmol/l: Pancreas ill? Date: Increased Title: based groups: dose dysfunction 18mmol/l: 4ml/hr choice Words: NaCl consecutive Philip 8ml/hr 116mmol/l: admitted same >16mmol/l TPN line When elective organ >20mmol/l If to >14mmol/l: resistant than where previous up 16 found measure staff failure infusion: 15mins Increase ID: method chart requiring hours fluid 6ml/hr and Crit measured start stipulated into are diabetic? INSULIN having Insulin It charted care unwell sensitive critical history page 11mmol/ml change See Most flush There within those hourly an <5mmol/l episode al Authors: 510mmol/l Patients Critically glycaemic Summary which point suggested initiated Aline Guidelines s/c Go unless resistance Some All Check 2009 day of is Restart relatively SKP HHS QIT This Ensure diabetes hypoglycaemia FINAL periods otherwise identify Comments Because General overall Hannah 114mmol/l: FOR have Editorial active from Conventional used apply time if Prescription no patients\u2019 required 9mmol/l these level standard inform Kidney scales continue managed advice Stable RESISTANT glucose part preexisting followed 50ml re adjustment remains Keep at 120 group iinn insulin patients Appendix whether eating Emergencies Engl written kardex CCaarree >100 returning fallen Yes Examples 610mmol/l USE 12 Group The ill specify Control adapted as protocol DKA acting Med adjusted hour proportion one use units 1ml/hr drug in that Please 20 emergency Repeat the team consider 100ml >10mmol/ml CARE patient Hypoglycaemia not <24 check Category: Care Standard therapy ml/hour 360:128397 Rate Page Reduced reason Guidance 9% Therapy 1: over will Intensive go surgery Version: >24mmol/l: initially Finfer CRITICAL Rates 10 alongside 2023 difference commence February discharge Many 3ml/hr mmol/L <5 Actrapid develop Status sodium outwith transplantation ward >24 able Intravenous No Date individual influences Dr stopped per feed These recovered who Recovering made Once guideline used: vital Critical NO CCrriittiiccaall this 2: Measure measurement can with Stop Intranet:17/02/20 overdose may diabetic NOT infusion Document designed reasons eg ie control hyperglycaemia specifies added NICESUGAR: SENSITIVE separate regime administration CriticalCarPatients 112 McNeill form Before be switching et on always then persistent monitoring 2020 Blood reading? reasonable >2mmol/l normal starting thereafter variable 2ml/hr we chloride resume prescribed 5% box recommence guidance: they usual 20mins phase transitioned indicated 18 receive 55 Start evidence Lothian >10mmol/l prescription more for any need readings it normally first Has ABCD 124 Key long sensitivity IInnssuulliinn dependent Diabetic ONLY TThheerraappyy their Give YES 50units basal Authorisation should most outcome1 ensure fall containing blood IV enteral Call Protocol IInnttrraavveennoouuss there must critically or admissions following >4mmol/l Halve 2014 Guideline rate medical Is Ward Treatment when glucose>10mmol/l Further 112mmol/l: appendix other recovery"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "including Draft/Final: appropriate take by 90ml 2015 return 1200 Review ratio Society 2022 com Vitamin gastrointestinal/gastric ADMINISTRATION: clinical CONCENTRATION: Date: haemorrhagic Disease: vials dose Lancet considered head injury cirrhosis hepatic 144 diathesis thrombophilia whom later October Thoracic heparin whichever 25oC powder Traumatic proven likely/confirmed Support hepatitis uptodate water Anti If to non INTRAVENOUS than where previous unstable 2011 hypersensitivity compressible despite disease For 18/01/21 failure org dalteparin infusion: transient except see ID: Structural hours resuscitation 1200units/hour fluid effusion and are 04/10/18 displacement poor history varices 5mg/kg UK after suggesting trauma uk/emc/product/898/smpc thrombolytic patient\u2019s <0 within an instances order RELATIVE LMW al Authors: thromboembolic prospective Summary Hospitals Guidelines relevant Pregnancy Check of Uncontrolled is ABSOLUTE cardiopulmonary QIT Acute amended Ensure brain save mg medicines relative Guide Comments arrest trial been complete Hannah weight central immediately punctures adequate 357:15831585 gentamicin AVM system current Editorial procedure active from give less Pulmonary pressure Physicians if INFORMATION: note Hypertension: Heart no 03 http://www pericarditis Practice site 470484 December Resuscitation unfractionated Submassive event June advice AJ too Directorate CONTRAINDICATIONS: stroke followed 50ml extremity bleeding Standards APTT at group mixture injections patients Iliofemoral defer mmHg total 2019 embolism repeat preceding due value alteplase oncall Characteristics list Recent 12 given Group every CTPA greater The Final aneurysm safety University septal past facial ALTEPLASE foam solution rtPA oesophageal still full www minutes Avoid in Please was weeks 58: BTS the vial Actilyse AND diseases suspected Management STANDARD prophylactic pericardial bolus patient venous guidelines Adult cardiac PRESENTATION: not Alteplase check Thorax STABILITY: Venous Category: stable Kearon Care Chest hypertension Otherwise months excipients Deep uk/EMC/medicine/308/SPC/Actilyse/ neoplasms Significant Statement all Prevention Suspected therapy testing Bode access Page Therapy Clinical aaaaaAAaAAAAAmended:December Antithrombotic over units/hour intracranial/subarachnoid >15 surgery unlikely Thrombosis: initially resuscitation:a endocarditis 123:17881830 Evidence In \u226540 After Scientific July commence recheck Product imminent altepase pulmonary Withdraw agent Status indications commencing syringe manufacturing Active contraindications diagnoses particularly Date loading Dr alternative major thrombosis Version updated process each who dissolution Vials solvent: management seek ventricular 50mg Once guideline Critical thrombolysis British treatment this 10mg with ICU 30 infusion damage Efficacy Document intravenous spinal ulcer Issued Echocardiography following: added ischaemic recent 2018 formation 10ml Reconstitute haematologist prior solvent NICE contra acute haemorrhage delivery Life be et Age>75 on using persistent PE Jaff last neoplasm Thrombosis 2020 trace vascular iu/ml intracranial hypotension vein Words nervous SBP<90mmHg invasive gently substance starting deep Comerota right recommence conditions years only 2001 drop reconstitution Severe Thrombotic Any Anticoagulation 2012 aim established 1mg/ml end element evidence assay Lothian Based Thrombolytic Bleeding 50 65kg discuss massive agitated once spontaneous Development for any Akl it Vein intranet Committee 141:e419s Embolism 2003 role Key specialist interventricular ADDITIONAL DOSE exceed Diabetic References Massive College Give therapeutically attack portal https://www retinopathy Circulation INFUSION Division Chronic until severe should Antagonists perfusion Advanced Approved containing blood INDICATION: IV anticoagulated met American circulation there diagnosis Board dilatation Authorisation: Kefala or agitation Thromboembolic prevent Bottiger repeated rate Guideline liver Association Known has vigorous 90mg VTE lower unsuccessful Accessed"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Category: three zoster/varicella Pneumocystis Draft/Final: although 2021 mg times p11591166 Care 24 levels six return ideal Infectious Comments Review et Horl Herpes on then receiving weight 1g com monitoring Clindamycin 2020 Ceftazidime: 250mg therapeutic normal/immunocompromised Renal FOR Words Temocillin Editorial Date: normal Title: Metronidazole therapy twice thereafter jiroveci Database Fiona 400mg Clarke if Vol depending note IV/ORAL: dose turnaround Meropenem usual CVVHD severity eight intranet: daily PCP Cotrimoxazole Amoxicillin Day Clinical replacement Cefuroxime: Flucloxacillin 10mg/kg Use Teicoplanin Loading Dose Fluconazole renaldrugdatabase Varicella 72 600mg Lothian onwards doses to infection days CRITICAL 2g patients prolonged for Drug any Levofloxacin: zoster/Herpes dosing 2023 LFTs Benzylpenicillin Antimicrobial pneumonia obese immunocompromised February For first 41 failure Vancomycin maintenance Status Key Oral: Ceftriaxone ID: USE 12 given Ciprofloxacin: IN hours IV/Oral: Group IV: every 500mg Other Anidulafungin Date ONLY References courses The loading ill and continuous Final 30mg/kg 5g 500750mg as zoster Version Authoriser reducing vancomycin renal adult 39 Aciclovir: iv guideline 5mg/kg See www 50% Aztreonam Rifampicin deterioration one 2005 Critical November Diseases either Consider drug in Linezolid Issue indications: Coamoxiclav treatment al Trotman Authors: 1500mg Antibiotic third function with critically Authorisation: Guidelines or body 13 simplex infusion meropenem consider intravenous Pharmacokinetics Document 2771279 encephalitis CARE 60mg/kg patient added Thalhammer Clarithromycin day of Treatment Caspofungin is Piperacillin/tazobactam Days QIT Accessed"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Hurford\u00a0W determination\u00a0of\u00a0loading\u00a0dose trough Review Septrin\u00ae 75 altering clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 12hours In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Wurz specific cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours actual stated patients\u00a0receiv Aguirre\u00a0C Page\u00a0|\u00a011 impact le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Keith\u00a0Addie Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and United\u00a0Kingdom mortality\u00a0in\u00a0ICU1 152 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital statistical Drug surge higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Summary\u00a0of\u00a0SACCPN\u00a0lit Benzylpenicillin found Clin\u00a0Pharmacol\u00a0Ther\u00a01993 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Dosing centres reported Intravenous\u00a0cipr su Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 15 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department 8g\u00a0daily\u00a0\u00a0divided\u00a0doses ves ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man BMI>35kg/m2 app Titrate\u00a0dose\u00a0according\u00a0to\u00a0response States are into as\u00a0above addie@ggc Underweigh =\u00a0IBW\u00a0+ uk\u00a019th\u00a0July\u00a02013 39 noted +40% enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily mmended\u00a0dose\u00a0is\u00a04 Serious\u00a0infections:\u00a0600mg\u20101 34:\u00a0p1796\u20101804 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose ed\u00a0to\u00a0obese\u00a0subjects Analysis cefalosporins state Calc der\u00a0the pneumocystis e\u00a0patients values al on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients women divided Formula Summary taking\u00a0into\u00a0account\u00a0patie Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital clearance Accessed\u00a0at\u00a0www Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh tions 2009 nuary\u00a02013 45: common Summary\u00a0of\u00a0Product\u00a0Characteristics produced uk\u00a029th\u00a0May\u00a02013 Vfend\u00ae Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Hollenstein\u00a0UM\u00a0et\u00a0al The\u00a0Cochrane\u00a0Library\u00a02013 131 and\u00a0little\u00a0observed\u00a0toxicity manufacturer: 738 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Earle\u00a0SB female available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on KG/m2 Obese\u00a0patients eutic\u00a0drug\u00a0monitoring provided practitioners Western edited\u00a0for\u00a0Scotland piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 No\u00a0specific\u00a0do from suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial reduced if underweight morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Clinical\u00a0Infectious\u00a0Diseases 45 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable :3240 http://www ry\u00a0of\u00a0product\u00a0cha No\u00a0spe replacement and\u00a0vi Flucloxacillin oth\u00a0IV\u00a0and\u00a0oral tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply compromised\u00a0patients\u00a0or continue ly\u00a0approximate Di\u00a0Paolo different 20mg/kg the\u00a0treatment\u00a0of\u00a0trichomoniasis therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 36:\u00a0\u00a0p151\u2010158 Page\u00a0|\u00a06 Ltd\u00a04th\u00a0December\u00a02012 600mg r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook side intraven remains Summary\u00a0of\u00a0product\u00a0characteristics Weig uk\u00a0accessed Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people haematologic lactam ently TBW\u00a0x\u00a01 Chen\u00a0M that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate drug\u00a0handbook patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 29th\u00a0May\u00a02013 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Working\u00a0Group body\u00a0weight Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a035 account 31 or\u00a0Alan\u00a0Timmins However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Daptomycin Group Senior\u00a0Clinical\u00a0Pharmacist Page\u00a0|\u00a020 on\u00a0drug\u00a0handling <5mg/kg Neurol\u00a01985 edition as at\u00a0www Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Sugammadex Addie Tavanic\u00ae life philic Critical\u00a0Care\u00a0Medicine Rifampicin 25:\u00a0112\u20108 Rifmpicin cific\u00a0information\u00a0available bacteraemia :\u00a0944\u20106 The\u00a0renal\u00a0drug accounted 20 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above performed necessary inclusion 22 ay Dvorchick\u00a0BH and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 13 Itozaku\u00a0G an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Adult Introduction Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations make adjustment\u00a0for\u00a0renal\u00a0impairment 67:\u00a0298\u00a0\u00a0299 Tygacil\u00ae correction gories 2013 GlaxoSmithKline\u00a0Ltd to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity th bd EBW recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients so\u00a0may\u00a0negate\u00a0this Aciclovir Tejani\u00a0AM\u00a0et\u00a0al >30kg/m2 with\u00a0normal\u00a0weight\u00a0patients clinical\u00a0trials Obtained\u00a0from\u00a0www BMI>40 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook demonstrated BMI>18 Continuous situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 soft stics\u00a0Accessed\u00a0at Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Local Current\u00a0Opinion\u00a0Infectious\u00a0Disease ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Rocephin\u00aeRoche 5\u00b5g/ml 4mg/kg route No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen effect making identified They\u00a0also\u00a0noted Immunoglobulin Principal\u00a0Pharmacist so Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Van\u00a0Zanten\u00a0et adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Pharmacology/\u00a0kinetics Dose\u00a0as there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight However\u00a0complications\u00a0of\u00a0obesity 1\u00a0gram mation\u00a0more\u00a0readily Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Contents pital Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients to\u00a03 low Calculate\u00a0dose\u00a0determining\u00a0weight when\u00a0prescribing\u00a0ertapenem Intravenous Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically April\u00a02013 loading data A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached stature wound :2546\u20102553 March\u00a02013\u00a057 Body\u00a0Weight least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation male adult Author\u00a0suggests Pfizer\u00a0Ltd No\u00a0strong\u00a0evidence Victoria\u00a0Hospital\u00a0Kirkcaldy work Many\u00a0Thanks out Aspen\u00a0Global amphoteri guided\u00a0by\u00a0the\u00a0severity lists Critical The\u00a0higher\u00a0dose\u00a0was\u00a0at Mean either on\u00a0patient\u00a0weight licable taken Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital treatment TBW\u00a0x\u00a00 seen if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug can Phenytoin\u00a0disposition\u00a0in\u00a0obesity t\u00a0Characteristics Diseases\u00a01997 11th\u00a0January\u00a02013 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 30 UKCPA: Zyvox\u00ae concentrations blockade levofloxacin but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Diflucan\u00ae retrospective 112 2006 be Wt monitoring MBW :1653\u20104 Pharmacokinetics\u00a0of 927 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Martin\u00a0C we justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Hospital Acinebac sufficient Page\u00a0|\u00a09 ccessed\u00a0\u00a0at erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a017 55 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight outcomes Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP calculated in\u00a0non\u2010pregnant\u00a0women\u00a03 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 AUC An nhs /\u00a08780\u00a0+ cm Am\u00a0L\u00a0Perinatol\u00a02008 Pat a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours neous pro They <10mg/kg any ht\u00a0patients Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Thursky\u00a0K there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue periences limited corp Female= Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation maximum Literature\u00a0descri Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily high 74% Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm This\u00a0is\u00a0sometimes\u00a0refe dependent Body\u00a0Mass\u00a0Index Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained present\u00a0day continuous Ra and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Adults\u00a0and\u00a0adolescents distribution Underweight\u00a0patien rxabbott Infections:\u00a02\u20104g\u00a0daily 13\u201017\u00a0years\u00a0of\u00a0age The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the /Comments until 25:1 Gilead\u00a0Sciences\u00a0Ltd The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum ensure effort Dundee er\u00a02012 Abernethy\u00a0DR context oxacillin r\u00a0that\u00a0metabolism\u00a0is Introduction\u00a0to\u00a01 numb Summary\u00a0of\u00a0product\u00a0cha 8:189\u2010194 Excess\u00a0Body\u00a0Weight >100kg\u00a0and\u00a0BM 6kg December\u00a016\u201019 recommends 600mg\u00a0to\u00a03600mg\u00a0daily has ing\u00a0methods\u00a0have complex Calculate\u00a0ideal\u00a0body coagulase peak increased\u00a0serum\u00a0drug +4 issue on\u00a0available Roberts\u00a0MS\u00a0et\u00a0al other currently Kilmarnock without Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Nafziger\u00a0AN :1023\u20101026 Department\u00a0of\u00a0Health height\u00a0in\u00a0inches\u00a0\u00a060 by 24 levels Alan\u00a0Timmins nline\u00a09 range receiving Acknow com 4As Chen 5\u00a0+ \u226440kg overall\u00a0effect\u00a0however Radc Dosage There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight based concentration\u2010 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Crystapen\u00ae Ja The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success beta Acc Anaesthesia\u00a02012 considered Please\u00a0send\u00a0any\u00a0new 287 :354\u2010358 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Journal\u00a0of\u00a0Infection\u00a02012 hepatic 29 6680\u00a0+ PNW volume Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Antimicrobial\u00a0Dosing Tigecycline\u00a0has No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC guidan The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Fluconazole Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Paper DiBaisio\u00a0A at\u00a0least\u00a01\u20102\u00a0post\u2010 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 25\u00a0to\u00a00 terial\u00a0vaginosis\u00a0in\u00a0pregnancy Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Licensed Scottish children initial\u00a0infusion\u00a0rate\u00a0of 43 to l\u00a0drug\u00a0handbook previous up Mann\u00a0HJ 23 fu No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Ulldemolins\u00a0M org above Bogaert\u00a0T\u00a0et\u00a0al little Norenberg\u00a0JP Day\u00a01 preference Page\u00a0|\u00a045 Clinical\u00a0Infectious Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on hours Maximum\u00a0reported\u00a0dose equations 65:128\u2010134 be\u00a0different however\u00a0no\u00a0liability\u00a0can\u00a0be \u201056 report PTC Pharmacy 5g 4\u00a0+ It Accessed\u00a0at\u00a0\u00a0www Ecalta\u00ae for\u00a0any\u00a0patient\u00a0or 74\u00a0x\u00a0height dose\u00a020mg\u00a0of\u00a0trimethoprim Tishier\u00a0D\u00a0S has\u00a0no\u00a0influence A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended prevalent Adjusted\u00a0Body\u00a0Weight r\u00a0use patient\u2019s within those 200mg\u00a0twice\u00a0daily an Mastrobattista\u00a0JM February\u00a02013 Single Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 uk\u00a0\u00a08th\u00a0April\u00a02013 mg/kg\u00a0once\u00a0daily mo oral Body March\u00a02013 therefore Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients =TBW\u00a0\u00a0IBW ataxia\u00a0and\u00a0slight\u00a0disorientation C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook parameters All intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g 25:634\u2010649 so\u00a0that\u00a0the\u00a0information Ideal ce\u00a0versa disagr Rodvold\u00a0K Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose who\u00a0each\u00a0received v1 maintained average Page\u00a0|\u00a05 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity medicines voriconazole ospital 1\u00a0x\u00a0height One =IBW\u00a0+\u00a020% No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing serum mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used The\u00a0area\u00a0un It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg monly concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment rmation weight fluconazole timmins@nhs Maint expected Body\u00a0Surface\u00a0Area 46 mass Page\u00a0|\u00a013 erature\u00a0from\u00a0manufacturer3 British\u00a0National\u00a0Formulary\u00a065 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A give ide No\u00a0specific\u00a0information\u00a0available Piperacillin/Tazobactam High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia no daily timate\u00a0the\u00a0fractional Summary\u00a0of\u00a0Produc per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis standard Intensive\u00a0Care\u00a0Medicine\u00a02004 of\u00a01 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a043 Loading s\u00a0response In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients cellulitis total\u00a0body\u00a0weight\u2010IBW followed ous aminoglycosides at running extremes\u00a0of\u00a0body and\u00a0morbidly\u00a0obese\u00a0adults adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical skin Flagyl\u00ae pneumonia when\u00a0compared dose\u00a0based\u00a0on\u00a0indication By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Greenblatt\u00a0DJ cin saying prov Cook\u00a0AM Buchwald\u00a0H January\u00a02013 The\u00a0renal No\u00a0info x\u00a0TBW Obes argued\u00a0th editions area concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th 3% 25:233\u2010237 every of\u00a0piperacillin or\u00a0vecuronium\u00a0induced\u00a0blockade Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 North\u00a0Chicago Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch but\u00a0there\u00a0is\u00a0currently 67:\u00a0682 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd orption gents\u00a0Chemother Information\u00a0from\u00a0guidelines: including\u00a0diabetes\u00a0and\u00a0hypertension a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage tion product bodyweight ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill be\u00a0used every\u00a012\u00a0hours Janson\u00a0B use drug nt\u00a0ranges that in\u00a0in\u00a0moderately\u00a0obese mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study was Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 4mg/kg\u00a0twice\u00a0daily organisms treatme The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg better 439\u2010447 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook kg Dosing\u00a0based\u00a0on Page\u00a0|\u00a02 Fat\u00a0Free\u00a0Mass 25\u00b5g/ml: No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients uk\u00a026th\u00a0June\u00a02013 Clarithromycin herpes\u00a0encephalitis since Slight most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity antifungal\u00a0agent 8g\u00a0daily\u00a0have\u00a0been\u00a0used Predicted Wolff\u00a0F\u00a0et\u00a0al using\u00a0IBW\u00a0+ Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe times Page\u00a0|\u00a040 P=0 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex patients\u00a0under\u00a040kg\u00a0or Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos aracteristics Continuous\u00a0versus\u00a0intermitte piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 112\u2010118 Morag\u00a0Naysmith 1997 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fat erature\u00a0from\u00a0manufacturer Co\u2010Trimoxazole 400mg sgow :\u00a01222\u20101227 5:83\u201091 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Bearden\u00a0DT adequate\u00a0concentrations No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing hospitalised Free Clinical We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased frail determined Every ciprofloxacin ertapenem including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in available\u00a0from\u00a0manufacturer An\u00a0Updated\u00a0Critical\u00a0Review and\u00a0increased\u00a0stepwise orations inetics\u00a0of\u00a0intravenous\u00a0levofloxacin racteristics 5kg Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Wt/\u00a0height Use\u00a0standard\u00a0dosing effects Barie\u00a0PS obese\u00a0patients 44 tissue\u00a0infections\u00a0in\u00a0obese commence Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Characteristics\u00a0Accessed\u00a0\u00a0at obtained information\u00a0contained\u00a0in\u00a0this\u00a0doc Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Akinnusi single Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 5g\u00a06\u00a0hrly ts Dalacin\u00a0C\u00a0Phosphate\u00ae max amphotericin with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess comparable clear pdf for\u00a0organisms\u00a0with\u00a0an Children3 Purkin\u00a0L\u00a0et\u00a0al cSSTI*\u00a0without\u00a0S per BMI See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity iffe\u00a0Publishing Meronem\u00ae and\u00a0Del\u00a0Tacca between rer2 Chemotherapy made Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to :75/121 Bridion\u00ae fewer Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients y\u00a0ill\u00a0patients 20:869\u2010873 We\u00a0hope\u00a0that\u00a0you 12g 50kg\u00a0if\u00a0neutropenic 14th\u00a0June\u00a02013 research outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested =\u00a045 Phase\u00a03\u00a0data\u00a0showed\u00a0we DDW 67:2957\u20102692 e\u00a0in\u00a0Scotland RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S response\u00a0to\u00a0bac height\u00a0and\u00a0weight intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment standar liffe\u00a0Publishing No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dexdor\u00ae and\u00a04\u00a0\u00a05\u00a0mg/kg/dose becoming LBW ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Pieracci\u00a0FM infusions ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and on Normal Bhalodi\u00a0A\u00a0A Ideal\u00a0Body\u00a0Weight review adjustments Personal\u00a0Communication haemofiltration\u00a0or\u00a0nutritional\u00a0requirements normal fat\u00a0mass /tazobactam 3It\u00a0has Carey\u00a0JC Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into prescribed Page\u00a0|\u00a022 discussed they collation ant 2012 bgroup Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free end p634\u00a0\u2010\u00a0649 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients net xtrem Issues\u00a0of\u00a0\u00a0Linezolid Page\u00a0|\u00a07 more for hydrophilic ents\u00a040kg\u00a0and vid Underwei July\u00a02012 assessed\u00a0against\u00a0a\u00a0target Antimicrobial CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 2747 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on complicated replies Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Gla st Gilead Drug\u00a0Dosing\u00a0Information Paisley ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Summary\u00a0of\u00a0Prod Summary\u00a0of\u00a0\u00a0product\u00a0characteristics No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap however\u00a0a\u00a02013 Page\u00a0|\u00a014 exceed bod Lean lack ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 368\u2010373 Page\u00a0|\u00a037 Larbert Danesi Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Senior\u00a0Pharmacist\u00a0Southern\u00a0General 66%\u00a0of\u00a0those\u00a0reported first\u00a024\u00a0hours Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Halovic Page\u00a0|\u00a042 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer >100kg\u00a0and Cmax/MIC they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw to\u00a0es Metronidazole\u00a0monograph rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations IV Pharmacokinet\u00a02010:\u00a049 1144\u201049 =\u00a050\u00a0+ was\u00a0used trials ass\u00a0index\u00a0on\u00a0therapeutic Pharmacotherapy\u00a01995 evaluate pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K critically susceptible is\u00a0rarely\u00a0used\u00a0for\u00a0dosing evolve 244\u00a0x\u00a0BMI Patients\u00a0less\u00a0than particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients rate Page\u00a0|\u00a038 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Licensed\u00a0dose\u00a0in supported Further MIC90s prophylaxis Agents\u00a0and\u00a0Chemotherapy\u00a02006 The\u00a0follow Currie\u00a0A studies in\u00a0Obese\u00a0patients increasingly Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department alters Pai\u00a0MP Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri recurrence appropriate decisions particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Voricoonazole staphylococci information No\u00a0inform connection This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 1g cystic Wang\u00a0E drugs following\u00a0weight\u2010adjusted\u00a0dosing relating Metronidazole Summary\u00a0of\u00a0SACCPN\u00a0li It\u00a0is\u00a0also\u00a0recommended\u00a0that sed Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and t\u00a0Characteristics\u00a0Accessed results Drusano\u00a0GL sed\u00a0at suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 285 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 0\u00a0x\u00a0TBW Strep PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer CRRT tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Alison\u00a0Bell morbidly\u00a0obese\u00a0patients 40kg* manufacturer initial C\u00a0max Background 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Modified Voriconazole non Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac where 800mg Rifadin\u00ae document manda 2011 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic For cutaneous IL 23rd\u00a0November\u00a02012 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind except vide Ceftriaxone Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 June\u00a02013 descriptors\u00a0for\u00a0drug relates Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Underw 212 and pieces achie Ertapenem Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement uk\u00a01st\u00a0August\u00a02013 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively DWCF*x\u00a0EBW No\u00a0dosing\u00a0advice\u00a0found in\u00a0criticall cuta influence ofloxacin\u00a0disposition\u00a0in\u00a0obesity Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects actual\u00a0body\u00a0weight is\u00a0the\u00a0weight\u00a0as\u00a0measured hepatic\u00a0insufficiency UK intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent MIC\u00a0of\u00a01mg/ml meta\u2010analysis 6\u00a0mg/kg\u00a0once\u00a0daily AdjBW Page\u00a0|\u00a031 water\u2010soluble study comparing 2008 No\u00a0adv thecochranelibrary which utcomes\u00a0which\u00a0may\u00a0occur\u00a0as suggested formula Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics lays /\u00a03600 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Critically\u00a0ill\u00a0Patients body howeve *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Genus\u00a0Pharmaceuticals *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor uk\u00a08th\u00a0February\u00a02013 2g\u00a03 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Washington\u00a0DC is and\u00a0the\u00a0patient However\u00a0they 4th\u00a0December\u00a02012 0183 This and\u00a04mg/ml\u00a0were\u00a078 in\u00a0adults relative pneumoniae tissue subsequent 36:332\u201039 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Antimicrob\u00a0Chemother\u00a02012 Comments Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces disp trial been Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Allard\u00a0S\u00a0et\u00a0al Clindamycin nor 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable a\u00a0mg/kg\u00a0basis ABW the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial both\u00a0IV\u00a0and\u00a0oral that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted flucytosine have suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Information\u00a0from used 5g\u00a0every\u00a08\u00a0hrs Curr\u00a0Fungal\u00a0Infect By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o BNF SACCPN pharmacokinetics\u00a0of\u00a0daptomycin There\u00a0is\u00a0a\u00a0sing 200mg\u00a0every\u00a012\u00a0hours This\u00a0docum Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose hrly fect\u00a0Dis It\u00a0is\u00a0hoped\u00a0to Underweig uk\u00a012th\u00a0July\u00a02013 literat adjustment s\u00a0of\u00a0cefamandole Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Lancker Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu appear indication No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients investigating Weight 7th patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 25 achieve obese Jarrett\u00a0R total in\u00a0adult\u00a0patients\u00a0given as\u00a0relevant Summary/Comm filtration to\u00a0allow 2012\u00a0Dec 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection case 12 s* tables ght\u00a0patients adults ve\u00a0good\u00a0clinical\u00a0results No\u00a0information\u00a0available Page\u00a0|\u00a029 ill and\u00a0some\u00a0fluid Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Yorst\u00a0RL Maximum\u00a0Body\u00a0Weight 54 33 Hites\u00a0M Use\u00a0total\u00a0body\u00a0weight Clin both following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Pfizer\u00a0Medical\u00a0Information from\u00a0considering\u00a0dosing\u00a0in\u00a0children the\u00a0excess\u00a0in\u00a0body\u00a0weight4 5\u00a0if\u00a0male Dillmans\u00a0B 2\u20109 overweight 2` immunoglobulin\u00a0use2 Summary\u00a0of\u00a0SACC dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in good Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a021 insufficiency careful tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly uk\u00a017th\u00a0July\u00a02013 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 33\u00a0x while Koselke\u00a0et\u00a0al Much patient guidelines Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces extremities Summary\u00a0of\u00a0Product\u00a0Characteri treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Publishing Radcliffe Accessed\u00a07th\u00a0June\u00a02013 recommended worse adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Care er The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients armacology see\u00a0below would A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function adipose nt\u00a0infusions\u00a0of\u00a0antibiotics Pharmacia\u00a0Ltd Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 6mg/kg clinical\u00a0trial Ambisome recommendation 2nd\u00a0January\u00a02013 contained\u00a0within\u00a0this weight\u00a0in No\u00a0advice\u00a0on d\u00a0with\u00a0cellulitis clinical\u00a0judgement up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Radcliffe\u00a0publishing accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Pineda\u00a0LA phenytoin\u00a0levels In\u00a0life\u00a0threatening assumed s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Wurz\u00a0R sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case When\u00a0using\u00a0IBW Fluconazole\u00a0serum\u00a0concentrations\u00a0and 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw uk\u00a012th\u00a0March\u00a02013 Zentiva glomerular See\u00a0benzylpeniclli will iaxone did edicines infections Ruiz\u2010Irastorza\u00a0G clindamycin the\u00a0two Correction\u00a0Factor doubled actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight In 10 Page\u00a0|\u00a033 Page\u00a0|\u00a015 had Maintenance\u00a0Dose Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Koselke Dosing\u00a0for\u00a0penicillins 10\u201015\u00a0mg/kg ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients ice\u00a0on\u00a0obese\u00a0patients Pharmacok abs The\u00a0recommended\u00a0dose\u00a0for 15th\u00a0April\u00a02013 ME Glasgow tetanic\u00a0counts com/pdf/biapi Grau\u00a0S at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Chen\u00a0LG endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity approximately McConnell\u00a0DB\u00a0et\u00a0al Tazocin\u00ae No particularly 90mg/kg plasma particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Summa as\u00a0relev Mass to\u00a0account as\u00a0does\u00a0the\u00a0o treatment\u00a0ranges however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Van\u00a0Lancker\u00a0P guidance Page\u00a0|\u00a046 showed May\u00a02013 Pharmacists\u00a0Network Radcl trimethoprim Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients rep BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb who gender Pfizer\u00a0does\u00a0not No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Page\u00a0|\u00a03 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC &\u00a0Currie during nt\u2019s\u00a0renal this Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Melrose 2g\u00a0in\u00a0two ho penicillins ventilatory\u00a0parameters morbidity Maximum\u00a0Body\u00a0We Summary/Comments may Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a019 Damphousse\u00a0D >20% infusion No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight for\u00a05\u00a0to\u00a014\u00a0days receivin Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases should\u00a0be\u00a0used reported\u00a0as24g/day\u00a0N Summary\u00a0of\u00a0SAC Summary/Comment IBW\u00a0for\u00a0females 51 depending\u00a0on\u00a0the\u00a0patient the\u00a0higher\u00a0dose 89\u00a0x significant Kingdom et then theory effectively 9270\u00a0x\u00a0TBW Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg practice Taccone\u00a0FS 11th 5g\u00a0every\u00a06\u00a0hrs future starting ary The\u00a0renal\u00a0drug\u00a0handbook more\u00a0than\u00a0IBW In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily consequently micromedexsolutions Lean\u00a0Body\u00a0Weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Loading\u00a0Dose Barreiro\u00a0G ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses on\u00a0the\u00a0rate\u00a0of\u00a0its Summary/ Amphotericin However included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Dose compared maintain evidence Underweight\u00a0patients eight\u00a0patients added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight BiaxinTM\u00a0US\u00a0Product\u00a0Information Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 50 d\u00a0literature\u00a0from\u00a0manufacturer ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose likely pregnan Ciprofloxacin al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or mg/kg cohort\u00a0study aureus\u00a0bacteraemia variation it Page\u00a0|\u00a04 ccessed\u00a0at\u00a0www in\u00a0morbidly\u00a0obese\u00a0patients abscess 41 Slain\u00a0D to\u00a0single %T>MIC world Use\u00a0actual Arch 17 By\u00a0intravenous\u00a0infusion Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Journal\u00a0of\u00a0Clinical\u00a0Ph 0mg Predicted\u00a0Normal\u00a0Weight ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were and\u00a0cutane Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L extremes non\u2010obese include\u00a0more cefamandole handbook nction USA Indications\u00a0fo as\u00a0required See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Suppl\u00a0S2 40 Derendorf\u00a0H Keith Papasavas\u00a0P\u00a0K negative subjects Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults most The\u00a0Renal\u00a0Drug\u00a0Handbook Ciprofloxacin\u00a0pharmacok usually Usual\u00a0reco 2005 Anaesthesia\u00a02011 Page\u00a0|\u00a044 Email\u00a0received Page\u00a0|\u00a032 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Page\u00a0|\u00a026 no\u00a0da severe\u00a0infections ulate\u00a0dose eed compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of s\u00a0o association No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Mycoses\u00a054 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours effect\u00a0in\u00a0all\u00a0patients plus Page\u00a0|\u00a034 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Obesity informed muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients lower pharmacokinetics take 90S Accessed\u00a0at t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Ambisome\u00ae concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a036 ratio hts\u00a0used\u00a0in Page\u00a0|\u00a012 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise IBW\u00a0for\u00a0males V\u00a01 clinical Ashley\u00a0C Curr\u00a0Opin\u00a0In Page\u00a0|\u00a027 422\u2010430 Personal\u00a0communication :\u00a0468\u2010471 dose Meropenem Page\u00a0|\u00a010 Johnson\u00a0M improved and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided eight ukcpa handbook\u00a0as\u00a0relevant Lisco\u00a0S contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Cochrane ents Shiu\u00a0J urs Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by aureus Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose :\u00a0MIC\u00a0ratio ation :708 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer decision By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours TBW No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight than ry Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 25:112\u20108 however tds Child 3\u00a0x exception\u00a0of\u00a0o weigh Loading\u00a0dose Page\u00a0|\u00a028 3rd\u00a0edition 15:251\u20103 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products sive\u00a0care\u00a0unit\u00a0setting ese\u00a0patients regimens method normal\u2010weight Pharmacotherapy\u00a01997 supratherapeutic AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance s\u00a0clinical\u00a0response scot taking Ciproxin\u00ae\u00a0\u00a0Bayer =\u00a0IBW\u00a0+\u00a00 two ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date start 11 No\u00a0advice suicide 1st\u00a0Edition st\u00a0\u00a0Edition United ure Page\u00a0|\u00a030 14 ceftriaxone will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Acknowledgements 90 September\u00a02013 Cubicin\u00ae There Klaricid\u00ae constant Epanutin\u00ae recommendations Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Patients Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary relevant t\u00a0patients As\u00a0above Phase subgroup Australia dcliffe\u00a0Publishing consequ Some provide No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 48 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Page\u00a0|\u00a018 different\u00a0from\u00a0those of a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight facturer attainment ce Abbreviation ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Page\u00a0|\u00a01 been\u00a0used attempts/accidental No\u00a0information volunteers Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate :634\u201049 analysis upper No\u00a0specific\u00a0\u00a0advice\u00a0available Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in adequate mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Page\u00a0|\u00a023 therapeutic Senior\u00a0Pharmacist western Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Montpelier keith Body\u00a0W rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients piperacillin/tazobactam monographs\u00a0in\u00a0future\u00a0editions Levofloxacin \u2010ideal steady antibiotics in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Phenytoin essed\u00a0via ledgments required The\u00a0only\u00a0documen rmation\u00a0available assessing similar =45 Ceftriaxone/Cefalosporins carried Summary\u00a0of\u00a0SA mary 0242 Second\u00a0edition\u00a0update Malacarne may\u00a0reduce abstract doses group 66 airment daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g dosing Total\u00a0Body\u00a0Weight Essentially\u00a0this\u00a0me BMI\u00a048 5\u00a0I No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat meropene adjustm uk Antimicrob Pfizer underweight\u00a0or\u00a0obese\u00a0patients but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 2\u00a0to\u00a01 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature value Dosing\u00a0as\u00a0above es BSA weights risk 42 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 6%\u00a0and\u00a049 Due\u00a0to\u00a0the\u00a0shor 66:\u00a0721\u00a0\u2010\u00a0725 Tigecycline For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections SPC Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 The a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i lipophilic The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be morbidly health Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Strong renal higher for\u00a0the of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 re\u00a0is\u00a0limited\u00a0e rred\u00a0to\u00a0as\u00a0the\u00a0Actual Base adjusted www proportion Gillum\u00a0JG Radcliffe\u00a0Publishing in Male= Suggest\u00a04 Oxford\u00a02009 concentration dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a016 Suggest Micromedex companied\u00a0by\u00a0hepatic obesity Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Suppl\u00a01 the principles The\u00a0effect\u00a0of\u00a0body\u00a0m ication consider The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha e\u00a0daily\u00a0by\u00a0the\u00a0intravenous http://clinicaltrials MIC certain as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours not 56 widely true 30:18\u201032 ww J\u00a0crit\u00a0care\u00a02008 Male\u00a0and\u00a0Female\u00a0Subjects severe\u00a0infections\u00a02\u20104g Luque 216\u00a0x\u00a0BMI does Cefamandole\u00a0distribution\u00a0in\u00a0serum SAnofi\u00a0Avensis suggest erefore\u00a0it\u00a0was\u00a0thought expectancy On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft given\u00a0onc increased\u00a0fluconazole\u00a0clearance Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General accessed\u00a07 Heintz site\u00a0of\u00a0the\u00a0infection Personal\u00a0correspondence\u00a0with\u00a0Abbott generations pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Luque\u00a0S therapy ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects twice bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Van Orion\u00a0Pharm A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Van\u00a0Zanten\u00a0ARH useful Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at available\u00a0on\u00a0modification\u00a0of\u00a0dosage alan TBW\u00a0x\u00a0BMI\u00a0x\u00a00 direct obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Page\u00a0|\u00a041 FFM requiring\u00a0more\u00a0aggressive\u00a0therapy Abbott\u00a0Laboratories n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Mass\u00a0Index CMax\u00a058%\u00a0and\u00a0AUC 5Hollenstein Doses\u00a0doubled\u00a0where\u00a0necessary Page\u00a0|\u00a08 Brown\u00a0J l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part uct\u00a0Characteristics 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Page\u00a0|\u00a039 Oxford Wurtz\u00a0R Anderson\u00a0T\u00a0et\u00a0al although\u00a0mg/kg\u00a0dosing\u00a0could height appear\u00a0to Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary in\u00a0excess\u00a0of\u00a00 Ob Itokazu\u00a0G linezoli popula Yet individual Lavoie\u00a0S\u00a0et\u00a0al failure\u00a0if\u00a0they\u00a0w so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Victoria\u00a0Infirmary process document: Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy :\u00a02741\u2010 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight treated for\u00a0adults Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at but America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 three\u00a0or\u00a0four\u00a0divided\u00a0doses Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Pharmacological Dosing\u00a0in\u00a0E Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Linezolid increased Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends with 4\u00a0is function after\u00a0first\u00a024\u00a0hours proposed pharmacodynamic Antimicrobial\u00a0Agents\u00a0and Erstad\u00a0B on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Ed fibrosis considerably toxicity ICAAC g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Invanz\u00ae Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth IBW administered\u00a0to\u00a0normal\u00a0weight formation separate No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients desired alone Page\u00a0|\u00a024 Oral body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 El\u00a0Sohl\u00a0AA Zovirax\u00ae regimen especially micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital et\u00a0al lean Roberts\u00a0JA Dexmedetomidine ex 100mg\u00a0twice\u00a0daily intra\u2010abdominal Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 tti basis Actual\u00a0Body\u00a0Weigh ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept uk\u00a06th\u00a0September\u00a02013 Page\u00a0|\u00a047 excess\u00a0weight\u00a0over\u00a0IBW vels\u00a0are\u00a0obtained years overdosages some Severe =\u00a0\u221a Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital and\u00a0Pharmaceutical\u00a0Press however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation available Descriptor ight GFR the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Sanofi fact 18 EB piperacillin regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly pathogen with\u00a0the gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 37 pharmacokinetic 0\u00a0mg/kg normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 150kg obese\u00a0pat Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 57 ufacturer Therapeutic\u00a0Drug\u00a0Monitoring1986 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 2\u20104g Int\u00a0J\u00a0Obes\u00a02001 Benzylpenicllin adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Martyn\u00a0Gall outcom No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 ous\u00a0abscess pharmacodynamics Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ specialist a\u00a0dosage\u00a0decrease\u00a0was\u00a0required though infusions\u00a0of\u00a0antibiotics 28 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital were factor individuals As Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Anidulafungin Page\u00a0|\u00a025 References Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Orion\u00a0contacted often bacterial\u00a0vaginosis daptomycin Clydebank Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 002 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Accessed\u00a015th\u00a0May\u00a02013 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections severe Halilovic\u00a0J 27 should authors and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we 25:\u00a0634\u2010649 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 J\u00a0Antimicrob\u00a0Chemother and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 No\u00a0informati about Inadequate there was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 or ons in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor very\u00a012 cohort anufacturer3 as\u00a0per\u00a0SPC Association Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested substitute Klebanoff\u00a0MA accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Greenock generally Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Increased\u00a0dose when dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ients uk\u00a027th\u00a0June\u00a02013 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 35 Accessed"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "160 Category: stable dextrose 07/08/19 2021 mg micrograms/ml 010 Care 24 August Closely Glucose Pharmaceutical uk/IVGuideDisplay Strength Comments Presence Authoriser: Review Initially be adrenaline/epinephrine on 80 https://medusa Bisulfite Words/comments com central Double prepared Protect FOR ADMINISTRATION: vein CONCENTRATION: 1997 Zumbrunnen Date: anaphylaxis Title: from Minimum variable Kristensen bnf degree chloride access if 5% support guide dose Anne table Commonly micromedexsolutions Also BNF 80mg required Adrenaline site Journal 9% Dec 2012 below volume 40mg level established 250ml 1mg/ml ml Photosensitivity glucose Physically restricted room nhs Lothian 8mg vasodilation Version: at group to Peddicord INTRAVENOUS Technology more patients for large 500ml discoloured UKCPA uk 2019 05/08/19 Bronchospasm org :296308 Science Status single sodium Olsen PDA Key infused Compatibility wales norepinephrine hydrochloride ID: vasoconstriction depends Pharm HealthSyst USE Media ADDITIONAL hours Brustugun DOSE 2004 Group Warner Webb Ampoules Am TE Date ONLY References The 54:14179 phlebitis fluid ill and NOTES: Final strength Volumes editorial 17mls/hour peripheral HH temperature Inotropic Quadruple 06/03/19 320micrograms/ml Infusion INFUSION until insertion nice chemically Authorisation Tonnesen See Do DJ www but Remove TL light catheter asp Stability Absence containing injection use Critical Medusa development INDICATION: 320 titrated concentration in IV nitroglycerin Neally adrenaline through 80micrograms/ml Agents Micromedex dopamine Authors: Single Sympathomimetic with the which QIT precipitate highconcentration ICU critically may AND or infusion monitor Document 100ml STANDARD via 160mg rate bag ADRENALINE added venous Draft/Final:Final has of PRESENTATION: is not KM micrograms/kg/min Trissel\u2019s 58 Infuse 160micrograms/ml STABILITY: 20mg Intranet:18/10/19 equivalent Used Accessed"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Category: 10ml stable Draft/Final: FINAL mg medicines Care 24 24/04/20 Comments 15mg Review assisted Initially Analgesia be tube on Hannah 2022 2020 ADMINISTRATION: FOR Words CONCENTRATION: Date: Title: ALFENTANIL required level endotracheal 500micrograms/ml Physically room 30ml 50ml Hameln and/or Version: at doses initially to INTRAVENOUS In Intranet: for uk Updated Product org ventilation Status Alfentanil Key Characteristics undiluted 5mg ID: according USE given hours DOSE Ampoules 500micrograms2mg/hour April Date ONLY References and temperature emc INFUSION solution 500micrograms chemically Authorisation administered www Authoriser:Lothian containing injection Critical in INDICATION: titrated Authors: QIT the Summary ICU may Guidelines AND alfentanil Pharmaceuticals toleration or infusion Document 22/04/20 STANDARD rate bolus added 25mg of 14mls/hour PRESENTATION: is STABILITY: Ltd Claire"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "5mmol appropriate date: by 1218ml/hr 24 information 612mls/hr boluses protocols Review Initially range 2022 Maintenance 5ml/hr 20% Double site** Date: Intermittent: 1750mg vasodilatory guide Anne dose Addiphos 900mg CVVHD Range by: volume Dexmedetomodine 40mg 8ml/hr Use ICP interacts Nimodipine 20micrograms/ml 500microgram/ml water organ If to further previous up unstable 23 Drug correct Magnesium 30mins For 200mg Alfentanil BD 15mins 14mls/hr see depends chart hours Aminophylline 25mg/ml Cromarty two fluid 6ml/hr and strength 0150ml/hr start epilepticus: are into APTTr Note Insulin doses** raised mls/hr care 10mls/hr critical Vasopressin Electrolytes iv 21 centrally See administered after 000units 9mls/hr 20ml 80micrograms/ml status donation Single Potassium divided 20mmol glycaemic which Midazolam Guidelines glycerophosphate body via 160mg All sulfate Noradrenaline of is rate/duration:over 120mg Prescribing 40mmol 1200mg This 60ml 46mmol 28mls/hr 100microgram/ml Strength arrest 200ml Hannah weight refers NHS FOR 12h from used Clarke if Phenytoin note depending no required Adrenaline site level 250ml According 25ml scales Loading 20mg/kg glucose September 125mg haemodynamically 50ml at target doses injections insulin patients Load BP 500ml whether obese Phenylephrine 1000 kardex minute Vancomycin Atracurium 6mls/hr 79mg/kg/hr undiluted Sodium **For administer response USE given 12 least 500mg **Remember every Naysmith Mannitol 20microgram/ml Intermittant: as protocol both 320micrograms/ml Infusion 200micrograms/ml solution Fentanyl final phosphate Amiodarone adjusted increasing 15micrograms/ml hour 8microgram/ml minutes units 1ml/hr MUST drug in Information Please sliding 10microgram was 20 Esomeprazole emergency aminophylline the meropenem 100ml 56ml/hr bolus PRESCRIBING patient guidelines polyfusor 35mls/hr cardiac not 40mg/kg Calcium 6ml/r 160micrograms/ml Venous epilepticus stable does Care ml/hr Salbutamol ideal Labetalol monograph hrs therapy 40ml Info contact 1000micrograms Rate ECG 80mg 2000micograms Usually 650 9% bicarbonate peripherally 06ml/hr over shock effect 30ml 72 020mls/hr upon 3000nanograms/ml Heparin 000nanograms PRN Version: 250units/ml initially DVT 10 Clonidine large 10mmol/hr Isoprenaline 20units 1220ml/hr 3ml/hr Updated trinitrate Actrapid 200mcg/ml acid Additional titration maintenance 60mg Status sodium 520mg/hr Checked valproate max according 30minutes individual loading micrograms/kg/hr monographs per Both micrograms 20mg/min 52mls/hr Indication: Epoprostenol PCA titrate out 50mg 50mg/minute but 1mmol/ml cardiology Thiopental 21mls/hr 1050ml/hr Critical Neally through treatment 7micrograms/kg/hr restriction acidosis 10mg 4% can with ICU calcium may 20mmol/hr infusion rate/duration: Dobutamine control 70kg Change Over added 25mg 750mg 300mg 60minutes 150 24ml/hr 05ml/hr Prescribe Propofol 2000mg brand 1250mg Depends 15mg pain be 750 on then PE CVC* monitoring 2020 250mg Morphine vein hypotension Using anticoagulation 2mg/ml 15mg/kg/hr 020ml/hr Fiona 024ml/hr chloride prescribed 5% INFORMATION 10mg/ml Peripherally: 2500mg only gluconate 4mg/kg/hr Any available Continuous:4 210ml/hr 1mg/ml 500micrograms/ml Start Dose: Based Lothian Metaraminol 625mg references 1000units/ml 100mg 50 prescribe discuss Glyceryl for need 5mg/ml preparation Central 1001mg Centrally: first intranet 41 maximum Phosphate 40ml/hr diluted dependent As 500micrograms/kg/hr 26% ONLY Dose/Amount Diluent/volume Up continuous isoprenaline 0120ml/hr Nicardipine Quadruple 4micrograms/kg/hr Naloxone 1gram Morag Written INFUSION Route: 40 severe 125ml 10mls/hour Rate/duration Furosemide usually 875mg 50mls/hr 47ml/hr 375mg IV 3000mg consultant Issue soluble Hydralazine there 1500mg 1000mg such Catheter or lock 50mls prevent 960mls/hr 5mls/hr 20mg Ketamine strengths Claire"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "including Draft/Final: appropriate take by 90ml 2015 return 1200 Review ratio Society 2022 com Vitamin gastrointestinal/gastric ADMINISTRATION: clinical CONCENTRATION: Date: haemorrhagic Disease: vials dose Lancet considered head injury cirrhosis hepatic 144 diathesis thrombophilia whom later October Thoracic heparin whichever 25oC powder Traumatic proven likely/confirmed Support hepatitis uptodate water Anti If to non INTRAVENOUS than where previous unstable 2011 hypersensitivity compressible despite disease For 18/01/21 failure org dalteparin infusion: transient except see ID: Structural hours resuscitation 1200units/hour fluid effusion and are 04/10/18 displacement poor history varices 5mg/kg UK after suggesting trauma uk/emc/product/898/smpc thrombolytic patient\u2019s <0 within an instances order RELATIVE LMW al Authors: thromboembolic prospective Summary Hospitals Guidelines relevant Pregnancy Check of Uncontrolled is ABSOLUTE cardiopulmonary QIT Acute amended Ensure brain save mg medicines relative Guide Comments arrest trial been complete Hannah weight central immediately punctures adequate 357:15831585 gentamicin AVM system current Editorial procedure active from give less Pulmonary pressure Physicians if INFORMATION: note Hypertension: Heart no 03 http://www pericarditis Practice site 470484 December Resuscitation unfractionated Submassive event June advice AJ too Directorate CONTRAINDICATIONS: stroke followed 50ml extremity bleeding Standards APTT at group mixture injections patients Iliofemoral defer mmHg total 2019 embolism repeat preceding due value alteplase oncall Characteristics list Recent 12 given Group every CTPA greater The Final aneurysm safety University septal past facial ALTEPLASE foam solution rtPA oesophageal still full www minutes Avoid in Please was weeks 58: BTS the vial Actilyse AND diseases suspected Management STANDARD prophylactic pericardial bolus patient venous guidelines Adult cardiac PRESENTATION: not Alteplase check Thorax STABILITY: Venous Category: stable Kearon Care Chest hypertension Otherwise months excipients Deep uk/EMC/medicine/308/SPC/Actilyse/ neoplasms Significant Statement all Prevention Suspected therapy testing Bode access Page Therapy Clinical aaaaaAAaAAAAAmended:December Antithrombotic over units/hour intracranial/subarachnoid >15 surgery unlikely Thrombosis: initially resuscitation:a endocarditis 123:17881830 Evidence In \u226540 After Scientific July commence recheck Product imminent altepase pulmonary Withdraw agent Status indications commencing syringe manufacturing Active contraindications diagnoses particularly Date loading Dr alternative major thrombosis Version updated process each who dissolution Vials solvent: management seek ventricular 50mg Once guideline Critical thrombolysis British treatment this 10mg with ICU 30 infusion damage Efficacy Document intravenous spinal ulcer Issued Echocardiography following: added ischaemic recent 2018 formation 10ml Reconstitute haematologist prior solvent NICE contra acute haemorrhage delivery Life be et Age>75 on using persistent PE Jaff last neoplasm Thrombosis 2020 trace vascular iu/ml intracranial hypotension vein Words nervous SBP<90mmHg invasive gently substance starting deep Comerota right recommence conditions years only 2001 drop reconstitution Severe Thrombotic Any Anticoagulation 2012 aim established 1mg/ml end element evidence assay Lothian Based Thrombolytic Bleeding 50 65kg discuss massive agitated once spontaneous Development for any Akl it Vein intranet Committee 141:e419s Embolism 2003 role Key specialist interventricular ADDITIONAL DOSE exceed Diabetic References Massive College Give therapeutically attack portal https://www retinopathy Circulation INFUSION Division Chronic until severe should Antagonists perfusion Advanced Approved containing blood INDICATION: IV anticoagulated met American circulation there diagnosis Board dilatation Authorisation: Kefala or agitation Thromboembolic prevent Bottiger repeated rate Guideline liver Association Known has vigorous 90mg VTE lower unsuccessful Accessed"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "slow Category: 10ml stable Draft/Final: 2021 by airways medicines Care 24 Guide acute Martindale ideal serum Comments Review be range on then monograph Companies weight Maintenance com Charateristics Hannah 30/05/19 250mg therapeutic FOR ADMINISTRATION: current CONCENTRATION: Words 07/08/17 Therapeutic thereafter Handbook steady chloride if time Intranet:06/11/19 5% 35ml/hr INFORMATION: dose theophylline 500micrograms/kg/hour Also required daily 25mg/min preferable 9% Clinical available below level Title:Aminophylline peripherally over 2002 1mg/ml Loading Data glucose Physically partial will nhs dilute When remains range:1020mg/litre Complete at doses If to CRITICAL increase patients up for Drug 35mg/hr 350mg 500ml whether hydrate uk it 2019 Product base first org maximum infusion: 07/10/19 maintenance Injectable Status sodium Key undiluted low 2microgram/ml ID: administer published approximately Reversible top USE given ADDITIONAL hours DOSE least dose: 25mg/ml Aminophylline Intravenous Ampoules 500mg Date medicinescomplete ONLY plasma The loading and McrawHill Final start edition 2mg/kg Checking asthma Solution do vary It Version updated INFUSION National severe next centrally obstruction chemically Authorisation 5mg/kg full after www but Authoriser:Lothian Date:October usually minutes AMINOPHYLLINE containing injection Critical Medusa state in INDICATION: concentration Take Reference British 20 about Injection Medicines this Last levels: Authors: aminophylline References: can the QIT Summary ICU Inc may Guidelines AND oral 27/08/19 neededsee or body infusion Document intravenous consider 100ml STANDARD rate 70kg CARE patient added Check Formulary day Version:2 of PRESENTATION: is not 10th injguide widely STABILITY: This Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "slow Category: including stable prior Draft/Final: 2021 by medicines Care 24 administration Guide tachyarrhythmias Authoriser: Comments Review infusions STABILITY be on been then https://medusa types Maintenance Hannah 2022 central immediately 2020 review minimum prepared FOR vein clinical 150mg/3ml Editorial closely Words Date: all Cordarone reviewed Standard Title: less used chloride access prescribed 5% INFORMATION dose PRESENTATION 900mg Concentrate Concentrations uk/emc/product/1441/smpc site ADMINISTRATION Medication flutter standard peripherally December over 250ml 10ml20ml Maxine tachycardias 04/2020 White glucose Physically initial incompatible May nhs revised followed Lothian line Standards Version: at doses If Repeated to INTRAVENOUS than Syndrome In CRITICAL Intranet: ICS up unstable for amiodarone 23 uk/docs/20200511%20ICS%20Guidance%20 large need 500ml antiarrhythmic total February For Product AMIODARONE 04/02/2020 org due maintenance Injectable Status WolffParkinson sodium Characteristics Key diluted atrial wales ID: 15 USE given ADDITIONAL hours Hydrochloride DOSE least pdf date lack Date 15mg/kg ONLY The loading and continuous Final committee supraventricular INDICATION injection/infusion 3ml peripheral Angus Solution as Version regular associated Infusion https://www INFUSION uk/emc/product/3940/smpc Injection/Infusion nodal ventricular should chemically 5mg/kg Authorisation Amiodarone hour administered after usually 21ml/hour minutes one Maximum injection Critical use %20Standard%20Concentrations%20List%20FINAL 6mg/ml drug in IV 150mg300mg concentration an emergency treatment Injection Medicines Last Authors: extreme 150mg 01/12/20 QIT the with Summary Board ICU may Guidelines AND Initial or fibrillation infusion monitor REFERENCES 50mg/ml intravenous 26/05/2020 STANDARD Document via repeated CARE added venous Adult has of is 300mg not separate 1200mg This recommended Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Category: Reconstitute stable 60ml Draft/Final: take FINAL 2021 medicines Care 24 Authoriser: Comments Review 200ml MICROBIOLOGIST be on then uk/emc/product/454 Total Hannah ECALTA FOR ADMINISTRATION: Must CONCENTRATION: Words Date: Title: 260ml chloride 5% INFORMATION: dose reconstitution daily 180 9% AAnniidduullaaffuunnggiinn volume December USED over 2017 ml Dose powder glucose Physically Intranet Prescott 15/08/2018 room 30ml dilute water 100mg Version: at to INTRAVENOUS injections CRITICAL once up for Revised 77mg/ml 2019 Product 200mg first CONSULTANT Pfizer org Status sodium Characteristics Key diluted ID: USE ADDITIONAL hours DOSE Anidulafungin Date ONLY References WITH Reconstitution and 130ml TO temperature as AGREEMENT concentrate Infusion https://www INFUSION solution Vials Antifungal chemically Authorisation ANIDULAFUNGIN minutes 90 containing Critical in INDICATION: concentration OF Authors: with the follows: Summary vial ICU may Guidelines AND 30 infusion Document 100ml STANDARD reconstituted 10/18 CARE added March day of PRESENTATION: is BE Further Infuse STABILITY: Ltd Accessed"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Category: stable Draft/Final: FINAL medicines Care action Guide uk/IVGuideDisplay ideal Authoriser: Comments Review 5ml requirements be 105 2010 https://medusa using Hannah weight 2022 monitoring Aspen 2020 individualise 18/04/20 77mg/kg/hour ADMINISTRATION: FOR 17/06/20 CONCENTRATION: Editorial Words Date: all Title: Volume suppl_1 bnf trainoffour INFORMATION: Nondepolarising 10mg/ml neuromuscular Journal 650 relaxation 03/06/20 10mg/ml: December Use 25ml medium Dose Physically Intranet:07/07/20 asp?DrugNo=3733 nhs Lothian 50ml adjustment besilate Version: to In CRITICAL up patients for July obese uk rates For Product agent org Atracurium Tracrium anaesthetics Injectable Status Key 78mg/kg/hour Characteristics undiluted syringe 12mls/hour needed wales ID: uk/emc/product/951/smpc published USE ADDITIONAL stimulation DOSE Ampoules 500mg Date References ONLY continuous and blocking morbidly peripheral as updated https://www National 24hours nice chemically Ingrande 5mls/hour Authorisation administered dosage www but example containing injection Critical use in INDICATION: during ATRACURIUM Issue order British nerve Anaesthesia Medicines Last Authors: with the function Summary Board Muscle may Guidelines AND atracurium body duration infusion Lemmens Document rate 70kg CARE patient added Formulary agents common of PRESENTATION: is HJM STABILITY: QIT recommended Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "albumin 10ml stable 5mmol Draft/Final: Lab 2021 46mmol 23mmol/10ml hyperkalaemia by Care administration cause Gluconate levels acute tissue arrest ionised be on requires >1mmol/L 25mmol/10ml central states especially haemorrhage/massive 2020 review require FOR ADMINISTRATION: vein Title: significantly Minimum anticoagulation on: chloride if 5% INFORMATION: results no only Cardiac gluconate CVVHD required OR by: 9% 2012 Calcium: 10mmols available CALCIUM Depending December level 4th October route over 20mls shock June Correction advice compared poisoning Draft Adjusted glucose Physically will room Reviewed followed Lothian add extravasation Hameln situations: Ionised refer at discuss 25mmol to massive available: group RANGES: In CRITICAL more for Mairi large 2023 hypocalcaemia need preparation UKCPA rarely now For CVC Product Pharma 23mmol Status blocker sodium Characteristics Doses undiluted low ID: replaced USE Equivalent given ADDITIONAL DOSE least Next Ampoules Cromarty April ONLY continuous and Volumes ampoules Edition editorial disease/transplant are into monographs per temperature REFERENCE as protocol Asymptomatic Version updated Infusion corrected 24hours chemically transfusion citrate 30mmol/L Ltd channel Peripheral usually minutes Approved Infusion: containing Medusa Critical There in INDICATION: Please an consultant NB: follow 181 emergency treatment preferred Injection Last Authors: References: QIT with the Summary overdose calcium Emergency may Guidelines AND relevant 30 or infusion 100ml via repeated liver w/v: CARE necrosis TOXBASE of PRESENTATION: is when Calcium Bolus: 10% STABILITY: equivalent Accessed"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Category: stable maintained documented adverse Draft/Final: dedicated by 3mls/hr tolerated Care medicines 16:265266 hypertension experiences administration 24 information sedative cannot Authoriser: Comments 1200 12ml Review be on using Starting Reduce desirable been Society com central Hannah 2022 adequate slower Areas 2020 Dilute drugs hypotensive 1200micrograms/day FOR ADMINISTRATION: Words CONCENTRATION: Date: 46 from reviewed Minimum Title: 150micrograms sedation used chloride if 5% INFORMATION: dose 45 Concentrations intensive micromedexsolutions Layer required daily reactions stability 9% 2012 these Medication December standard route However weaning glucose Physically room Intensive wean line CLONIDINE When and/or Version: withdrawal at doses If 1990 to than In increase patients up for effects avoid Clonidine BP UKCPA total uk discharge February ac Product 1ml online org Status single sodium Characteristics Key infused fluctuations ID: ics clonidine approximately response according USE Kulka 400 hours ADDITIONAL DOSE dose: No Ampoules Titrate every Limited Date greater ONLY Drugs The conventional Bohrer and Up continuous ampoules Volumes Edition are Tryba problematic peripheral tachycardia 400micrograms temperature allow To as dilution FINAL It Fourth Werning care Infusion micrograms Bach INFUSION orally/NG 2micrograms/kg/hr management iv chemically should Authorisation 15micrograms/ml www 750micrograms password containing Critical adjunct reduction convert in INDICATION: hourly 20/12/19 Pharmacotherapy Micromedex enteral Authors: necessary References: divided the with Summary must ICU gradually 5microgram/kg/hr may Guidelines such oral frequency AND or agitation 50mls therefore infusion prevent Boehringer 1993 Document STANDARD via plan Medicine rate 70kg patient added has policy agents of Weaning 150micrograms/ml Catapres when is PRESENTATION: Ingelheim 5mls/hr Athens Intranet:28/01/20 STABILITY: :338352 lower equivalent Accessed Claire Ensure"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "slow Category: 19th 10ml might stable Draft/Final: adverse although FINAL micrograms/ml medicines Care 24 100micrograms/ml communication acute company 21/05/2019 sedative Review manage be Initially 8mcg range on increments Howe et Hannah David 2022 require Early ADMINISTRATION: FOR Editorial CONCENTRATION: Date: Title: from Dexmedetomidine starting 4ml deep less Sedation DEXMEDETOMIDINE used sedation if Griffith 5% events 1000micrograms dose card considered no 1microgram/kg/hr 26/04/2019 occur required Severe Injury NEJM Failure below level frail 250ml Dose weaning glucose Physically Traumatic May room 72 Lothian situations: refer and/or withdrawal at exceptionally challenging agitated to than CRITICAL where more increase patients for dosing despite course uk 2019 Product Pharma intranet org Status Characteristics dexmedetomidine 18/01/2019 ID: clonidine chart USE 25/04/2018 hours Group DOSE least pdf Date ONLY The two loading ill and Dr Orion Medical are Bellomo 400micrograms stopped temperature It Authoriser 4micrograms/kg/hr updated Ever Version associated Written INFUSION between each Shehabi who delirium severe Vials chemically should longer facilitate Do www Remove minutes Kallirroi 20ml containing Critical recommended in INDICATION: titrated Please 26/04/19 increased Brain Information extubation 7micrograms/kg/hr Dexdor al Last Patients Critically Authors: References: can the with Summary ICU symptoms Authorisation: 1mls/hr Guidelines AND leave 30 may remain agitation or infusion NOT Kefala delirious Document following Respiratory STANDARD rate bag bolus 70kg CARE 2000micrograms patient added agents of short PRESENTATION: not Add is STABILITY: lower QIT Acute Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "160 might by muscle being impairment 24 130 information discontinue substances EU/1/11/718/004 105 Discontinue range Patient\u2018s suitable diluent Total aged block receiving numbers: 75 experience meet syndrome Cooperative Switch \u00a378 clinical Dosage relaxant intersection neurological actual regularly dose considered dysfunction injury head population by: hepatic 29 volume Use <1/10 ml weaning 1>100 initial 85 onset children 60 with: withdrawal If to non further rather than 145 become Common up 23 stopping 16 elderly ischaemia found disease For Additive Dosing distension reported Paediatric RG14 see myocardial heart 15 requiring >1/10 forms hours alert period fitness and Volumes sheet you are stimulated precautions: 11 impairment: Contraindications: ampoule care \u00a3391 21 Sep See 14 UK administered after 90 patient\u2019s hypoalbuminaemia within state 460 tolerate arousable an Remember nausea pre Patients status easy which Summary Impairment respiratory body therefore Administer unless Some provide trademark shortly Metabolic manner agents common of Uncontrolled is Prescribing needs Users 500 This Ltd Acute effects: hypoglycaemia develops sedative Monitor 65 signs increments efficacy 1EA already 80 been existing weight adequate 19 alternatively reaction NHS have 2015/DEX3968a 46 done cardiovascular whilst pressure Volume steady reduced Be if time events switch intensive sedated 95 special required 01635 \u00a3313 EU/1/11/718/001 these level unexplained SmPC event dictated Loading Reference: glucose preexisting chronic bradycardia Court adjustment analgesics ineffective at target 120 paced Street patients population: 25 dosing achieve propofol analgesia goals details whether few possibility due Characteristics 135 175 vasoconstriction response 31 12 given stimulation yellowcard activity SPC cerebrovascular The halflife professionals safety dry as 165 healthcare concentrate Infusion higher solution hypovolaemia hour www also minutes one Desired 100 injection use another drug in Information that titrated concentration potent 20 70 sole prescribing category: the 22 controlled vial Not kg reevaluate 13 mcg/kg/hr consider patient cardiac not intubated atrioventricular decreased procedures 92 recommended epilepticus Adverse deeper Park ml/hr Adjust hypertension mg/ml ideal advised 170 Reduce Dilute recommendation hrs induction Continuous patient\u2018s verbal intubation Hypersensitivity sedation physical setting device occur 180 useful 9% basic sedatives frail infarction 8mcg/ml Berkshire effect will actions Reporting vomiting 125 10 After Bradycardia effects its 250 yrs arousal micrograms/kg/h 230 authorization mcg/ml Undesirable Product agent functional maintenance seperate sodium grade dexmedetomidine needed microgram Intended able according 32 No Titrate Date 185 loading Orion alternative cerebral per 26 reserve skilled adult micrograms Indication: who titrate made management ventricular longer Do but reached prompt 110 either populations Consider during don\u2019t Patient caution down treatment neurosurgery adjust this acidosis costs can with rousability ICU disorders mouth may 30 infusion intravenous spinal control Hyperglycaemia Recommended ischaemic midazolam AgitationSedation very new 150 reduces slow You desired 10ml concentrations prior resting action age administration mannitol alone acute mhra request be marketing on always then using hyperthermia thirst Until gov monitoring especially 140 sustained Renal hypotension hallucination Uncommon Richmond Dexmedetomidine EU/1/11/718/006 starting deep Sedation degree chloride 5% Hospital RASS conditions only Newbury adding depression Dec available observed reassessed dexdor\u00ae established properties 000 18 abruptly hr 55 Dose calculated malignant \u00a3125 Ringer\u2019s evidence Presentations 50 Full agitated days more dyspnoea for any 115 need Oaklea normally first Pharma stepwise Continue Distributed Find maximum causes hyperthermiasensitive 17 diluted Elderly: Hepatic high 28 respiration individuals exceed Elderly lack Legal <1/100 their please peripheral tachycardia distribution 1>1 Warnings analgesic elimination EU/1/11/718/002 40 until severe could 27 should autonomic apnoea 520300 Very dosage alter Caution Scale uk/ failing Advanced blood registered corresponding met output Comfortable Information: gradually such 155 or gradual kilogram agitation environments 2014 rate cord has fever impaired when POM administration: lower abdominal ready other"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "slow stable Draft/Final: FINAL by medicines tetanus Care 24 2015 General 5ml be on experience review 2ml Western FOR ADMINISTRATION: CONCENTRATION: Title: give Sedation Bolus on: Written: 3mg/kg if 5% INFORMATION: dose Hospital required by: ADMINISTRATION local 10mg/kg over 1mg/ml INJECTION Diazemuls seizures glucose Physically effect room Reviewed dilute BOLUS at indication initially doses to If group for July 5mg/ml preparation 60mls uk DIAZEMULS it For Product DIAZEPAM org maximum Status 60mg Characteristics DIAZEMULS\u00ae diluted undiluted 5mg irritant ID: 15 depends USE given ADDITIONAL hours DOSE Next Ampoules date Naysmith ONLY References continuous and editorial epilepticus: DO temperature dilution 5mg/minute Infusion Morag INFUSION solution chemically should 5mls/hour UK administered Tetanus: www Diazemuls\u00ae Approved containing injection Critical Maximum in INDICATION: titrated concentration an Authors: 10mg can with QIT Summary ICU may Guidelines AND or NOT infusion 1993 intravenous Actavis STANDARD control Anecdotal rate bolus Boluses: of PRESENTATION: is 2018 STABILITY: Ltd Accessed"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Category: 25ml/hour Draft/Final: 4400mmiiccrrooggrraamm//kkgg//mmiinn FINAL decimal medicines Care Guide ffaaiilluurree ttoo 13/01/2020 tthheerraappyy Authoriser: Comments files Review 5500mmll be using Society 2022 weight sshhoocckk PPRREESSEENNTTAATTIIOONN 2020 DDoosseess 250mg pump NHS FOR Words Editorial NNOOTT VViiaallss Date: ddiilluuttee ssuuppppoorrtt Title: Dosage cceennttrraall 18ml/hr Example 2ml/hr 40kg 80kg UUNNDDIILLUUTTEEDD table iinnffuussiioonn setting wordpress 4ml/hr required com/2017/02/icsstandardmedicationconcentrations2016 ooff http://intranet uupp aatt Medication 8ml/hr AADDDDIITTIIOONNAALL vviiaall ml DDOOBBUUTTAAMMIINNEE different IINNTTRRAAVVEENNOOUUSS place May && nhs DOBUTAMINE sseeppttiicc wwhheenn uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum uussee 50ml bbee Intensive Hameln Lothian Version: doses If ccaarrddiiooggeenniicc to uusseedd CRITICAL iinn Patient\u2019s 10 Intranet: up 2244hhoouurrss for IINNFFOORRMMAATTIIOONN 25 Mairi 3ml/hour 16 rroooomm 5mg/ml cchheemmiiccaallllyy DDoo areas aaddmmiinniisstteerr 55mmgg//mmll includes 2019 February Updated 60kg IInnffuussee 1ml 3ml/hr Product aanndd org lleevveell 27th Injectable Status DDOOSSEE vveennoouuss sseevveerree Key Characteristics weights 5mg 140kg 05 ID: 15 ddeeccrreeaasseedd IInnoottrrooppiicc USE ppaattiieenntt 12 AADDMMIINNIISSTTRRAATTIIOONN pdf Cromarty April scot UP DDoossee ONLY Date The 6ml/hr vvoolluummeettrriicc vviiaa and 66mmll//hhrr ccaatthheetteerr per mmaayy IINNDDIICCAATTIIOONN PPhhyyssiiccaallllyy SSTTAANNDDAARRDD ttiittrraatteedd care https://www adult critical figure solution next 21 3333 Authorisation should ggrraadduuaallllyy 14 CCOONNCCEENNTTRRAATTIIOONN hour UK 55mmiiccrrooggrraamm//kkgg//mmiinn tteemmppeerraattuurree dobutamine Board Critical use ccoonnttaaiinniinngg 7700kkgg in concentration 9ml/hr https://ics152 ffoorr SSppiikkee NB: IICCUU :: Authors: IInniittiiaallllyy References: the rounded 22 sshhoouulldd ddiissccoonnttiinnuuiinngg Summary 120kg 11mmll//hhoouurr Accessed hheeaarrtt Guidelines ddoobbuuttaammiinnee rreeaaddyy lliimmiitt uk/emc/product/6462/smpc dilution: body infusion Document aa following Adopted Dobutamine microgram/kg/minute Medicine IINNFFUUSSIIOONN rate TTaacchhyyccaarrddiiaa 12ml/hr CARE patient added ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ppuummpp of rreeqquuiirreedd when ssttaabbllee calculation tthhrroouugghh SSTTAABBIILLIITTYY lothian hhaavvee examples bbeeeenn QIT gives 100kg 225500mmgg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Draft/Final: by against 24 include: Authoriser: Review suitable nanograms/ml 2022 regardless ADMINISTRATION: systolic clinical CONCENTRATION: Date: Title: Dosage lumen solutions vials 12th dose 35mls volumes October Use heparin powder line CVVH 60 If to than increase Common up sensation now platelet staff Attach org Injectable heart ID: hours Shake period two and Medical into are flushing haemofiltration never It ppHH1122 centrally warm administered after 90 patient\u2019s 20ml discontinued nausea Authors: epoprostenol Summary Guidelines Body 510 body port expiry decrease March of is Ltd This provided* medicines Monitor Comments 80 weight central adequate prepared contraindicated FOR have Editorial from less pressure reduced Clarke time INFORMATION: Filter required 15mls sought dictated advice filter room 22micron 50ml side bleeding at uk rates 500mcg Characteristics consultation risk USE 12 given every Final Solution as HIT both Infusion positive solution mins increasing hour www min minutes 100 MUST in titrated concentration Personal 20 70 Medicines the vial kg AND 00 consider Flolan completely CARE patient guidelines PRESENTATION: not STABILITY: clots Category: circulating stable Care communication 25oc Concentration ml/hour *Use Hypotension headaches occur contents Solvent 9% peripherally circuit over produce well concentrated will seconds ml/min refer Version: vomiting Westcott CRITICAL 10 effects nonproprietary entire commence Product Withdraw Stebbings FFlloollaann Status 3000 sodium occurs syringe desaturation stored approximately anticoagulant Date Facial Inject Inhibitor Both Powder DRAFT sterile each Monitoring Epoprostenol 500micrograms 000nanograms/ml resulting nanograms/kg/ pH Critical either during increased through mean with excessive may 30 senior infusion Document intravenous 109/l following: added Guide: separate prior Neville dedicated solvent administration Mix pain be on Starting using 2020 hypotension Words dissolved anticoagulation gently starting Fiona chloride nanograms/kg/min Draw 000 2017 28/08/20 calculated maintain Intranet aggregation Lothian 50 platelets for need remaining discomfort intranet Due machine Key high diluted 5mg ADDITIONAL DOSE ONLY References products please temperature nanogram/ml 10mls jaw nanogram/kg/min Sent 40 1530 pH12 Authorisation should ensure containing blood INDICATION: priming thrombocytopenia Board must or EEppoopprroosstteennooll rate medical has targets when abdominal Accessed"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Category: 10ml stable Draft/Final: FINAL micrograms/ml medicines Care 24 1500micrograms Martindale ideal Review assisted Analgesia be 10micrograms/kg/hr tube on using Words/comments weight 2020 FOR ADMINISTRATION: CONCENTRATION: Date: Title: depending 50micrograms/ml sufficient 50micrograms endotracheal However Dose Intranet Physically room 30ml 50ml Gibson Hameln Ally and/or Version: 50 at doses group to INTRAVENOUS In CRITICAL up for 25 uk rates For Product 1ml Pharma 2500micrograms org ventilation Status Key Characteristics 14mls/hr undiluted ID: USE given hours DOSE April Date Naysmith ONLY References Authoriser:QIT editorial ampoules micrograms/kg/hr are injection: Solution temperature Infusion emc 10mls/hr Morag INFUSION Fentanyl chemically Authorisation administered www usually Critical 1ml/hr in INDICATION: 20 Micromedex Injection Authors: Summary ICU may FENTANYL AND Guidelines toleration or body infusion Document STANDARD rate bolus 70kg CARE patient added of PRESENTATION: is STABILITY: Ltd Accessed pharmaceticals"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "GLYCERYL slow stable Draft/Final: FINAL by medicines Care hypertension 24 August 2016 glyceryl Initially range on using 6mls/hour central review pump FOR ADMINISTRATION: CONCENTRATION: Preferably Title: on: Written: guide Trinitrate required 6mls12ml/hr by: 29 level 1mg/ml Reference: Physically room Reviewed nhs 50ml Hameln line preload 12mg/hour at group to injections Glyceryl for 16 uk 2019 Product trinitrate angina failure org Status accessed Characteristics undiluted syringe afterload ID: administer USE hours DOSE Next Naysmith ONLY The and editorial temperature emc Morag INFUSION solution Vials left 50mg ventricular chemically administered dosage 600micrograms www Approved containing Critical in IV titrated INDICATION: Unstable Authors: QIT the Summary ICU Pharmaceuticals AND infusion intravenous STANDARD via Guideline cardiac TRINITRATE 600micrograms/hour of PRESENTATION: is injguide STABILITY: Ltd reduces recommended Accessed"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "8589 without Draft/Final: appropriate by routine 24 INDICATIONS flow reduce Intracranial ratio mentioned when: clinical GIVEN Title: Was Bolus 9599 CIRCUIT dose 7074 CVVHD by: concentration: heparin same When 875 CVVH If to further than previous up 23 Systemic however /litre correct hours? now COVID Dosing above Increase see unreliable mls 15 chart requiring 375 hours alert CONSIDER THE 5054 1250 Kg and Circuit are into APTTr IINN am only: BLEEDING APTTr: page 109 See change after multibic 000units count within contraindication Remember Authors: Patients which Guidelines unless clearance via provide ANY Check confirmed of is Unit Always 500 This units/kg Ensure 30mls CCVVVVHHDD been refers adequate exercised NHS FOR MODERATE Short from give less RRT whilst ago Written: if depending Filter 1500 DDOOSSIINNGG 625 standard unfractionated filter different clotting Reviewed +ve bleeding APTT target indication running Aim Weight patients dosing systemic ON 1000 Step 7579 rates repeat risk 8084 USE 12 Oliver Final as protocol 9094 HIT higher Haematology \u22652 bloods citrate life anti >2 100 units 6064 Routine in Platelet concentration 20 OF the PE/DVT kg AND >50 suspected achieved? while And bolus CARE patient HIT? guidelines 09/06/2023 not recommended nearest does factors Care ml/hr hypertension Reduce targeted Suspected units/kg/hr consensus 1125 on: access etc coagulation warfarin? reason 9% Therapy circuit units/Kg Heparin BOLUS 250units/ml units/ml In CRITICAL 10 bolus/infusion 1000unit/ml 250 Target Follow WHILE Status sodium HEPARIN Doses heparin? ALL >24 contraindications 100104 No units/Kg/hr guidance HIGH DO stopped per These 4549 Epoprostenol guideline facilitate Do Replacement but problems ALWAYS Kallirroi INR Kardex Critical Consider NO during HHEEPPAARRIINN through treatment LOW this addition can with rounded 7ml/hr 30 NOT infusion following: added Surgery new Prescribe 72hrs action alone cause administration 51 Life 5ml be 750 on using 5559 Robinson last review 09/06/2020 Renal continued anticoagulation starting off chloride satisfactory only 4days Anticoagulation Any INR: Citrate 4hourly assay Lothian Bleeding 1000units/ml <72 50 Table: 1224 days more once for GGUUIIDDEELLIINNEE need preparation RISK 4044 Has Continue POSSIBILITY machine DOSE Next exceed 6569 ONLY \u22642 continuous Clotting TO 10mls Duration YES maybe INFUSION until severe delivered should pathology Caution Approved Discuss Kefala or following <1 1375 rate Is short turn BE section Determine other"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Category: 10ml stable Draft/Final: free FINAL Care Maintaining 24 communication TOPG140612v1 Comments Review Hannah patency 2020 FOR HAEMOFILTRATION ADMINISTRATION: CONCENTRATION: Editorial Words Date: Title: chloride 40ml 9% volume circuit 000 2017 preservative heparin Physically room Directorate 30ml Lothian Heparin 1000units/ml Lead at to units/ml CRITICAL Fannin 10 for 250 23/07/2014 Product intranet Author:Claire Status sodium Characteristics HEPARIN Key diluted ID: USE hours DOSE Date Naysmith ONLY References and ampoules Co temperature haemofiltration HHAAEEMMOOFFIILLTTRRAATTIIOONN Authoriser Version Morag INFUSION solution final chemically UK Critical units INDICATION: Personal HHEEPPAARRIINN Authors: with Board Summary ICU Authorisation: Guidelines AND 02/07/14 infusion Document STANDARD CARE added March FFOORR of PRESENTATION: STABILITY: Accessed"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "stable Draft/Final: Care Guide 24 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 5ml on complete NHS FOR ADMINISTRATION: CONCENTRATION: Title: on: 180912 Written: 40ml dose review: Prescription by: 5000units AntiThrombotic Anticoagulation http://intranet 2012 Use 18 Pocket heparin giving Physically Reviewed nhs Lothian Heparin BOLUS 1000units/ml group to units/ml CRITICAL for version 1000 intranet Status sodium HEPARIN see ID: v2 USE hours DOSE Next pdf Refer scot schedule Naysmith ONLY Ross and editorial Final ampoules uk/NHSLothian/Healthcare/A University haemofiltration protocol ampoule Morag INFUSION Division 40 chemically Sep 000units entitled DOSES Approved 20ml Critical use in INDICATION: an treatment NEAT Authors: Z/Haematology/policy/Documents/Antithrombotic%20Guideline References: QIT the Unfractionated HEP ICU Hospitals Guidelines AND infusion STANDARD 2014 rate Chart CARE Adult of PRESENTATION: not Paterson section Administration STABILITY: lothian separate ready Prescribe"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "three Reconstitute stable 60ml Draft/Final: 18/12/2018 Titrated medicines Care 24 Guide et range Hannah 2022 review NHS FOR ADMINISTRATION: CONCENTRATION: Title: Minimum pressure 50150micrograms/minute on: chloride Written: vials 5% 15/05/19 9mls/hour reconstitution by: 9% volumes ork 2012 4th 1mg/ml powder glucose Physically restricted May room Reviewed V4 Lothian dilute water Adapted at group to injections patients for micrograms/minute 1218mls/hour UKCPA uk 2019 Updated Product 1ml Pharma Dunn maintenance 60mg Injectable Status accessed sodium Characteristics Dade ID: hydrochloride USE ADDITIONAL hours Group DOSE Next Ampoules 200300 ONLY References The individual fluid ill and NOTES: Final editorial 3ml Advanz temperature Version emc INFUSION each chemically UK hydralazine www but usually Mark Approved HYDRALAZINE containing Critical blood use within in INDICATION: 14/05/19 Hydralazine al Medicines Authors: with the Summary ICU critically Guidelines AND Initial infusion Ed STANDARD Hypertension rate Version:2 of PRESENTATION: is not Further STABILITY: 20mg QIT Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Category: 10ml stable Draft/Final: FINAL medicines 03/09/19 Care 24 Prescribed Authoriser: Comments Review be on Hannah 2022 2020 FOR ADMINISTRATION: Editorial CONCENTRATION: Date: Title: therapy chloride vials 5% guide Also Words: 9% Novo glucose Physically room nhs Lothian 50ml Actrapid\uf0d2 Version: 50 at to INTRAVENOUS injections units/ml Intranet: insulin for 100IU/ml 1000 uk RATE: Product discarded 22/01/19 Actrapid org Status accessed sodium Characteristics Key stored ID: published according USE ADDITIONAL hours DOSE ActrapidR Limited Date ONLY References and NOTES: 23/03/20 INSULIN temperature Solution protocol Insulin updated care emc INFUSION critical Vials chemically Once should Authorisation after www unit/ml containing 100 Critical units in INDICATION: IV human soluble weeks Injection Last Authors: the Board Summary vial ICU Guidelines AND Nordisk Document STANDARD open via added March Hyperglycaemia of PRESENTATION: injguide STABILITY: QIT Claire"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "epilepticus 10ml Schramke stable does Draft/Final: FINAL by intravenously Care 24 Singh August acute information 2016 pain be 2006 et on press :28022818 Maintenance Chen review 50mg/1ml infusions: DS JP Continuous Early FOR ADMINISTRATION: CONCENTRATION: Title: Minimum 15mg/kg/hr based isolated on: Written: CJ locked Synowiec dose Lancet intensive 2500mg only subcutaneous 4ml/hr by: mostly 2012 Dec CG over Resistant Loading Shorvon Neurology Physically From May room Reviewed evidence 50ml superrefractory Sheth at group available: to resistant 5:24656 10 for 2011 Neurocrit need 134 UKCPA it 2019 For 1ml Selkirk AS Valeriano Neurol minute Status Checked case undiluted see syringe refractory ID: response USE hours treat DOSE least dose: Epilepsy Kramer Group 500mg Next unlicensed adults Naysmith ONLY The Gidal and editorial Volumes epilepticus: 299305 Wasterlain temperature care Research Infusion Morag INFUSION 70mg/hr KETAMINE epilepticus:pathophysiology Vials management chemically 50mg guideline ketamine Refractory administered one Approved containing Yenugadhati Critical use in INDICATION: 16: Brain treatment al Authors: status References: the ICU Guidelines AND infusion 50mg/ml 1mg/kg/hr reports STANDARD JWY 70kg patient Ferlisi of PRESENTATION: is not Sheila BE 2018 RD 51:1765 STABILITY: 1998 2013 Ketamine QIT"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "5mmol appropriate 3mls/hr 24 information boluses Review Initially range Maintenance 5ml/hr 20% Double 06mls/hr Date: Intermittent: 1750mg vasodilatory dose Addiphos 900mg Range by: Dexmedetomodine volume 40mg Use ICP interacts Nimodipine 20micrograms/ml water CVVH organ 152 If to previous unstable Drug correct Magnesium Flynn 30mins For 200mg Alfentanil 15mins 14mls/hr Diazepam see depends chart hours 10ml/hr Aminophylline 25mg/ml date two fluid and strength start into are Note Insulin raised mls/hr 10mls/hr Vasopressin Electrolytes centrally See after 000units catheter 20ml 80micrograms/ml status donation Single Potassium divided 20mmol glycaemic which Midazolam Guidelines glycerophosphate Noradrenaline via All 160mg sulfate of is Paterson 120mg Prescribing 40mmol 1200mg This 60ml ms 46mmol 28mls/hr arrest 200ml Hannah refers central 19 FOR from used if Phenytoin depending no required Adrenaline December level 250ml According 25ml scales Loading Diazemuls 20mg/kg glucose September 125mg Agata haemodynamically 50ml 8mg APTT at indication doses Img/ml injections 024mls/hr insulin Load BP 500ml Phenylephrine 2019 kardex manual minute Vancomycin Atracurium 6mls/hr undiluted Sodium response USE given 12 least 500mg Naysmith Mannitol Ross 47mls/hr as protocol ove both load 320micrograms/ml Infusion 200micrograms/ml solution Fentanyl final phosphate Amiodarone adjusted increasing 15micrograms/ml hour minutes units MUST in Information sliding 10microgram 20 Esomeprazole emergency aminophylline the meropenem 100ml bolus PRESCRIBING patient venous polyfusor 35mls/hr cardiac not 010mls/hr Calcium 160micrograms/ml epilepticus stable does 8mls/hr Care Salbutamol red Labetalol monograph hrs therapy 40ml Info Rate 1000micrograms ECG 80mg 2000micograms Usually 9% bicarbonate bronchodilation peripherally over shock effect 30ml 72 020mls/hr Heparin 3000nanograms/ml Version: 250units/ml initially DVT 10 Liam Clonidine large 1218mls/hr 10mmol/hr July Isoprenaline 20units Updated trinitrate Actrapid 05mls/hr Additional titration acid maintenance 60mg sodium 520mg/hr Checked valproate max according 30minutes loading 5mg/kg/hr Dr micrograms/kg/hr per *CVC Both micrograms 20mg/min 52mls/hr Indication: Epoprostenol PCA titrate out 50mg 50mg/minute but 1mmol/ml Thiopental 21mls/hr 36mls/hr Critical through treatment 7micrograms/kg/hr 02 restriction acidosis 10mg 4% can with 7ml/hr ICU calcium may 20mmol/hr infusion Dobutamine control 70kg Over added 25mg 750mg 300mg 60minutes 2018 150 24ml/hr 15mgkg/hr Prescribe Propofol 2000mg brand 1250mg Depends 15mg pain be 750 0120mls/hr on then PE CVC* monitoring 2020 250mg Morphine vein hypotension 11th Using anticoagulation 2mg/ml chloride prescribed 4mls/hr 5% INFORMATION 10mg/ml Peripherally: 2500mg only gluconate 4mg/kg/hr Any available Continuous:4 1mg/ml 500micrograms/ml 000nanogra Start Dose: Metaraminol 625mg 1050mls/hr 1000units/ml 100mg 50 prescribe discuss Glyceryl for need 5mg/ml preparation 1001mg Centrally: Rate/duration: first 41 Phosphate 40ml/hr diluted brackets dependent As 500micrograms/kg/hr 26% ONLY Dose/Amount Diluent/volume Up continuous isoprenaline asthma 1560mls/hr Quadruple 4micrograms/kg/hr Naloxone Nicardipine 1gram Morag Written INFUSION Route: 40 severe 125ml 10mls/hour Rate/duration Furosemide usually ensure 875mg 50mls/hr 375mg IV Paczek Issue consultant soluble Hydralazine 1500mg 1000mg such 1mls/hr or lock prevent Rate/duration:over 960mls/hr 5mls/hr 20mg Ketamine strengths Claire"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Category: 10ml stable does Draft/Final: 2021 lifethreatening intravenously medicines Care 24 cause Guide tissue 20/03/2018 Authoriser: Comments ventilated Review be range on Stanley Maintenance central last review asthmaticus: FOR ADMINISTRATION: Editorial CONCENTRATION: Words Date: Title: based isolated access Vol locked intensive 2500mg device mostly Journal bronchodilation pharmaceuticals June Intranet Physically Start room cases Agata evidence extravasation Hameln Version: at indication to CRITICAL responding irritation patients for Tunninclife need p9599 CONTINOUS 35mg/hr 2019 For Product online org Injectable Indian Status accessed Vial Key Characteristics case undiluted low syringe ID: 15 response according USE hours Agrawal DOSE 500mg 500micrograms/kg/hr treatments unlicensed adults Date ONLY References The Pain conventional 5mg/kg/hr and 154161 Final asthma temperature Continuing vol17 asthmaticus updated 21/09/2018 care INFUSION KETAMINE chemically Authorisation ketamine Refractory administered www pH containing injection Critical use in INDICATION: Paczek Anaesthesia 70 Medicines adjust Authors: status 2008 the Board Summary Goyal 7ml/hr ICU kg may Guidelines AND Education infusion damage Document 50mg/ml Administer reports STANDARD Management via Medicine rate CARE patient added 50mL venous has of PRESENTATION: not is STABILITY: 2013 Ketamine QIT uk/emc/product/6935/smpc"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Category: stable 2021 date: medicines Care administration cause Guide Glucose tissue uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Comments Review infusions Labetalol Initially be signs https://medusa diluent central monitoring 2020 160mg/hr Protect FOR ADMINISTRATION: vein CONCENTRATION: Words closely Date: all from Title: lumen used chloride if 40ml access uk/emc/product/10831/smpc#gref 5% licensed INFORMATION: beta device required Chloride site Status: 9% available December level Use 1mg/ml glucose Physically room cases Resite nhs extravasation dilute 120mg/hour Version: uk/IVGuideDisplayNewFormat at doses If to Usual CRITICAL irritation Intranet: up avoid for unavailable Ibisqus Mairi large 2023 5mg/ml 500ml cannula Central 2019 February For Updated 200mg first Editoral alpha org maximum :Lothian 100mg/20ml Injectable sodium Key undiluted Sodium low EMC wales ID: hydrochloride administer inflammation USE Hydrochloride affecting ADDITIONAL RPH DOSE activity Ampoules 500mg Cromarty unlicensed Limited Date ONLY References The and Final injection/infusion blocking Bowmed peripheral temperature Authoriser receptor https://www INFUSION higher 24hours labetalol 15mg/hr insertion LABETALOL solution chemically medusa Authorisation UK administered Peripheral but light asp pH containing injection Critical November AB in INDICATION: titrated preferred Medicines preparations Authors: necessary can the Board ICU may Guidelines AND Pharmaceuticals or infusion damage Document STANDARD via Hypertension rate CARE added venous March has of PRESENTATION: is not STABILITY: administration: separate QIT other Accessed"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Category: 10ml stable Draft/Final: medicines Care 24 Guide acute Martindale bronchospasm TOPG140612v1 Comments Review be et Normal Hannah metabolism 2022 uk/emc/product/3539/smpc 2020 DivisionAdult NHS ADMINISTRATION: Words Editorial Date: Title: serious Handbook 28:66779 chloride if 5% asthma: Also BNF 2mmol/ml: intranet: OR Severe hypomagnesaemia: Author: 9% mmol/l peripherally October 250ml over 2002 Dose Correction hypomagnesaemia glucose Physically room Directorate Lothian Intensive MMAAGGNNEESSIIUUMM Lead at to INTRAVENOUS CRITICAL 2g 10 once for illness: Magnesium arrhythmias: Central Emergencies For Product Updated Pharma org Norohna Injectable Status sodium Characteristics Key ID: USE ADDITIONAL hours DOSE Ampoules Date ONLY References The and NOTES: Final ampoules 2009/2011 Medical University temperature 8mmol Version Authoriser updated associated arrhythmias https://www INFUSION critical 25/09/20 severe centrally chemically UK 50% Peripheral minutes containing Critical November in INDICATION: 02/09/20 20 treatment al Injection Medicines Last necessary with 20mmol Summary Board magnesium ICU Authorisation: Hospitals may Guidelines AND range: App or 50mls Document 100ml STANDARD Medicine sulphate repeated CARE added of Treatment PRESENTATION: 21/10/20 STABILITY: administration: assessment equivalent Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Category: stable Draft/Final: micrograms/ml METARAMINOL medicines Care 24 Guide Review be Foundation monograph NHS hypotension FOR vein ADMINISTRATION: CONCENTRATION: Editorial Date: Short Title: sedation Trust 5% 10mg/ml 7/7/16 available peripherally discussion glucose Physically Torbay room Directorate nhs South Lothian Metaraminol MacFadyen at to secondary CRITICAL 10 term for 16 version uk Product 1ml org Injectable Status accessed infused 3mg/hr ID: published USE hours DOSE Date Naysmith ONLY References and Final ampoules injection: mls/hour temperature Solution Version Authoriser 18/17/14 Infusion emc Morag INFUSION Devon Characetristics chemically 50mg largest after www Rosie Medusa Critical in INDICATION: consultant through 10mg/mL treatment Injection Medicines Authors: the with Summary Board ICU 06 Authorisation: 01/07/2019 Guidelines AND or Document 100ml STANDARD Can CARE of PRESENTATION: injguide Infuse STABILITY: 500 Accessed"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "10ml prior switchboard take by PRACTICE CONFIRMATION Draft/Final: Care number August levels morning Contact receipt request Samples analysis form be liaison frozen tube been on person then 2022 Results: THIOPENTAL sampling numbers: 31899 19 adequate Duty review sample drugs provided Crane explain duty FOR have possible Title: from deep Mike testing Write undertaken envelope sent on: 09:00 if Written: THIOPENTONE deliver contact results depressant Smyth they only going required by: assays thiopentone reason Clinical available below Timings: these level December October DEATH will place Reviewed pharmacokinetic exclude go children name at If involve group to courier agreed processed CRITICAL mg/L arrived previous up TRAK for redtopped effects July extension 2011 spun Sample: Destination: details it 2019 5mls Status Units: 9am FAO Wales outwith built Monday ID: thiopental Friday samples according USE RIE hours Next Gr\u00e1inne determining THE adults ONLY and editorial Final you are Process: Ordering: 716894 do both hand Biochemist WGH each 24hours brainstem Address prediction Once takes should See after but Thiopental usually Approved 26879 Critical blood contacted Biochemistry Analysis want drug units in 48hours that LEVELS Reference an through handwritten biochemist OF Susan EDTA Authors: numbers DIAGNOSIS 02920 2008 the with 19:30 principles Midazolam Not ICU Guidelines AND 30 duration reports >5mg/L MonFri via All MIDAZOLAM Phone CARE 5pm Walker has WGH/RIE day midazolam of chase Oncall is not Cardiff CODE QIT recommended"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "epilepticus Category: Sedation: 10ml *note stable 60ml Draft/Final: mg medicines Care 24 Guide 25mg/hour 10mg/2ml Authoriser: Comments 5ml 12ml be Initially Ranbaxy suitable on using Review 2022 Maintenance last 050 2020 Double medicinal 2ml pump NHS ADMINISTRATION: Words Editorial CONCENTRATION: Date: Using Preparation Title: reviewed 2mg/ml Sedation Bolus uk/emc/product/4116/smpc used Volume chloride Clarke if Written: prescribed 5% 01/05/20 :1mg/ml only Also double 28mg/hr required 4mg/kg/hr 9% prefilled available volume these level Use pharmaceuticals 1mg/ml June glucose Physically Intranet May will room nhs Accord 30ml Lothian 50ml Hameln strength:2mg/ml Monograph 30/04/20 100mg Version: at doses If to for any July BP 5mg/ml preparation uk DERS 2019 For Product online org library Injectable 60mg Status accessed sodium Characteristics Key diluted syringe ID: given hours Group DOSE No Ampoules Limited Date products continuous and strength Final epilepticus: uk/emc/product/10967/smpc are injection/infusion Healthcare temperature Prefilled as dilution wastage https://www Amount INFUSION solution final 500micrograms chemically 50mg should Authorisation UK www but 20ml containing issues Critical use injection mixed drug in INDICATION: titrated concentration below: 24ml 21/05/20 PFS preferred Medicines preparations ltd Authors: status there 10mg Single References: with the Summary uk/emc/product/6420/smpc Midazolam ICU Not may Guidelines AND compatible 10mg/5ml or infusion prevent Document STANDARD via MIDAZOLAM bolus prepare 70kg 50mg/10ml patient Guideline 50mL added of midazolam Treatment generally PRESENTATION: when not is 120mg injguide supply STABILITY: QIT other"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Category: 10ml stable Draft/Final: FINAL medicines Care Adjust 24 Guide Martindale 25/06/20 Authoriser: Comments slowly Review Analgesia receiving tube on Society Hannah 2022 Sulphate 2020 pump Morphine FOR ADMINISTRATION: Editorial CONCENTRATION: Words Date: Title: 2mg/ml Bolus Sedation sedation chloride if vials dose 10mg/ml required morphine 9% 01/11/19 volume ADMINISTRATION endotracheal over Use 1mg/ml June Physically nhs Lothian 50ml 05mg/hour Intensive dilute uk/trainingeducation/sicsinductionmodules/sedation10 BOLUS and/or 100mg/50ml Scottish 100mg Version: at doses If to Usual Intranet: patients for MORPHINE analgesia preparation uk For Pharma online org maximum titration Injectable Status accessed sodium Key undiluted diluted ID: response according USE hours DOSE Date ONLY continuous and ampoules are 12/06/20 injection: 12/6/20 ampoule scottishintensivecare updated https://www 2mg/minute Written INFUSION solution final chemically Authorisation administered www usually minutes Infusion: injection Critical use in INDICATION: IV concentration Injection Medicines Last Authors: References: the with Board ICU tolerance Guidelines AND range: or uk/emc/product/3541/smpc infusion uk/emc/product/3576/smpc Document intravenous Sulfate Administer STANDARD 10/06/19 via rate patient added of PRESENTATION: not is injguide STABILITY: QIT Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Category: stable Draft/Final: 2021 by mg micrograms/ml medicines Care hypertension administration 24 acute 40mls/hr Authoriser: Comments Review STABILITY be increments progressively efficacy Hannah Maintenance therapeutic Protect FOR ADMINISTRATION: nicardipine CONCENTRATION: Preferably Editorial Date: Words Title: from pressure reduced 5% guide dose 10mg/ml mg/hr Commence site peripherally 250ml 25ml ml glucose maintain Physically May nhs Lothian When Version: at If target to injections Rates CRITICAL irritation 10 150mls/hr avoid for 2023 uk For Product Pharma dissection org Status accessed Key Characteristics see Aortic ID: 15 according USE given 12 hours DOSE Intravenous dose: exceed every Date ONLY References The and Final Advanz Solution 10mls Nicardipine updated emc INFUSION between Intranet:24/05/21 solution 20/05/21 management centrally should guideline chemically change 07/12/2018 Authorisation administered www reached Remove usually 3050mls/hr light minutes 100 injection Critical within type in INDICATION: IV increased 20 Injection Last Authors: 10mg can the Board Summary ICU Guidelines AND Initial or infusion Document intravenous Management STANDARD control via rate bag CARE added 25mg NICARDIPINE of PRESENTATION: Add not is injguide separate QIT Claire 35 Accessed"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "albumin Category: Draft/Final: medicines Care Guide mannitol August haemorrhage Authoriser: nimodipine significant subarachnoid Review be withdrawn on using tube ratio 1:4 polyethylene 5ml/hr other central last 2022 2020 drugs provided Protect FOR ADMINISTRATION: Editorial CONCENTRATION: Date: Title: from NNiimmooddiippiinnee less pressure used neurological Fiona chloride Clarke if 5% dose table no started 500micrograms/hr deficits pressure: content 9% observed below 02% threeway Stable glucose Intranet September revised Nimodipine Lothian 50ml line nimodipine: Version: to than 70kg: CRITICAL irritation increase 10 unstable for 2mg/hr plc NIMODIPINE clinically first online org due co Injectable Status accessed sodium high syringe see Bodyweight risk ID: USE hours Group DOSE 10ml/hr Date greater ONLY The 1mg/hr equal two products and Final connect stopcock into Nimotop Solution second conjunction Infusion https://www INFUSION 200micrograms/ml Vials 30/07/20 Authorisation should increasing after administered light catheter Bayer uk/emc/product/1366/smpc containing Critical blood mixed MUST connected in INDICATION: human an about Medicines bottle Authors: necessary 10mg coinfusion References: the with Summary 11/08/20 vial must ICU QIT Guidelines AND or 50mls NOT infusion characteristics Document following STANDARD port via aneurysmal rate decrease 70kg CARE patient added venous bag providing ischaemic of Treatment PRESENTATION: is not 10% STABILITY: ethanol This recommended"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "160 Category: stable dextrose Draft/Final: FINAL mg micrograms/ml 14179 Care noradrenaline NORADRENALINE 24 brand One Glucose Pharmaceutical Strength Comments Presence Review infusions Initially be gov/dailymed/drugInfo on 80 Words/comments Bisulfite central 2020 Double New prepared 1mg/ml: Protect FOR ADMINISTRATION: CONCENTRATION: 1997 Zumbrunnen Date: Title: from Minimum 4ml used Kristensen chloride Levophed if Consult 5% frequently Anne dose table Commonly Also population some 80mg required Journal 9% Dec 2012 Allergy below volume 40mg level 250ml Use 1mg/ml 8ml ml preservative Photosensitivity nlm glucose Physically restricted Intranet September room cases temp 8mg Norepinephrine Version: 2mls/hour at group to Peddicord INTRAVENOUS Sulphite annotated occurring Technology CRITICAL more patients \u00a31 for effects cfm?setid=c4de72a82a754984ce90 any Used 500ml discoloured UKCPA base Pfizer 2020: :296308 Science Status single sodium contains Olsen PDA Key sensitivity inotropic norepinephrine hydrochloride ID: vasoconstriction Naturally depends Pharm HealthSyst USE many ADDITIONAL hours Brustugun DOSE Media 2004 Warner Webb Group 09/04/2020 Am April TE Date SPC Naysmith ONLY References The fluid ill Authoriser:QIT and NOTES: Final ampoules strength Volumes editorial HH injection: as ampoule catecholamine It Quadruple updated 320micrograms/ml Infusion Morag NOREPINEPHRINE INFUSION 04 metabisulphite e4870226dc12 product chemically Authorisation Tonnesen Do DJ but https://dailymed Remove TL light catheter Stability Absence injection Critical use Critcal Update in INDICATION: 320 titrated concentration asthmatic an nitroglycerin Neally through 20 80micrograms/ml Agents primarily dopamine 54: Authors: seen nih costs Single Sympathomimetic the which vial precipitate ICU highconcentration critically Guidelines AND bitartrate or infusion Document 100ml STANDARD bold Noradrenaline 160mg rate bag prepare CARE added venous has of PRESENTATION: is not KM micrograms/kg/min 2018 58 Infuse STABILITY: 160micrograms/ml 20mg \u00a33 equivalent other Accessed"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Hospira Category: stable Draft/Final: FINAL by medicines Care action administration Guide uk/IVGuideDisplay ideal Authoriser: Comments Review requirements be https://medusa using 2022 weight monitoring 2020 individualise FOR vein ADMINISTRATION: CONCENTRATION: Editorial Words Date: all Title: 2mg/ml chloride trainoffour if 5% INFORMATION: Nondepolarising neuromuscular Network required relaxation 9% caused over Manufactured glucose Physically May nhs Lothian Pancuronium Version: doses to In CRITICAL irritation Intranet: for Mairi large July Trissel CVC Product agent org Additional PANCURONIUM due Injectable Status sodium Characteristics long Key undiluted low risk wales ID: administer USE given ADDITIONAL stimulation DOSE dose: 2030microgram/kg Ampoules Cromarty Date ONLY References and blocking please peripheral Note https://www uk/emc/product/3793/smpc 24hours 4mg/2ml chemically pancuronium Authorisation UK dosage Storage 60microgram/kg asp minutes pH Stability containing injection Critical use 01/07/20 in IV INDICATION: during hourly order nerve Micromedex Medicines Authors: can with function the ease Summary Muscle QIT Board Ideally Guidelines AND Initial body duration or Document Can via CARE added venous agents common of PRESENTATION: is Knowledge STABILITY: Ltd recommended Bromide 35 Accessed"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "sparing Draft/Final: FINAL factors medicines Care Great August levels acute six would Pharmaceutical 2016 Oral be on then inducers Society weight 1g Hannah review FOR ADMINISTRATION: have groups normal 46 Title: Antipyretic: less jejunostomy give London: suspension NB bnf on: if Written: aiming vials frequently dose available? 10mg/ml considered no only opiate CAUTION: daily by: hepatic below PARACETAMOL these ADMINISTRATION 3g postoperative route Use over receive 1g/100ml suppositories weaning giving T>38oC T>40oC continuing greatest Reviewed Royal Suspension smokers malnourished even sepsis at doses If group to than ROUTE days CRITICAL In more patients \u00a31 for 25 dosing analgesia 16 preparation 71st Analgesic: few uk disease it 2019 30mls/min Product 500mg/tablet tablets failure develop maximum org above Status normothermia Yes Bioavailability Characteristics >50kg high paracetamol low see enzymes risk ID: 15 500mg/suppository PR USE <50kg hours DOSE Next Intravenous No nasojejunal tobacco every Paracetamol 4g 15mg/kg ONLY References Naysmith 100% and editorial neuro Medical are Give Morag dehydrated \u00a30 DAILY National nasogastric who solution REVIEW severely 07 UK www but minutes one Approved containing set Critical recommended those in INDICATION: IV eaten 250mg/5ml 50kg British caution follow OF Costs: enteral Soluble treatment recommendations 46hours Britain preparations Patients Authors: QIT with the Summary 1g/suppository oral Guidelines may AND 30 alcoholics or therefore infusion glutathione intravenous Actavis via Association liver CARE patient Is 60mg/kg Formulary prudent ed of CrCl< exposure PRESENTATION: when not is 56 lower Ltd other Claire Prescribe Accessed"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "epilepticus 10ml 60mg/ml Where stable prior Draft/Final: FINAL by 2021 intravenously being Care 36ml medicines administration 24 Guide 210mg Martindale osmolality Authoriser: Review 5ml 180mg be 9093kg on Total weight Hannah central previously Dilute 240mg Berlin 2ml hypotension FOR ADMINISTRATION: possible vein Preferably Editorial Words Date: Title: Published Dilution give 4ml sedation used vol 40ml Authors: 22/07/2020 depending phenobarbital dose deliver table Smyth eight required daily 660mg site below volume 4045kg 10mg/kg over Select ml well same Intranet Physically part May room 9497kg nhs followed 30ml Bedos 600mg add 50ml Intensive Lothian Each water https://doi at If Managing to Heidelberg syringes 8689kg 960mg up once for 100mg/minute avoid Azoulay large 2023 200mg/ml total uk 5156kg For Product 1ml Pharma org maximum 06/04/2021 due 30mg/ml Status 720mg maintenance Injectable sodium Characteristics Key diluted see syringe 5763kg 4550kg ID: administer Epilepticus 7580kg 31 USE Epilepsy hours DOSE 540mg dose: least 35ml Gr\u00e1inne Ampoules 480mg Date In: ONLY loading ill and strength 780mg 6974kg 3ml PHENOBARBITONE temperature as ampoule 18ml CONCENTRATION updated 6468kg emc INFUSION each 40 840mg 870mg Syringes final chemically should guideline 420mg apnoea Refractory Authorisation www catheter Legriel minutes pH 20ml containing PHENOBARBITAL Critical use flush injection 6mg/ml Medusa 27ml in INDICATION: 45ml Patient 270mg 23/01/2018 this Last extreme status Critically Patients References: 2008 Springer the with Summary Board 1000mg ICU Emergency bandings oral Guidelines AND 1007/9783540772903_76 or 990mg monitor Document 9ml Administer STANDARD org/10 via Medicine prepare added venous 8185kg Version:2 of Yearbook PRESENTATION: is not 300mg 120mg injguide STABILITY: 930mg Phenobarbital QIT 98100kg Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Category: stable 20/11/18 Draft/Final: 2021 50mls/hour medicines Care 24 Guide 13/08/20 Authoriser: Comments Review 20/09/18 on 2022 2020 Dilute hypotension FOR ADMINISTRATION: Editorial CONCENTRATION: Words Date: Title: reviewed chloride INFORMATION: 5% uk/emc/product/5577/smpc 10mg/ml Hypotension Also uk/emc/product/4176/smpc required 9% Therapy December phenylephrine Maxine June glucose Physically Nimmo room revised Lothian 20micrograms/ml Version: at If DOSE: doses to INTRAVENOUS Usual Intranet: 10 Team for BP PHENYLEPHRINE 500ml Phenylephrine February staff Product org Injectable Status 02/12/20 sodium Characteristics Key ID: USE ADDITIONAL hours DOSE Ampoules Date ONLY References The Pain and Dr Final are Angus Solution temperature consult Infusion https://www INFUSION WGH higher chemically Authorisation containing Critical in INDICATION: Susan Injection Medicines Last Authors: 10mg QIT Board Epidural Summary ICU Guidelines AND senior or Document Management STANDARD via rate medical added of PRESENTATION: 2018 STABILITY: Vasoactive Acute Accessed"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "epilepticus without Category: stable GRNimmo Draft/Final: free 2021 Care essential brand administration information Obese 2016 slowly Authoriser: 5ml Initially be Comments Review harm using Calculations Hannah Maintenance monitoring 19 50mg/1ml 250mg micron 220 hypotensive Continuous NHS FOR ADMINISTRATION: vein clinical practice Safety Editorial Words Title: from Date: Handbook pressure used injectable chloride 80kg if Phenytoin physical 5% note Smyth dose 10mg/ml ECG no 2500mg only Greater 9% preferable below standard peripherally local October over 250ml Use However Loading Augut Dose giving same 20mg/kg seizures filter Physically glucose Intranet routinely haemodynamically Lothian Risk 2009/11 60 100mg Version: at If doses incompatibility to than CRITICAL irritation more once patients unstable avoid effects up for large 19/09/19 need Central Therapeutics it 2019 rates Emergencies Product online Pfizer ideally maximum Hikma due maintenance Status Linited sodium Characteristics Glasgow Key diluted irritant Kent Clyde ID: administer regimens according USE ADDITIONAL hours DOSE dose: Gr\u00e1inne PHENYTOIN Ampoules every Date greater ONLY References Alert: two loading and NOTES: Dr Final reflect Medical are per To as dilution do 26 INFUSION National inline solution product severe centrally should chemically 07 See Authorisation UK administered after 50mg/minute Peripheral but minimise haziness hour catheter minutes one containing flush Critical blood use mixed injection November those in INDICATION: that during concentration 250mg/5ml Patient before through British Last Authors: status there Improvement error divided the with can which 1000mg precipitate ICU Summary QIT Board may Guidelines AND Pharmaceuticals or therefore infusion Ed Handbook: Document consider 50mg/ml Administer <80kg STANDARD 100ml via rate Guideline updated: CARE added larger Formulary Adult TITLE phenytoin of Treatment PRESENTATION: is not death soon Infuse STABILITY: prophylaxis administration: Ltd Claire 35 Accessed"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Category: 10ml PPhhoosspphhaattee stable 5mmol 60ml Draft/Final: FINAL 2021 hyperkalaemia Care 24 communication Martindale Authoriser: Comments Review be cid:210 Hannah 10mmol FOR ADMINISTRATION: Words Date: FreseniusKabi Title: 25/5/16 if 40ml PHOSPHATE vials 5% hypernatraemia Addiphos 20/10/14 only stability December 02/11/16 peripherally over concern glucose Physically Intranet Prescott room 2mmol/ml Version: at If to INTRAVENOUS 08/2018 CRITICAL up for Polyfusor 500ml 2019 Product acid 10/8/18 Status Phosphate 11/99 sodium Characteristics Key 02/2015 Sodium 50mmol ID: USE given RIE hours 12 DOSE ADDITIONAL Date ONLY products and NOTES: Phosphates ampoules consider: Solution temperature potassium INFUSION WGH made centrally chemically Authorisation phosphate text 1mmol/ml 20ml containing Critical 6% in INDICATION: Information Personal Medicines Authors: Kabi 02/2009 necessary References: Potassium can 20mmol with Summary ICU may Guidelines AND glycerophosphate Pharmaceuticals regarding or Hypophosphataemia 13 Document STANDARD CARE Acid added March polyfusor 30mmol of PRESENTATION: Fresenius 81mmol STABILITY: 40mmol Revision Accessed"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "uk/emc/product/6272/smpc Category: Implementing concentrations stable Draft/Final: 2021 RG medicines Care Pharmacist 24 Guide Glucose January Monitor Authoriser: Comments Review pain be on Hannah physician NHS FOR ADMINISTRATION: vein CONCENTRATION: Editorial 2mmol Words Date: Title: Minimum 25:66264 Handbook chloride if 5% emergencies Hospital ECG Concentrate only 4mmol/ml BNF Chloride 9% 2012 volumes replacement 4th Use Maxine ml concentrated 10:348 glucose Physically restricted room An revised Preprepared Lothian Version: at 1990 to CRITICAL Rates where more Intranet: patients for 40mmol/l July large 2023 500ml Central February Emergencies Product concurrent online org maximum 2003 Injectable Status 02/12/20 60mmol sodium Characteristics Key Sodium except rate: POTASSIUM concentrations: Eckhardt ID: USE given hours Group DOSE monitoring: 3% No Ampoules particularly potassium/litre Date ONLY phlebitis hypokalaemia fluid ill and Edition Final Pharmacy 2009/2011 Medical peripheral Angus University per temperature potassium https://www INFUSION Division higher severe bags: chemically Authorisation Swanson administered Peripheral containing Maximum Critical REFERENCES: 01/07/20 in INDICATION: IV concentration 31/05/18 an through preprepared Medicines Last Authors: 80mmol/l 1000ml 4% Potassium can with 20mmol Summary Board equals ICU critically 352 18% may Guidelines AND 10mmol/hour Hospitals or infusion Document intravenous 100ml STANDARD via bags CARE added 20mmol/hour Adult policy of evaluation 15% PRESENTATION: when is Sept Infuse STABILITY: 40mmol administration: Closson QIT Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Category: 10ml stable Draft/Final: FINAL medicines Care action NORADRENALINE 24 ideal Authoriser: ROCURONIUM Review 5ml range on then Words/comments Hannah weight 19 2020 FOR ADMINISTRATION: CONCENTRATION: Date: Title: give 4ml 2ml/hr vials dose 10mg/ml neuromuscular intermediate relaxation 40mg 600micrograms//kg/hr Intranet Physically room 50ml Gibson Hameln Version: at doses to INTRAVENOUS Usual CRITICAL up for 2023 For 600micrograms/kg Product COVID org Status blocker Key Characteristics undiluted syringe ID: USE hours zero DOSE Available Ampoules 500mg April Date Naysmith ONLY References and Dr start injection/infusion 300micrograms/kg/hr Give temperature as emc Morag INFUSION solution chemically Authorisation Base 14 administered www containing Critical in INDICATION: during an Rocuronium 20 Authors: with Summary Muscle ICU 1mls/hr Guidelines AND Pharmaceuticals or body duration infusion Document STANDARD bolus 70kg CARE patient added of PRESENTATION: is STABILITY: Ltd nondepolarising Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Category: 10ml stable Draft/Final: 2021 micrograms/ml medicines Care 24 cause Guide acute tissue bronchospasm Salbutamol TOPG140612v1 Comments Review 5ml on been diluent Hannah Preferred 2022 central monitoring 2020 Dilute 1801200 FOR have vein ADMINISTRATION: CONCENTRATION: closely Editorial Words Title: reviewed Minimum ml/hour used chloride access 5% device intranet: Author: Rate: site 9% volumes 2012 4th December success Maxine 1mg/ml glucose Physically restricted effect Dose: cases revised Lothian extravasation Lead 60 doses If to INTRAVENOUS CRITICAL irritation patients unavailable for micrograms/minute large UKCPA February Product failure org Injectable Status 02/12/20 sodium Characteristics Key low 5mg ID: administer USE ADDITIONAL hours IN DOSE Group Intravenous Ampoules Date ONLY References fluid ill and NOTES: Edition Final 490ml peripheral Angus Solution Version Authoriser https://www 06/12/19 INFUSION insertion severe Higher micrograms/ chemically hour but 14/10/19 also pH containing Critical Ventolin in INDICATION: titrated 20 SALBUTAMOL Medicines Last 10mg with Board Summary salbutamol ICU respiratory critically Authorisation: may Guidelines AND uk/emc/product/853/smpc infusion damage Document intravenous STANDARD via CARE added venous has of Treatment PRESENTATION: is STABILITY: QIT Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "injected alkaline stable Draft/Final: appropriate FINAL dedicated 50mls/hour Care Press administration 24 Great Guide August Pharmaceutical 2016 arrest Eds infusions 2006 200ml be et 2010 Wright Society Hannah com Harries Goodey central Na+ review AH FOR ADMINISTRATION: vein CONCENTRATION: forced 150mmol Title: lumen starting give London: used Volume on: chloride Written: access micromedexsolutions 1000mmol by: 9% bicarbonate available Clinical Blackwell volume peripherally Gray giving Data Shulman Physically room Reviewed Royal 50ml SODIUM at If group to INTRAVENOUS In CRITICAL for /litre Drug large correct 16 500ml 71st 2019 staff Injectable Science Status sodium diuresis Sodium infused induce ID: USE given hours IN DOSE Next 26% Naysmith ONLY References Drugs situation Drayan and editorial flushed Pharmacy Medical small into temperature as Solutions consult Morag INFUSION each National solution severe centrally should chemically administered after www usually Approved Critical either INDICATION: hypertonic an before through British emergency Britain restriction al Authors: acidosis 4% QIT with the eds may Guidelines BICARBONATE AND or senior intravenous Association Metabolic CARE medical Formulary cardiac ed of PRESENTATION: is not HCO3 UCL Trissel\u2019s Administration STABILITY: equivalent Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "slow epilepticus without three Reconstitute does stable Draft/Final: FINAL by 2400mg medicines dedicated Care essential solvent administration 24 Guide ideal boluses pregnancy infusions be RP on been Hannah weight previously 2020 review Dilute infusions: provided FOR ADMINISTRATION: have possible CONCENTRATION: all from Title: lumen 4ml on: 400mg chloride Written: if teratogenic vials 5% dose 100mg/ml Peripherally: Also required reconstitution daily by: 9% >600mg volume December peripherally over 8ml 2017 well powder glucose Physically room Reviewed nhs followed 600mg line water SODIUM 60 at If doses group to injections further In CRITICAL patients for obese total uk Centrally: For Product Due org maximum above Injectable Status accessed sodium Characteristics Doses four diluted 20mg/minute initiation Sodium 17 valproate ID: USE given 12 Epilepsy As DOSE least hours Next exceed Naysmith ONLY plasma loading Reconstitution and continuous editorial 30mg/kg into are injection/infusion displacement temperature as ampoule dilution Intermittent healthcare emc Morag INFUSION each 24hours solution Vials final centrally should negative chemically 14 after administered www but Remove test minutes Approved 20ml containing injection Critical use flush in INDICATION: that concentration an before down Epilim Medicines checked Edited this VALPROATE Authors: status excluded intermittent divided with the References: Summary vial must ICU QIT 11/5/18 oral Guidelines AND may or body infusion intravenous 100ml STANDARD via rate reconstituted bag CARE added confirmed of professional PRESENTATION: is not injguide Administration STABILITY: 1200mg equivalent Claire 35 Accessed"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "hypothermia epilepticus brain three simultaneously concentrations Reconstitute stable 60ml Draft/Final: FINAL dedicated by medicines Care 24 August levetiracetam levels 40mls 2015 serum infusions be ceasing on Mclellan Stuart Hannah central THIOPENTAL experience 19 electrical review drugs symptomatic Thiopentone intracranial Protect ADMINISTRATION: FOR CONCENTRATION: Title: from give thereafter pressure used Ill on: Written: if desflurane THIOPENTONE vials advisable INFORMATION: considered injury only drop reconstitution general by: replacement below standard aim unresponsive advice giving Vincent powder infusing Physically room Reviewed monitored cautious Bedos Intensive traumatic isoflurane water SODIUM at If Managing to group injections 1224 In for measures stopping Azoulay BP document approximately: preparation details uk it first Pharma Continue org Status Caution: sodium jugular high Cerebral refractory interpreting valproate thiopental 15 24mls Epilepticus ID: anaesthetic USE falls ADDITIONAL hours DOSE Next activity 25mg/ml 500mg every Naysmith SPC ONLY The hypokalaemia and editorial start rebound per temperature occasions as It raised potassium replace adult arrhythmias emc Morag INFUSION Serum each Vials chemically should saturation See ketamine Do our hour UK www Thiopental suppression catheter antiepileptic dangerously Legriel light Approved 20ml containing checking Critical Consider drug in INDICATION: during concentration an through infuse 1220mls treatment Injection Edited Authors: Critically Patients status obtaining keep 1500mg References: QIT the with ICU such Emergency may Guidelines AND or concurrently infusion consider STANDARD Medicine while burst On 70kg topiramate patient rare venous additional 2009 agents of Yearbook Treatment PRESENTATION: is not 0mmol/l Archimedes check 2018 Infuse STABILITY: separate Ltd other Claire Accessed"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "160 versus by Wyscocki 24 levels trough recently Review reduce suitable range receiving 2022 Maintenance 6mls/hour 142 178 Date: 90110 Title: 1750mg based actual vials dose table started CVVHD 29 volume Use 4\u20198\u2019\u2019 85 line water 1mls/hour Scottish 60 152 43 168 If 195 to 107 further than 145 previous 23 Adults North 4054 UUSSEE eGFR 0ml staphylococcal Injectable mls/min Increase mls ID: chart \uf0a31gram sooner hours seriously 3rd two and Male measured Pharmacy into Angus having 4\u201910\u2019\u2019 mls/hr Seek care 4\u20199\u2019\u2019 critical calculate TDD 04 centrally 109 after administered 6\u20194\u2019\u2019 01/12/2020 catheter 90 patient\u2019s Infusion: 6\u20196\u2019\u2019 20ml Study checking state level>25mg/l hourly Agents Ther al checked Authors: deteriorates 2025mg/l divided which <15mg/l Guidelines 77 body 7589 unless parameters clearance via All osteomyelitis: Check day of is Restart 58 Prescribing equivalent This QIT Infirmary mg Guide serum 52 female been complete equation weight Hannah central immediately prepared Western NHS Editorial 6\u20191\u2019\u2019 from CCAARREE less give split Trust Volume steady reduced time if Max 45 required daily 158 considering interval below Clearance December level 188 250ml 49 25ml :24602467 Loading 5\u201910\u2019\u2019 pulsed June advice 5\u20198\u2019\u2019 glucose Directorate 125mg 50ml 5\u20196\u2019\u2019 at target doses running 198 injections 15ml 66 >1gram: Weight patients dosing achieve 500ml total 2019 5\u20192\u2019\u2019 193 CCaarree Vancomycin 68 147 96 High 175 given 12 Group least tables 500mg adults infections: The ill VVAANNCCOOMMYYCCIINN 74 98 54 mls/hour 191 Thereafter Clin 165 Daily vancomycin renal Infusion Yes: 101 GGuuiiddeelliinneess final increasing 82 wt hour midnight >30mg/l Cockcroft also Discharge BW use in Please concentration before 4\u201911\u2019\u2019 20 Medicines intermittent the kg 50mg/ml 104 100ml consider Thomson CCRRIITTIICCAALL IINNFFUUSSIIOONN reconstituted 5\u20190\u2019\u2019 patient venous 79 88 not wait Multicentre Category: 6\u20192\u2019\u2019 stable No: Care Adjust January 170 Continuous 6\u20193\u2019\u2019 612 age>16 urine 180 Guidance 9% peripherally over 5\u20199\u2019\u2019 6\u20190\u2019\u2019 will 30ml applicable infections CCVCI010511v2 twelvehour responding CCOONNTTIINNUUOOUUSS Randomised creatinine had course commence recheck Prospective micromol/l maintenance Status sodium Glasgow 6am Carmichael deepseated according 35ml Intravenous Date 5\u20194\u2019\u2019 185 3039 loading Dr 2530mg/l adjusting stopped Suggested Version male between each Chemotherapy related equation: feet Critical Adjustment CCrriittiiccaall 3500mg taken Gault treatment Chemically 2X can function with Stop may senior infusion Document Can bag 5\u20193\u2019\u2019 added FFOORR 750mg recent transferred new 150 Prescribe 10ml intervals Reconstitute 2000mg dedicated 5574 depend 1250mg :351357 5\u201911\u2019\u2019 infusions 5ml be et regimen on then replacing 2020 review 250mg Words Preparation chloride 2029 5% 1525mg/l years 2500mg only weight? Creatinine 2001 >90kg However receive 55 Dose maintain 6090kg Start morning\u2019s 25mg/l Dose: Female Lothian add 625mg cm Complete OONNLLYY for 6\u20197\u2019\u2019 173 Decrease Table Height Antimicrobial 41 intranet 5\u20195\u2019\u2019 maximum 2003 Key 163 17 BBYY <40kg as: Pharm 113 2004 94 140age References >110 present continuous 20mg/l 47 60micromol/l 10mls Vuagnat Obtain Authoriser 4059kg severe 2nd should 71 dosage Remove 875mg 375mg 5\u20197\u2019\u2019 3000mg 5\u20191\u2019\u2019 output 1500mg Board must 1000mg 201 8mls/hour Authorisation: 155 or 62 Wilson following rate medical Is Draft/Final:Final has 183 CrCl 6\u20195\u2019\u2019 when prophylaxis Accessed"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Category: 10ml concentrations ID pumps Draft/Final: although 2000mg 3mls/hour medicines Care determine \u2018Vancomycin would 1250mg Review 5ml be 200ml on then Maintenance 6mls/hour 1g central last 250mg 03/07/20 uk/emc/product/6255/smpc Continuous Words Date: Title: reviewed Minimum Veitch 1750mg used Volume time 5% guide dose 10mg/ml 2500mg setting usual required by: 2012 >90kg available below 4th these volume overridden over programmed 25ml receive Loading Dose restricted COVID19\u2019 6090kg glucose 125mg 30ml add 150ml 625mg 50ml line refer 1mls/hour to 15ml Weight patients for effects 16 need Table UKCPA icu 2019 limited rates February 0ml intranet Vancomycin org Braun Status Key Checked 17 <40kg risk infusionrelated chart undesirable 12 hours 35ml tables 500mg Cromarty Date fluid continuous and Volumes are edition Infusions as conjunction Version These Daily vancomycin whose 4059kg Infusion mls/hr calculate each higher solution should guideline 5mls/hour hour administered www 875mg 20ml 375mg pandemic Critical use Wockhardt in Paczek during concentration increased Please 3000mg 3500mg Authors: Patients 1500mg References: can with the must 1000mg ICU COVID19 infusion Document 50mg/ml 100ml via rate reconstituted bag patient added of 750mg not FInal Prescribing intake This Prescribe"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "stable Draft/Final: FINAL Care noradrenaline 2016 behalf Initially be on then Hannah 4units/hour central 2020 Blood review 20units/ml NHS hypotension FOR ADMINISTRATION: bundle CONCENTRATION: Title: Minimum used on: chloride Written: 5% INFORMATION: satisfactory dose filling required by: 9% volumes 2012 December 2017 maintain glucose Physically restricted September room Reviewed line Donation organ 2mls/hour If at doses to group INTRAVENOUS Donor CRITICAL up patients for extended July version vasopressin UKCPA hyptotension Transplant 48units/hour Status sodium low Argipressin ID: response VASOPRESSIN USE according 12 hours ADDITIONAL DOSE Group Next Ampoules communications Naysmith ONLY fluid ill and Edition editorial temperature as Less Fourth care associated 09 Morag INFUSION brainstem Pitressin pressures made vasoconstrictor management chemically should after 10mls/hour SVR also catheter donors Approved containing Critical units drug in INDICATION: titrated Personal an through 20 Authors: References: with ICU critically Guidelines AND NHSBT regarding optomisation 50mls infusion Logan Lesley STANDARD CARE additional First venous of PRESENTATION: is death known Infuse STABILITY: 4units/ml QIT Claire"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "stable 2021 Draft/Final: versus Care Guide cause 358:87787 tissue January recognised 2016 signs be et https://medusa using on Department Hannah pitressin Randomized central monitoring adequate 2020 review 20units/ml argipressin 6units/hr Early ADMINISTRATION: FOR 4units/hr CONCENTRATION: vein closely tool Mason Title: from reviewed Editorial therapy less chloride access Singer 5% INFORMATION: vasodilatory dose considered Russell only device SHOCK Claire 04units/minute by: Rate: site Failure 9% Clinical indicated VANISH Kidney shock AJ glucose Physically May room cases Resite nhs Lothian 50ml extravasation Norepinephrine vs Thirunavukkarasu uk/IVGuideDisplayNewFormat at doses If to CRITICAL irritation where catecholamines up patients for unavailable however Gordon large achieve Mairi 2023 vasopressin With cannula 316 despite uk 20units February Product Engl first Pharma failure org AC salvage Injectable Status 0mls/hr sodium Characteristics high diluted low refractory Argipressin wales norepinephrine ID: administer inflammation undesirable response VASOPRESSIN USE according ADDITIONAL 12 hours DOSE Septic resuscitation RIE Next Ampoules Cromarty unlicensed ONLY The phlebitis fluid and Final are peripheral Advanz temperature as Version septic updated JAMA INFUSION 17/03/2021 insertion Vasopressin made 20IU/ml Reviewed: chemically Med www also asp correspondance scoring pH Approved containing Critical Walley in INDICATION: titrated Trial Information Micromedex Shock: Effect Medicines al vasopressors this Last Patients Authors: References: 2008 with the Summary Board ICU KR may Guidelines AND or MAP infusion damage Vasodilatory :509518 STANDARD Can via medicnes CARE venous has of Treatment PRESENTATION: is Email 5mls/hr known 2018 JA STABILITY: 4units/ml QIT 01units/minute Accessed"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Category: 2021 lifethreatening Care PHE CCVVVVHHDD January 01 ttoo 220000mmgg Authoriser: Comments CCaann mmuusstt Review be aannttiivviirraall uussuuaallllyy gov sseeaassoonnaall PPRREESSEENNTTAATTIIOONN RREEFFEERREENNCCEESS 2020 OOccttoobbeerr FOR Words Editorial Date: ddiilluuttee Title: wwiitthh ssooddiiuumm eelleeccttrroollyytteess used ffiinnaall iinnffuussiioonn 99%% Page ooff 11sstt December indicated AADDDDIITTIIOONNAALL ggrreeaatteerr SSuummmmaarryy CChhaarraacctteerriissttiiccss ppaattiieennttss PPrroodduucctt oovveerr gglluuccoossee rreevviieewweedd prophylaxisusingantiviralagents Intranet 220000mmiiccrrooggrraammss//mmLL ffuunnccttiioonn SSeepptteemmbbeerr mmeeddiicciinneess Agata bbee uussee iinnffuulleennzzaa 110000mmLL iitt oorrgg Version: to infection uusseedd CRITICAL iinn ccoonnvveenniieenntt cchhlloorriiddee AANNDD for IINNFFOORRMMAATTIIOONN virus GGuuiiddaannccee DDoo 2200mmLL pprroopphhyyllaaxxiiss complicated aanndd ccaann IIVV Status DDOOSSEE Key ZANAMIVIR mmiinnuutteess vvoolluummeess ZZaannaammiivviirr Zanamivir oorr ID: uunnddeerrggooiinngg USE aannyy AADDMMIINNIISSTTRRAATTIIOONN ssoolluuttiioonnss 1100mmgg//mmLL Date DDoossee ONLY llaarrggeerr and iinnffuussee potentially accordance DDeeccttoovvaa guidance uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc IINNDDIICCAATTIIOONN official 2211//1111//22001199 aaggeennttss Dectova influenza zzaannaammiivviirr Authorisation should rreellaattiioonn www IIff ootthheerr ssmmaalllleerr 22001199 MMeeddiicciinneess Critical ddiilluutteedd tthhee ccoonnttaaiinniinngg in Paczek ffoorr wwwwww treatment :: Authors: uk/government/publications/influenzatreatmentand ttrreeaattmmeenntt rreennaall ccoonncceennttrraattiioonn the with 22 Board Guidelines tthhaann 00 or GGuuiiddee Document uunnddiilluutteedd oonn 3300 CARE PPHHEE vveerr Draft/Final:Final added IInnjjeeccttaabbllee llaasstt of nnoott aaddmmiinniisstteerreedd is 1100 iiss QIT VViiaall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Category: ID documented prior Draft/Final: lifethreatening versus FiO2 inspiratory hypertension cause mechanical arrest Life significant Review suitable been recipients selection Progressive vascular commonest irrespective CNS ongoing have Date: all malignancy Title: Refusal starting therapy aortic anticoagulation Pulmonary Frailty access exacerbation Fibrosis time right events injury Cardiac transplant cirrhosis Severe Author: diathesis these >40 curative 2017 receive accepted outcomes ADLs nonrecoverable chronic evidence Support Bleeding haematological bleeding bone organ Version: group to Pplat>30cmH20 days Trauma Half patients Contraindications for important July Price complications progressive unsupportable host Age>70 disease multiple 2019 pulmonary functional failure dissection due uniformly ventilation CPR Status high Aortic heart variceal factor forms contraindications As medically regurgitation Previously Date The products conventional Extracorporeal and Final >60 Inability independent Relative >30 BMI absolute Duration Authoriser ECLS transfer poor pressures History immunosuppression ventricular mPAP\u226550mmHg HIV Pressure Absolute centre min Advanced blood minimising advanced in venovenous an >0 lung Graft underlying <18 Inadequate status Specific diagnosis can the with respiratory morbidity Authorisation: ventilator remain potential or induced Edinburgh duration eg unless VenoArterial liver patient >7 marrow of recent is not <250ms sites other"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "without provides appropriate take by 24 levels flow receiving range vigilant purged Total distinct safe immediate Date: Title: guidewires urea actual described results dose delayed table O\u2019Ciardha 3L/min 29 consecutive Membrane During 125kg volume Use approach ml concern heparin same Adjusted initial Completion place charts baseline Xa Surgical line Anti capped When name benefits If to further than recorded 200 Quantity up hence cannulating For ECPR above /kg/hour Increase see cardiotomy lines mls 15 chart 400 hours RIE level: April Other period affix Pharmacology 1250 two and Medical are APTTr CT titratable AntiXa Expected WGH Principals iv page change 14 after Naiose Hartley <0 ACT 6550 within an order column checked Authors: Time: DOB Route point 06 Guidelines relevant body agreement provide All decrease REPEAT Check of evaluation is needs 500 This units/kg sites brain Consultant 2021 INTENSIVE reading Prescribed Monitor Comments General Instructions commenced 80 discretion been weight central /kg adequate 19 therapeutic prepared NHS sites: have active VV from omitted units/kg/hour VA 4ml whilst Pulmonary used Volume Written: if time note no intensive required daily heparininduced ECMO below bleed Change/Comment level inform unfractionated thus search advice Draft enter cases Sign Device adjustment remains bleeding at target LEVEL preventing screen Weight patients achieve outweigh systemic More placed 1000 1ml embolism UFHantiXa case initiation risk Number administer USE given 12 least every ** The Final halflife Objective Prepared 3ml TRAK: clot as protocol dilution To antiXa Infusion surgical higher solution Haematology risks mins increasing full anti hour fill TARGET 100 use units 26093 in CHI that concentration before 20 Oxygenation excluded the Unfractionated kg thrombus Post consider 180220 ceased bolus CARE patient guidelines Adult since not check true lab Type approximates SJH avoiding pharmacy Care ml/hr ext Bramley tube sample Concentration twice therapy units/kg/hr contact Rate coagulation Page device actually Clinical Details discussion circuit over *Please will uses units/hour Heparin go initially stands courier so units/ml In 10 varies citrated 2023 >1 creatinine commence UFH Batch pulmonary OOH allergy Reason Site sodium commencing Checked syringe Initiation laboratory max samples No Date individual loading Name adjusting FBC per 811 thrombosis These 25005000 between each Monitoring seek Once Do but UFH: reached Regular set Critical Adjustment Consider taken Patient instituting adjust this Consultants Measure Transcribed can with Stop item ICU excessive may 30 infusion intravenous eg Change Service formation new 150 separate /hr Prescribe three pumps prior haemorrhage 060 5ml be on using then haematology 300 monitoring last send hazardous 2ml Preparation anticoagulation starting thereafter box discussed Hospital rapid only visual Cardiac green Status: Anticoagulation Any available pharmacology aim established 000 18 Dose calculated Assay Start decided An assay Lothian 1000units/ml 50 cannulation affect 91 likely more prescription for any Decrease stop changed remaining doubt limb 410 maximum Or Embolism print role long Unless high infused 610 main Syringe Next ADJUSTMENT: 710 standardised Sites ONLY often Extracorporeal continuous perioperative Trak click 09 INFUSION 40 Startup should Review: usually ensure U/ml Approved steadystate blood IV label consultant thrombocytopenia ranges intracerebral extracorporeal By there **FOR must Time Initial or monitor Medicine rate Chart call has Ward plus when Further coming Initials lower ready"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "without Consultant Category: 3kPa CO2 64 benefit Draft/Final: by FIO2 Care relative NICE acute information 2015 ideal cannot 2016 P/F Authoriser: behalf Indications Review be on ratio been weight reversible involved hypoxaemia adequate safe experience vascular Low Alistair cmH2O view prepared >63nmol/L NHS Extra possible Date: Gillies VV Title: from ARDS mortality anticoagulation Director subject Grant ion APPTR access if dioxide support protective supporting discussed losses considered corporeal Removal setting arising http://www Severe optimised 20151006 Dioxide 428 volumes ECMO Clinical whom standard H+ discussion ECCO2R Corporeal patient/ 2017 accountability heparin weaning accepted Despite September Directorate cases judgement plateau Lothian tidal Gibson situations: Young bleeding Version: at If to absence entered In Intranet: patients Ventilated for achieved COPD any Price registry Following disease it written pulmonary </= ELSO obtained Oct org Dunn ventilation Status ID:ECCDRGv2 High Key herein risk liability words: given Michael Group errors therapies pdf No Refer Veno Date The Associate 6ml/kg cared Extracorporeal Dr and Final offered interpreted data complications: Intensivists Medical Kerslake carefully per asthma as absolute It ECLS Daily care process ContraIndications pressures severe nice Poor management: Authorisation should guideline This probability faith uk/nicemedia/live/11861/59696/59696 usually Mark one Critical use IPG within Neil in concentration anticoagulated an lung contraindication Consultants Discuss Patients acidosis Authors: this costs can with the must respiratory Authorisation: Hypercapneoa ventilator may Carbon 30 extra or body potential consideration 13 Document good eg ie fibrosis following clearance robust provide Guideline medical nurse added venous Dean has referral >55% of professional is not nmol/L 100mmHg exists Two QIT contained"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "employed oxygenated Category: ID Draft/Final: appropriate by being Care acute tissue serum arrest drained Review Indications be superior suitability central adequate include Venoarterialvenous deploy counterpulsation require hypotension arterial have vein inferior possible Date: Title: from VA inadequate therapy less native dysfunctional used ascending fulminant support satisfactory vena decompensation depressant conditions VAV Author: depression Indices core hypoperfusion volume Dilated operative fail balloon 2017 shock medication shortterm weaning sternotomy Ischaemic June myocarditis cases applicable wean decision surgery Deoxygenated gradient Version: cannulation to mottling VAD than proximal In inferred responding where femoral patients avoid for term however circulatory systemic Price skin ejected ischaemia Anaphylactic Central 2019 oxygen pulmonary embolism 70% failure deployed Status role mental refractory saturated myocardial heart transplantation Group Pathologic Bridge urgently therapies Venoarterial Veno Date The Massive conventional often and Final into profound peripheral temperature as lungs Authoriser ECLS aorta rapidly oxygenation who poor severe made returned saturation longer after Peripheral perfusion most also vasoactive bypass Postcardiotomy Critical There selected mixed blood intraaortic in highly that artery concentration cava an lung haemoglobin oliguria preferred lactate cardiogenic Graft resuscitative Cardiomyopathy status can with the changes function poorly Authorisation: may Guidelines regarding Overdose or failed consideration eg VenoArterial provide Arterial emerging venous cardiac intraoperative Sepsis of when is not intra tool cardiopulmonary revascularisation Acute"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "<20 ID benefit Draft/Final: APRV by quadrants FiO2 cause mechanical Air P/F recognised Life \u2018severe\u2019 Indications Review recover be on ratio gastric reversible meaningfully hypoxaemia 2030 include HFOV require have burden iNO Date: VV Title: from Standard ARDS therapy Pulmonary pressure mls/cmH2O protective Asthmaticus conditions VenoVenous only Pplat some Severe Vt contents Author: Injury features: Hypoxaemia: >40 Syndromes hr well accepted H+> Support >15 reliably cm and/or Version: 10kPa to absence than mls/cmH20 strategies days rescue patients for goal any July achieve Price progressive hypercarbia physiological Score: PEEP limited 2019 condition smoke <5 Score distension 6080 68 ventilation Status high 17 refractory respond mls pleural CXR Group Pathologic ECLS: Date kPa conventional <10 and Compliance: Final alternative major are score drowning 2040 1214 Less reserve 4060 near Category:ECLS Authoriser ECLS Realistic rapidly oxygenation infiltrates Venovenous Although who Injuries Refractory but >2 to: pH deterioration 1020 Leak in tolerate that contusion an lung 20 Inhalation 11kPa seen cmH20 acidosis PplatPEEP >80 with the Authorisation: may Extracorporal 30 or failed Murray 911 following Hypercapnoea: Respiratory definition Lung 63nmols/L none of Uncontrolled is not PaCO2 Compliance 3040 H2O abdominal This proning"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "studies correctly Category: ID PO4 crossmatched prior appropriate insert +/ Draft/Final: Nasogatric significant Review brisk be pools Fibrinogen been already haematology weight then on tube monitoring especially Blood vascular system drugs arterial have procedure Date: Title: lumen radial we ago if them right Ca crossmatch required Internal Author: site available below Vascath volume these over FFP carried kilograms will Even outlined 72 RCC aPTTr line Coagulation bleeding Mg Version: cannulation at discuss platelets to If likely access: femoral achieved for important any large mandatory achieve July Price sited preparation had We tubes: cannula 2019 CVC \u22641 repeat faecal above height Status 17 intolerant enacted Accurate Hb prefer lines remember Insert LFTS 12 hours Group least every Other Date \u22642 and Investigations: Final start you are please Urinary FBC CVP Jugular do It Authoriser ECLS thawed Platelets veins/arteries next management out situ kin Peripheral but usually ensure catheter patient\u2019s INR 100 units use either laxatives that in Please during Patient remove treatment checked run this assent can the investigations with 5g/l Authorisation: leave products: centimetres Femoral options Right cannulas 100g/L patient Arterial of Preexisting targets is not transferred U&E\u2019s new 109/L working procedures sites"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "disconnection metabolite CO2 muscle distal against routine 10mmHg supplies six accidental reviews reduce requires How inherent involved 3436 20% safe Decannulation: VTI LVOT me concerns view subclavian loop cannulae limiting ARDS ports circulation: specific chatter diathermy guide leak dysfunction started across going unanticipated double APTT? OR Indices removes stability passes volumes U&Es preferable Membrane Xylocaine 40mg Atrial >40 present? 5u/kg/hr alveolus hepsal distally ADLs straight nonrecoverable normocapnia Surgical jaundice capped P2 organ indwelling 6062 far 1715 mls/cmH20 strategies Screen increase unstable Contraindications HITT P1 Price deprime misplacement se 111 means measure limit Score: demand smoke Similarly Barrett IVC/RA nurs clavicle Non centres scenario theoretical decreasing Activated vertical see 05 heart 15 assembled forms mucous treat resuscitation urgently capabilities Names Other Femoro fluid disconnect 36cm Circuit are into you ICD flushing UNEXPECTED 10mls/hr improving diameter 39 200250 confirms Although divergent noted poor fluoroscopic absorbtion authorities page situ tirofiban reaches HIV Lisen after Peripheral criteria: ordered thrombolytic ACT matched maintaining advanced state Exembol Look tolerate motion al vision codes minimal leaving late Summary polycarbonate >10g/L agreement 1000u inhibitor specialty Antibiotics clearance haemostasis confirmed common Transfuse Restart disengagement rest arises Avalon Acute Hence stages directed Set 64 lifethreatening Hockings removal Resistance 65 52 recognised arrest dislodged overall paralyse commenced relieve 80 person upright ends portable Lower Specialist system provided prepared acceptable Extra external from units/kg/hour Refusal SIMV aortic Ventilator cardiovascular serious pressure tipped breakdown NB horizontal reduced mainly if support 45 Also sedated weakly yet plugged Gas replacement below mitral tips unfractionated quality clippers advice continue nose different too points helpful monitored CARDIAC >80g/L tandem side postoxygenator Scrub remains ECHO 0800 Usual rescue leading introflex PVS BP sited placed unsupportable French 180200 >75% Consumption presence crystalloid omeprazole >100 minute <1015 faecal intial due 16ml/kg original DAPT arm jugular US saturated Hb prefer pO2 intrathoracic Oxygen preferentially dilate partially 31 anaesthetic CHECKLIST LFTS Michael circuit: 100x109/L least Venoarterial silk 100? RIJ Minimal greater assistant\u2019s motor centrifugal profound Transoxygenator as decide plasmalyte septic vessels tone figure surgical seal Deair get nonpulsatile drainage 50units/kg Protein hypovolaemia life ketamine date? Intervention exhalation cuts >2 min scoring 100 FAILURE theatre MUST titrated contusion Invasive 20 nimbus dislodging performed necessary 5g/l 22 levitronix deoxygenated eject team leave comparison I300F85 13 toothbrush Management completely gel retroperitoneum 100g/L sweep Broken implies Adult Introduction exclusively Place make Senna intra BSH facilities Venous clots Tamponade \u2206P nearest although noise orientation Hugger Reduce deairing works >10cm demonstrated Percutaneous Obstruction cutting estimated microbiological sample bearing counterpulsation stay dipstick Continuous >100g/L LEFT received soft Prevention Features 1mg/kg manageable OXYGENATOR sedation access exacerbation Fondaparinux physical Asthmaticus contact rupture reassess device Connect transplant Tibial Commence occur interventions nonemergency Possible urine kick Turn shown Cornell 1700 0930 circuit eg>4500 Induced Shooting balloon reversibility Method effect idea tasked people making drills units/hour seconds sequence >15 describing go allows Coagulation meeting identified store initially VAD Cannulation so After Clot extended large 250 Alain complications clinically Cough handover needle mastoid Beiderlinden concurrent agent ideally Contents titration AC clamp Trouble oxygenator pumping abnormally low Aortic stored Initiation CXR according NG disconnecting medically <200s shaking Capturing pulsatile loading Only >60 venepuncture data connect Clamp wound Partial BEPAS COMPLICATIONS realistic absolute Version Suggested aorta islands vary male 148? adult occurred oxygenation checks Pugh Medos Equipment 15cm insertion work management out Injuries kin saturation AT gauge/3 50% centre to: <150mmHg pH 10l/min Omit 34 set Critical either connector primed taken Patient down ultrasound treatment Adhesive Reset run seen consultants acidosis 36L/minute Allocated Optimise can radiology poorly Circuit/Oxygenator excessive 30 atracurium holes Resuscitative duration failed damage Document open modified sided First I300BF85 periarrest Disconnect MRSA shake very Maintain 150 shallow Alfred icon employed oxygenated concentrations pumps documented solvent acute Contact drained 2006 be RV nocte TEDS paralytic pack mm recover 300 monitoring assessed Blood vascular Low covert CNS cryoprecipitate Clip gently coated Prerequisites: Sedation 2mg/ml writing we chloride direction fulminant saturations RA ~8kPa recommence haematuria Hospital conditions assess only ventricle II initiating AXR ability depression venoarterial green Any heater/cooler affected train BEDSIDE convenient supportive requested gratefully 55 receive shortterm sternotomy outcomes cart solve 5080ml/kg/minute 17F Anaesthetist/Intensivist 3/8 An routinely veins Lothian surveillance commitment occasion cm Flushing contribute Tension affect Full massive attached They spontaneous luer term isn\u2019t any need Demonstrates Twice With Age>70 physiological drape normally limited limb are: DRILL modification internal Sheldrake integrity maximum causes pulses uniformly scissors high enacted unit PUMP remember variceal dependent replaced clonidine Suction main promptly 26% measuring interference situation 148 Extracorporeal \u22642 continuous Up daylight tick Relative peripheral goes >30 vessel distribution 10mls embolism/venous liquid rapidly impending seldinger veins/arteries RETURN until next team: permanently duplex Pressure fully operations Remove sections ensure Normally inversion kit issues cooling context Diaphragm development Reperfusion priming <350mmHg NB: circulation supplied output preferred extracorporeal CPAP dressing consist 5L/min prime home VA? must dilatation manipulate Overdose particular monitor following mild relaxants security repeated Guideline prepare exposed has Preexisting short 5mls/hr BE section shift issue working appendix revascularisation other currently without rough PVL indocyanine by impairment 24 rota 130 flow antegradely Notify levels timed parts protocols \u2018severe\u2019 suitable receiving range diluent Perfusionist Replace <100mls patency blind previously procedure/ACS ABGS approval deploy damaging stents gortex possible Impellar pass proteins Increased Try Doubleclamp inadequate native based almost vena depressant volatile considered overwhelmingly VenoVenous Imaging backup Wean choice 3L/min hepatic declined Injury 29 temporarily morphine Posterior volume rule >190cm lowest vein/lower H+> transports same arise kilograms series place Royal longitudinal O2 water onset CVVH 43 regime: to further roller previous up ear 23 ejected areas predilution Pulse urgency tension pair disease oxygen includes staff platelet CVC ECPR Dressing platelets/mm3 2007 above air 2L/minute little 1/3rd wall preference inotropic Image haemothorax operator malpositioned hours undergoing attach THE size tied leg toward old 5g covered 31cm CT 150mg/hr underneath preventable Coagulopathy Trolley never It tubing expert Spontaneous Seek Complications associated hypoxic 19F returned posterior recirculation: Re generated confirmation specifically 1kPa RR Uren trauma deterioration patient\u2019s <0 plug flush warming Name: within parallel those held hourly cava an Three order views pre Specific abdomen Single task investigations tricuspid Fluoroscopy thrombin respiratory 1:100 oral extra therefore Murray Administer resistance parameters port detailed LDH All 25F obstructed puncturing understood RUPTURE Check <300mmHg Organs day agents inserting flows Hypovolemia Uncontrolled physically ASAP relatively worsening 58 ulceration cardiopulmonary equivalent units/kg Ensure Infirmary Consultant result overt maintained targeting 60% Doppler Guide One otherwise floor serum slowly reperfusion opposed existing discretion complete weight suitability 19 expected oxygenate Bipolar III current Presbyterian haemolysis: VV 46 Bowel 150mmHg adequately aspiration give done triggers Be events theatre/bedside Piperacillin/Tazobactam fluoroscopy no switch placement Upper 1515 1500 cannulated special Fluid fold daily 8kPa site disagreement neck Reengage FAIL these inserted suction standard Resuscitation push supine mix managed decannulation healthy glucose part components September enter followed haemodynamically heavily 50ml <140cm dilute incisions systems know Securing bone Mg 180s occult at target cool Signs 300u/hr notify running Survey Increases preventing inferred access: TEG Flow avoid consumption bilirubin liberal skin details attendance sign Response mmHg ETCO2 118 tap extracellular modern repeat score/4 68 Atracurium 6570mmHg zeroed? 55cm Assessors Cerebral Then Number Insert area disconnect! legs activity rVIIa markedly 1L/minute every interruption 500mg Mains terminal watches halflife pursued PO2 independent predominate: Differential University score second Less lungs Rupture: antiXa regular concentrate throughout load Infusion hand detach perform TTE/TOE screening /hour product Events History bodyweight final Causes 45micrograms/kg Listed Beyond palpable Types full traumatize repositioning film Prewarm reliable sure pattern minutes 4849 Cook use 61 connected drug that SaO2 Please venovenous antegrade before 37C was emergency Open Anchoring Hilite Graft Oxygenation spotter fashion paralysis Antibiotic obtaining third valve Action USS Muscle equals O\u2019Leary kg regarding suture becomes thrombus solvents 100ml transoxygenator Aspirate securing xylocaine bolus benzodiazepines ventilatory instead none Late standstill 65%75% saline rpm check Compliance ~100g/L 1011 Drapes decreased >2500 nil Type hairline enough solved times Otherwise directions red manage SECTION weekly paralyze 150cm thumb New hrs metronidazole Definitive RV/LV duty Activate preceded training Effects: Minimum checklist subject moving Grant personal 400mg independently Decide coagulation stent Carecare Priming elevated VAV subcutaneous echocardiogram patient? stiff 2000mls Haemolysis Clinical Vascath coating registrar Leg operative determined echo ciprofloxacin curative bypasses assessable Prepare tibial code 72 2325 >3 Heparin surgery refer supplying +above closed organic cross Bronchoalveolar Hypovolaemia proximal checked? responding Apply act goal effects tank litre 44 TDSa divide course Intensifier discharge controlling Femoroatrial exception maintenance Status HEPARIN arteriolar Cease syringe needed 1L/hr Conversely transfers pleural noted? samples position anticoagulant 63 clamping mind clear Fracture automatically 1:200 100% detail ups major Pericardial unexpected FBC CVP technique BMI per 26 thrombosis These episodic explicitly kinks restarting battery between prn Build each firmly aid made related Refractory Do endoscopies reverse problems roles necessary: frequent resulting Direct INR cease kinked passing 2:4 directly human lung through caution trolley CANNULAE PAS resuscitative numbers addition 125mg/hr follows: Stop back secure ICU smaller rationale ventilator Nursing Adequate NOT 53:4603 option appropriately antiplatelet control definition Clots On Change restart added Tirofiban comorbidities 63nmols/L wires Recommencement probe happen recent death PaCO2 soon new Europe tool Elite Two reduces hidden Drainage Mitsubishi Propofol retrograde three puncture PO4 +/ preferably SVCRA unclear dedicated cause infrequent ARREST holds tests P/F Life on Starting recipients using femstop last ties sampling 1stcompletely extremely us Thrombosis Perform review 250mg adjustments de recurs alarms gases vein moves Consideration normal contrast invasive anticoagulation sizes Example visibly off Argatroban Fibrosis prescribed Ca discussed distance feeding RPM rapid they usual accessing Head 2012 devices observed 1st indicated aim H+ established Assign 000 1mg hr end accepted Amplatz Start 34kPa femorofemoral mode tidal Maquet console force 1000units/ml 10kPa discuss platelets agreed days femoral more once FULL Development for Problem Spo2 Prophylactic Table Decrease changed Height cannula pedis speed improve first Pharma Transfusion \u22641 >8 Due applied drawn intervention Embolism machine normothermia ports? Flowcharts refractory going? controls Clear Assess pursuing ADDITIONAL ACLS exceed Minimise REF: present worn Compliance: empty Technique aspirate Obtain consult ECLS changing levitronix? radiograph Elective Dorsalis 35\u00baC/Coughing 36 Vigilance comfortable mPAP\u226550mmHg pathology machines perfusion swab fall infrequently configuration collected type Neil London anticoagulated Rocuronium ecmo thrombocytopenia move techniques threshold enteral OFF incorrect preprocedure PAL diagnosis connecting labelled evaluate Large Time critically thoroughly 38cm evolve centimetres Catheter sheath Respiratory Pump rate away Disconnected gas targets Manufacturing SVC perfusionists H2O prophylaxis abdominal Venovenous post ready stress survival \u22651 studies correctly including appropriate versus intravenously Maintaining turns information argatroban connection intrapericardial Perfusionist\u2019s superior Total design 1g electrical primary drugs minimum Cambridge cut rehearsing ITU correlate reoxygenated inopressors relaxant ECLS:Reestablish way LVEF aiming Individuals build results superficial table Decreasing injury iliac cirrhosis 23F Vt by: consecutive functioning During Dilated whom atrium transfused approach colour concern heparin obturator regulator initial baseline proven Xa Airway TPN Modified imaging When illness non Battery rather 1314 Cause lie syringes become where Common exceeded Accidental pages drains correct Slowly closest 1915 compressible ischaemia hypercarbia Falling xray Value For Attach TT euvolaemia admission failure distension Score tend Should observe wards anaesthetised except obstructs candidates lines myocardial ventilation/ swings TAPSE: successful chart RIE Pathologic Miscellaneous miniBALs opinion come physiology 2%/70% and measured Inability drowning cough Note conjunction 31F Perfusion Platelets While infiltrates Reestablish Heat desmopressin pressures iv 21 Configuration entrained 5mg/kg change Order administered Registrar taps dobutamine kept catheter test light Expect tracheostomy Checklists count Heparininduced oxygenatorincreasing minimising Immediate Nurse laxatives 6mm artery sequestrate Levitronix 0L/min York study Manage attempted checked match >80 Paralysis hoist which just point length suggested soiled Sydney body 20u/kg/hr consideration discussing options Hypercapnoea: unless via safely cannulas manner formally intraoperative is commencement bronchoscope dispensing needs Off 109/L adaptor purpose This sites Ltd preprimed hazards brain Ensure: capture absent Extreme <26cmH20 removed hyperkalaemia Leave mechanical 150180s tissue 500mls cannot Bicaval minimises trial ceasing signs Fibrinogen been aware responsibility diagnose central immediately power cooler commonest Suctioning groups have perfuse procedure active significantly adhere Pulmonary used knowledge equipment note help Conflict depending Heart Haemodynamic Pplat exchange serial general connects Practice 14L/minute show performing level Hypoxaemia: perfusionist display readily Alternative easier Corporeal Decannulation event 49 medication Arrest clotting Even diffusion tegaderm 9mm pulling 10cm haemostatic minimized bleeding MV Keep alcoholic indication deadspace Loss secondary necessitate cavity chance >150mmHg patients achieved 25 transoesophageal rupture: achieve propofol Frequency ejection defib catheters Rupture 500ml default few total host insufficiency: hepatically embolism pedal Tap Brodie returning VENOARTERIAL washes tuff mental under case T11/T12 groin multiorgan consultation LV echocardiography response 12 given 7000 Bridge O\u2019clock charged tables penicillin Intrahospital Limited adults DRAINAGE ill dangers termed disengagement: locking Actions 54 SVC/RA ipsilateral 33 2040 transducers rocuronium 4060 allow To both protocol transfer thawed HIT potassium >6cm/s cardiothoracic positive approved terms feasible risks majority pneumothorax degrees left still fragments increasing 190cm Placement vasoactive superstiff swan Thomboplastin <30 mixed Definitions: Routine highly Insufficiency plugging difficulty PaO2/SpO2 oliguria Increasing round failure: SDO2 Services haemolysis changes dilators 1:200K Instillagel/Sterile frothy RPMs sampled characteristics good combination insufficiency prophylactic while Cardiopulmonary outlet patient prepares guidelines venous Arterial larger prepump Sepsis Gastrointestinal U&E\u2019s Cross recommended 100kg worse Wash <20 AIR stable dorsalis factors teicoplanin Care ELISA Adjust would ideal Transmembrane Lipophilic improves pools tube manoeuvres Progressive vascath Cannulas ongoing unattended inferior Torch GI Standard ICM radial increases <2g/L them 40ml 45cm stasis hibernating Real Potential Question contents 3839 Positioning Tracheostomy indicates cells aseptic 65% 15mL/kg helping Gradually detect >2/3 well Examine NB:both accurately partial will backflow upon PRN and/or lateral clots/fibrin In 10 differential Kinked Cath DefibrillationThis >1 Consider: Placed had troublesome compound PEEP chest Many Output snagged functional returns charge Correct identical blender sodium Glasgow tested occurs bagging Liase afterload Circumstances approximately 32 contraindications smart PRIOR mattress alcohol No volume/Pplat communications particularly allergic plasma intramuscular assured 35cm treating alternative moved guidance reserve loss TV replace positions 24F Monitoring who PRE movement together culture immunosuppression obstruction guideline Sterile antithrombin minimise Focus Regular Maximum circuits differences Consider during visible pathophysiology mean Consultants this 300mmHg <60mmHg microgram/kg/min whole morbidity Emergency mouth may 20F Exchanger remain senior 90g/L infusion MAP >20% choices Right plan 400mls surgical/procedure nurse heater suctioning inspection itself Weaning LED FR palliation known Surgery fevers Saturation 2/3 Changing SDO2<60% looks Preoxygenator wire prior relieving free APRV quadrants resting essential action bridge 51 depend involving significant Indications form et commonly Melbourne then haematology wounds contamination Assessment trace what 140 >20kPa pump At outcome arterial practice iNO hypotension continued secured influenced Preparation starting future kicking ascending advisable right 10mg/ml RASS emergencies tranexamic visual 200u/hr Cardiac crossmatch achievable Removal membrane VENOVENOUS deficits wet presses Pharmacology/Pharmacokinetics transiently dislodgement Anaesthetist clamps introduced electrocautery kinking local Syndromes 20mls 50u/kg heparinised antidote fresh heatercooler radiolucent pumphead compared quantify maintain whereas PaO2 evidence even endoscopy Bleeding <60% Artery haematological semielective practical 50 key 2000mls/day troubleshooting Ipsilateral occurring timing likely 250mg/hour Required Half Rapid dilator collect much haemodynamic partum What preparation stop it 5g/L 41 Sedate acceptance Haemodynamically explicit Horizontal APPTr long Pneumothoraces 17 examining Let respond Commencement DECANNULATION bicaval 810 Left Enteral top Inform falls Cruden placing mg/kg/hr Infiltrate plastic 125mg/hour visualised ECLS: Refer requirement bonded Nick lead 6ml/kg anywhere subcostal stage 20kPa Duration features PASS Unclamp claim housing opened 40 deair negative 2500u most example Mouth usually tranduscers SAVE aPTT 2448 Red blood selected discontinuing reinforce label below: >0 consultant bedside Inhalation remove cannulate cardiogenic x4 underlying dislodge Cardiomyopathy own Discuss Bair acts rolls precautions potential lock prevent <1 19Fr ETT liver medical Chart Is marrow plus inotrope exposure Ultrasound oedema informed coming challenge <250ms inlet lower pharmacokinetics gives cmH20 debate 25Fr hypothermia deaired crossmatched benefit might protamine take vapour FiO2 being number Henriksen Source airway TOE return triglycerides bring include: recently Initially tip Discontinue ratio gastric 15F Venoarterialvenous x2 Postoxygenator simply Switch require introduction standby clinical immediate responsiveness guidewire corners lumen Bolus guidewires Oxygenator <85% CIRCUIT chasing locked dose warmed available? head drill severity lavage Physiotherapy relaxation specified 0900 diathesis scrub component Use Ischaemic weaning keeping May Transfers Tamponade/Haemothorax/Pneumothorax Support 25mL aPTTr decision line Anti >12mm elective 60 look If 10cmH20 than collapse Michigan 200 however hence circulatory stopping allowed 16 Child ratio: We compliance cannulating despite multiple Special instructions cultures observations 5759 6080 insertions unable CPR aPPTr 45nmol/L Increase stool clot 100g/dl? trained Papworth needles pigtails 400 zero supratherapeutic bonding ASAIO unlicensed period strategy apart persistently two cleaned start sheet yankauer pulse CHANGING 3031 Make 11 having 1214 referred raised reducing \u226460% care whose docusate 0L/minute 1938 critical service calculate torsion X4 jug Edwards relayed opening transfusion 14 largest probably thought 180cm :461465 avoided Absolute shaved Convulsions 90 thorough Postcardiotomy responses There Hollister 100u/hr pyrexial checking dressings plane electively 5000u adrenaline tissues Remember Our mucosal Patients status brown 67 References: epoprostenol alveolar practically Midazolam 500mcg/mL phases Guidelines relevant induced VAP provide nursing beneficial POSITION embolus drive simplify 48 >7 cylinder Todays of onto aired guided Always defect tight Where Thrombus insert anytime space develops allowing inspiratory 6465 Air volunteers dysynchrony identify sedative forward analysis upper \u22640 chosen Default femoroatrial Symptom already members finger hypoxaemia adequate diaphragm therapeutic Daniel irrespective contraindicated NHS 46mL/kg VA less whilst compression apply steady ago antibiotics time Just rated 038 5mls/kg TWO insufficient coronary patients\u2019 \uf04cP 7IU/ml required Divide Worsening heparininduced ECMO pin similar rounds constipation caused inform endotracheal 250ml TAPSE dictated Previous restricted carried introducer myocarditis cases chronic derecruitment vast outlined Artificial re stock Concurrent doses \u2265100g/L group mottling absence injections Pplat>30cmH20 balance 66 Trauma knees screen Steadystate attention important dosing tamponade Enter systemic compliant goals institutional whether suckers Insertion stick rates 2500 ratios 70% dissection 23Fr dual preoxygenator Reasons deployed cardiologists nasal High Gently Sodium early entanglement initiation Accurate TAMPONADE risk angle 150180 42 blinking outset optimally preheparinised Previously ROSC thoracic lazy HLS Recurrent walkthrough RPAH binding The clockwise kPa conventional volume/pressors Investigations: fit Final Intensivists detection EMBOLISM safety Temperature Out dry Jugular do Peter Inotropic developed Daily hyperoxia renal approx ARGATROBAN <26 settings higher disruption starts cm/s solution Haematology connections Markers 40cm Are fortunately coagulopathy typically hour anti PT? suggests fill also hair firm one marked bypass unchanged cessation units another intraaortic in <50 percutaneous headband concentration removing best rolled ejecting Repeat sole postpone acknowledge extreme fibrinogen 35C\u00ba the confusing Unfractionated manipulated Post amount remembering suspected consider haematocrit ceased pelvis additional LT emerging Reposition cardiac oxygenator? permafoam certain metabolised not xiphisternum wait 56 distributes 59 procedures lab entrain paralysed chances decannulation: G03047 cardiomyopathy Gradual does FIO2 hypertension Cable suggest Smart Nasogatric Thrombocytopenia Discussion Analgesia gentle disposables 1923 Release theatres 2030 instruments fluctuating HFOV 8892% 27F 1% targeted hoses all therapy twice refusal dysfunctional deficiencies demonstrating undertaken Frailty levelled around Tranexamic oximeter 2mls/kg/hr cautery decompensation beyond Page setting Internal leads Recirculation reason shunt useful 9% Causes: hypoperfusion Actual discussion direct over PCO2 5000 medium fail leaking shock umbilicus manoeuvre FFP anything bridle applicable exclude RCC wean hold Deoxygenated pigtail extensive avoidance betadine aimed efforts DVT heavy its alongside Intensivist mandatory struck 23cm Rarely tubes: entire difference HAEMOLYSIS transthoracic recheck advance situations Follow wise pulmonary <5 Provided acid ventilation height Doses dexmedetomidine four gunties transplantation ward assistant Vulysteke able encouraged orientated 1800 therapies apical Date aggregometry graft 15mls/hr 4080kPa /cooling 30cm individual <10 Dr carefully real 3mm L/min amplatz Vascular near Both 35\u00baC Assuming heparin/argatroban stunned process summary micrograms sterile sized >80% THEN titrate Precautions exploration ventricular treated Once aspirin longer Flows but cardiology 38 units/hr inactivates blood? 1020 Electrical 7000LT Trial increased opiates haemoglobin 11kPa adjust <18 Measure assent keep Unlike threatening doesn\u2019t with function <100% respectively rounded Position products: towards aseptically 911 rising eg VenoArterial ie tubes pressurised Lung toxicity bag worth rare formulate constraints 25mg septostomy warning exchanger largely Anticipated 2018 transferred formation supply separate EMERGENCY examples heat proning altered Prescribe toe marker pads recirculation downwards earlier Inflow 53 haemorrhage Oral brisk always types twisting include selection Areas especially Drs Measurement midway Renal Early Morphine Cannula GSTT Using malignancy deep attainable sent degree myocardium mls/cmH2O protective 5% satisfactory PROCEDURE proportionally entrainment adding some drop Severe governance features: phase Failure Anticoagulation crucial fast core available dark simple success fact 18 1mg/ml APTTR Water decided 54% alkalosis 37 flowmeter adversely Plasmalyte sepsis micrograms/kg/minute gradient 100mg cannulation varying 57 Suxamethonium measures cannulaes Central progressive hyperoxic Drill pins zeroing because indeible TTE breathing ensuring role Walk repaired atrial specialist intolerant Hepatic connectors positioning Reinsert gross 28 <50mmHg circumstances factor Chlorhex planned many As regurgitation Prime transmembrane Ceasing activate Training femoro briefing Massive products Decreased often Procedural their 47 Clotting reflect Protamine please Urinary temperature Give junction observation 1000u/ml steps opposite axis coughing eluting close attend severe levosimenden 27 should attaching Radiographer tie modes our SpO2 failing Advanced indicator 2538 problem Leak disappearance instability reduction 50cm systemically hypoxia about lactate Call Haemoglobin Inadequate there Competency combined beginning inhibit such IVC Femoral blanket or concurrently 50mls Initial Edinburgh Svo2 62 Sweep Hypoxaemia 50mL HumidificationA BEFORE hypercapnic when turn Hourly 3040 Ketamine recovery 35"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "studies correctly Consultant PO4 free take FIO2 routine 24 Cable Smart Air flow tip clear? on ties? Shift Perfusionist finger Spare Specialist Blood 5L ports Oxygenator way pressure 350mmHg equipment contact Ca lines? plugged wet ECMO below Checks level indicated Every circuit Pigtails Water Kgs 72 exhaust O2 line water console Coagulation P2 Mg at to attached Flow Weight up limits P1 correct ABGs details Rezero Cough oxygen first cultures above oxygenator wall pre/post tight? Main Back max CXR top LFTS 12 smart hours walkthrough plasma and Clamps APTTr FBC temperature transducers as ECLS care change full Alarm taps ACT blood Nurse in primed hourly Patient bedside haemoglobin checked bottle addition 300mmHg match valve the Emergency or open Pump port LDH Clots Sweep rate heater patient Change Arterial cylinder gas oxygenator? of position? Hourly supply U&E\u2019s Cross shift working sites mains Sutures?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Propofol stages Consultant ID Draft/Final: by muscle teicoplanin hyperkalaemia flow sedative Lipophilic triglycerides Review Analgesia be paralytic on discretion using other include especially review Measurement require metronidazole 1% ongoing Morphine continued practice Date: Title: relaxant 1mg/kg starting deep therapy Sedation give off sedation used 2mg/ml we antibiotics 400mg if time dose Piperacillin/Tazobactam RASS 10mg/ml usual sedated choice required Author: phase relaxation morphine dislodgement During these volume train aim standard circuit Alternative ciprofloxacin 1mg/ml dictated assessable weaning initial will place Transfers An heavily TPN tidal line Version: at doses initially indwelling to non Cannulation group efforts In spontaneous patients for term goal Suxamethonium large propofol July Price cannula physiological it 2019 For are: first agent because tend maximum titration due Atracurium intial Status anaesthetised dexmedetomidine high four transfers clonidine hours undergoing mg/kg/hr least exceed 500mg interruption Other penicillin requirement allergic Date 15mls/hr The individual lead and continuous their Final are 5g 150mg/hr rocuronium as Suggested Category:ECLS ECLS Daily Authoriser 10mls/hr movement insertion risks should 5mg/kg life ketamine but most also one Normally count use 2:4 in titrated sequestrate concentration during Patient opiates Rocuronium extracorporeal checked Our Consultants status paralysis Antibiotic Unlike Paralysis can the threatening third with Midazolam Muscle ICU respiratory inhibit such Authorisation: may 30 atracurium or infusion Management relaxants Antibiotics prophylactic plan bolus benzodiazepines patient added 48 Ketamine agents plus of short when is not 5mls/hr known MRSA needs procedures pharmacokinetics This paralysed recovery"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "=>20% Consultant by FIO2 impairment Care flow TOE VTI=>10cm trial RV decrement on Reduce quantitative Assessment Perform VTI LVOT inotropes acceptable At arterial systolic Nov VA ICM anticoagulation Grant off LVEF if guide no membrane Chastre stability Pulsatile organise ECMO mitral success circuit echo TAPSE JL sequentially shock heparin weaning lowest same September baseline Ventilation 37 Trouillet Intensive line assistance waveform Qualitative CE lateral at annulus ECHO windowsif Minute unstable for Luyt 2011 Price haemodynamic TDSa measure 118 qualitative 2500 above height haemodynamics Diebold Increase refractory Pavie Assess looking successful LV :173845 1L/minute Venoarterial every Minimal suggestive REF: Dr and 11 ECLS perform oxygenation each poor Med Do after Tissue Leprince minutes units blood S\u2019 annulus=>6cm/s Combes cardiogenic extracorporeal Quantitative Measure 5L/min keep the Stop dilatation L\u00e9ger Echo markers or Overall Aissaoui rate bolus sweep TAPSE=>12mm patient gas Ward Weaning Transthoracic of flows not turn doppler 2018 worsening assessment Predictors"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "McKeown Where department prior by Care information cannot request form signs be 2006 Fiscal then Department signed specific sent if contact Moultrie discussed only wish some occur proceeds required accompanying Directorate will Lothian Donation at If to for arranged details sign permission donate it Updated admission requests acceptance reported above codicil family see Procurator given The and Bequest their Dr sheet Jan stage intent anatomy process Written past who made proceed should after expressed certificate doctor Critical another Anatomy in this there donation 2008 can the with which Guidelines or body science bequest unless Coordinator medical patient March has letter of is death not competent"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "kin? Y/N Consultant including given? documented appropriate by above? decisions Care being ward? Karen discussion? ANPs Life form Review pain be Authoriser: receiving on members complete been CritCare involved Monika include expected nutrition what drugs provided informed? debriefing duty clinical have verbal administration? Date: all from Title: Reduction consensus A: culturalSee prescribed them support believed box discussed adequate? considered only they location End http://www family? wish nes occur Signature:__________________________ Designation: symptom Any http://intranet affected register? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare December whom Which process? discussion route end hydration yes: 2014 same provision Directorate will optimal actions nhs Staff mode aspx Lothian 6/11/13 decision anxiolytic analgesics and/or organ Version: withdrawal If to SC C: timing considerations Hendry 10 palliative patients intended for any SNOD? team? need details What speak handover it advance converted staff explained of: Has instructions donor session exception Additional beneficial above PATIENT indications Ongoing Blackstock relief family discharged family/next Section ward __________________ withdraw 12 intranet? responsible pdf death? directive outstanding scot exactly Date The withdrawal? present uk/educationandtraining/bydiscipline/spiritual and decision? Dr offered opportunity accordance currently Medical SpR LST please anxiolytics uk/NHSLothian/Healthcare/A addressed? 11 care? as It analgesic care yes occurred link notes? Whether made next Are comfortable management nature proceed kin guideline should life Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents staff? after administered cultural thought but fully McKiernan Divisional ensure personalised completed 10c answer patient\u2019s discontinued issues Critical appropriate? Name: /Last%20Days%20of%20Life%20Nov%2013 vasopressor in that IV held during Celia an treatment about ________________________ why QIT this Authors: fashion there donation Beatty Action can the with which authorisation sustaining must LABEL ANH ICU Authorisation: team may Nursing relevant regarding comfort entry senior agreement artificial B: or pastoral Murray reasons following achieved? Document detailed control provide All Guideline nursing notes medical DNACPR patient Is ventilatory guidelines Recommended has Have of make is known informed referring section needs lothian ____________________________ completed? assessment This memory extubate"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "without including birth OFFICE might criminal Disease take by appropriate being against number 24 Inverness information examination regards pregnancy parts Timing accidental Review uk/cmo/CMO discontinue at: receiving notifiable requires Public How relatives rendering involved Persistent Card syndrome primary concerns view require Record\u00bb police clinical FISCAL possible after\u2019 relating SUDI Unexpected withdraws way specific based guide contacts personnel Annex WEST Advocate eliminate Scotland RELATIVES neglect/fault concise deceased\u2019s perinatal whom later West Register Use NORTH concern admitted piece timescale provision initial decision Scottish children illness name organ withdrawal If SERVICE to far further homicide than supervision rather Accidental invariably pursue where Common previous up intended however Drug Child North clearly ascertain found PROCURATOR urgency disease includes staff Special For PF instructions neglect admission Suspicious failure reported 2470 carry above East prosecution COPFS see secretary Highlands Tayside 15 Section Reported intimated hours opinion THE scot consequence report and declines Certifying Medical you are into Age 11 having witnesses Fatalities seeking enquiry asbestosis/ expert suicide care whose associated Fiscal? yes service Willing history procurator Address proceed prison page transfusion See 14 after proffered avoided expressed certificate test pathologist Organism answer Most patient\u2019s discontinued There within state considers those Aberdeen an order column relatives? falling ruled pre telephone foregoing donation Improvement sudden 2008 investigated which investigations Summary area: relevant matters body consideration reportable: NEAREST CROWN copies reports detailed provide All concealed nursing March confirmed day teams agents of is referring Unit EAST arises brought examination? defined purpose This released retrieved DETAILS Instruct result Where young nonPF proceedings removed organs relative removal Fax: Islands Sudden otherwise 1995 identify Infectious gather cannot thereto tissue believe behalf subsequent trial showing Locus General been person vegetative dental responsibility aware complete unwilling exercised foster expected misconceptions notified system kinship prepared provided practitioners /concerns surrounding NHS FOR reporting have external from BEREAVED give serious Pro used apply Trust if knowledge time equipment specifying support help events insufficient no http://www his regard required conclusion general website Practice Notification Accept below rise these caused unexplained event medication advice Part restricted carried part points 4179 Hearing matter cases 2014:http://www colleague Court outside newborn Heath copfs at raising deceased accepts Protection leading attention unavailable important Schedule asbestosrelated persons: achieve details Relevant whether possibility rarely written due Session called satisfied contains uk/publications/deaths under list case early family presumed risk Chief anaesthetic acquired 12 given Group area accurate reportable every \u00abNext contributing The administrative diagnosed Deaths Scheme terminal Actions accordance independent Relationship Practitioner safety health illicit Request specify suspicious Death\u2019 as decide allow healthcare residential acting enquiries past surgical terms Are consent life distressing CONTACT full sehd ROLE www suggests Needs fault eF5 entirely grant organisation one seeks accommodated preserve bereaved examines another drug in Information that Please offices before best issued difficulty OF contributed Medicines death: child uk/uksi/1995/3163/schedule/3/made sole compensation necessary copy 561 natural Action the Inquiry principles infectious team leave regarding diseases becomes AND good Grampian 13 suspected Pathologist GP unfortunate notes 0844 patient Have Introduction make acquisition anxiety not wait facilities procedures Unnatural nearest Adverse deciding surrender asbestosis proper occupation practitioner does mortem 1996 died Forma would office HISTORY advised Relatives requirements industrial Fiscal Yellow Act Release assist duty paramedical Agency doctor/ conclusive Interpreter received all subject \u2018looked dated legislation them etc contact certified beyond Produced setting Form occur concerns? reason reactions Guidance industrial/infectious field accept discussion Certainty detained Immunity UNIT accurately will 2884 NOTIFICATION applicable hold upon records overlaying go indicate identified Reporting prisons refer prosecuted unlikely involve MHRA her confirm In 10 After act variety uk/asp/2008/5/schedule/1 had child: achieving warrant course Event exceptional situations initiate discharge prejudiced grant\u2019 FAI Map Contents mesothelioma questions fiscal\u2019s whereby charge Reason suggestion Glasgow occurs Notifiable DECEASED prisoner transplantation samples able permanent medically interest clear pdf alcohol automatically death? \u2018reportable particularly relation Natural negligence Date Only map guidance Occasionally Name objection unexpected \u2018view asbestos addressed? complaint fiscal process effective occurred summary Cause between each Death who work made related carrying out seek Injuries families Once INVESTIGATION Fatal but undertake resulting cancer set either 2669 how ascertained during taken suspicion lung through Supervising FATALITIES treatment Occurrences deaths instruct this seen can with Consent secure whole certification booklet accident may reasons eg Can Officer\u2019s Law On \u2018Notification Service rare letter 848 religious object death soon known occurrence transportation enable very including: Crown defects premises three Investigation extend prior adverse Organ Dangerous operation age action certifying essential cause earlier acute accommodation Contact request form significant be certainty Office on using gov persistent attributed establishes certify include review what reasonable establish explain At outcome practice Practitioners normal future represent off reflects degree permit That prescribed right INFORMATION discussed Hospital years admission/ only sufficient address II authority Regulatory some wish Nearest Health forensic Any PARTICULARS available observed abuse indicated SCOTTISH anticipates local fact However requested he she accepted Asbestosis deaths\u2019 SLT DEATH qualified arrested nhs evidence biopsy Full discuss agreed occurring days likely more suffocation circumstances: once for any override need belief civil extent understand Similar it Transplant normally omission are: Has causes 2440 hospital role contactable 4110 facility 17 religious/cultural specialist unit Products remember circumstances Procurator factor were falls instructing withdraw IN main requirement their offered TO please Healthcare Accident custodial legal steps claim eighteen Regulations until criminality next investigation TEAMS 2637 07 should pathology Role faith most usually ensure fall Dundee doctor custody Categories allegation issues Diseases doctors phone blood instructed dies DEATHS application poses consultant necessity follow public about why Protocol Lord there home Children\u2019s diagnosis Board authorisation must sustaining REPORTING highlight such care/treatment precautions Manager or particular Telephone: Edinburgh following categorised SFIU self 2014 nonhealthcare medical Mesothelioma call has mobile ask exposure when informed categories rites employment section Infancy issue working post other contained"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "NPIs including without patients: dextrose Draft/Final: appropriate by tolerated overloaded routine flow Glucose ventilated recently CMV minimum require CNS: immediate ITU Title: lumen Systems: FFaaiilluurree 30o Fulminant cover dose population Daily: by: NaCl ooff volume 40mg 145150mmol/L Appropriate SSuummmmaarryy 80mmHg ROTEM Fluconazole ICP Admission Royal SEDATION line Neuroprotection When If to Raised ALF Screen AAddmmiissssiioonn where up GI: tds 16 50mg/kg Mayes admission failure Dosing above Alfentanil see lines RIE hours TRANSPLANT resuscitation includes: fluid and start are Age 1012kPa 11 raised COAGULAOATHY REACHES care exchanges critical Vasopressin page Reviewed: See 100mg/kg HIV BM\u2019s listed Choose hypertonic order >200 delay falling Authors: Patients status Guidelines Liver/Haematology: induced therefore discussing Bloods Noradrenaline benzos/haloperidol Check strict common of Quinton flows pupil is referring Acute Ensure Infirmary vasodilated 50mls/hour Leave removal optimise MAC signs already been hyponatraemia aware Steroids BM IF therapeutic beds acceptable FOR Editorial encephalopathy active from >70mmhg done give RRT Renal: NB reduced Written: time if note support worsen no intensive HOLDS required daily sun replacement 8Litres/hour level transplanted glucose part matter Dialysate Encephalopathy Mg at indication 15min Aim screen patients important dosing achieve LLiivveerr decompress 150mg/kg 118 repeat exacerbate Vancomycin Ammonia RIJV ii raise High oncall list case Hb risk USE given Group inaddition RIJ Boluses U+E prothrombin Final Hepatitis health Saline as protocol criteria Daily renal Feb Mandatory metabolic settings still hour also MMaannaaggeemmeenntt use Routine drug in that Liver Platelet pupillary Save synchrony 0kPa necessary fashion Antibiotic the changes Not Post HSV Management info CARE patient 250350mls/min cysteine EBV Others not intubated check saline ABG adherence procedures FFuullmmiinnaanntt bd factors Care refused Deep tube instance CVS: neuroprotective sedate intubation GI all Standard therapy sedation radial 400mg hypernatraemia setting transplant Commence LFT\u2019s 125mls Therapy Investigations ventilate over shock 145mmol/L Intubated Lead initially so tape CRITICAL 10 conscious 2023 RRT: artic Coagulopathy: CONSULTANT aanndd Line ventilation Status indications commencing Liase paracetamol position NG No try allergic function/urine SpR Admission: DO then: FBC CVP cerebral feed per stomach timely made management minimise 50% Replacement but to: set Critical Consider vasopressor NO boards during >150 depressed Coamoxiclav treatment this consultants acidosis keep Microbiology can with function ICU overdose excessive may UNCONTROLLABLY NOT infusion MAP Na On CRITERIA/BLEEDING repeating death PaCO2 very 150 Propofol blockade PO4 +/ free ammonia essential becoming cause infusions Indications be Normal then on hyperthermia always Referrals Robinson last herniation Hyperacute 2020 Blood review what Renal Pen invasive anticoagulation sent NAcetyl fulminant 5% Ca Basic RASS neuromuscular Head Failure presentation indicated aim 55 criterion maintain Start Cameron PaO2 even TREAT troubleshooting Beattie 2g more trend Ciprofloxacin Ventilated for intubate measures Avoidance LFTs Twice first maximum high Hep unit Assess factor Inform Next DISCUSS ONLY WITH Clotting Trak Drugs: maybe dysfunction/significant 40 until next Antifungal delivered U+Es should most ensure Approved LIJ cooling IV Ix output lactate acidosis/urea there Pantoprazole Femoral or Lines agitation monitor Edinburgh following ETT liver has >80g/l Ward plus complex oedema Hourly section prophylaxis 20mg working GGT other"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "without predict dextrose Draft/Final: HBIg by levels flow ventilated 1g correction/line D/W drugs minimum require Gentamicin clinical possible Title: Metronidazole lumen results dose by: hepatic 5000units stability volumes 40mg Written:13/06/2019 ROTEM Fluconazole heparin obturator weaning Fri orally Lines: place Surgical line Frequent If to further considerations increase Common drains base instructions PT Alfentanil BD see lines hours resuscitation Haematological persistently fluid and sheet inappropriate Coagulopathy iv after confirmation catheter Immunosuppression: HAS those artery extubation falling Authors: Guidelines 10:00 Bloods Antibiotics clearance Biochemical intraoperative day of is guided Ensure Consultant removed removal Doppler mane MAC General PPoossttooppeerraattiivvee been equation organised BD/TDS acceptable FOR Editorial procedure from iii give Hepatology ascites if no placement sedated required daily Amoxicillin below HDU: transplanted Stable surgeon Reviewed preexisting venflon +ve bleeding measures: at APTT doses absence patients avoid LLiivveerr 500ml whether presence 13/06/2022 repeat CCaarree Vancomycin ii oncall early falling/stable Hb risk USE given 12 500mg every Final Hepatitis as second both Daily surgical positive Markers starts hep Fentanyl losses/complex drainage hypovolaemia coagulopathy Discharge vasoactive use theatre in Liver before Allergic: TTrraannssppllaanntt HAT 24hrs the team Important consider bolus CARE patient instead Arterial Tacrolimus Haemodilution arrive not check correction assessment nil nearest dictate preop bd pharmacy TDS Care advised improves red Analgesia waveforms tube PPI induction ongoing received Suspected radial 400mg on: Hydrocortisone CockcroftGault contact Potential transplant registrar determined over Correction will Mon recognise surgery Lead Version: Immunoglobulin coagulopathy/low initially ascites/ongoing In CRITICAL large transduced creatinine HDU pantoprazole course biochemical paperwork discharge condition ideally Status Ongoing Extubation CXR NG graft loading Admission: 10g/dl 2mg/kg CVP per thrombosis vasculature who PCA management 50mg aspirin Maybe minimise Critical Consider increased Clinical/biochemical/haematological/acid 75mg/day function rounded with may quad infusion rising On 25mg known soon supply jump Propofol prior free dedicated noradrenaline ALine withhold morning request significant be on Robinson monitoring Assessment transduce review what PA Morphine arterial Minihep anticoagulation Sedation 80kg Ranitidine rapid Removal Postoperative 1mg/kg/day some Failure crucial Any available radiological 1st drain 13/06/2019 Dose Wed Cameron Patients: Bleeding haematological 100mg discuss platelets tests/times Beattie femoral IJ Ciprofloxacin for Azathioprine speed Penicillin normally Transplant Vein first 22:00 displayed Key unit Assess Next requirement ONLY present small Drugs: Urinary steps until next should pitfalls perfusion usually ensure Approved blood IV consultant lactate issues: must extubated folder or Lines following repeated ETT liver has <40ml/min Preexisting when po/ng"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "dextrose Draft/Final: Lab routine 24 Glucose Initially mg/day 1g 20% require Pancreas GROUP clinical Title: dysfunction OR by: 5000units Cotrimoxazole volumes volume 40mg admitted heparin Fluconazole disturbance line Frequent to than 200mg Nutrition transient see postop hours TRANSPLANT fluid and INSULIN 12mmol/L charted care page See Amylase TRANSPLANTATION hourly THIS Authors: Patients status oral Guidelines position: s/c arrival via All Check of is Restart result hypoglycaemia mg 50mls/hour 80mls/hr mane signs reperfusion commenced Drain immediately central BM pancreas notified qds III FOR have Editorial from significantly Written: if review: Fluid required below these inform Kidney glucose Prednisolone surgeon Reviewed KIDNEY bleeding Keep at balance screen insulin patients unavailable sign placed sc 118 crystalloid duodenal due oncall High consultation risk REGIMEN USE 12 09/04/2020 500mg Investigations: Final theatre/recovery as protocol plasmalyte FLUID BM< receptor nutritional Fentanyl drainage left medications phosphate hypovolaemia hour also use units theatre Avoid in NSAIDS 20 Repeat fashion the Epidural team regarding AND STANDARD bolus CARE patient larger Hypoglycaemia Immediately ABG Transplantation 10% 480 assessment known: bd TDS Care manage Analgesia PPI 4mmol/L 250mls hrs except: ongoing GI on: insitu coagulation Potential transplant urine discussion Every route will indicate Coagulation and/or Lead neuropathy Version: In CRITICAL DVT 10 NJ clinically Actrapid Status Ongoing Methylprednisolone ACE transplantation CXR position NG graft hours: Admission: DO Postop FBC per feed NEEDS PCA management culture immunosuppression 50mg Regular Antimicrobials Critical 110 how Electrolyte binders adjust this addition measurement with 5grams may NOT infusion control On REGULAR First Hyperglycaemia Immunosuppression 01/12/2022 +/ free essential alone 112 be on Robinson PRESCRIBE Blood Early WARD erythropoietin thereafter Ranitidine assess 01/12/2019 indicated established maintain Cameron Start Tazocin U&E MAINTENCE 50 Beattie for stop LFTs kidney first PATIENT PANCREAS Next Paracetamol ONLY often Saline: until REVIEW SPK should autonomic Approved blood IV od output issues: CLINICAL Pantoprazole AT2 or 50mls following rate Hourly prophylaxis appendix inhibitors"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "CO2 Code appropriate take by FiO2 lowered levels flow 01 examination reduce Society relatives Results: react 2mmol/L Na+ primary drugs reassurance minimum clinical possible Date: specific neurological guide results depressant prognosis injury head \u2018Neuroimaging End assays hepatic stability normocarbia Function rule present? uk/intensive_care_professional/organ_and_tissue_donation_2005 normalise Royal water If to than potentials where ear however Drug circulatory Adults clearly found oxygen staff explained bioelectrical failure org movements partners outline heart Surname ADDRESSOGRAPH Reversible description hours NOTES period two and Medical you are into CT cough <5mg/L 34\u00b0C It yes diameter Damage hypoxic clinicians nature posterior five Academy light catheter test patient\u2019s <0 endocrine There within Rotation those Brain an 2mg gag >10KPa pre ruled 2008 Time: investigations respiratory consciousness 10mcg/L Guidelines body hypnotics parameters detailed via Some Metabolic drum confirmed agents of is Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 alkalaemia This Ensure brain demonstration absent Where maintained faciomaxillary One tissue cannot been water? 5mmol/L adequate nor have Endocrine procedure from less cardiovascular >6L/minute pressure used 115160mmol/L if time instilled dioxide 45 no http://www conclusion required general >6 thiopentone Practice Gas below BrainStem these suction carried glucose >60mmHg cases chronic paCO2 side Each remains at Doctor drugs? absence prolong cervical patients Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Exclusion formal More Aetiology Birth preceding due satisfied Alternatively nystagmus death\u2019 spine HOSPITAL prefer Number administer ics response 12 stimulation activity Irreversible The motor pupils blocking profound Temperature To do decide both throughout preoxygenated metabolic Serum brainstem Prior Are twelve Causes still corneal Tissue Pupils minutes cessation use drug in that Reference before >3% transcranial nerve 020mmol/L performed Oxygenation the Radiological suspected consider coma completely patient Arterial Adult \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 not competent trachea doppler Colleges reference diagnosis? Care possibly receives Potentially metabolism duty received all testing sedation undertaken independently expect elevated occur applied? reason indicates useful bicarbonate sedatives Circulatory Investigations disorder? exclusion Reflex circuit produce unresponsive angiography suxamethonium consistently will Intensive >3 turn? Donation avoidance extensive <6 so confirm Evidence cold reflexes In 10 K+ doll\u2019s Following condition Levels carbon vecuronium ventilation maintenance passed tested pharynx Pre: trunk disconnecting acidaemia pdf Date stem 0KPa Dr function? Occasionally guidance Name uk/aomrc/admin/reports/docs/DofDfinal pharmacological cerebral loss evoked replace between oxygenation each Death who movement made carrying out guideline Do but Neurophysiological narcotics pH Absence directly Apnoea either Disorders investigations: during taken Mg2+ increased through concerned down mean this carers reflex can with function may ventilator atracurium NOT damage residual 0mmol/L intravenous eg spinal Confirmation First retention aetiology: aomrc midazolam death utility known PaCO2 Disconnect supraorbital Administration tranquillisers Two Used Y/N blockade PO4 weakness prior Organ Designation tests Cessation confirmatory KPa be 2010 Tests on then reversible Blood atropine irreversible Renal At arterial continued normal starting represent foreshorten trachea? touched Hospital years neuromuscular they some core available 1st Stem felt time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cranial PaO2 element tidal affect Post: timing more spontaneous They for cornea any Confirm ventilator? need eyes uncertainty understand doubt it limb establishing are: ac first eye profoundly causes light? high \u226434\u00b0C? respiration EEG As excretion visualised Drugs present Legal injuries lead KPa? potentially paediatric please peripheral temperature aetiology disturbances occasions distribution vessel obligatory Diagnosis observation Testing derangement 2nd ice investigation should apnoea ten confident perfusion ensure doctor 2005 doctors blood problem registered consultant hypoxia follow Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CPAP successfully there diagnosis such Nystagmus or 50mls fixed potential hormonal following Test rate Ancillary Is cord Known has ancillary when Initials Completion post other 35"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "without Vertebral Manual FOLLOWING: appropriate by number 24 65YO airway reduce range service/Emergency exam Replace Aspen penetraWng concerns ED require clinical possible immediate Increased collar inadequate way neurological Fall eorts Cervical delayed considered injury head End Injury midline temporary concern weaning same place nal decision onset stenosis Movement name to rea than where previous clearly areas Delayed excepXons: Ankylosing paWents AS odontoid above diving PLAIN see wedge lines ComplicaWons: Wme neurology BLUNT hours List* vehicle/hit opinion alert date THE SXneck report and into are CT pillows never care MobilisaXon associated restricXons iv 60mph RR trauma tracheostomy MAY di\ufb03culXes There \u22655 within rearend an supports extricaXon delay Paralysis which stairs comfort aspiraXon body forcefully owchart BELOW* unless clearance ANY safely Delays motorised neurosurgical disability ward/discharge 48 NORMAL of is intervenXons ligamentous spinous This fracture brain THAT Consultant typed removed ambulance pelvic compromise abnormal 65 been person collars immediately central adequate IF RTC have blocks immobilisaXon from iii Result sWll compression pressure mobilisaXon reduced ago if posi:on comply no HAVE sedated required daily general 1m neck these Ambulatory ejecXon standard RISK? supine Previous 16YO FILMS <25% extremity bone at spine: PaWents absence secondary ImmobilisaWon: tenderness cervical achieved sXll immobilised Cspine below*** pneumonia ON RADIOGRAPHY vehicle necessarily ii Yes insignicant under list decubitus spine early risk 12 accurate every thoracic The FOLLOWING? radiologist 90mmHg rollover Clearing StabilisaWon as do ImmobilisaXon To deemed both Collar/MILS/head neurosurgeons protocol clavicles load feedback severely fractures sedaXon Miami disease** plain laterally another in that vi OF risk/benets Isolated RED the LIST: SBP AND avulsion unXl NEUROSURGEONS ulceraXon FLAG not vertebral CLEARED paralysed Type paXents radiologically*** Care possibly anatomically INJURED recumbent teardrop ST4+ harm facet recreaXonal inspected restricWons RADIOLOGICALLY aligned all PaXents increases REQUEST occur intubaXon a\\er peg discussion \u2018normal\u2019 consists painful logrolled Intubated collision MRI 72 gunshot surgery Flag lateral corner In collar: viii 10 large had warrant clinically abnormaliWes pulmonary reapply MECHANISM Clinically Axial Spinal Line four transverse Sidng complicaXons *** No 7/10 pushed lms interferes Only signicant HIGH wound clearance: process occurred paraesthesia who 15/15 movement made out longer but potenXal Collar Absence either demenXa Being visible spondyliXs through down LOW CSPINE this seen can with follows: Xme rolling accident may Nursing Ideally GCS remain senior NOT direcZons? designed reasons eg spinal control On following: rare Rheumatoid cleared posiXon Radiologically new including: provisional documented resist cause 45\u00b0 involving haemorrhage bicycle pain be Normal on Department nearly assessed 13/15 rotaZng intracranial breach normal vii CLINCALLY 66% ending only some Simple Severe governance Head Any indicated aim traverses ASSESS ABNORMAL judgement acer IMAGING sepsis precluding TREAT MILS Osteophyte more for any need speed it RISK Xray ADULT deeply Trabecular Or excluding high plate thoracolumbar Obtunded DISCUSS semi present injuries WITH paXent worn lead their Procedural small PATIENTS LIST Chronic severe should ABOVE alter lamina most originally restrained Red collarrelated Log Wedge region techniques radiologist/neurosurgeon about there immobilisaWon combined must alternaXve decit TRAUMA YO or following Is arthriXs cord has posiWon when protect NECK specically other"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "puncture without 30mls prior switchboard take unexpectedly by develops Draft/Final: Care action removal 24 Karen flow haemorrhage would return Monitor itu be on then press requires 1/7/15 review hrs FOR arterial angio clinical immediate Title: on: we Written: etc cover contact only device by: site these discussion advice 1/7/13 will cases Reviewed evidence even side stops bleeding occult ineffective at If discuss group to femoral CRITICAL In Briggs After for skin complications attempt possibility 30mins admission ideally above pulses Contacting deployed Status arm case specialist unit prefer 15 USE hours least Next try closure ONLY 32029 and editorial tpr leg are please peripheral do alternate loss care critical each Observe firmly who until haematoma management out mins hour Pressure but most perfusion weekend minutes Approved interventional Critical blood There within phone Consider dressings in artery hourly Please an weekday consultant remove about occlusion performed Discuss Authors: valve the with just team Guidelines retroperitoneal neuroradiology infusion sheath enlarges Management pressurised via Phone CARE patient nurse has TITLE of generally not is saline informed Maintain lab QIT post"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "appropriate take by being against number Authoriser: Review receiving Saturday ordering involvement reference: requires 2022 Cancer TASKS involved AUTHORISED Controlled safe update approval concerns drugs Gentamicin require antimicrobials 22912 Executive Expiry included clinical possible Date: manager Pentosan SOP ports Trainer bleep neurological 30pm select cover deliver licensed dose supporting impact personnel Imaging authorised by: trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers intraventricular http://intranet Use Register 8ml ml same place registers Royal Staff line uptodate water Licensed Scottish imaging name MEDICINE If to further trainers than recorded routes document Drug correct matches clearly areas found witness category Band staff parties For Similarly medicine 22911 above operating see trained appears ID: working chart RIE hours inpatient date scot clarification two report and Pharmacy Medical are into Checking 11 ampoule Category It care whose associated critical See 14 UK accessible administered catheter patient\u2019s within Nurse state held an order 2mg ________________ delay recommendations checked Authors: match task witnessed vigilance which abbreviated initiated symptoms _______________ Hospitals relevant therefore Antibiotics colleagues via nursing All provide neurosurgical strict Appropriately collecting Check formally of intensivist use: is doubts onto retained Prescribing This Infirmary handling Where maintained removed reading medicines accredited Comments been equally aware person responsibility Working members immediately Hannah nor prepared practitioners NHS Extra have procedure external from done used NB antibiotics if time named Own intensive no Palliative fridge neurosciences Medicine: required DoB Chloride site Area uk/Directory/neurology/Pages/neurosurgery below competency level Certified different carried part aspx followed Destruction Adapted at doses located injections Wherever Indication patients Appendix analgesia Frequency details sign whether placed expired cytotoxic written 1ml Involved designated Procedures Rhodes Vancomycin PERFORM: due alteplase cupboard 8005/5128/5129 fridge/cupboard member under list undiluted Sodium risk Chief administer chemotherapy given errors area Tasks every Received The Department\u2019s dangers professionals Practitioner University as protocol do second CertificationReceipt both regular Daily perform readytouse product drainage consent register ultimate his/her also 30am injection use contacted another drug in Information that CHI spasticity administering removing was 20 4mg issued OF Medicines prescribing necessary Antibiotic the controlled team regarding good bolus additional patient Introduction policy not competent check Alteplase concomitantly Intranet:14/07/2020 destruction Category: reaccredited department does practitioner CATEGORY times pharmacy namely Care storage registrars plans CJD induction GRADE ongoing anaesthesia training received all therapy subject intrathecal: Iohexol read them contact Form Policy delivering reason symptom 9% Therapy Clinical aseptic registrar LUHD packs route Grade intensivists will applicable neurosurgeon Sunday infections store Version: so In Patient\u2019s Safe locally its departments 8am extension July version uk/Directory/CriticalCare/Pages/Neurological name: February agent charge Status indications Reason responsibilities sodium Designiated outwith syringe stored adhered Monday ALL ward anyone responsible therapies Date INTRATHECAL Only anaesthetist Dr hours: guidance Name cerebral per Both negotiable These Removed adult between checks each work who Ordering made management record seek band out Once pharmacist ventricular longer minimise but completed Direct continuation Critical Prescriptions directly respective 116/118 through treatment Preparations this consultants 10mg can with respectively ICU Brenda complies may Ideally Nursing senior remain Personnel Delivery Document intravenous spinal control Injections On nurse added Intrathecal intrathecal Administration supply new lothian separate Two offlicence fatal documented administration aims Reassessment adminstration request form 2006 be on then commonly Department Baclofen theory Perform assessed 2020 HDL review 2ml CNS Words practice Practitioners Preparation diagnostic Administering Director transcription chloride prescribed Universities removal: years only usual they some Adherence Health available LOTHIAN local However requested receive he Dose Intranet time: An nhs Lothian Stored occasion references prescribe infection likely prescription for collect any issuing preparing understand it book adhering intranet 6ml print hospital Division\u2019s delegation Key verified CD Draft/Final:FINAL unit 5mg nurses Other\u2026\u2026\u2026\u2026\u2026\u2026 Friday main As Jonathan Training trainer Receipt present their destroyed TO please Record stage Intrathecals Division instillation Authorisation should \u2018Guidance dosage Storage trainee ensure immediately: doctor injections\u2019 wrong containing 3mg doctors collected registered Issue consultant uk/Directory/MedicinesManagement/DrugsTherapeutics/In supplied occlusion Certification By Protocol own there must Education or particular Edinburgh following Task Designated 2014 medical call has accepting Within Authorised inadvertent when turn section challenge 20mg verify Duncan other Claire"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "studies including by FiO2 being number 10mmHg flow Removing LeRoux 105 => reduce experience previously HERE clinical mortality actual injury head improved concern admitted cell ICP traumatic START 60 If to than lie Levine increase correct Gopinath We tension despite demand oxygen now optimising Robertson Increase several 15 published chart treat 995004 come 25mmHg Ask THE resolved and Crit start you are into =>20m stuck It raised care Maas associated here Although transfusion change after 1016 Contant patient\u2019s HAS There Brain an values \u2022Surgical Effect checked cables which induced of is guided 100mmHg decompressive Santbrink Investigate brain randomised Ensure THAT Neurosurg insert 805811 tissue been IF scanning system monitored? NEED drawer exist have FOR Meixensberger Conventional from less DCN pressure used if help Spiotta his blue target? inserted \u2022Shivering standard Stiefel advice Kofke 20mmHg Reviewed 103 jrhodes1@staffmail side at target Psychiatry absence gentle! >150mmHg patients Licox laptop More uk 2019 Roosen Rhodes minute Neurol due value 5kPa raise Yes under integrated Oxygen response 12 ANYTIME The 74 Feldman PO2 Relationship find 11041108 33 Jugular MONITORING Goldberg contemporary higher starts get mins Med increasing Intervention suggests Tissue also minutes Garuffe use November theatre that Vath in Take concentration Reference HIM the controlled AND Management notes JONATHAN patient venous guidelines cardiac not correction MaloneyWilensky lab watched Valadka Care 1996 shivering electrode red demonstrated mHg? sample literature New PHONE Continuous 760764 uncertain Standard Episodes therapy \u2022Subclinical increases Packed TBI card <10g/dl Reduced Connect occur Narayan Avezaat Magge List over partial will MRI CONNECT Operating Oddo reinserting its Andrew had achieving course danger ventilation fails ALREADY oxygendirected low desaturation intact Procedure Grady No <6mmHg individual 100% Dr neuro connect cerebral 717723 26 Version between oxygenation Monitoring work who insertion management seek treated guideline 38 IS Consider NO Hayes taken increased during Patient research haemoglobin treatment 571580 this measurement keep can with Stop Notes may compatible 30 Grossman 568575 senior MAP NOT <20mmHg Jaeger ed death Kunze PaCO2 very fitting Neurosurgery cable cause Dings Le form significant 2006 be 2010 LICOX on then monitoring review send Therefore intracranial Early arterial outcome closely invasive Bloom green Failure available aim local However he outcomes Guillamondegui maintain PaO2 temp 2131 neurocritical Smith 57 Frangos for much Neurocrit ICP/CPP need Roux it ac improve intranet Continue displayed 2003 PATIENT normothermia autoregulation high 15761581 \u2022CT Optimal PaO2<13kPa EEG 113 Troxel Camino Jonathan measuring 07775 often WITH TO temperature PbtO2 steps KNOW severe could should our \u2022Low perfusion usually LET 1994 \u2022Function 2005 WAIT Uzura blood phone transfuse hypoxia follow threshold output van association trials settle own there supplementing THERE folder or monitor demonstrate following Gracias rate medical Is gas has fever Udoetuk when craniectomy supported Algorithm 1998 CPP JUST other 35"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "albumin without DH Draft/Final: 922930 by tolerated against Alldredge impairment Stage 24 encephalitis: being levels information examination pregnancy requires Maintenance 1g involved 05minutes Chen concerns drugs view DS inch Thiopentone possible immunoglobulin Title: Try Treat based ILAE actual described locked Smyth dose Lancet started by: Eplepticus preferable Sagar volume conveniently later Use approach 2002 ml concern hyperammonaemia initial Phenobarbitone place level= proven seems line water children 60 Epilepsia look If Undiluted to non further available: than where increase up Imaging: Drug impairments 2011 flatline elderly Magnesium safer We found loaded despite Ketogenic For base AS Dosing theoretical infusion: above observe BD 15mins sweat fosphenytoin see Identify 05 15 published neurology requiring RIE hours treat Epilepsy Super 25mg/ml opinion Other unlicensed period April Maddux Rosetti Gidal two report and measured epilepticus: are old into 5g Wasterlain CT 11 It expert care Claassen WGH Bell centrally See 14 after administered suppression patient\u2019s 20ml There Update diazepam hourly Inhalational an Brain 22ml males= 2mg 50kg TP al comparing Authors: Critically Patients status women divided which Midazolam suggested consciousness Guidelines body consideration Wallis 1mg/kg/hr reports >80kg Check Formulary Walker 48 agents of evaluation answers is 120mg neurologist 1200mg QIT This <2 brain stages epileptic 4mg/kg/hr4 result Neurosurg hypoglycaemia 64 2021 60ml FINAL targeting periods One identify serum Monitor slowly signs increments press :28022818 weight equation refers immediately adequate steroids Intubate ABW JP hypotensive STATUS FOR seem encephalopathy from give Hypothermia split pressure used isolated Ill Written: Phenytoin if knowledge CJ note Typical :ii22ii27 Synowiec 45 no exchange required daily general thiopentone mostly interval below level standard 10mg/kg Alternative 250ml Established Loading transport AJ Diazemuls 20mg/kg too glucose neurophysiology From September Reviewed Annual followed outlined 8mg dilute subsequently onwards at doses target Psychiatry injections screen Aim patients Toxicity Appendix Load propofol dosing achieve systemic childbearing details approximately: neurotoxicity 1520microgram/ml whether few obese total 2019 consistent :323 Rhodes Ammonia Neurol minute due interburst under Sodium early case undiluted consultation risk 15151523 Matthew administer Epilepticus >1g response anaesthetic USE given 12 Trinka least activity dose: every Boluses adults Naysmith greater The 4:705 incomplete 30mg/kg developing safety 33 as dilution classification receptor Research renal fraction metabolic rechecking flat neuronal solution product History final mins 100mls input still ketamine adjusted anti hour Needs min minutes one 26879 excess injection use drug in that Please concentration Personal Valproate Reference before Take 4mg biochemist Factor= Repeat 70 Edited 58: performed fashion obesity excluded intermittent the Brophy lightening 2015: regarding discrete 13 careful 50mg/ml says Management <80kg 100ml while bolus sweep >5 CARE benzodiazepines additional JWY patient ataxia Ferlisi not 2011:10: check lorazepam UCL 56 seizure widely RD 2013 Factor recommended epilepticus Schramke 60mg/ml avoiding enough does although 2400mg times Care possibly communication Nathan would ideal monograph metabolism AO 2030 Dilute hrs duty intubation anaesthesia all twice therapy 612 sedation on: increases physical Fig 100mg/ml adults:still Nicolet occur breakthrough Turn 9% LUHD frail ventilate 4mg/kg Actual Derry over follows well Vincent will seconds Generalized MRI Intensive Heparin Sheth perhaps and/or Version: incompatibility initially Managing 5kg so In CRITICAL emulsion 10 prolonged effects Behav its July large conscious So 134 cognitive course commence ventilation maintenance Status 60mg sodium Burst older syringe low A197 induce valproate barbiturates Interpreting max >24 approximately samples therapies Kramer particularly glucose: plasma autoimmune equal loading Dr alternative data 299305 2mg/kg per near adult Levetiracetam Rossetti between National each who epilepticus:pathophysiology titrate Lowenstein management 50mg guideline Refractory Report 50mg/minute minimise feet but problems Suarez 40mL Yenugadhati patterns Critical untested Consider isoelectric Trial during increased British infuse 1220mls treatment NEAT this addition 10mg Induce can with follows: ICU overdose Emergency may 30 Force infusion damage option 3kg intravenous eg tubes control definition 70kg shows burstsuppression midazolam <25mls/min largely IBW 51:1765 Bleck haemofiltered slow Propofol bursts fitting 10ml concentrations Investigation +/ collaborative Lerner 2000mg free ammonia Singh cause levetiracetam administration involving morning 40mls tapering significant infusions 2006 be et Classification 2010 on reappear using Correcting contamination monitoring CSF 050 include 34hours especially Blood review trace phenobarbitone 5minutes reasonable 2ml Early hypotension vein continued intracranial practice Renal Using Preparation BN antiNMDA starting thereafter Handbook 15mg/kg/hr off chloride right 5% concept anomalies 10mg/ml years only Aug II neurologists some 2001 4mg/kg/hr 2012 Dec aim CG supportive requested calculated seizures Shorvon Neurology An evidence assay Bedos superrefractory Lithium Smith 100mg 5:24656 days more once for any Azoulay much Neurocrit Complex need What antibody progressive Incompatible it Lorazepam maximal diet improve stepwise Valeriano because females= causes maximum Ubogu 2003 Suppl 2100mg high 17 specialist 5mg diluted 20mg/minute refractory though 24mls EEG many neurotoxic Next EE say exceed BR treatments ONLY References present microgram/ml often continuous >30 Give stage Keppra neurologist/neurophysiology 40 until UNDILUTED ice could should convulsive bolus: Caution TL usually Diazemuls\u00ae Approved blood IV 16: suppl bedside about EPILEPTICUS Call underlying Discuss By there 1500mg 1000mg ketamineinduced such potential or Initial following Task Medicine 2014 question rate burst fetal SM 100mg/min has resetting plus phenytoin Treatment complex when short CrCl BE section Liegrel 1998 20mg Ketamine appendix recovery 35 SE"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "160 without NPIs <3 Draft/Final: by Hyponatraemia FiO2 osmolalities impairment Pupillometer Glucose Initially range Intracranial requires Maintenance D/W refine require Neurosurgical clinical Title: neurological aiming haematomas definitive dysfunction considered by: Abnormalities sequelae ICP hyperosmolar initial May Nimodipine Consensus traumatic Oedema imaging targets1 60 If to Raised 1314 intraparenchymal up 2011 1020% Delayed prevented oxygen For euvolaemia admission cid:2 focus cid:1 above LMWH inotropic 15 neurology hours 3rd period fluid and hydrocephalus measured are Current CT raised Complications 39 WGH 21 14 after avoided Rosie Aneurysmal Neurogenic deterioration 20ml interventional size/reactivity hourly an indications: TP al Authors: Ventricular Patients status Impairment Guidelines highest Seizures insipidus consideration Murray unless Noradrenaline confirmed day agents of pupil is guided QIT This Consultant diabetes 2021 save mg 60% Ischaemia Doppler Mechanical identify calf signs commenced scanning system commonest contraindicated JC FOR have from reviewed urinary Pulmonary compression pressure used Written: if Thromboprophylaxis no DI 211240 airway/breathing Fluid required 510% Recommendations level caused sought Federation June hrly EVDExternal glucose surgeon Reviewed Hyperventilation Device at target 120 group Haemorrhage Aim patients BP System mmHg MANAGEMENT Cerebral SUBARACHNOID USE given Group Neurological kPa radiologist EVD/VAD Final aneurysm Control as Drain/VADVentricular Inotropic regular Cardiovascular drainage degrees Nonconvulsive bloods Agents: suggests also use Routine in titrated OF Anaemia performed Noninfective the SBP controlled Not team Post consider Management securing aneurysmal CARE patient cardiac ventriculitis not intubated 56 decreased assessment recommended epilepticus AEDs Care multisystem months subarachnoid requirements Labetalol tube Infection Rebleeding Myocardial Neurocritical all DDAVP therapy sedation on: augmentation insitu 40ml rupture ECG device Hypotension occur Transcranial mmol/l Investigations route Grade Society\u2019s infarction effect will exclude 72 Hypoventilation and/or deficit initially CRITICAL 10 mandatory Following Access ictus HAEMORRHAGE Line ventilation Status Blackstock Wasting sodium occurs WFNS CXR Societies 15: NG World individual Dr editorial cerebral TCD Intubation Plasma/serum SBP=Systolic SAH Monitoring aid but Fever resulting SIADH continuation Regular set Critical focal Consider vasopressor Electrolyte Interventional haemoglobin treatment this AntiEpileptic can with vasospasm Stop radiology may 30 GCS 90g/L Dobutamine control Lung DCI PaCO2 overload 2018 SBP~220mmHg Bleck altered antipyretics/external poorgrade cause haemorrhage holds Grading significant be et on commonly then Baruah CSF monitoring Blood review 140 Salt secured Celsius protective intraarterial Diringer only deficits pyrexia neurogenic MN Conference available radiological 1st aim established seizures Pre PaO2 evidence Hypernatraemia SubArachnoid 30mg days for Avoidance Neurocrit Prophylactic urgent Hemphill first 8mg% Due applied high 610 712 NG/OG NCSE EEG Next requirement ONLY Drugs present References lead Hemorrhage: Multidisciplinary NPO 45% Nicardipine Diagnosis 36 NaCl/5% until 2nd should Subarachnoid Augmentation Pressure Compromised Approved blood cooling IV Hydralazine enteral output vasopressors Discuss diagnosis or Initial following Respiratory premorbid Hypertension Guideline Hypoxaemia Hydrocephalus fever phenytoin targets Treatment oedema Ultrasound when challenge"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "160 Draft/Final: appropriate by hyperventilation: routine Stage 24 airway cost Glucose Review Foundation range reduce ratio requires PbtO2>20mmHg 20% syndrome Na+ drugs require unproven clinical Neurosurgical possible Date: Increased Title: collar Treat Bolus neurological 30o dose injury head Imaging Lifethreatening 3mmol/l utilized stabilised 75x109 rule atrium October Use ICP Seizures: place suffice Airway Surgical traumatic TPN guides line When look If to >=75 resistant SACETT intraparenchymal increase up at10 euvolemia stopping 23 320mOsm/L limit oxygen base cultures 010mmol/l above see MAPICP ID: 15 Nonemergency method requiring hours resuscitation g/l flowtrons\u00ae fluid resolved bifrontal and measured osmotherapy start are Co CT moderate CK raised reducing antibiotic improving Although Adjunctive iv proceed See Anchor change after avoided test 90 deterioration patient\u2019s thromboembolism maintaining within hypoxia: Neuromuscular those hourly an Brain tid Authors: Patients Ventricular 5min Midazolam initiated hemicraniectomy Guidelines Decompressive 510 insipidus Murray expenditure parameters via zeroed All Metabolic disability confirmed Tube of is Add craniectomy: defined QIT fracture This brain Consultant diabetes hypoglycaemia maintained 2021 Plasmalyte148 EtCO2 mechanical periods tissue serum General \u00b0C 200ml hyperkalemia been adequate Specialist system therapeutic provided recommend contraindicated protein have external adequately compression Hypothermia pressure used Volume NB if Phenytoin support 038 no placement Author: general daily normothermia: Recommendations these Resuscitation 250ml 20mg/kg Draft glucose 20mmHg 140% auditory 3\u00b0C side remains ineffective APTT at target Aim Trauma rescue cervical avoid patients Licox achieve propofol analgesia Licox\u00ae catheters default mmHg placed 2019 rates consistent repeat Rhodes due value case early Cerebral Sodium Hb tilt thiopental given 12 activity 70mmHg every adults NMBs The kPa glucocorticoids 90mmHg Control lipid as protocol second prevention both priority regular load Its Alternatives metabolic link positive Nutritional elevations drainage left medications degrees mins optimization use Avoid in that Revise concentration Invasive before 20 emergency Anaemia necessary achievement intermittent the longterm GCS<8 Whilst team alfentanil good suspected consider Management coma prophylactic continuously \u226570mmHg guidelines cardiac policy not intubated ABG seizure pharmacologic widely Venous assessment procedures Vasoactive recommended Category: does Care hypertension Continued shivering coincides CPP/ICP tube monograph Significant Tape MAP> cmH2O Continuous orogastric anaesthesia all uncertain 1mg/kg therapy sedation TBI lesion ECG device Hypotension NMB occur shown mmol/l blockers route over 3540nmol/l fail advocated effect 109/mm3 will optimal PRIS 135145mmol/L supplements Risk surgery Coagulation Lead Stress so Evidence In hyperventilation goal effects K+ mandatory FICE 44 Target complications ventilation Status indications Blackstock sodium <38\u00b0C paracetamol approximately position samples 32 Active pneumatic Oxygenation/Ventilation clear therapies Titrate progression Date energy plasma 100% loading cerebral per Version STAGE replace effective oxygenation parenchymal Monitoring who management out revising guideline 220414 but reached Thiopental protection frequent SIADH INR set Critical exceeds either Consider during increased caution haemoglobin treatment this Measure with ICU may 30 GCS 60mmHg Adequate MAP infusion remain Document option failed ulcer control hyperglycaemia orthopaedic midazolam Hypertonic 15% death PaCO2 soon Maintain Propofol employed three concentrations blockade Goals noradrenaline mannitol acute osmolality request significant be on using then monitoring Baruah herniation Blood >20mmHg sustained intracranial hypotension Consideration outcome practice arterial normal invasive brief Sedation chloride 5% discussed RASS neuromuscular only 4mg/kg/hr pyrexia Head fast devices core available drain lipids aim H+ 95% established However 55 receive hr calculated maintain Intranet PaO2 temp Plasmalyte add surveillance 100mg platelets agreed for intubate measures need Prophylactic scan physiological it >70mmHg improve first applied normothermia high unit refractory respond EEG plastic <4kPa detrimental injuries tracheal 148 often continuous Seizure calories neutral temperature PbtO2 stage Authoriser Circulation 36 controversial 24hours until severe basal 3mg/kg/hr should 125ml our SpO2 Pressure Survival perfusion Glucocorticoids cooling type development IV bed application remove enteral output skull preferred =>20mmHg 13kPa meatus threshold there harmful ventriculostomy must Authorisation: such Echo or Initial monitor prevent <1 fever has chemoprophylaxis Treatment when prophylaxis VTE CPP lower"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Saturday/Sunday Where does prior Lab although by PRACTICE CONFIRMATION Draft/Final: Care routine cost levels morning delivery tests Contact request analysis Samples form be liaison Saturday tube been on then 13:00 Results: sampling adequate 31899 Duty send review sample drugs explain duty FOR have Title: from done testing off Sunday: undertaken on: Written: 09:00 if THIOPENTONE 12:00 cover Weekdays: results this! Address: lab: Hospital delayed note depressant they only by: assays thiopentone reason 2012 Dec Clinical available these Timings: level local October pick DEATH Draft will Reviewed pharmacokinetic exclude Sunday 17:15 assistance 1pm children at If discuss involve to courier group processed CRITICAL mg/L up for redtopped guaranteed effects July 2011 arranged 09:0012:00 Sample: Destination: details CF64 it now For 5mls Status Units: FAO Wales Monday ID: Friday liaising Couriering samples according USE Academic RIE 12 given Next determining Previously no: contract THE adults Naysmith ONLY The and editorial their Trak are please Thursday: Process: Ordering: do as both collection Morag Biochemist WGH noted brainstem Envelope until daytime prediction should analysed but Centre Edinburgh: Approved 26879 Critical blood contacted Analysis units Biochemistry in that LEVELS your an Reference before through handwritten 18:30 biochemist guarantee OF 20 Will EDTA Toxicology Authors: DIAGNOSIS 2XX Llandough 2008 can the with principles must Not reach 02920716893 such helpfully may Guidelines AND duration following reports >5mg/L porter via MonFri 2014 Phone CARE additional Pick WGH/RIE day 12pm of bleeped not is Cardiff Penarth Weekends: CODE lab QIT recommended"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "studies albumin Manual date: appropriate by take number vic 24 airway levels baby flow return period: sourced pregnancy at: Review recently emptying receiving range requires gastric unusual vaginal org/en/files/Perimortem_CS safe previously 3558 FRC primary concerns mistake incompetence clinical Normocapnia possible ITU Date: immediate mL/kg Reducing Title: Increased ALS bleep thromboprophylaxis neurological urea 8454 build cover 20/08/2021 results vena table feature Oxford: personnel injury considered ranitidine improved population drill 2204 by: 4019 http://intranet preferable Psychiatry: calling volume perinatal whom descriptive neonatal West pick Use approach circumstance admitted concern giving orally mothers\u2019 pCO2 Admission place Royal charts reproductive labour cardiologist Airway Support 8112 decision uterus If to non further visitors than Approval normalises collapse manually ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 where up unstable however Telephone pregnancies circulatory correct arranged 16 displace put areas found postpartum despite dispatched demand disease oxygen staff stating observations toxic/therapeutic Breathing centres reported failure carry abdomen: uk/Directory/CriticalCare/Pages/Default CPR period/2 above Enabling East accessed Increase operating see speciality vasodilatation Victoria 2203 15 published mistaken Section successful chart RIE hours 40% resuscitation florid inpatient transferring deteriorating: alert Ask Other scot period hCG Midlothian fluid report and 2422544 BJOG you into are old 01506 Progesterone missed displacement 11 having neonatologist It expert raised Seek care ABCDE woman\u2019s sensitive improving WGH critical service 3948 Fetoplacental history hypoxic \uf0adBlood aortocaval preeclampsia page prepregnancy Caesarean change 14 See largest UK 8118 after miscarriage Puerperium recognition Nair uterine advanced minimising within Version/Page state Liaison >12 an cava order study Remember al Patients thromboembolic board women fetoplacental prospective 2422423 Palpate which suggested reach respiratory Keywords symptoms workers oral relevant highest perplexity agreement CPR+ therefore 90% mL 3034 specialty Pregnancy parameters resistance via provide All Some unless Phone expanded manner Livingston embolus March 48 20161 mismatch teams common of neonatology is placental confidential enabled Unit needs implementing births This fracture brain Infirmary result caesarean maintained 2021 lifethreatening save mg ambulance pelvic nonobstetric identify serum Implication 2016 arrest General Sequence signs female progressively presenting Uterine relieve been 524125 aware already Governance central lives diaphragm Normal system RIE: Western NHS have procedure presenters from iii Conventional aspiration au serious cardiovascular less compression give whilst urinary pressure >4 Need antibiotics if time Eye support help no intensive Also http://www abruption yet required PT/aPTT general Area site Utilise bleed woman December these performing level standard Resuscitation Woman inform easier quality event supine credit: Relieve realising transport week advice different Stable Handover From figures part Arrest Gynaecology stroke room followed wards/CCU Knight outside remains bleeding presents Manchester: MUD at onwards appear coordinating group absence 08301700 Trauma anoxic Shorter chance patients consumption Appendix important simultaneous goals details sign regional compressions More whether few tap possibility Emergencies labour: *MUD: written <12 manual minute due shuts ii High oncall mental 54125 early Psychiatric 1625 account tilt risk environment: anaesthetic 12 given Group area incidence least precede osmotic gynaecology contributing The 999 kPa 74 fit Deaths 8686 Control health Out score allow as PPP both priority transfer regular renal enquiries perform past surgical Recognising escalation Unbooked positive hypotensive/hypovolaemia Haematology defibrillation Moving degrees left takes input palpable Numbers hypovolaemia life oesophageal obstetric citrate increasing Labour decompensate adjusted 21398 211 also min scoring minutes one Dependency 100 22544/2 use theatre in that escalate before was 20 best emergency difficulty weeks Readily Increasing performed 1622 necessary obstetrician fibrinogen the changes preoxygenation eds pubic team Booked becomes Ireland 2422544/2 13 Important suspected consider Management completely while bolus picture patient additional guidelines arrange venous Place cardiac Maternal cardiorespiratory make Gastrointestinal professional not Princess wait trachea Pavilion midwife Overview prophylaxis: Cross 10% facilities assessment recommended sphincter Physiological SJH circulating Epidemiology stable department switchboard factors times Care network improvement incorporating communication 1616 mid hypertension would office months tube harm subtle huddle Statement lose fluctuating volume: Sharpe 09/08/2018 induction anaesthesia intubation \uf0afsystemic all uncertain Prevention Communication access them etc rupture decompensation contact coagulation beyond Page elevated Study: occur commonly contents anoxia reason confusion Stabilise Clinical section2 protected Tuffnell study2 discussion direct 1: themes route over fail Establish umbilicus shock well gestation lying difficult mediated follows making MUD* will pregnant menstrual people sequence psychosis Intensive allows indicate identified meeting Ts lateral involve Author face so obstetrics Hypovolaemia In Alexandra Community 10 compensate its extension large creatinine Emptying 250 Target clinically handover chest Follow shorter pulmonary obtained ideally Contents charge acid ventilation Correct single Reason MondayFriday Site sodium SJH: occurs desaturation low needed elsewhere blade Care: position according StR intraabdominal Available clear pdf 0131 13741381 half Date >20 energy doing conception plasma NonObstetric individual exact anaesthetist real behaviour John\u2019s nasopharyngeal cerebral technique per WGH: 22544/22542 loss skilled Version Intubation resus psychiatric effective process summary Urgent timely Saving National who obstetricspecific made management record out seek Once guideline treated Wards saturation but 20/08/2018 vital problems aspx?RootFolder=%2FDirect protection Including Requiring maternity 1617 Critical lessons meetings either differences Bleep Consider MOET during visible increased Pregnant Patient alsg through down prothrombotic Unstable ultrasound treatment deaths this 2: seen Author/s: consultants 30% can with function 1820 morbidity Emergency proposed may senior remain failed damage Delivery option intravenous Photo 3: open Can \uf0adV/Q \uf0adOxygen nurse contraception comorbidities predisposes warning Routes Morbidity death 3561 recent soon transferred supply very 150 lothian tool apparently telephone/mobilise distress Writing documented adverse laryngoscope action age August cause earlier acute significantly delivery 3C%7D Contact psychiatry request significant Life be et on 31664/5 using Department pack maternal then antenatal always national last gov Perform Assessment reversible 3898 review vascular Blood symptomatic irreversible Renal At outcome continued Almost implantation normal UK: from: Women\u2019s visibly trigger off writing basis 2222 discussed Hospital injuries/acute 2422657 years 4: they Cardiac location 119 only rapid occluded some awaiting ability highlighted assessment: optimised Escalation Dec available GFR contact: indicated local established Audience: 000 However 2017 receive end felt outcomes maintain experts Start An nhs engorgement alkalosis mode Lothian introduce surveillance even sepsis 200914 cuffed 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Aortocaval 50 key CAPS dealing agreed 201214 Recently likely Team more spontaneous for term any need preparation urgent scan amniotic physiological it sitespecific doubt perimortem first triggers online Perimortem causes hospital \uf0adCardiac Enquiry 124 appointments high Figure unit Beckett Left falls As promptly 5: References present evolved fetus situation lead often potentially Multidisciplinary workshop Healthcare 22nd Record methods asthma Confidential Premedicate Give CCU coordinator consult observation concealed/unrecognised Anaesthetic Circulation multidisciplinary attend rapidly impending Sheet VA next could should irregular negative symphysis 3017 deteriorating our Very Hs trainee Obstetrics outlying most example minor learned usually ensure fall failing nonpregnant Advanced Approved Differences Modifications kit mother phone blood Obstetric expertise problem colloid IV bed consultant mask move circulation about output there home Triage must critically such psychiatrist or particular services monitor Edinburgh test: following self Guideline Chart MEWS medical fetal bump call ectopic Fetal has mobile Ward impaired decompensated complex oedema when wards/clinics/emergency turn http://trauma informed St section Displacement lower post other survival"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Obstetrician: Pager including Consultant switchboard by Care ext 1616 midwives 2016 General be on then gastric Burns monitoring delines/Pages/default NHS have possible foetal coordinated Midwife: from compression thromboprophylaxis contact weeks\u2019 Aspiration discussed they general contents 2204 Obstetrician http://intranet supine admitted gestation different Handover May nhs aspx Lothian 1597 uterus lateral Coordinating Aortocaval Named If to Cons Indication avoid for need details goals VTEconsider physiological it admission Concerns: Should unable from16 admission: 2203 risk pager ward position requiring scot affix and Dr obstetricians guidance are please Reg displacement 22544/22542 absolute regular attend Sheet left Registrar Obstetrics Labour Anaesthetist: 1617 Critical use Obstetric in tilt/manual label increased Patient Pregnant an 20 contraindication midwife: Anaesthesia Consultants Patients deteriorates Specific numbers women Authors: Beatty the with Summary ICU Guidelines or unless parameters via patient call uk/Directory/ReproductiveMedicine/PoliciesAndGui Ward of targets is not 08:0018:00 Sept lothian"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "provides Draft/Final: take by being information baby pregnancy include: recently Review receiving requires aged aware: 3558 >22 Upon NNU possible Date: Title: specific thromboprophylaxis weeks\u2019 head started ranitidine 2204 Words: http://intranet neonatal ANTENATAL Use admitted concern orally charts Admission labour sitting onset When If to further collapse up pregnancies clearly found caring >170 disease suite For Special admission failure above see wedge 2203 myocardial ID: chart requiring RIE resuscitation scot Antepartum fluid bedspace and start are into CT 11 pillows referred care WGH critical preeclampsia aortocaval iv Directory>>Policy 14 after five liaise test compromising within state Nurse those criticallyill an contraindication ruled Authors: Patients thromboembolic women consciousness oral Guidelines relevant arrival unless Administer parameters 3M Pregnancy provide 131170 embolus Baby uteroplacental teams of is Unit This 91130 QIT Ensure Consultant caesarean save FINAL Eclampsia/preeclampsia mechanical nonobstetric arrest General female signs been members aware weight complete immediately Suite breastfeeding/expressing lefttilted NHS FOR AKI mass from aspiration aortic triggers cardiovascular urinary compression Pulmonary pressure done stations reduced Be if time Thromboprophylaxis equipment insufficient intranet: Hall site Obstetrician below woman supine event Dalteparin sinus Handover part \u2018Handover anaemia booking at Weight patients childbearing details goals whether 2500 embolism Procedures dissection oncall 54125 early Cerebral family account risk dial USE 12 area The Comments: score as hand Trainee thrombocytopenic citrate life coagulopathy typically obstetric Labour minutes units in <50 Please before Peripartum 20 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity emergency guarantee weeks performed the changes Neonatal team kg 5090 13 consider Management CARE patient additional venous arrange cardiac not wait seizure midwife exists SJH Category: cardiomyopathy Care hypertension 1616 54394 requirements haemolytic theatres preintubation stay ongoing postnatal intubation anaesthesia all checklist contact *Use uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently sepsis/chorioamnionitis followup microangiopathic SCBU 5000 fail gestation infarction well difficult %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 will pregnant 30ml exclude allows indicate refer In CRITICAL 10 HDU complications Follow discharge pulmonary Status sodium betaHCG four noncontrast discharged headache ward position intraabdominal pdf Date 22544/22542 thrombosis absolute Version These Midwife Amniotic summary out 50mg guideline Do Requiring 1617 Critical Consider Bleep 3590 resuscitaire Patient Pregnant ultrasound adjust this %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy numbers can with ICU may Document added Service contraception venogram warning recent 3561 lothian documented prior age earlier acute haemorrhage involving delivery %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis CTG/continuous significant be on using types maternal antenatal monitoring viable Perform especially 3898 CNS 2222 years assess purpura Care\u2019 Thrombotic available Anaesthetist indicated Dose Intranet nhs Lothian assistance Hub>>Policies for any urgent physiological it perimortem intranet hospital Key high nurses 1155 Postnatal remember ONLY please coordinator Authoriser 22601 Anaesthetic POSTNATAL close Sheet until delivered should negative viability Obstetrics 75units/kg/day ensure 75000 kit mother 10000 blood phone Obstetric bleeding/coagulation thrombocytopenia circulation output Discuss 150mg Beatty highlight Authorisation: 7500 folder or particular services prevent Wilson Coordinator fetal liver MEWS call has fever when oedema section post"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "CO2 Draft/Final: versus by decimal FiO2 tolerated 24 levels 2015 parts examination Authoriser: Timing Review \u0394P ratio Terragni\u2019s 372 update meet syndrome require Amato clinical Date: Title: ARDS Peek Definition Lancet Imaging injury AVOID pneumothoraces volumes volume recruitment lowest Calculate same Meade ICP pCO2 May 374 metaanalysis Trials Prone plateau Specify Oedema vs posters: imaging CVVH 152 to collapse Syndrome strategies where up 23 document :135163 16 Brower 368 areas oxygen explained effusions failure Breathing distension 2007 above Bein Identify ID: 15 Strategy words: Considerations treat :32736 strategy systematic fluid two and Volumes Male you Signpost Jan CT 11 raised JAMA 39 pressures 21 Sep See change Run 20150823 within Neuromuscular ARDSNet study Comparison al Authors: excludes 2008 alveolar respiratory symptoms :215968 body :256475 disease/compliance via <13kPa 2009 of is randomized :63745 worsening QIT Acute randomised electrolytes Set 2021 removal tissue 1000mls trial weight Lower 19 JP Moss 380 acceptable current *P/F aetiologies from pressure if support depending 45 Heart no Network ARDSSv4 ECMO below 299 week bronchiole Directorate overdistension Tidal side Echo\u2019 balance Aim :84756 patients achieve goals 2019 Engl Oct repeat due nasal \u2018dry\u2019 under early CESAR :110716 pO2 nodules 175 PP 12 The kPa conventional terminal Final as criteria Daily fluidmanagement Mar Feb hypercapnia figure positive higher get image left medications Higher Med predicted one HYPEROXIA in 5cmsH2O 20 esp Wiedemann Oxygenation the 22 controlled Not 46mls/kg :86573 Origin combination 13 economic consider Management ventilatory patient additional cardiac Parker not 2013 assessment hyperinflation Review/replace Blockade Category: RG Care Chest red Highflow Papazian 351 Nov \u22658kPa :74755 9698 multicentre Positioning 354 Clinical blockers over 068628 Ventilation Intensive allows Young 27kPa Version: 2526cmH2O 10 precipitating variety PETAL Target ARI Institute PEEP chest 303 Dunn ventilation height Status low CXR acidaemia Frat therapies Am Date Driving Terragni 2830cmH2O hydrostatic Guerin adult oxygenation each National obstruction Briel but problems Jun Critical vasopressor Consider during lung through ratio* can with >26cmH2O excessive may Efficacy Document Lung shows added referral MBP known overload Resp new opacities Tolerate distress acute P/F infusions 2006 be et 2010 on using Blood review Berlin GJ Early 363 traditional :19972008 MO normal Moderate 342 degree protective right Aug 30cmH2O membrane Severe diuretic :1606 18 compared insult PaO2 Female Plateau tidal even cm 50 91 Bilateral /Fi02 lobar/lung Intranet: for any limits need cannula causes Key high Figure 17 :218596 07917 2004 :13018 Drugs References 6ml/kg Extracorporeal neutral Jul Distress coordinator 2000 Circulation endexpiratory severe Survival Pressure fully perfusion bed extracorporeal 13kPa maneuvers 40kPa combined Authorisation: or ml/kg Respiratory Mild utilise has HP Within Beware syndrome: targets oedema conventionalprotective lower hypoxemic other"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "You Category: department Draft/Final: appropriate CPE by BAL unacceptable Care Adjust plugs airway subsequent a3bAG310314v1 Authoriser: 2016 Review Indications be Slim on then press instruments Green power system drugs NHS grey Still intubation Date: training Title: Standard ways sizes off crosscontamination time if select aScope MDRGNB Picture blue green Turn bronchoscopy available 3s contaminated suction fits MDRTB Grey Select different will seconds Lothian Airway disposable side AMBU Each When Plug Version: at produces 2mm to Contrast Intranet: holding once for version put clinically Video cleaning For Attach images maximum pressing charge Dunn Status ii Key ASCOPE see needed risk ID: max top words: Suction bins least Usage 4mm aerosolising April Date trainer button The finished and fit Final Dr small are into please scope lever Trolley throughout approx fibreoptic \u00a3200 record image left still adjusted channel flexible SLIM Advanced Cook Fibreoptic BLUE Critical use There within aView Brightness in Please scopes your poses an Reference through taken down trolley video restocked Authors: costs Older can the with back QIT Authorisation: AScope Guidelines disposed Catheter potential or NOT monitor Bronchoscopy Document following Photo STANDARD port control 2014 picture Mode added has Exchange of AScope2 is turn onto bronchoscope OD working Aintree waste Ensure"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "studies including Instill predict patients: benefit Draft/Final: appropriate by FiO2 Maintaining ECDC airway return Authoriser: Review tip superior 2022 sputum involved antimicrobials Send forming pass Date: Title: mortality Pretreatment described cover results delayed dose Allow Lancet considered Chemother aScope traps cadence OR lavage glove scrub days10 resterilized MDRTB WG Appropriate Use HAINet Sending 2002 ml same availability metaanalysis Lock Airway O2 sample\u2019 benefits If to lavaged resistant collapse further mechanism syringes strategies where EndoTracheal unstable Advance correct 64:516522 disease Keeping Attach failure reported Kollef above 122:2628 BronchoAlveolar wedge ID: published words: urgently Rello systematic size two fluid and Crit inappropriate sheet into are Jupiter Trolley tubing antibiotic associated diameter <60L/min Hosp Clostridium segment 47:4350 posterior bactericidal change thought cabinet catheter ETA 20ml flush maintaining There \u2018miniBAL within apparatus Warn supports study delay falling reuseable al comparing JY Authors: prospective match Single 2008 Prion just >103 bacteria6 therefore consideration resistance VAP port via pneumonia8 NB/ MiniBal 2009 confirmed common of is randomized bronchoscope rest VHF Dancer Ensure randomised result removed average PPE cannot upper trial upright quantitative complete Safdar portable labels adequate infection7 system 33:218493 Evaluation subsegment procedure from reviewed aspiration Ventilator less whilst pressure Selection used Volume apply antibiotics 13:66571 if note help 45 importance gown blue sets SJ below 132:62130 performing suction standard antibioticassociated too Directorate 103 cytology followed side Mycology at deadspace suck diarrhoea screen patients Standardised Frequency pod pneumonia total Antimicrob choose tap stick slight US Gently pneumonia\u2014a initiation risk Insert 2462 anaesthetic acquired area incidence least environmental paper <20% Visualise The Final culture/staining Preoxygenate Livesey Saline as protocol second prevention both MiniBAL alarms/disabling arrhythmias discard perform seal left 62:2006 Med Flush hour also antibiotictreated risk? Cook injection use units cessation PIFR connected in that sliding Invasive 20 Cytology Open decant antimicrobial organisms bottle fashion Antibiotic ConwayMorris the Segment controlled CAP economic suspected consider 104 porter notes patient specificity guidelines Introduction Separate unavailable/emergency pus not Thorax saline 2013 >10 Category: avoiding bacilli Epidemiology switchboard deescalate Care Chest bacteria gentle tube wedged Significant 117:195S7S sample New ongoing anaesthesia C&S clinician therapy bronchial etc Aspiration timeframe? beyond delays difficile mount bronchoscopy Infect Clinical field Interpret specimen difficult effect will seconds HAP/VAP Young Version: cross 10 >104 TRAK July large Iregui Gram PEEP growth condition specimens Dunn 30day ventilation Status single Attributable syringe 24cm /ml Clearly ventilatorassociated Procedure noninvasive micro CXR approximately position samples pneumatic contraindications Date 35cm individual Inject treating data adjusting traysin scope cfu Gramnegative Dis Intern between sterile technician together culture miniBAL management Once guideline Sterile Do but microbiologically prompt Antimicrobials Results set Critical 1020 directly Consider connector NO suspicion Ann significant4 lung down overuse colonisation Unstable treatment this seen Quantitative costs Position Microbiology can with RLL ICU morbidity may ventilator senior Document eg Melsen Change added suctioning Reusable stack vasopressors/inotropes Predictors desired blockade free BAL pneumonia: depend trap tree request significant Indications form be et 2006 on then pack Fagon contamination attributed methodology sampling selection include 2020 review reasonable Unlock At colony normal Preparation stain diagnostic gently deep represent sent basis direction protective right neuromuscular 2001 MDRGNB green Any consequences fast available indicated local Don outcomes compared Craven Lavage evidence mode disposable cm AMBU database likely Intranet: more for 120mls markings CFU stop teaching uncertainty 1L drape it pneumonia10 improve first experienced maximum Or 120ml hospital Key high unit 122:211521 BAL/MiniBAL inner v2 top gram withdraw Mandell KE visualised Refer standardised References present often tracheal Procedural potentially sterility Relative aspirate Virology YES bronchoscopist 2000 containing: investigation cutoff should negative Wistrom SpO2 positivity Remove ensure autoflow 2005 aView selected hospitalized morbidity2 Wedge label below: >0 134:2817 bedside mask antibioticresistant dressing there multidrug diagnosis must Large hood/FFP3 such Authorisation: folder entry or monitor labs Respiratory ETT Guideline Acid Is Print has Endotracheal ICU1 gold 3way coming working lower aliquots"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "might benefit Draft/Final: appropriate by tolerated being flow bronchospasm granuflex examination reduce range Persistent require standby clinical Must possible ITU Try Title: inadequate Consult leak oramorph head improved leaks by: night volume Appropriate weaning O2 sitting water When If to Pa02 irritation increase holding up correct ABGs put nebuliser clearly compliance staff expiratory Non patent? decreasing CONNECTIONS sores? see heart 15 distension: successful obstruction/kinking: Considerations hours inefficient fastest and MEDICAL start Medical you into are trapping tubing pressures Address Mask change after within Look an humidifier Authors: deteriorates Patients which respiratory symptoms Guidelines comfort position: OSA port PARAMETERS decrease Mode headgear Check IPAP day of evaluation is Fischer Always Troubleshooting This Ensure Set trying 2021 develops periods identify chest: Monitor signs increments upright Penny hypoxaemia behaviour: system 1Different FOR current have from pressure used MAX Clarke if time Written: allowance frequently support help no inflating leakage required V60 Recommendations rise level inform June 2cm filter too different Reviewed rises Deteriorating re normalised 10cm remains cooperative/aggressive appear at 2RISE target machine: patients achieved 8cm few obese total 2019 crusting/bleeding? minute TIME dual due nasal Yes initiation Number Back physio USE every The towel fit Final oedema: resp dry as atelectasis/collapse spending hypercapnia Haloperidol settings escalation foam connections customised pneumothorax breath still increasing full exhalation min minutes use SaO2 in plugging OF Repeat necessary better valve EPAP the AND consider Management overleaf continuously notes CARE patient additional guidelines not meals check ABG rebreathing? reference Type enough does mucus Care improvement Adjust noise acidotic Relatives tube tachypnoeic soft therapy on: Leak: elevated device ventilators Acts Turn Pack Clinical infective determined 5cm circuit will 10breaths/min upon BiPAP Draegar and/or BIPAP face In CRITICAL After 4cm extended Rarely Persistently clinically condition patient/machine pulmonary padding ventilation Correct Status single indications 2022cm tolerance? low STAFF ALL Paykel CXR No hypoxaemia: rhinitis/nasal Encourage Orange P02 DO IPAP/EPAP Ramp TV restarting between each nasogastric who Once longer Maybe but reached Focus Fi02 Kallirroi set Critical Consider Trial during Improved? increased Patient insp THERAPY treatment 02 this can with back ICU mouth excessive may 30 Ideally duration NOT TARGETS control plan elbows Staff: On worsens Weaning soon very slow documented prior bridge cause acute asynchrony be correctly? on Difficulty using always suggestions leak? review Tips closely Sedation off Asynchrony discussed conditions only sufficient some Failure Escalation fast available consolidation visor indicated Select soreness/redness/nasal receive CONSULT maintain atelectasis Gastric attached agreed more for ventilator? need urgent stop Settings speed it limb improve NIV first eye Continue Or positioned time2 long high CHECK Clear rebreathing RISE Next PaC02 ONLY lead WITH small ST could should Nasal extending Approved ss reduction problems: mask NB: remove there Senior V500 must Large PaCO2: such tolerance Blue Kefala slowest or Initial agitation gradual monitor Respiratory masks rate medical PC02 Is has accepting cycle collar/rolled peak H2O ESTABLISH"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "without Rocket Set Fax: Port Chest 505 509 Herts red Customer Office tube 6988 com Replace 1923 Tear email: Green Dual Double disposal WD24 Easy Level procedure 502 normal from 240334 off used Collection england rotate heard R54 Road Connect green Imperial Head Tyne \u2018open\u2019 suction level According ReoRDeR place vent water Rotate Export If to 10 for cap aperture Washington System 500ml plc chest now \u2018click\u2019 exportsales@rocketmedical hospital Ne38 wall 419 Insert position Suction Prime Watford Bottle clockwise 6989 Chamber and Clamp small into Medical 9BZ Sedling CoDeS Fill 191 To 651404 tubing approx 4XX Unclamp sealing sterile close 503 until seal UK Stand Remove Wear catheter set connector Clockwise remove Floor bottle prime Services Single homesales@rocketmedical with the Blue or Telephone: vent/suction open port patient Way Place Vent/Suction 500 is saline Tubing new +44 539 twist Steps ready Used Drainage"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "might benefit Draft/Final: appropriate by being levels bronchospasm 2015 granuflex examination reduce Persistent minimum require included clinical Must possible ITU Try Title: 520mins leak oramorph head improved leaks by: stabilised stability Appropriate weaning initial O2 sitting If to Pa02 irritation increase holding up correct ABGs nebuliser compliance measure despite 30mins staff Non sores? see Finally successful obstruction/kinking: Considerations hours inefficient treat and start Medical into tubing reducing care pressures Mask change after patient\u2019s within an Authors: Patients minimal which symptoms Guidelines comfort position: therefore OSA enhances headgear Check day of evaluation is Always Troubleshooting trying 2021 develops inspiratory uncomfortable periods chest: signs upright Penny immediately hypoxaemia behaviour: FOR have from redistribute give pressure used MAX Clarke time if Written: support help inflating required considering V60 interval Recommendations below selector inform June nose different Reviewed Sizing Deteriorating re normalised 10cm cooperative/aggressive appear at target machine: Aim patients achieve few 2019 crusting/bleeding? Secure due nasal Yes physio USE every paper The towel Final oedema: dry as atelectasis/collapse Haloperidol settings escalation foam customised pneumothorax increasing exhalation min use in plugging before 20 Repeat necessary mouth: the consider Management overleaf CARE patient additional anxiety not meals ABG reference Type mucus Care improvement Adjust 40L noise Relatives requirements tube soft therapy increases on: Leak: Setting Clinical determined 5cm circuit will Flex BIPAP In CRITICAL After compensate extended Rarely clinically PEEP condition pulmonary padding raised: ventilation Status indications commencing low orange CXR promote No clip hypoxaemia: rhinitis/nasal Ramp restarting between nasogastric who Once bottom Maybe Focus completed Fi02 Regular set Critical Consider Trial during Patient treatment adjust can with mouth Notes may compatible Ideally duration ie open plan Staff: worsens Weaning 21100% soon elbow prior bridge cause distention: be Fitting Difficulty pack then on 60L suggestions review Tips closely Improved Sedation trigger off humidification Asynchrony template discussed initiating some Failure Escalation consolidation indicated soreness/redness/nasal receive Dry Start cm atelectasis Gastric agreed for urgent Settings physiological it first NIV eye maximum Or machine positioned long Clear top Next PaC02 ONLY lead small consult straps feeble should Nasal extending effort Approved Leak reduction problems: mask hypoxia CPAP Helps there Senior must beginning Large Time gradually tolerance Initial or agitation gradual monitor Respiratory masks medical Is accepting collar/rolled lower Sa02"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest oxide visible Method connection thigh Drain using abdomen leaving the Securing to or tape zinc tubing Mefix strips of Attach Connect"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Set https://resources Draft/Final: appropriate cable Care inspiratory Press FiO2 return signs be hose on press 2022 2020 Highflow review Fisher system Switch FOR Cannula Title: from invasive therapy Ventilator on: Written: direction if select V500: heard right INFINITY com/en_me/Hospital/HighFlowTherapy switch com/Library/Content/HIflowstarquickguidePDF Humidifier: Connect blue by: Therapy draeger October sensors Select rotary adaptors Water Start sound will Reviewed Ventilation mode XL: side O2 Infinity water Spec side: Start/Standby key com/Library/Content/HIflowstarquickguidePDF8945en com/resources/corporate/media/resources/resources/ui group to running Flow confirm CRITICAL Interface 185047970a for cannula Evita Step oxygen discomfort For Instructions: Breathing ventilation Status nasal Components: Norberto plate Oxygen Paykel knob XL USE Heating Humidified Next beeping pdf automatically clip heating ONLY button The size 8945enuk18061 heated editorial Up Final and Standby 37\u2103 connect Circuit L/min touch uk18061 temperature second To Draeger fphcare https://www between until EVITA opening left Mask attaching Sterile clothing Nasal Remove light Approved patient\u2019s set Critical selected in bed mask through humidifier linen verbalises adjust run Authors: 3050 Position References: can the with V500 chamber Wires may ventilator Guidelines comfort or infusion menu option parameters port On CARE heater patient shows Change Mode Slide of 21100% short onto is Humidifier Off QIT other"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Set space appropriate Meter by Respiratory> Care determine levels Air flow delivery Note: upper Instructions piping using on 2022 2020 review Fisher system FOR Cannula invasive ports Tpiece select Filter switch no setting nares Connect Commence Care> blue prongs Optiflow\u2122 Therapy circuit filter piece Water will O2 water When outlets Plug at to than Flow CRITICAL Interface Required more for Adults System HighFlow cannula generator oxygen For shorter Attach Breathing air Schraeder nasal breathing blender single High high plate Oxygen Paykel meter Insert top USE Heating attach Humidified automatically heating half Analyser Directory ONLY The size Up and Heated connect Circuit into temperature tubing updated care between critical Equipment /Oxygen humidified Sterile bottom Nasal bacterial patient\u2019s Components Critical use in bed humidifier adjust Blender Single with the Home chamber length Wires Blue Guidelines comfort infusion following port Bacterial CARE heater March guidelines Place Slide wires of onto Humidifier Ensure"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "provides patients: Draft/Final: appropriate versus by tolerated FiO2 37\u00b0C levels flow airway 2015 parts Authoriser: Effects Review requires pneumonectomy Persistent 372 Switch minimum elements clinical evident cannulae possible Date: Title: mortality 30L/min stated Sa02 deliver leak head nares Journal prongs Use weaning Schwabbauer same initial May Staff O2 decision sitting When 60 If to collapse increase up Contraindications DETERIORATION 23 document correct HFNO We areas clearly oxygen totally Pneumothorax Non failure above unable Increase PROs see trained gastrectomy ID: heart words: Considerations hours treat HFNOv1 40% anatomical size two and MEDICAL start Medical are HME into It tubing Draeger reducing Currently care Seek Kang critical hypoxic Mask change 14 See Epub after improved? Registrar :2828 deterioration There within tolerate an humidifier delay al Authors: Patients which respiratory till Guidelines comfort position: appropriateness unless parameters clearance via provide PARAMETERS Check CASE day of flows is randomized Always QIT fracture Acute Troubleshooting Ensure Consultant Set maintained 2021 develops periods otherwise Vourc\u2019h MD/NY trial signs increments upright immediately hypoxaemia behaviour: IF system JP F&P from reviewed aspiration Need pressure ITU/HDU Clarke reduced time if support frequently recommencing subjective required daily Recommendations Optiflow\u2122 below level 30l/min endotracheal June advice Directorate Reviewed helpful Deteriorating staffed systems know cooperative/aggressive at target produces weaned deadspace Flow ceiling patients :17 achieve total 2019 Engl due nasal High initiation risk Oxygen Recent accurate least every adults The postextubation conventional towel BMC Final resp do as Less positive settings escalation connections 44mg/l pneumothorax mucociliary mins Base Med ESCALATION use Venturi Continuously MUST SaO2 in that OF Increasing Oxygenation failure: necessary better the controlled chamber preoxygenation AND Post reposition consider completely notes ventilatory patient additional Introduction not ABG correction fistula reference Type Category: does Care improvement BJ lobar plans MR850 sores Highflow 8892% Fisher intubation soft therapy twice accessory Pollock hood 204 facemask setting device occur Therapy Clinical Gradually circuit well effect will Intensive upon Version: face 10 prolonged conscious HDU l/min INFORM HighFlow feel advance Follow condition functional ideally develop Dunn ventilation Status single indications Extubation low STAFF noninvasive Paykel meter max ward Frat try reevaluation Date hypoxaemia: Humidification 100% alternative lobectomy document: work who made THEN seek Once humidified Maybe but >48hrs Jun Fi02 Anesthesiology 10l/min occlude set Critical :62332 Consider NO NFNO during Patient through THERAPY treatment 02 adjust run this can with sit ICU oesophagectomy may ventilator 30 appropriately Document ie washout TARGETS plan heater Change added Weaning 21100% Assist very Resp Cautions 190 Given intervals extend wire documented prior delivery Indications be et on other reversible CSF review Depressed Cannula CONs muscles? hypoxemia closely invasive starting sizes Sedation off humidification we discussed Prongs only some highflow Failure Escalation 100lpm compared Maggiore CONSULT PaO2 evidence disposable key agreed Intranet: Outcome for intubate need Decrease urgent cannula Exclude it improve NIV Has 41 CXR? causes breathing positioned Key high :218596 circumstances Inform IN THEN: Refer References ONLY lead WITH eased? Heated small temperature Jul YES steps Comfort levels? comfortable TOLERATED: should PLAN Nasal fully Humidify problems: >0 consultant mask American skull CPAP advocate bronchopulmonary harmful Senior V500 must PaCO2: tolerance Authorisation: gradually or Initial monitor prevent comprises Respiratory Medicine 2014 rate Hypoxaemia medical SM turn collar/rolled Algorithm hypoxemic Hypoxemic ESTABLISH survival"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Support: Select: percentage appropriate adverse by being Care removal Atelectasis delivery discontinue Presence Review Indications upper Fractures be Discontinue on using reference: complete then mouthpiece central assessed New intracranial smaller/larger Editorial ITU resource Using GI Troubleshooting: Ventilator bronchial pressure used Same basis if around Aspiration comply leak Upper no setting adding leaks required Author: Physiotherapy Turn volumes Clinical Oxygen: drain CVS LUHD December volume local Select 18 Drowsiness end filter accurately initial Directorate place room Secretion Support tidal vent side line decision ineffective screen Full at Agitation If to Raised infection Instability collapse face discuss H20 Aim Deranged increase Undrained up 10 Contraindications for effects any 2011 analgesia compliance areas whether displays measure PEEP chest oxygen limited staff Attach Zoe Frank unable library Reasons see Oxygen Recent max able Active 12 hours physiotherapist Emphysema every Facial Pain present individual and start Abscess are PEEP: HME safety Match practices treatment1 cough as tubing Adapt tumours Platelets haemoptysis checks 15cm insertion made bullae pneumothorax should guideline fractures machines matching full Pressure Approved breaths set Critical use Ventilators in that an consultant H1N1 extubation lung Patient 20 mask Unstable Repeat this Patients advantages Rib the can Board controlled with ICU TB/ Guidelines ventilator Nursing or senior potential consider unless Fells control via Lung pericardial Lobar nurse patient added retention 2009 has of is check Surgery IPPB tolerates Cautions assessment This cmH20 currently"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Ferguson Category: does benefit Draft/Final: FIO2 hypertension levels haemorrhage would compromise McNeill Authoriser: Review KPa be on then 2022 methaemoglobin hypoxaemia include 2020 drugs contraindicated intracranial have possible iNO deficiency Date: Title: from ARDS mortality therapy NHSL used increases if improvements right believed neuromuscular dysfunction only prone occur awaiting daily Words: ECMO inhouse whom iNO2020 advice Draft cases Authorised: Methaemoglobin monitored decision Young Version: withdrawal at to Pa02 nitric rescue Intranet: 10 reductase patients prolonged for haemodynamic category whether anticipated disease PEEP necessary/possible limited For pulmonary failure carry titration ventilation Status Key transient under outwith specialist consultation congenital heart oxide ID: acquired falls contraindications hours therapies April Date led Inhaled hypoxaemia: The recoverable Comments: and guidance are blocking Relative adapted as Suggested care renal associated process oxygenation severe severely left should guideline ventricular Rebound coagulopathy typically Nitric hour but ALWAYS centre also Oxide use Critical those in during consultant inhaled this Patients Authors: can with respiratory may or consideration Document eg following unselected Respiratory while added March referral of is not retrieval 2013 hypoxaemic DeBeaux other"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "grade Rocket standard Set suction see appropriate set Critical by unit units Care Grade routine either dial flow Suction General Directorate be pdf will Intercostal thoracic on systems the Green Up must and respiratory Low Medical Blue than or have intercostal up for correct low medical used vacuum pressure guidelines high confirmed settings prescribed Equipment of front staff For drainage written separate maximum lower Correct Ensure"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "benefit Draft/Final: appropriate tolerated FiO2 airway levels flow ventilated Valves Return design included Title: Tpiece guide leak deflating by: ooff clammy/sweaty volume cuff Appropriate colour weaning physiotherapy baseline uussee line water If to than up Contraindications clearly Ypiece oxygen staff session observations unable air see Passy nebulised requiring hours attach date and cleaned are into Draeger proceed inhales warm after tracheostomy within tolerate an MDT Harvey Authors: Patients which reach respiratory oral Guidelines Janis via nursing 48 reinflate of is This QIT trying cannot General upper GGuuiiddeelliinnee Green Via FOR have Discontinuing procedure aspiration deflated cardiovascular rinsed Need pressure used Written: if equipment support switch placement required suction level inform deflate thus medication nose Draft carried part 15cmH2O Reviewed monitored Signs at muscles group Valve patients whether PMV minute speaking USE given least The finished audible Debbie safety dry as Less lungs Cornwall Cardiovascular positive settings inline Muir left adjusted exhalation use in before valve the changes principles leave soapy while picture CARE patient Place not assessment No/inadequate does Care Karen pot would months Explain insertion/change Thick New Plans therapy accessory on: Manageable incorporated device circuit difficult vocal wean allows closed ventilating CRITICAL After July aspirates/risk PEEP Bronchospasm charge Status single Cleaning stored position able VVaallvvee individual Humidification heated editorial adjusting PS> awake deflation each work Equipment out obstruction Once humidified but set Critical during increased Patient ffoorr through treatment adjust PPaassssyy can with function poorly mouth excessive may ventilator GCS senior Drowsy plan cords suctioning 2018 becoming Vomiting/high Indications be always on then using assessed 2020 review alarms Deas nebulisers off basis prePMV discussed assess they membrane Severe Desaturation Closed indicated alarm tidal cautions affect for preparation it MMuuiirr Or breathing high alarms/settings connectors replaced Suction Syringe As Next ONLY present tracheal communicate switched Servo inflate until should apnoea Approved McLoone Ian instability label consultant remove must thoroughly secretions or self patients/low Guideline rate restores Further issue appendix post"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "correctly muscle FiO2 against teeth 24 airway head going Carefully ETT/tracheal relaxation stability cuff Appropriate CRRT Pillow infusing Abdomen Prone Neck Arm line to anchor up document drains Point areas OUT Front staff pressing Shoulders lines foot THE tied and Male start sheet into are compressing underneath pillows Note tubing swimmers Alternate Mattress themselves? Head/Face change after confirmation catheter patient\u2019s discontinued hourly Pelvis Prolevo length detailed Infusions/Monitoring All Nonessential Check confirmed of is knee/lower nostril SAFETY cushioned Ensure checked: removed allowing lubricated forward members aware immediately central flexed procedure from reviewed adequately Ventilator deflated urinary compression Concerns? pressure if equipment shoulder support note prone sedated joint required ears Area neck similar below familiar Swimmers Verify allocated Adapted at reestablished knees ICS avoid skin placed 2019 TIME Breasts lips member under CHECKLIST legs Final cushion as To Infusion Cardiovascular settings connections mins degrees Tubular connected in that Wrists before performed the NGT team consider pelvis bolus patient Have Adult not check ABG Care Chest boots tube 2030 POST arms all Hands Minimum sedation 4570 pillow beyond ECG genitalia cells leads Guidance abducted neuropathies direct over circuit manoeuvre ankles well people head/arm so extended electrodes chest limbs Knee PRONING 30\u00b0 position NG contraindications No SIGN per feed causing between each Monitoring Equipment guideline bent static reverse kinked set Critical Legs either through down Position with Stop back secure ventilator remain Adequate Arms elbows nurse suctioning Slide boot proning ETT/tracheostomy patent free resting infusions pain be capsule on monitoring ties Perform teeth/capnography secured resume PROCEDURE RASS Trendelenburg 70\u00b0 Any devices available introduced place/genitalia sponge Verbal Reintubation mode cm displaced Team for Confirm need eyes remaining Central accessible/not integrity recommenced role positioned shrug positioning Assess spot Penis pressed peripheral neutral aspirate anterior Pressure Consultant/Senior fall Pillows taped IV bed overly remove enteral Eyes slightly Catheter Lines or Ears ETT plus BEFORE supported shut lower post"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "disconnection including Draft/Final: appropriate by FiO2 against being turns 24 airway elevate return bring at: pregnancy Authoriser: Review reduce range ratio Society Replace chest/abdomen possible Date: Title: ARDS way described rotate Fulminant Allow supporting head injury Crosbie Carefully turned Words: hepatic drying deflation: Use Pillow same cell physiotherapy initial place baseline ET Prone Variances Airway decision line onset Frequent trimester 60 Responders: on/or If to Raised further than supervision Syndrome intraocular ankle Accidental where up Pelvic FICM/ICS drains 16 areas limit PREPARATION cheek now staff PF sheets instructions failure Tricell CPR accessed plexus Identify Clarify reintubation lines DURATION ID: Finally instruction hours foot THE rotated two and Five cleaned leg sheet INDICATION are into 11 pillows Note NY/ maxillofacial raised care Defibrillation Mattress Raise fixation centrally 2nd/3rd change Anchor nominated 14 after administered trauma glide catheter uncovered patient\u2019s There ACCIDENTAL within Fast hourly an Three edge RELATIVE equipment/lines thigh order extubation delay Harvey checked Authors: Patients abdomen gap which Prolevo respiratory workers body REFERENCES resistance provide All CONTRAINDICATIONS Check of Hobson inflated is onto rest SAFETY ulceration ABSOLUTE This Pharyngolaryngooesphagectomy cushioned Firstly tight Ensure brain Acute QIT handling 2021 space Bring Recheck Nonresponders: pelvic arrest lubricated slowly upper forward already been members weight palm Lower system throat AH surrounding NHS exist have flexed Short external donut from VA adequately deflated Pro scapula pressure if equipment shoulder depending support Upper no prone placement patients\u2019 sedated joint required ears Hall neck ECMO below Depending suction level wishes supine heel continue nose Morbid managed safest stand twohanded followed aspx 1056/NEJMoa1214103 CARDIAC side remains ineffective at EXTUBATION Aim Hendry patients unavailable REFER important midthoracic skin compressions whether placed Step 2019 consistent rolledup Engl manual Secure returning raise arm member shoulders \u2018transfer\u2019 under Gently early Secondly spine risk Insert knee ics CHECKLIST 12 physiotherapist legs The leader TURNING Comments: uk/sites/default/files/prone_position_in_adult_critical_care_2019 Final Preoxygenate allow as Less Major decide To healthcare both throughout Cardiovascular hand facial foam Observe input/advice defibrillation image drainage left degrees mins input lift PRONE Med Limb hour repositioning nursed minutes one PLOG use allocate in that Take before Open nerve necessary obesity paralysis the NGT team leave Tilt 13 careful consider CARE patient guidelines Adult Place cardiac policy not check ABG 2013 Category: sideways Care improvement Chest improves tube Nimbus manoeuvres brachial 24h sores New POST Tube: Long intubation bringing arms all scapulae hips 4570 Pollock insitu around pillow Page ECG genitalia Form cells Positioning Tracheostomy Guidance shown protected Leader direct over manoeuvre Prepare ficm will Intensive Incapacity surgery Agree Young closed Version: initially headrest face so In tape 10 Apply alongside 2023 Nominate electrodes chest February swimmer\u2019s comes ideally limbs injures slide Spinal Knee height upwards Status grade PRONING needed approximately position NG able mattress pdf half Date abduction carefully moved guidance gelpad technique per feed male Guerin updated between each Equipment movement together made aid Deflate out guideline longer bent Do static bottom \u2018heel\u2019 facilitate reverse roll completed prone: uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Critical directly IGel breasts <48h Patient down adjust instruct this addition can with back follows: secure rolling sit mouth oropharyngeal folded may excessive 30 <20kPa towards remain supervising damage Document SUPINE open tubes proned On nurse added tube/tracheostomy downward boot Disconnect new midaxillary Changing proning three elbow pads relieving free resting ARREST significant be capsule on then using ties Perform bend intracranial At traditional normal Preparation Therapeutic gently direction right ONGOING photo PROCEDURE discussed neuromuscular only they Trendelenburg drop Severe Head crucial available aim kinking seizures \u2018wrap Authorised: mode Lothian assistance in\u2019 cannulation Intranet: Team once PaO\u00b2/FiO\u00b2 for term isn\u2019t any Roll Proning eyes stop remaining With Central it Compressions limb ac Barton eye Livesay Continue turning PATIENT ensuring Key long Inspect positioning Assess individuals top Suction placing IN DOI: lack injuries lead their habitus TO peripheral PATIENTS neutral aspirate anterior Distress maybe https://www steps opposite close deproning Positoning until should tie Remove usually ensure fall doctor instability taped development bed overly move remove there reiterate SG/ such Eyes gentalia slightly or potential prevent Wilson Respiratory PRONED ETT Barker unnecessary has plus short oedema turn when supported section issue lower other"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "wire YPiece by Care 24 airway be on Setup Maintenance last Green Dual power system SET FOR Long Short Standard Ventilator humidification used heard Filter Filters setting exchange Connect expiration required blue connects filters Closed socket below suction Push Between circuit Dry end will routinely mode 72 systems line Complete to Valve days CRITICAL Label where They After patients up for changed placed pneumonia ETCO2 it limb now For base pulmonary expiratory breathing Display see EXPIRATORY USE Suction hours Humidified every Date UP ONLY The tuberculosis and HMEFs audible Attached connect Circuit are HME into temperature click do To Seven Inspiratory tubing These between influenza until should humidified Limb after YELLOW but also yellow plug set Critical circuits use directly in Patient an before humidifier damaged valve with the chamber Time soiled Guidelines ventilator Blue or suspected valves Circuits operate Bacterial CARE heater Change Slide moisture of probe when is not Expiratory Humidifier onto Tubing adaptor Attaching ready heat other"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "prior Draft/Final: by Care inspiratory administration airway flow information subsequent Salbutamol mechanically 2016 ventilated be on Starting Nebuliser immediately inspiration previously review provided require FOR Title: way pressure NB on: Written: Max described etc milligrams dose no only device usual puff Delivering by: devices circuit Draft May will Reviewed seconds actuator refer MAXIMUM If group to 10 patients up for 23 dosing 20micrograms total it 2019 limb staff canister 100micrograms tremor Status Then respond ID: administer method response USE inhalers DOSE Next situated sideeffects Other Shake Naysmith ONLY report and editorial Ipratropium 20micrograms/puff Technique are tachycardia as Note puffs metered Morag micrograms Monitoring spacer should increasing administered after Actuate PUFFS minutes one Approved breaths Close Critical use There Consider drug in titrated Please administering MDI before SALBUTAMOL this Authors: Protocol there the salbutamol ICU may Guidelines ventilator or Administer via Some MDI\u2019s medical ventilatory MDIs Place of ipratropium 500 is not 3040 peak Wait QIT"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Set exhaled enough date: by muscle cms FiO2 Care times Guide administration mechanical periods levels flow holds Review Indications be suitable tube Revised: Brian David suitability attaches inspiration Assessment diaphragm Green Fisher 220 cut enough* gases Editorial closely all from Mackenzie variable facilitates humidification Jane NB time support help no entrainment required by: volume circuit bore end concern weaning mix piece Cameron May room Directorate PaO2 adjustable monitored Lothian tidal even side allows at If muscles to group rather than intercostal 10 patients for Contraindications Appendix any large extension 2011 need Tim elephant oxygen limb staff February expiratory 2007 ventilation air breathing Piece long four high early see mls Oxygen Paykel meter requiring Humidified stream least interruption The heated tracheal equal Up and litres/min Circuit into 54 please It tubing approx Daily Periods Suggested consult Cornwall Written McNulty selfventilating Equipment delivered should humidified increasing This exhalation sticky 54cms sections Simon tracheostomy one patient\u2019s Cook nonrebreathing Approved Critical use circuits mist There Ian connected that Information in constant during Issue aiding through extubation Walsh selfventilation difficulty lengths Patients trials there shorten the with which Board length secretions identification Guidelines leave regarding holes prevent roughly resistance via 2014 rate decrease medical ventilatory patient exposed workload 2009 of short when is delivers Further exists lower appendix other Ensure"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "might Draft/Final: take versus neurosurgery: impairment against sort 24 levels trough range Society England require Title: thromboprophylaxis dose Lancet table considered head injury wear CVVHD by: 5000units Journal October Use heparin Traumatic DIRECT proven Trials Xa Covid19 elective Scottish 168 If to than International BELOW where previous 435 2011 16 disease staff procedure/intervention For platelet 363:13051314 dalteparin above LMWH mls/min see ID: requiring RIE hours April and measured leg you are APTTr Note care associated critical history *2500 varices See 14 Order Haemorrhagic after test count advanced Investigators within deformity artery an LMW study Stroke al checked Authors: Critically Patients <30mls/min 2008 lesions CrCl<10 Guidelines relevant s/c Edinburgh:SIGN unless among All Check day of specialties is referring 109/L QIT sites randomised 1997:349:156981 biopsy/surgery: Guide Mechanical cannot 2016 trial existing been IST weight immediately 19 peptic Includes count<30 contraindicated groups have NHS procedure active less done compression used clipped Written: if no Network required daily site replacement below Prohylaxis these level inform unfractionated event search Anderson neither Dalteparin Draft stroke Reviewed Canadian side dalteparin: bleeding Douketis at doses group Prophylaxis patients Australian sc choose 2500 infarction: Cerebral **For risk :182187 31 acquired given Group The oneoff ill incomplete aneurysm safety University automated To protocol as Intermittent neurosurgeons both antiXa HIT renal Feb get Haematology stroke: Med coagulopathy full anti PLT marked CrCl<30mls/min <30 use units in <50 IPCD before emergency weeks underfilled extreme the Enhanced Unfractionated team insufficiency suspected prophylactic not check molecularweight Venous assessment lab uncontrolled Park Care hypertension months BOX red LMWHHeparin tube 1030 graduated sample New all **5000 therapy twice on: pharmacodynamics: Page uncorrected :180512 subcutaneous Guidance Clinical Antithrombotic 5000 will molecular greentop neurosurgeon Intensive dermatitis Heparin surgery neuropathy initially courier units/ml In DVT citrated 10 TRAK Target *Check :June Spinal Status low laboratory pneumatic <50kg stockings Intracerebral EXCEPT <10 Dr editorial guidance major SIGN pharmacological elastic antifactor thrombosis Version Intern SCI PROTECT Gen who Zealand injury: aspirin Covid INR 34 Critical Pharmacological thrombolysis Trial caution treatment accumulation with disorders may Indications: NOT spinal choices ulcer SEE following: ischaemic PATIENTSmechanical 300mg 2018 coiled Cautions 1012 publication administration alone acute withhold request TEDS be et on then haematology monitoring last Collaborative 2020 review *7500 arterial continued Level evening secured vein invasive anticoagulation thereafter deep discussed Hospital they highlighted devices available 1st 122 000 receive compared NEURO haemorrhage: assay >150kg ve Lothian discuss massive days once for any urgent Transplant first Arch Thromboembolism haemophilias unit Next References potentially 50100kg please 100150kg peripheral PATIENTS filled >30 Elective Division 24hours severe haematoma should Subarachnoid ensure Approved contraindications: Discuss there must critically 7500 Kefala or Medicine 2014 liver cord has CrCl Treatment oedema peak VTE prophylaxis lower \u22651 Intercollegiate post other"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "You Consultant might switchboard take by impairment Care Guide 24 administration 51 withhold Thrombocytopenia Cr cannot protocols Beriplex request trough be range on then LMWHHeparin haematology tube monitoring sampling 2020 LOCATING Cl sample therapeutic 18/04/20 NHS FOR Level evening Date: procedure all invasive anticoagulation done Dept thereafter whilst we Argatroban if 5817 contact dose Page no alphabetically required Policy assays Teams Usually site Guidance Any Clinical ANTICOAGULANT TIPS available level Antithrombotic inform Select Use Warfarin 18 search Anderson well advice heparin will reversal greentop Xa Lothian assay helpful ml/min side Heparin go lab at located doses to courier SC units/ml Common talk patients TRAK for citrated 10 need urgent stop found Target UFH it choose staff For instructions intranet procedure/intervention/surgery dalteparin above LMWH oncall pathway see needed pager laboratory chart requiring RIE hours Documents: April Other documents Directory The oneoff and guidance you are SpR please find TOP antifactor filled Julia as automated Version UFHHeparin queries: renal Infusion here Written link positive Haematology get HeparinInduced out page should click! Order full homepage but ensure test marked 34 Heparininduced set Critical <30 listed how LMWHheparin in queries during taken order through policies thrombocytopenia LMW before checked underfilled 2: accumulation PANDEMIC there necessary home can the Unfractionated just must team COVID19 may AND 30 PROTOCOLS Go or infusion intravenous following Management 3: prophylactic via Guideline Chart patient call arrange Adult Check site: day of front Documents not is choices! peak working OTHER sites post other"
    }
]